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Summary
Macrophages are cells of the innate immune system and play essential roles in the regula-
tion of inflammatory responses in all parts of the body. Furthermore, macrophages are also
involved in different tissue–specific functions and maintenance of the tissue homeostasis.
These functions are controlled by the epigenetic landscape, consisting of promoters and
enhancers that together regulate gene expression. Enhancers are stretches of regulatory
genomic sequences in the non–coding regions of the genome that can be bound by lineage–
determining transcription factors. These enhancers can loop in three–dimensional space
to be in close proximity to promoters and contribute to the regulation of gene expres-
sion. Previous studies suggest that there are about 1 million enhancers in the mammalian
genome, of which only about 30,000 – 40,000 are selected in each specific cell type. This
dissertation studies the regulation of the epigenetic landscape of murine macrophages by
utilizing different tissue macrophages, different complex and simple stimuli, as well as nat-
ural genetic variation as a mutagenesis screen.
The overarching research question of this dissertation is to understand how the enhancer
landscape in macrophages gets selected and regulated in order to control gene expression.
In more detail, the main questions answered in this dissertation are: What are the epi-
genetic mechanisms that are responsible for tissue–specific functions? How do complex
stimuli change the epigenetic landscape of macrophages in comparison to simple stimuli?
How does natural genetic variation influence the epigenetic landscape and gene expression
in murine macrophages?
In Chapter 1 (Gosselin, D., Link, V. M., Romanoski, C. E. et al. (2014) appeared in Cell)
we investigate the influence of the tissue environment on the epigenetic landscape in mouse
macrophages. We compare macrophages residing in the brain (microglia) with macrophages
from the peritoneal cavity by measuring mRNA expression, as well as enhancer activation
(H3K4me2, H3K27ac, and PU.1). We find highly expressed genes unique to one popula-
tion of macrophages, which correlates well with the activity signature at enhancers in the
corresponding cells. By analyzing the enhancer landscape, we find that the macrophage
lineage–determining transcription factor PU.1 plays a key role in establishing the enhancer
repertoire, creating a common, macrophage–specific enhancer landscape. Furthermore, ex-
pression of tissue–specific transcription factors in collaboration with PU.1 drives a subset
of tissue–specific enhancers regulating the differences in gene expression between different
tissue–specific macrophage populations.
In Chapter 2 (Eichenfield, D. Z., Troutman, D. T., Link, V. M. et al. (2016) appeared
in eLife) we investigate the effect of complex stimuli onto the epigenetic landscape in
macrophages on the example of wounds. Stimulation of macrophages with homogenated
tissue to mimic a wound environment shows a unique pattern of gene expression, which
is different from gene expression patterns found after single stimuli (e.g. LPS, IL–4 etc.).
To gain insight into the regulation of the enhancer landscape after complex stimuli, we
compare the epigenome after single stimuli and tissue homogenate and find substantial
differences in enhancer selection and activation. We find that the complex damage signal
promotes co–localization of several signal–dependent transcription factors to enhancers not
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observed under the single stimuli. Therefore, more complex polarizations of cells lead to
new combinations of signal–dependent transcription factors and an epigenetic landscape
different than observed with single stimuli.
In Chapter 3 (Link et al. (2018b) appeared in bioRxiv) MARGE (Mutation Analysis for
Regulatory Genomic Elements) is presented, a new method to analyze the effect of natural
genetic variation on transcription factor binding and open chromatin. MARGE provides a
suite of software tools that integrates genome–wide genetic variation data (including inser-
tions and deletions) with epigenetic data. It provides software to create custom genomes
based on a reference genome and variation data, to shift coordinates between different
custom genomes, as well as do downstream ChIP–seq analysis. The main algorithm in
MARGE analyzes if mutations in transcription factor binding motifs are significantly af-
fecting transcription factor binding or open chromatin. MARGE provides a pairwise com-
parison, in which the significance of each motif is calculated with a student’s t–test. It
compares the transcription factor binding distribution of each mutated motif in individ-
ual one with the distribution in individual two. For a more general approach that allows
comparisons of many individuals MARGE implements a linear mixed model, modeling
transcription factor binding with fixed effects motif existence and random effects locus and
genotype. The development of this software allows in depth analysis of genetic variation
data in combination with epigenetic data.
In Chapter 4 (Link et al. (2018a) under review in Cell) we analyze the effect of natural
genetic variation in five diverse strains of mice on the epigenetic landscape. We choose
three well–known laboratory inbred mouse strains, as well as two very diverse wild–derived
inbred mouse strains. We investigate the enhancer landscape, open chromatin and binding
of the most important macrophage lineage–determining transcription factors. We observe
substantial strain–specific differences in gene expression of which the majority can be ex-
plained by cis–regulatory elements. Application of MARGE onto the transcription factor
binding data reveals roles of about 100 transcription factors in establishing the enhancer
repertoire in macrophages. Unexpectedly, we find that a substantial fraction of strain–
specific DNA binding of transcription factors cannot be explained by local mutations.
Investigation of this phenomenon in more detail shows highly interconnected clusters of
transcription factors that reside within topologically associating domains. These intercon-
nected clusters are highly correlated with activation of enhancers and gene expression of
the nearest gene, uncovering a new layer of transcriptional regulation.
In Chapter 5, I briefly discuss additional contributions to the field of macrophage biology
I made during my Ph.D. Namely, I was involved in two additional projects. In the first
project (Pirzgalska et al. (2017) appeared in Nature Medicine) we identify sympathetic
neuron–associated macrophages (SAM) that import and degrade norepinephrine via ex-
pression of solute carrier family 6 member 2 (Slc6a2) and monoamine oxidase A (MAOa).
We demonstrate that SAM–mediated clearance of extracellular norepinephrine contributes
to obesity and we show the relevance of this finding in humans, as we found that SAMs
are also present in human tissues. The second project (Oishi et al. (2017) appeared in
Cell Metabolism) studies the role of nuclear receptors (LXR and SREBP) in induction of
anti–inflammatory fatty acids. We find that right after stimulation of TLR4 (during the
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induction phase) NF–kB dependent genes are upregulated, whereas LXR dependent genes
are repressed. This leads to activation of SREBP1, which drives the expression of enzymes
involved in mono–unsaturated and omega–3 polyunsaturated fatty acid biosynthesis. The
fatty acids produced by these enzymes repress inflammatory genes under the control of
NF–kB and the inflammatory signal gets resolved.
In summary, my studies used a combination of experimental and computational approaches
to investigate the effect of tissue–environment and factors, complex stimuli and natural ge-
netic variation on the epigenetic landscape in macrophages. These studies broadened our
understanding of the regulation of gene expression by the epigenetic landscape substan-
tially. We showed that there is a core set of lineage–determining transcription factors in
macrophages, which require diverse signal–dependent transcription factors to establish the
enhancer landscape. Not only did we show that transcription factors regulated by the local
environment play essential roles in establishing and maintaining tissue–specific functions
of macrophages, but also that more complex stimuli can re–direct and combine signal–
dependent transcription factors to establish new enhancers, not observed under the single
stimuli. Using natural genetic variation as a mutagenesis screen allowed us to estimate the
involvement of about 100 transcription factors in shaping the enhancer landscape, as well
as to uncover a new layer of transcription regulation due to highly interconnected clusters
of concordantly bound transcription factors.
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General Introduction
Macrophages
Macrophages are important cells in the innate immune system where they play an im-
portant role in responding to infection, inflammation and tissue injury (Geissmann et al.
(2010), Wynn et al. (2013) Lucas et al. (2010)). Macrophages can be found in every tissue
of the body where they perform their general immune functions, as well as contribute to
maintaining homeostasis of the host tissue (Wynn et al. (2013), Gordon et al. (2014)). One
of the first described in vivo functions of macrophages was surfactant recycling by lung
alveolar macrophages (Wright (1990)). Other known examples of tissue–specific functions
of macrophages include bone resorption and remodeling by osteoclasts (Teitelbaum (2000))
and control of insulin sensitivity and adaptive thermogenesis in adipose tissue (Odegaard
et al. (2007), Qiu et al. (2014)). Furthermore, it is known that microglia (macrophages
in the brain) are involved in neuronal synaptic pruning (Paolicelli et al. (2011)). These
functions are essential for the development and maintenance of healthy tissue. However,
dysregulation of macrophages can lead to chronic inflammatory diseases. A prominent ex-
ample is the important role of macrophages in the development of atherosclerosis (Moore
and Tabas (2011), Pollard (2004)). Dysregulation of macrophages in cancer can lead to
tumor growth and metastasis (Noy and Pollard (2014)). This makes macrophages an inter-
esting cell type to target for therapeutic purposes, which requires a detailed understanding
of the mechanisms by which macrophage phenotypes are controlled. This, however, re-
mains a largely unmet goal so far.
Macrophages have been studied for a long time with special focus on their response to var-
ious ligands in vitro (Takeuchi and Akira (2010)). This led to the characterization of two
different polarization programs. Macrophages can be classically activated with a proinflam-
matory phenotype (M1 macrophages) or alternately activated and show anti–inflammatory
traits (M2 macrophages) (Gorden (2003), Mosser and Edwards (2008)). M1 polarization
can be mainly achieved by stimulation of macrophages with lipopolysaccharide (LPS), a
component of Gram–negative bacteria. Stimulation with LPS leads to activation of toll–like
receptor (TLR)4, which induces members of the nuclear factor kappa-light-chain-enhancer
of activated B cells (NF–kB) complex and activator protein 1 (AP–1) (Figure 1) (Medzhitov
and Horng (2009), Smale (2012)). M1 phenotypes can also be observed after stimulation of
cytokine receptors through tumor necrosis factor (TNF) or interleukin (IL)–1/IL–6, as well
as activation of signal transducer and activator of transcription (STAT)1 after exposure to
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interferon gamma (IFNγ) and activation of its receptor (Liu et al. (2014)). Activation of
any of these factors induces hundreds of pro–inflammatory genes in macrophages leading to
the initiation of an adaptive macrophage immune response. In order to activate the alter-
nate M2 phenotype, macrophages can be treated with IL–4, which in turn induces STAT6
and interferon regulatory factor (IRF)4. These transcription factors activate a gene expres-
sion profile against parasitic infection (Gorden (2003), Takeda and Akira (2000)) (Figure
1). Furthermore, free fatty acids can induce peroxisome proliferator-activated receptor
gamma (PPARγ), which also drives M2 polarization.
Figure 1: Pathways that lead to classically activated/proinflammatory M1 macrophages
(upper part – red), as well as to the alternately activated/anti–inflammatory M2
macrophage phenotype (bottom part – blue). Figure is taken from Liu et al. (2014).
Enhancers
Much effort has been put into characterizing enhancer–like regions in different cell types
and organisms. There are about one million enhancers, of which about 30,000 to 40,000
are activated in any specific cell type. Enhancers were initially identified as discreet re-
gions of deoxyribonucleic acid (DNA) that increase transcriptional activity of promoters
from a distance (Banerji et al. (1981)). DNA is not openly accessible in vivo but as-
sembled in chromatin. DNA is wrapped around proteins, called histones. These histones
build octamers (consisting of the subunits H2A, H2B, H3, and H4) and can be modi-
fied post–translationally. The assembly of the histone subunits including DNA is called
nucleosome, which can be further packed into chromatin. Enhancer elements are estab-
lished by the binding of sequence–specific transcription factors (TFs), which compete with
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nucleosomes and push them to the side to generate nucleosome–free regions. Several ex-
perimental methods have been developed to measure open chromatin (see experimental
methods). Most TFs expressed in each cell type are not able to recognize their DNA–
binding motifs in closed chromatin. However, so–called pioneer factors (e.g. PU.1 in
macrophages) possess this unique ability and are therefore able to establish enhancers.
Systematic analysis of chromatin led to the recognition that enhancers are marked by
high abundance of mono– and dimethylation at histone H3 lysine 4 and concomitantly low
levels of trimethylation (i.e., H3K4me1high/H3K4me2high/H3K4me3low) (Heintzman et al.
(2007)). Promoters, on the other hand, display an opposite molecular phenotype (i.e.,
H3K4me1low/H3K4me2high/H3K4me3high).
Enhancers can be marked by different histone modifications, which are used to catego-
rize them as primed, poised or active (Heintzman et al. (2007), Barski et al. (2007),
Ernst et al. (2011)). Primed enhancers are usually marked by H3K4me1 or H3K4me2
(He et al. (2010)) without any additional active marks. Poised enhancers can be marked
with H3K4me1 or H3K4me2, but they are additionally marked with the repressive mark
H3K27me3 (trimethylation of histone H3 on lysine 27), which is mutually exclusive with
acetylation on the same residue (Rada-Iglesias et al. (2011)). On the other hand, active
enhancers are marked with acetylation of histone H3 lysine 27 (H3K27ac) additionally to
H3K4me1 and H3K4me2 (Rada-Iglesias et al. (2011), Creyghton et al. (2010)). Further-
more, studies showed that active enhancers are often actively transcribed by RNA poly-
merase II (Pol II), giving rise to enhancer RNAs (eRNAs) (Ernst et al. (2011), Hah et al.
(2011), Kaikkonen et al. (2013), Step et al. (2014)). All or a combination of these features
can be used to identify enhancers in different cells and tissues by chromatin immunoprecip-
itation coupled to massively parallel sequencing (ChIP–seq) and other sequencing–based
methods. Using these approaches, the mouse and human genomes have been estimated to
contain several hundred thousand enhancers, the great majority of which are present in
cell–restricted patterns (ENCODE Project Consortium (2012)). Some studies have demon-
strated that chromatin looping is facilitated by eRNAs (Schaukowitch et al. (2014), Hsieh
et al. (2014), Li et al. (2013b)). Consistent with this, changes in eRNA levels correlate
with changes in target gene expression (Li et al. (2013b), Kaikkonen et al. (2013), Bonn
et al. (2012), Kieffer-Kwon et al. (2013), Wang et al. (2011)).
The overall function of enhancer transcription, as well as the regulatory importance of eR-
NAs remain mostly elusive. Some studies in macrophages suggest potential roles in at least
some regional control of gene expression, however, the overall genome–wide significance is
still under debate. First, enhancer transcription at newly selected enhancers was linked to
the deposition of H3K4me1/H3K4me2 at these locations (Kaikkonen et al. (2013), Ostuni
et al. (2013)). Therefore, enhancer transcription might be potentially important in initiat-
ing and/or maintaining the histone signature characteristic of enhancers. Second, at least
some eRNAs appear to contribute to enhancer function. For example REV–ERB nuclear
receptors actively repress gene transcription in mouse macrophages by inhibiting eRNA
transcription of target enhancers (Lam et al. (2013)). In particular, binding of REV–ERB
at enhancers regulating matrix metallopeptidase 9 (Mmp9) and CX3C chemokine receptor
1 (Cx3cr1) gene expression represses enhancer activity and eRNA transcription, causing
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low levels of Mmp9 and Cx3cr1 messenger RNAs (mRNAs). This likely occurs through
the recruitment of the NCoR–HDAC3 repressor complex (Zamir et al. (1996), Yin, L. and
Lazar, M. A. (2005)). In the absence of REV–ERB factors, these enhances are de–repressed
and transcribe high levels of eRNAs, which translates into aberrant increase of Mmp9 and
Cx3cr1 gene expression.
More recently, the concept of stretch or super enhancers (SEs) was introduced (Hnisz et al.
(2013), Whyte et al. (2013)). SEs are defined as large genomic regions, (about one order
of magnitude larger than traditional enhancers) with an unusually strong enrichment of
active histone marks (e.g. H3K27ac), as well as binding of transcriptional coactivators.
Most cells show between 300 and 800 SEs, many of which are associated with genes encod-
ing cell type–specific TFs and other genes important for the identity and function of that
particular cell (Hnisz et al. (2013), Adam et al. (2015)).
Several studies estimate that there are between 35,000 and 45,000 primed and active en-
hancers in mouse macrophages (Ghisletti et al. (2010), Heinz et al. (2010)). Therefore, en-
hancers substantially outnumber the 12,000 active promoters in these cells. De-novo motif
analysis showed that macrophage enhancers are enriched for motifs that are recognized by
TFs relevant to macrophage ontogeny and functions. For example, one of the most enriched
binding motifs is an ETS motif, which is recognized by PU.1. Furthermore, experimen-
tally obtained PU.1 binding sites show a strong enrichment for H3K4me1high/H3K4me3low,
a combination of marks commonly found on primed and active enhancers. Motifs associ-
ated with CCAAT-enhancer-binding protein (C/EBP), AP–1, IRF, NF–kB, and liver X
receptor (LXR) TFs are also prevalent within enhancers in macrophages (Barish et al.
(2010), Ghisletti et al. (2010), Heinz et al. (2010)).
A collaborative/hierarchical model for enhancer selection and ac-
tivation
To select enhancers in closed chromatin the binding of so–called pioneer factors is required.
A subset of these factors functions as lineage–determining transcription factors (LDTFs)
(McPherson et al. (1993), Bossard and Zaret (1998), Lee et al. (2005), Heinz et al. (2010)).
Various examples of LDTFs include PU.1 in macrophages (Heinz et al. (2010)), forkhead
box protein A1 (FOXA1) in breast cancer cells (Lupien et al. (2008)), octamer transcription
factor (OCT)–4 and sex determining region Y–box (SOX)2 in cell reprogramming (Soufi
et al. (2012)), and paired box protein (PAX)7 in reprogramming a corticotrope cell line into
a melanotrope–like cell line (Budry et al. (2012)). A defining feature of pioneering TFs is
their ability to recognize and bind their DNA recognition motifs in closed chromatin, thus
effectively competing with nucleosomes to create nucleosome–free regions. TF binding is
then followed by modifications of the histone tails of the enhancer–associated nucleosomes
located in the vicinity of the nucleosome–free regions.
All TFs recognize short DNA sequences (6-12 bp) and their motifs show varying levels
of degeneracy (D’haeseleer (2006)). Binding of TF can be measured by ChIP–seq experi-
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ments (Johnson et al. (2007)). Analyses of a wide variety of different TFs have shown that
only a small subset of all possible binding sites is occupied by each TF (Carr and Biggin
(1999), Iyer et al. (2001), Yang et al. (2006)) and that the binding sites for the same factor
can vary between cell types. For example, given the size of the mouse genome, there are
potentially between 650,000 and 1.4 million sites where PU.1 can bind DNA (Heinz et al.
(2013), Barozzi et al. (2014)), yet only about up to 45,000 of those are selected in differ-
entiated macrophages (Heinz et al. (2010)).
There are likely a multitude of factors contributing to these restricted, yet functional, bind-
ing events of LDTFs. Among these factors, the collaborative activity between LDTFs and
other TFs appear to be fundamental to a significant proportion of actual LDTF binding
(collaborative enhancer selection) (Figure 2A). For example, the TF PU.1 is an impor-
tant LDTF in macrophages and B cells. ChIP–seq experiments showed that macrophage–
specific enhancers are enriched for binding motifs of PU.1 and macrophage–specific col-
laborative factors C/EBP and AP–1, whereas in B cells enhancers are enriched for PU.1
and B cell–specific factors E2A, early B–cell factor 1 (EBF1), and OCT–2 (Ghisletti et al.
(2010), Heinz et al. (2010)).
Further support of the model was gathered by analyzing TF binding in different strains
of mice. The natural genetic variation between mouse strains can be used to study selec-
tion of actual LDTF binding in macrophages (Heinz et al. (2013)). These studies showed
that mutations in a C/EBP consensus motif not only eliminate C/EBP binding, but also
abrogate the neighboring PU.1 binding. Importantly, mutations also affect associated en-
hancer and decrease abundance of H3K4me2 and H3K27ac marks at mutated enhancers.
Using human white adipose tissue cells from several different individual, it was possible
to show that mutations in C/EBP motifs disrupt nearby PPARγ binding (Soccio et al.
(2015)). Many cells possess the ability to quickly adapt their gene expression program to
changes in the environment. Further, the same signal can lead to the induction of the same
signal–dependent transcription factor (SDTF) but different transcriptional outcomes and
enhancer landscapes in different cell types. Studies showed that in more than 60%, SDTFs
bind to enhancers already established by LDTFs (hierarchical enhancer selection), explain-
ing how the same broadly expressed SDTF can exert cell–specific functions and responses
(Figure 2B). Investigation of the role of natural genetic variation between inbreed mouse
strains on binding of the NF–kB subunit p65, showed that 34% of mouse strain–specific
p65 binding was due to mutations in LDTF motifs, whereas only 9% was due to mutations
in the p65 binding motif itself (Heinz et al. (2013)).
The exact biochemical mechanisms involved in the collaborative binding of LDTFs is not
well understood. The motifs of the collaborative factors are in close proximity to each
other in sequence (<100 bp), but most of these are not found at a distance of < 20 bp
(Kazemian et al. (2013)). This implies a collaborative model that is not strictly dependent
on protein–protein interactions and allows for a limited flexibility in spacing requirements.
Consistent with this flexibility, the precise genomic location of cell–specific enhancers rel-
ative to target genes are largely not conserved between mice and humans (Cheng, Y., Ma,
Z. et al. (2014)), however, the cell type–specific combinations of LDTF motifs appear to be
conserved between species (Stergachis et al. (2014)). This suggests that while the spacing
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Figure 2: Collaborative/hierarchical model for enhancer selection and activation:
A Macrophage lineage–determining transcription factors (LDTFs) PU.1 and C/EBP bind
collaboratively to regions of closed chromatin where both of their binding motifs are
present. Upon binding they open the chromatin and mono– and di–methyl groups are
added to histone 3 lysine 4 (H3K4me1/H3K4me2) creating a primed enhancer (collab-
orative enhancer selection). B After macrophages are stimulated with LSP, the signal–
dependent transcription factor NF–kB gets transported into the nucleus and can bind to
the already established enhancers, thus activating them. This leads to acetylation of hi-
stone 3 lysine 27 (H3K27ac) and the production of enhancer RNA (eRNA) (hierarchical
enhancer selection). Figure adapted from Link et al. (2015).
has changed since mice and humans diverged, the meaningful combinations of TFs that
drive specific functions have largely remained the same. This is confirmed by experiments
with transgenes between species. For example, when the human globin locus is inserted
in mice, it is expressed with the same fetal–to–adult switch as it is in humans (McConnell
et al. (2011), Peterson et al. (1993)).
The collaborative/hierarchical model addresses three key issues with regard to enhancer
selection. First, it explains how relatively low numbers of binding sites are occupied by a
factor in comparison to all potential binding sites. In addition, it provides a molecular and
epigenetic mechanism whereby the same LDTF can set up very different enhancer reper-
toires in different cell types, as is the case of PU.1 in macrophages and B cells. Finally it
explains how broadly expressed SDTF can result in different cell–specific transcriptional
outcomes.
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Experimental Methods
This dissertation took advantage of many next–generation sequencing (NGS) methods.
This section gives a short introduction into the different techniques used and their advan-
tages and disadvantages, as well as the most common analysis strategies.
RNA–seq and nascent transcription
Measuring the transcriptome of a cell has been a long–standing goal in the research commu-
nity. It is an essential step in order to understand cell function, development and disease.
The earliest methods to quantify ribonucleic acid (RNA) in a large–scale approach go back
to the 1990s. The expressed sequence tag (EST) method (Adams et al. (1991)) measures
gene expression by partially sequencing complementary DNA (cDNA) clones in order to
detect the sequence, as well as the abundance of the transcripts. However, this method is
based on Sanger–sequencing and therefore relatively low throughput, as well as very ex-
pensive. Subsequentially, tag–based methods were developed that cut down on sequencing
cost by only sequencing small tags of the mRNA (e.g. serial analysis of gene expression
(SAGE) (Velculescu et al. (1995)), massively parallel signature sequencing (MPSS) (Bren-
ner et al. (2000)), and cap analysis of gene expression (CAGE) (Kodzius et al. (2006))).
Although cheaper than the EST assay, many of the tag–based methods were still based
on Sanger–sequencing resulting in low throughput. Furthermore, many of the tags cre-
ated in these methods could not be mapped to the reference genome. Another approach
was the usage of hybridization methods in which known oligonucleotides complementary
to known mRNAs were fluorescently labeled and attached to a microarray (Schena et al.
(1995), Lockhart et al. (1996)). After adding mRNA to the array, oligonucleotides that
bound to the microarray started to fluorescence and the presence of mRNAs could be
detected. These methods are high throughput and inexpensive, however they require pre-
vious knowledge of existing transcripts and produce a high level of background noise due
to cross–hybridization. Furthermore, these assays are not quantitative and comparison of
gene expression levels between different microarrays requires sophisticated normalization
methods.
The development of RNA sequencing (RNA–seq) (Nagalakshmi et al. (2008), Ozsolak et al.
(2009)) allowed to directly sequence mRNA molecules in a high throughput manner, sub-
stantially reducing the amount of background noise, as well as eliminating the need of a
priori knowledge of the transcriptome. Furthermore, RNA–seq provides a quantitative
measurement of mRNA expression, which has been demonstrated by using spike–in RNA
controls (Mortazavi et al. (2008)). Due to the higher stability of DNA in comparison to
RNA, as well as the limitations provided by most high–throughput sequencing machines,
mRNA is usually converted to cDNA. In order to eliminate ribosomal RNA (rRNA) (which
makes up approximately 80% of total RNA (Lodish et al. (2002))), two different methods
are commonly used (Figure 3A and B). For eukaryotic organisms, enrichment of polyadeny-
lated RNA is one of the most commonly used methods. Almost all protein–coding RNAs,
as well as many long non–coding RNAs contain a poly(A) tail, which can be easily targeted
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by oligo–dT molecules that are attached to magnetic beads (Figure 3A). Another approach
is the removal of rRNA by hybridizing cDNA probes and subsequentially digestion of the
DNA–RNA hybrid with ribonuclease H (RNase H) (Figure 3B).
Figure 3: Overview of RNA–seq and GRO–seq method. A polyA RNA–seq: genes contain-
ing a polyA tail are pulled down using oligo–dT molecules. After library preparation and
sequencing, data can be analyzed. B Ribo–zero RNA–seq: ribosomal RNA (rRNA) is hy-
bridized with specific probes and subsequentially digested, removing all ribosomal RNA in
the total RNA. After library preparation and sequencing, data can be analyzed. C GRO–
seq: transcription is temporarily interrupted and labeled nucleotides are added (run–on)
which can subsequentially be pulled down. Transcription is started again and biotin la-
beled RNAs are pulled down, measuring transcription of polymerase directly. After library
preparation and sequencing, data can be analyzed. D. Example of RNA–seq and GRO–seq
data in the mouse genome. RNA–seq signal is only observed over exons, whereas GRO–seq
signal can be observed over the whole gene body. Furthermore, bidirectional transcription
can be seen in GRO–seq data.
Measurement of the transcriptome gives valuable information about the expressed mRNA,
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but does not give any information about pre–spliced RNAs, a more direct read–out of poly-
merase activity. Furthermore, many active enhancers produce eRNAs, which can not be
measured by RNA–seq due to their short half–life time. Therefore, more sensitive methods
were developed, that measure nascent transcription (e.g. global run-on sequencing (GRO–
seq) (Figure 3C) (Core et al. (2010)) and transient transcriptome sequencing (TT—seq)
(Schwalb et al. (2016))). Instead of measuring mRNA, these methods measure nascent
transcription, convert RNA to cDNA and sequence these transcripts.
To get equal sequence coverage over the complete gene, a fragmentation step is necessary
(e.g. RNA fragmentation with hydrolysis or DNA fragmentation with deoxyribonuclease
I (DNase I) treatment or sonication). Each method introduces different biases that need
to be accounted for in the analysis step. After library preparation one common step is
to size–select for a certain fragment size to eliminate fragments that are too short (often
times micro RNAs), as well as very long fragments.
In order to analyze the sequenced libraries, the transcripts are either mapped to an already
known reference genome or assembled into contigs for unknown reference genomes. Short
reads, as well as highly repetitive reads provide great challenges for the mapping, whereas
longer reads or unique sequences can be mapped relatively easily. Most mapping software
(e.g. bowtie2 (Langmead and Salzberg (2012)), TopHat (Trapnell et al. (2009)), bwa (Li
and Durbin (2009)) or STAR (Dobin et al. (2013))) allow a certain number of mismatches
to offset potential sequencing errors. However, a great number of short polymorphisms, as
well as very long polymorphisms provide challenges for the mapping tools and might re-
quire a more precise annotation of the genome, deeper sequencing, or longer read lengths.
RNA–seq data can be used for a variety of different applications (e.g. examination of
splice junctions or alternative splicing events (Wang et al. (2008), Sultan et al. (2008),
Mortazavi et al. (2008), Cloonan et al. (2008), Trapnell et al. (2010), Griffith et al. (2010),
Colla et al. (2015)), detection of gene fusion (Maher et al. (2009), Asmann et al. (2012),
Velusamy et al. (2013), Qin et al. (2015)), as well as the description of novel transcripts
(Nagalakshmi et al. (2008), Mortazavi et al. (2008), Cloonan et al. (2008), Morin et al.
(2008), Lister et al. (2008), Wilhelm et al. (2008)). The most common application to date
is the quantification of differently expressed genes in different experiments (Wilhelm et al.
(2008), Mortazavi et al. (2008), Lister et al. (2008), Cloonan et al. (2008)).
RNA–seq methods only cover exonic reads, as mRNA is already spliced. GRO–seq however
covers the whole gene body, as it measures active transcription pre–splicing. Additionally,
GRO–seq also show bidirectional transcription, often a sign for an active enhancer (Figure
3D).
ChIP–seq and ATAC–seq
Studying epigenetic regulation requires information about the loci of TF binding, histone
modifications and open chromatin. One of the earliest methods developed for this is chro-
matin immunoprecipitation coupled with microarrays (ChIP–chip) (Iyer et al. (2001), Ren
et al. (2000)). Following the development of cheap high–throughput sequencing techniques
chromatin immunoprecipitation coupled to massively parallel sequencing (ChIP–seq) was
10 Introduction
developed (Johnson et al. (2007), Robertson et al. (2007), Barski et al. (2007)). ChIP–seq
is one the most commonly used method to detect TF binding, as well as histone modifi-
cations, and has led to many important discoveries in the last years (e.g. Deardorff et al.
(2012), Schaub et al. (2012), Mikkelsen et al. (2010), Ernst et al. (2011), Gerstein et al.
(2010), modENCODE et al. (2010)).
In order to measure TF binding or histone modifications, chromatin is cross–linked and
sonicated. The TF (Figure 4A) or histone modification (Figure 4B) is subsequentially
immunoprecipitated with an appropriate antibody. It is highly advised to keep some frag-
mented chromatin without pull–down as an input experiment. After pull–down, DNA
fragments are sequenced and analyzed. One important consideration for ChIP–seq ex-
periments is that not one single protocol will work in all cell types, under all conditions,
and with all antibodies. Furthermore, the quality of the ChIP–seq experiment is highly
dependent on the quality of the antibody used for the pull–down. Even different lots of
the same antibody can have highly variable degrees of pull–down efficiency. In a study
conducted by the model organism ENCODE project (modENCODE et al. (2010)), 25% of
antibodies failed specificity tests and another 20% of antibodies failed immunoprecipitation
experiments (Egelhofer et al. (2011)). Furthermore, ChIP–seq experiments only report the
average binding over the complete cell population per experiment. When ChIP–seq ex-
periments are performed for several factors and binding of these factors is observed at the
same locus, it is unclear whether these factors co–bind to this locus in the same cell, or
bind to this locus independently or even mutually exclusive in some cells of the population.
To address these question, sequential ChIP–seq methods have been used, that use two or
more antibodies in sequential order (Mendoza-Parra et al. (2012)).
ChIP–seq assays show the binding of one particular TF or histone modification. In order
to get a more general understanding of loci where the chromatin is open (and therefore
any TF can bind), several other methods have been developed. Some of the earliest meth-
ods were enzyme–based (e.g. MNase–seq (Schones et al. (2008)), DNase I hypersensitivity
sites sequencing (DNase–seq) (Sabo et al. (2006))) or sonication–based (e.g. formaldehyde–
assisted isolation of regulatory elements (FAIRE) (Giresi et al. (2007)), sonication of cross–
linked chromatin sequencing (Sono–seq) (Auerbach et al. (2009))). However, all of these
methods require large quantities of cells. Furthermore, the enzyme–based assays are chal-
lenging protocols to perform and give plenty of opportunity for failure. Recently, a new
method was developed to measure open chromatin, termed assay for transposase–accessible
chromatin using sequencing (ATAC–seq) (Figure 4C) (Buenrostro et al. (2013)). This
method requires relatively few cells (down to 10,000 cells per assay), is easy to perform
(about 1 day of bench work) and gives comparable results to FAIRE and DNase–seq.
Many computational pipelines have been implemented in recent years, however the most
fundamental steps are very similar between the different pipelines. Sequencing reads are
mapped to a reference genome and subsequentially genomic regions are identified that con-
tain an enrichment of sequencing reads greater than the background noise. For ChIP–seq
experiments, the usage of an input sequencing experiment is recommended. However, it
is not possible to generate an input sequencing experiment for ATAC–seq, requiring more
stringent enrichment calls. There are several different biases that can influence the data
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Figure 4: Overview of ChIP–seq and ATAC–seq methods. A Transcription factor binding
ChIP–Seq: a specific antibody for a transcription factor is used for pull–down. After
ligation of sequencing adapters, amplification and sequencing the library, data can be
analyzed. B Histone modification ChIP–seq: a specific antibody for a histone modification
is used for pull–down. After ligation of sequencing adapters, amplification and sequencing
the library, data can be analyzed. C ATAC–seq: Transposase Tn5 with specific barcodes
is used to fragment open chromatin. After ligation of sequencing adapters, amplification
and sequencing the library, data can be analyzed. D Visualization of ChIP–seq data for a
transcription factor, showing a very local enrichment of signal and a histone modification,
showing a broad signal that spans large domains. ATAC–seq shows similar signals as
ChIP–seq, but enrichment is found at more loci, as it measures all open chromatin, not
only the binding of one specific transcription factor.
and have been studied extensively (Chen et al. (2010), Khrameeva and Gelfand (2012),
Schwartz et al. (2011), Cheung et al. (2011), Minoche et al. (2011), Benjamini and Speed
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(2012), Nakamura et al. (2011)). As previously discussed the quality of the antibody for
ChIP–seq experiments is crucial for a good enrichment. Furthermore, the machine used for
sequencing can introduce biases. Other types of biases include uneven nucleotide distribu-
tions across reads, GC content, the distribution of sequencing errors and mappability of the
reads. However, commonly used mapping software (e.g. TopHat (Trapnell et al. (2009)),
bowtie2 (Langmead and Salzberg (2012)), bwa (Li and Durbin (2009)), STAR (Dobin et al.
(2013))), as well as analysis pipelines (e.g. Model–based Analysis of ChIP–Seq 2 (MACS2)
(Zhang et al. (2008)) or Hypergeometric Optimization of Motif EnRichment (HOMER)
(Heinz et al. (2010))) are accounting for most of these biases.
Genomic regions with enriched signal over noise are called ’peaks’. Peaks can be highly
localized signals, showing a sharp peak (Figure 4D), usually observed for TFs and open
chromatin. ATAC–seq signal can be found on more loci than ChIP–seq signal, as ATAC–
seq measures all regions of open chromatin, not only the binding of one specific TF. Fur-
thermore, peaks can also be signals that span large domains (then often called ’regions’)
(Figure 4D) usually observed for histone modifications, as well as Pol II. Each of these
shapes require different detection strategies. Some tools are able to detect both shapes
(e.g. MACS2 (Zhang et al. (2008)) and HOMER (Heinz et al. (2010))), whereas others are
specialized for one (e.g. SICER (Xu et al. (2014))).
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SUMMARY
Macrophages reside in essentially all tissues of the
body and play key roles in innate and adaptive im-
mune responses. Distinct populations of tissue mac-
rophages also acquire context-specific functions
that are important for normal tissue homeostasis.
To investigate mechanisms responsible for tissue-
specific functions, we analyzed the transcriptomes
and enhancer landscapes of brain microglia and
resident macrophages of the peritoneal cavity. In
addition, we exploited natural genetic variation as
a genome-wide ‘‘mutagenesis’’ strategy to identify
DNA recognition motifs for transcription factors
that promote common or subset-specific binding of
the macrophage lineage-determining factor PU.1.
We find that distinct tissue environments drive diver-
gent programs of gene expression by differentially
activating a common enhancer repertoire and by
inducing the expression of divergent secondary
transcription factors that collaborate with PU.1 to
establish tissue-specific enhancers. These findings
provide insights into molecular mechanisms by
which tissue environment influences macrophage
phenotypes that are likely to be broadly applicable
to other cell types.
INTRODUCTION
Macrophages are phagocytic cells of the innate immune system
that populate every organ, making key contributions to their
development, functions, and protection against infections and
injuries (Geissmann et al., 2010; Gordon et al., 2014; Wynn
et al., 2013). Accordingly, each population of tissue macro-
phages must adapt to its surrounding environment and engage
in tissue-specific functions to be effective auxiliary cells. In sup-
port of this, recent mRNA profiling studies revealed significant
differences between distinct populations of resident tissue mac-
rophages (Gautier et al., 2012; Okabe and Medzhitov, 2014).
Thus, in spite of common elements shared across all subtypes
of tissue macrophages, including dependency on the transcrip-
tion factor PU.1 and signaling downstream of the CSF1 receptor
for ontology and survival (Schulz et al., 2012; Wynn et al., 2013),
each subset of tissue macrophage possesses its own unique
gene expression profile that presumably allows it to function in
synergy with the tissue in which it resides.
Accumulating evidence suggests that signaling factors
derived from tissue environments play key roles in promoting
the ontology and phenotype of the residing macrophage popula-
tions. For example, absence of TGF-b1 signaling in the mouse
brain impairs the development of the microglia population (Bu-
tovsky et al., 2014; Makwana et al., 2007). In the peritoneum,
omentum-derived retinoic acid (RA) promotes expression of
Gata6 in a subpopulation of local macrophages (Okabe and
Medzhitov, 2014). Interestingly, Gata6 expression is exclusive
to this particular tissue macrophage population, and decreasing
or eliminating its expression interferes with their functions and
survival (Gautier et al., 2012, 2014; Okabe and Medzhitov,
2014; Rosas et al., 2014).
Precisely how these and other signals act on macrophages at
the genomic level to promote specialized phenotypes and
unique transcriptional signatures remains unknown. However,
strong evidence suggests that enhancers, which are funda-
mental determinants of gene expression, may play a key role in
this context (Andersson et al., 2014; Levine, 2010; Shlyueva
et al., 2014). Enhancers, in comparison to promoters, exhibit sig-
nificant enrichment for combinations of DNA recognition motifs
that correspond to binding sites for lineage-determining tran-
scription factors (LDTFs), which are required for the develop-
ment of distinct cell types. Different patterns of LDTF expression
drive the selection of cell-specific repertoires of enhancers that
are considered to be central to the establishment of cell identity
and regulatory potential.
Studies of primary macrophages and B cells indicated that
PU.1 acts as an essential LDTF that contributes to the selection
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of a large fraction of the cell-specific enhancer-like elements in
each of these cell types (Barozzi et al., 2014; Ghisletti et al.,
2010; Heinz et al., 2010). Macrophage-specific enhancer selec-
tion by PU.1 required collaborative interactions with additional
macrophage-restricted transcription factors (TFs), including C/
EBP and AP-1 factors (Heinz et al., 2013). In contrast, B-cell-spe-
cific enhancer selection by PU.1 required collaborative interac-
tions with B-cell-restricted factors, including EBF and E2A (Heinz
et al., 2010).
Pre-existing enhancer landscapes occupied by PU.1 and/or
C/EBP factors were shown to be the major sites that bound
signal-dependent transcription factors (SDTFs), such as NFkB,
nuclear receptors, and STAT proteins (Ostuni et al., 2013; Heinz
et al., 2010). A similar hierarchical relationship for LDTFs and
SDTFs was found in regulatory T cells, embryonic stem cells,
and dendritic cells (Mullen et al., 2011; Samstein et al., 2012;
Garber et al., 2012). The collaborative and hierarchical relation-
ship of LDTFs and SDTFs at pre-existing enhancers was vali-
dated at the level of the DNA template by studies of effects of
natural genetic variation on enhancer selection and function
(Heinz et al., 2013). Mutations in PU.1 motifs causing loss of
PU.1 binding resulted in loss of the collaborative binding of C/
EBPa. Conversely, mutations in C/EBP motifs causing loss of
C/EBPa binding resulted in a loss of collaborative binding of
PU.1. Either type of mutation abolished signal-dependent bind-
ing of NFkB, whereas mutations in NFkB motifs that abolish
NFkB binding rarely affected the binding of PU.1 or C/EBPa.
However, in contrast to the picture at pre-existing enhancers,
NFkB was also shown to be capable of selecting ‘‘latent’’ or
‘‘de novo’’ enhancers by collaborating with PU.1 to bind to
genomic locations lacking prior features associated with active
enhancers (Kaikkonen et al., 2013; Ostuni et al., 2013). These ob-
servations provide an example of an environmentally driven
modification of the enhancer repertoire by a broadly expressed
SDTF that is nonetheless cell type specific due to the obligatory
participation of PU.1.
Given that each tissue environment is distinguished by a
unique combination of signaling factors, it is likely that gene
expression in each corresponding macrophage population is
under the control of distinct combinations of SDTFs that can
modulate the activity of a pre-existing enhancer repertoire to
achieve context-dependent gene expression. In addition, it is
also possible that environmental signals control the expression
and activities of TFs that result in selection of tissue-specific en-
hancers, analogous to the establishment of ‘‘latent’’ or ‘‘de novo’’
enhancers. Here, we sought to determine the extent to which
environment shapes distinct macrophage enhancer repertoires
and the underlying mechanisms.
RESULTS
Environment-Specific Gene Expression
To investigate mechanisms responsible for tissue-specific
macrophage phenotypes, we isolated microglia (MG; brain
macrophages) and two distinct populations of resident perito-
neal macrophages (RPMs) that are discriminated by cell-sur-
face expression levels of MHCII—large peritoneal macrophages
(LPMs, low MHCII) and small peritoneal macrophages (SPMs,
high MHCII)—by flow cytometry (Figures S1A and S1B available
online) (Ghosn et al., 2010; Okabe and Medzhitov, 2014) (Fig-
ure 1A). These three populations of macrophages allow com-
parisons of gene expression and epigenetic landscapes in
distinct macrophage populations residing in the same envi-
ronment (i.e., LPMs versus SPMs), as well as different envi-
ronments (i.e., LPM versus MG). In addition, we included
thioglycollate-elicited peritoneal macrophages (TGEMs) and
bone-marrow-derived macrophages (BMDMs) for comparison,
as these macrophages, although maintained in culture condi-
tions, are widely used models of macrophage biology that are
derived from different sources (Figure 1A).
Gene expression profiles determined by RNA sequencing
(RNA-seq) from independent biological replicates revealed sub-
stantial differences in the patterns of gene expression across the
different macrophage populations examined (Figures 1B, 1C,
and S1C and Table S1), in agreement with previous studies
(Gautier et al., 2012; Okabe and Medzhitov, 2014). In particular,
7,000 genes are differently expressed in MG compared to
LPMs (p value < 0.01), with >500 genes being >16-fold more
highly expressed in MG and >600 genes being >16-fold more
highly expressed in LPMs. On the other hand, LPMs and SPMs
share strong similarities (Figure 1C), with SPMs expressing
only 108 genes > 16-fold higher than LPMs, and LPMs express-
ing only 5 genes > 16-fold higher than SPMs. These results
corroborate many previous findings, including the highest level
of expression of Cx3cr1 in MG and the selective expression of
Gata6 in RPMs (Figure 1D) (Cardona et al., 2006; Gautier et al.,
2012; Jung et al., 2000; Okabe and Medzhitov, 2014). Interest-
ingly, Ciita, a transcription factor that regulates MHCII expres-
sion (Steimle et al., 1993), is preferably expressed in the SPM
population (Figure 1D). Finally, gene clustering analyses
confirmed that, whereas LPMs and SPMs show highly similar
gene expression, MG differ substantially from the other macro-
phage subsets (Figure 1E). TGEMs and BMDMs are also more
similar to one another than either one is to any of the three in vivo
subsets, potentially reflecting the similarity of the cell culture
environment. Overall, these findings suggest a strong role of
environment in determining macrophage gene expression.
Common and Distinct Macrophage Enhancer
Repertoires
The dissimilarities in gene expression between different macro-
phage subsets revealed by RNA-seq analysis imply important
differences in how these cells organize and/or use their enhancer
repertoires. To examine this, we analyzed dimethylation status
of lysine 4 of histone 3 (H3K4me2) and acetylation status of
lysine 27 of histone H3 (H3K27ac) by chromatin immunoprecip-
itation sequencing (ChIP-seq) in these cells (Figure S2 and Ta-
bles S2, S3, and S4). H3K4me2marks promoters and enhancers
(He et al., 2010; Kaikkonen et al., 2013), whereas H3K27ac
correlates positively with transcriptional activity at these ele-
ments (Creyghton et al., 2010). Deposition of H3K4me2 results
from the binding of LDTFs and other TFs but is not necessarily
associated with enhancer activity. We therefore use a heuristic
of defining H3K4me2-positive/H3K27ac-negative regions as
‘‘primed’’ and regions positive for both marks as ‘‘active.’’
Genomic annotation enabled segregation of these regions into
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promoters or enhancers by proximity to gene transcriptional
start sites (TSS). Notably, the pattern of H3K4me2 deposition
in MG substantially differs from that of LPMs (Figure 2A),
indicating selection of distinct regulatory landscapes. Of 7,937
promoters marked by H3K4me2 in one or both subsets, 275
exhibit >4-fold differences (3%), far fewer than the 1,700
mRNAs exhibiting >16-fold differences in expression. Of
36,607 regions > 500 bp from TSS marked by H3K4me2 in one
A B C
D E
Figure 1. Variation in Gene Expression in Different Macrophage Subsets
(A) Macrophage subsets used for analysis and corresponding environmental factors (see Figures S1A and S1B for sorting protocols).
(B and C) Scatterplots illustrating relative gene expression of polyA-selected RNA transcripts in MG compared to LPMs (B) and SPMs compared to LPMs (C).
Values are log2 of tag counts normalized to 107 uniquely mapped tags. See Figure S1C for a representative replicate.
(D) Relative gene expression means for the indicated genes are shown from replicate RNA-seq experiments (error bars represent SD).
(E) Heat map of transcripts exhibiting an expression value of at least 64 normalized tags in at least one subset and differing in expression by at least 16-fold in at
least one of the indicated subsets.
See also Table S1.
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Figure 2. Variation in Enhancer Landscapes in Different Macrophage Subsets
(A) Scatterplots of normalized H3K4me2 tag counts at genomic regions marked by significant H3K4me2 tags in LPMs and/or MG (left) or LPMs and/or SPMs
(right). Points colored in blue are within 500 bp of a TSS. See Figure S2 for representative replicates.
(B) Heatmaps of normalized H3K4me2, H3K27ac, and nearest expressed gene RNA-seq tag counts at genomic locations showing >4-fold pairwise differences in
H3K4me2 tag counts between at least two of the five macrophage subtypes. Row order is the same for all three data types.
(C) Scatterplots of normalized H3K27ac tag counts at genomic regions marked by significant H3K27ac tags in LPMs and/or MG (left) or LPMs and/or SPMs
(right). Points are colored red if genomic locations are also marked by H3K4me2 (>16 tags) in both subsets, green if marked by H3K4me2 selectively in MG
(left) or SPMs (right), yellow if marked by H3K4me2 selectively in LPMs, or blue if not associated with H3K4me2 in either subset.
(legend continued on next page)
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or both subsets, 9,083 exhibit >4-fold differences (24%). The
vast majority of differential H3K4me2-marked regions are
thus distant from promoters and correspond to potential en-
hancers. In contrast to the comparison of LPMs and MG, both
the enhancer and promoter repertoires of the two subsets of
RPMs share a much higher degree of similarity (Figure 2A).
Furthermore, clustering analyses of the H3K4me2 deposition
pattern revealed that MG were more divergent from the other
subsets than any two other macrophage subsets are from
one another, which is consistent with gene expression data
(Figure 2B).
H3K27ac was present at a large fraction of H3K4me2-marked
regions and generally but imperfectly correlated with nearest
gene expression (Figure 2B). Overlap of the H3K27ac data
with H3K4me2-defined enhancers allowed the identification of
common but quantitatively differently activated enhancers, as
well as activation of enhancers unique to one subset. Figure 2C
illustrates such comparisons for LPMs versus MG and LPMs
versus TGEMs. Genomic regions marked by H3K4me2 in both
subsets are color coded in red and represent activation of an
enhancer landscape that is primed in both subsets. In contrast,
regions exclusively marked by H3K4me2 in LPMs, shown in yel-
low, represent LPM-specific enhancers. Conversely, regions
exclusively marked by H3K4me2 in MG or TGEMs, indicated in
green, represent MG or TGEM-specific enhancers, respectively.
Comparing LPMs versus MG, 60% of the active enhancers
resided at common regions of H3K4me2, 30% at LPM-specific
regions, and 10% at MG-specific regions. Specific examples
are indicated in Figure 2D. As expected, the Spi1 enhancer,
controlling expression of PU.1, is marked by H3K4me2 and
H3K27ac in all macrophage populations. Interestingly, the RA-
inducible Rarb gene is also marked by H3K4me2 in all macro-
phage populations, but high H3K27ac is only observed in
LPMs and SPMs, suggesting a role of local RA in enhancer acti-
vation. Finally, the Sall3 gene, which is exclusively and highly ex-
pressed in MG, is near a genomic region that is exclusively
marked by H3K4me2 and H3K27ac in MG. In sum, these ana-
lyses provide strong evidence that both differential activation
of a common enhancer landscape and the selection of sub-
type-specific enhancers contribute to the specific transcriptional
signature of each subset of macrophages.
Tissue-Specific Super-Enhancers Emerge from
Common Enhancer Landscapes
Genome-wide analysis of features of active enhancers, including
the presence of Mediator and deposition of H3K27ac, indicates
marked variation in their local distribution patterns. In all cell
types evaluated thus far,400–800 regions, representing a small
fraction of the genome, exhibit a disproportionately high density
of active regulative marks and transcription factor binding (Hnisz
et al., 2013; Lovén et al., 2013; Whyte et al., 2013). These re-
gions, recently termed super-enhancers (SEs), are selected in
a cell-specific manner and frequently occur near or encompass
genes that play essential roles in defining the identity and func-
tion of the corresponding cell type (Hnisz et al., 2013). Although
LDTFs are enriched in and likely determine cell-specific SE se-
lection, evidence also suggests that the extracellular environ-
ment can influence formation of SEs in endothelial cells (Brown
et al., 2014). To investigate this relationship in tissue macro-
phages, we defined SEs in each macrophage subset based on
H3K27ac ChIP-seq. In agreement with previous studies, we
observed common and subset-specific SEs, with 600 to 750
SEs being identified among the five cell types examined. Clus-
tering of these SEs results in the same relationships between
subsets as observed using RNA-seq, H3K4me2, or H3K27ac
data (Figure 3A). This analysis also revealed a high concordance
between the distribution of SEs genomewide and the expression
level of the nearest genes (Figure 3A). This strong relationship is
further illustrated for SEs and nearest gene expression inMGand
LPMs, in which the correlation coefficient was 0.62 (Figure 3B),
much higher than that observed for the individual enhancer ele-
ments not associated with SE regions in these subsets. This may
be due to a more accurate assignment of SEs to their target
genes than conventional enhancers.
Approximately 40% to 50% of the SEs in a particular macro-
phage subset are unique to that subset, illustrated by the Venn
diagram of LPM, MG, and TGEM in Figure 3C. In concert with
previous findings (Hnisz et al., 2013;Whyte et al., 2013), common
SEs are associated with numerous genes important to macro-
phage ontology and functions, including Spi1, Cebpa, members
of the Irf family,Csf1r, Fcgr2b,Ctsb, etc. (Figure 3D). This pattern
is exemplified by the region upstream of Spi1, which is scored as
a SE in all five subsets (Figure 2D). In contrast, many SEs are
macrophage subset specific and reside near or surround genes
that are highly differentially expressed (Figure 3E). Although
some SEs exhibit highly specific H3K4me2 and H3K27ac mark-
ings, such as the LPM-specific SE upstreamofGata6 (Figure 3E),
the majority of SEs are located at regions that are marked by
H3K4me2 in multiple macrophage subsets but only attain SE
status in one or a few subsets. For example, LPM-specific SEs
reside in the vicinity of Rarb (Figure 2D) and Alox15 (Figure 3E)
genes, which are selectively expressed in LPMs but that also
exhibit H3K4me2 in other macrophage subsets. Similar relation-
ships are observed for the MG-specific SEs surrounding Gpr56
and Cx3cr1 and the TGEM-specific SEs surrounding Fabp5
and Gpnmb (Figure 3E). These findings suggest that environ-
mental signals play roles in the transition of collections of primed
enhancers to genomic regions exhibiting features of SEs.
PU.1 Colocalizes with Distinct TF Motifs at Subset-
Specific Enhancers
The observation that PU.1 localization to macrophage- or B-cell-
specific enhancers is dependent on collaborative interactions
with alternate LDTFs (Heinz et al., 2010) led us to consider the
possibility that an assessment of PU.1 binding in different
macrophage subsets might yield insights into the TFs that
(D) UCSC browser images of selected genomic regions with corresponding RNA-seq data plotted as bar graphs. Bars labeled SE indicate super-enhancers, and
vertical highlights designate regions of interest for subset-common (Spi1) or subset-specific (Rarb and Sall3) loci. All data are normalized to input and library
dimension.
See also Tables S2, S3, and S4.
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drive the selection of subset-specific enhancers. We therefore
extended existing genome-wide binding profiles for PU.1 to
include MG, LPMs, and SPMs. These studies indicated that
PU.1 bound to both common and subset-specific genomic loca-
tions, exemplified for LPMs and MG in Figure 4A (all compari-
sons in Tables S2 and S3). The great majority of subset-specific
binding sites were observed at distal regions (>500 bp from an
mRNA TSS, Figure 4A), which is consistent with the patterns of
H3K4me2 (Figure 2A). Examples of LPM-specific and MG-spe-
cific binding sites for PU.1 in enhancer-like regions vicinal to
Msr1 (expressed exclusively in LPMs) and Nav2 (expressed
exclusively in MG) genes are illustrated in Figure 4B.
De novo motif enrichment analysis of 200 bp sequences
encompassing PU.1 peaks identified the identical PU.1 recogni-
tion motif in both LPMs and MG as the most enriched sequence.
However, completely different motifs were coenriched within the
two subsets (Figures 4C and 4D). Using GC content-matched
genomic sequence as background, enriched sequences specific
to LPMs corresponded to motifs known to bind C/EBP, AP-1,
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Figure 3. Variation in Super-Enhancer
Landscapes in Different Macrophage Sub-
sets
(A) Heatmaps of H3K27ac tag densities at super-
enhancers and RNA-seq tag densities at nearest
genes. Rows are ordered the same for both plots.
(B) Scatterplot of the relationship between ratio of
MG to LPMs H3K27ac tag density at super-en-
hancers (x axis) and the ratio of nearest gene
expression (y axis).
(C) Venn diagram indicating overlap and specificity
of super-enhancers in MG, LPMs, and TGEMs.
(D) Examples of genes associated with common
super-enhancers.
(E) UCSC genome browser images of selected
subset-specific super-enhancers and associated
genes with subset-specific regions of interest
highlighted.
IRF, KLF, and GATA transcription factor
family members (Figure 4C). Conversely,
MG-specific PU1-binding sequences
were coenriched for a PU.1-IRF compos-
ite sequence and motifs corresponding
to CTCFL, HIC2, MEF2, and SMAD TFs
(Figure 4D). In addition, by using alterna-
tive subset-specific PU.1-binding sites
as background, motifs recognized by ret-
inoic acid receptors (e.g., NR2F2) were
identified to be coenriched with PU.1-
binding sites in LPMs (Figure 4C).
Previous studies indicated that motifs
for collaborative binding partners of
PU.1 typically reside within 100 bp of
the PU.1 motif itself (Barozzi et al., 2014;
Heinz et al., 2010). We therefore analyzed
the genomic distance distribution of en-
riched motifs (from Figures 4C and 4D)
within a 400 bp window relative to the
bound PU.1 motif of LPM- and MG-specific PU.1 peak sets
(Figure 4E). This analysis indicated that C/EBP, AP1, and
GATA motifs frequently occurred near PU.1-bound motifs in
LPMs, but not in MG, indicating that genomic loci containing
PU.1 and closely spaced C/EBP, AP-1, or GATA motifs were
more likely to become LPM-specific enhancers. The GATA motif
was selectively enriched in LPMs relative to MG, suggesting a
fundamental difference for the LPM resident population
compared to elicited macrophages (Figure 4E). In contrast, the
SMAD motif showed MG specificity (Figure 4E), which is consis-
tent with TGFb signaling in the brain. These findings provide ev-
idence that selection of subset-specific enhancers is in part
driven by collaborative interactions between PU.1 and alterna-
tive sets of TFs in each subset.
Use of Natural Genetic Variation to Validate and
Discover Collaborative TFs
Although motif enrichment suggests the identities of TFs that
contribute to the function of subset-specific enhancers, this
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approach does not establish whether or not they are required
for collaborative binding. Loss-of-function strategies are chal-
lenging for this purpose because many of the identified motifs
are recognized by multiple members of corresponding TF fam-
ilies. An alternative means to test for collaborative binding is to
mutate motifs recognized by the TF family of interest and deter-
mine whether this results in loss of binding of a nearby factor. We
considered the possibility that this could be accomplished for
informative motifs on a genome-wide scale by leveraging the
vast degree of natural genetic variation provided by inbred labo-
ratory and wild strains of mice.
To explore the potential of this approach to validate and
discover TFs required for collaborative binding and function
of PU.1, we determined the genome-wide patterns of PU.1,
H3K4me2, and H3K27ac in LPMs and MG isolated from
NOD/ShiLtJ (NOD) and SPRET/EiJ (SPRET) mice (Table S5).
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Figure 4. PU.1 Binds to Subset-Specific
Enhancers
(A) Scatterplot of normalized tag counts for PU.1
peaks in MG versus LPMs. Points colored blue are
within 500 bp of the TSS.
(B) UCSC genome browser images of PU.1 bind-
ing in the vicinity of the Msr1 and Nav2 genes in
MG and LPMs cells and association with H3K27ac
highlighting specific regions.
(C) Motifs enriched in the vicinity of PU.1-binding
sites that are specific for LPMs versus MG using a
random GC-corrected genomic background (top)
or a background corresponding to MG-specific
PU.1 peaks (bottom).
(D) Motifs enriched in the vicinity of PU.1-binding
sites that are specific for MG using a random GC-
corrected genomic background.
(E) Distribution plots of motif frequencies (y axis)
for the indicated motifs within 400bp centered on
the PU.1 motif at genomic loci bound specifically
by PU.1 in LPMs (blue) or MG (red).
Compared to C57BL/6J (C57) mice,
NOD mice have about 5 million SNPs
and indels, whereas SPRET mice have
about 40 million (Keane et al., 2011).
This variation is associated with corre-
sponding levels of strain-specific binding
of PU.1, illustrated for LPMs derived
from C57 and SPRET mice (Figure 5A).
Similar observations are made with
respect to MG (Table S6). Approximately
8-fold fewer strain-specific PU.1-binding
sites were identified in LPMs and MG
derived from NOD mice compared to
C57, which is consistent with the lower
number of variants between these two
strains. Strain-specific binding of PU.1
was associated with corresponding
strain-specific H3K4me2 and H3K27ac
marks (Figure 5B), suggesting that many
strain-specific PU.1-binding sites localize
to functional enhancers.
To search for motifs mediating DNA binding by collaborative
TFs, we analyzed strain-specific binding of PU.1 that was not
associated with mutations in PU.1 recognition motifs. This was
accomplished by scanning a 200 bp window surrounding
PU.1-binding sites lacking PU.1motif mutations for the presence
of the DNA recognition motifs of the 100 most highly expressed
TFs in LPMs and MG in C57 or the alternate (NOD or SPRET)
genomic sequence. Mutated loci were then queried for a corre-
sponding decrease in PU.1 binding relative to the unmutated
strain. The significant result for ISRE motif mutations affecting
PU.1 binding in LPMs is exemplified in Figure 5C. The ISRE
was found to be mutated in the vicinity of PU.1-binding sites
93 times in LPMs isolated from C57 mice (indicated by red
hash lines in Figure 5C) and 106 times in LPMs isolated from
SPRET mice (indicated by blue hash lines in Figure 5C). PU.1
binding strength is rank ordered from most C57 specific at left
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to most SPRET specific at right. Many mutations are not associ-
ated with strain-specific binding, which is consistent with prior
studies indicating that the specific position of the variant (i.e.,
core versus periphery of motif), the distance of the motif from
the peak center, and presence of additional redundant motifs
affect the impact of individual mutations (Heinz et al., 2013).
Overall, however, C57 mutations in the ISRE were associated
with SPRET-specific binding of PU.1, whereas SPRETmutations
in the ISRE associated with C57-specific binding of PU.1 (p = 83
1010). This strong genetic association implicates factors bind-
ing to the ISRE as collaborative partners of PU.1 in LPMs.
This analysis was repeated for each motif of interest in each
macrophage subset (LPMs and MG) for the comparisons of
C57 versus NOD and C57 versus SPRET. Vertical compression
of the plot shown in Figure 5C allows stacking of plots for multi-
ple motifs, indicated in Figure 5D. Overall, 37 motifs were found
to reach statistical significance in at least one macrophage sub-
set and strain (Figures 5E and S3). Many more motifs were found
to be significant in comparisons of macrophages derived from
C57 and SPRET mice than C57 and NOD mice, which is consis-
tent with the much larger number of informative mutations. The
most highly significant motifs corresponded to sequences
recognized by ETS factors that are similar to motifs recognized
by PU.1 itself. Most of thesemotifs are closely situated to regions
of PU.1 binding for which the PU.1 motif itself was considered to
be intact. It is therefore unclear at present the extent to which
thesemutations directly affect PU.1 binding or represent binding
sites for collaborative ETS factors.
Twelve non-ETS motifs were identified as being significantly
associated with PU.1 binding in both LPMs and MG, including
a C/EBPa motif, which is an established collaborative binding
partner of PU.1 (Figure 5E). In contrast, 14 motifs exhibited pref-
erential associations with strain-specific PU.1 binding in LPMs
(Figure 5E). This list includes recognition motifs for KLF4,
GATA factors, and AP-1 factors, independently identifyingmotifs
discovered through de novo motif analysis. Finally, motifs for
four factors were preferentially associated with PU.1 binding in
MG, including a recognition motif for SMAD3.
Tissue Environment Regulates Collaborative and
Signal-Dependent TF Expression
To investigate the importance of tissue environment in mainte-
nance of specific macrophage phenotypes, we placed LPMs
and MG into culture under the influence of IL-34 or M-CSF for
7 days. Whereas M-CSF is important to peritoneal macrophages
(Witmer-Pack et al., 1993), IL-34 is critical for proper MG
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Figure 5. Motif Mutations in Potential
PU.1 Collaborating Transcription Factors
Confirm Cooperative Binding for Sub-
set-Common and Subset-Specific Factor
Combinations
(A) PU.1 binding between SPRET and C57 is
shown for 200 bp regions where green signifies
differential binding (>4-fold, p < 1 3 104, n =
13,199), blue similar binding (<4-fold, p < 1 3
104, n = 11,022) and orange in between (n =
12,367).
(B) Heatmap of 2 kb differentially bound PU.1
genomic regions (rows) centered on PU.1 binding
for ChIP-seq tags of PU.1, H3K4me2, and
H3K27ac between C57 and SPRET (columns).
(C) An example of motif mutation analysis is shown
for the ISREmotif. 200 bp genomic sequence at all
PU.1 bound loci (in A) were queried for genetic
variants that mutated the ISRE motif matrix in
either C57 or SPRET. Mutations were colored
according to the genome mutated: red, C57; blue,
SPRET. ISRE mutations were plotted according to
the PU.1-binding strain ratio (y axis) as measured
in LPMs at that locus and rank-ordered on the x
axis. Boxplots of corresponding color indicate the
effect of ISRE motif mutations on PU.1 binding
where whiskers extend to data extremes and p
value are from two-sided t test.
(D) Results from analyses described in (C) are
vertically compressed and shown in rows for PU.1,
C/EBP, Unknown, AP-1, and ISRE motif mutation
events.
(E) Heatmap showing p values resulting from
analysis described in (C) and (D) for motif muta-
tions best matching transcription factors indicated
on x axis. Each motif was tested for affecting PU.1
binding between C57 and NOD and between C57
and SPRET both in MG and LPMs (y axis).
See also Figure S3 and Tables S5 and S6.
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ontology and/or survival in vivo (Greter et al., 2012; Wang et al.,
2012). This environmental transition resulted in vast changes
in gene expression (Table S7). Comparison of the gene expres-
sion program of LPMs freshly purified from the peritoneal cavity
with LPMs maintained in M-CSF for 7 days is illustrated in
Figure 6A. Data points colored in blue represent genes that
are expressed more than 16-fold higher in LPMs than MG, indi-
cating that the LPM-specific program of gene expression is
preferentially lost in culture. Comparison of the gene expression
program of MG freshly isolated from the brain or maintained in
culture in the presence of IL-34 for 7 days is illustrated in Fig-
ure 6B. Data points colored in red represent genes that are ex-
pressed more than 16-fold higher in MG than LPMs, indicating
that the MG-specific program of gene expression is preferen-
tially lost in culture. In both LPMs andMG,many genes exhibiting
low levels of expression in vivo are markedly upregulated in
culture.
In view of recent findings indicating important roles of TGFb
signaling in MG and RA signaling in peritoneal macrophages, we
examined the expression of the main receptors for these factors
A B D
C E
F
G
Figure 6. Environmental Influence on Gene
Expression in LPMs and Microglia
(A and B) Scatterplots illustrating relative gene
expression of RNA transcripts in freshly isolated
LPMs compared to LPMs maintained in culture for
7 days (A) and freshly isolated MG compared to
MG in culture for 7 days (B). Genes specific to
LPMs are colored blue in (A) and specific toMGare
red in (B).
(C) Normalized gene expression values for mem-
bers of the RAR and TGFb receptor family mem-
bers.
(D) Heatmap showing the fold-change of RNAs for
the indicated transcription factors upon removal
from the peritoneal cavity and culture with IL-34 or
M-CSF.
(E and F) Effects of chronic stimulation with RA in
M-CSF and/or IL34 (E) on LPM-specific or com-
mon mRNAs or TGFb in M-CSF or IL34 (F) on MG-
specific or common mRNAs.
(G) qPCR validation of maintained expression by
RA of key transcription factors in cultured LPMs
(error bars indicate SD).
See also Figure S4.
in each macrophage subset. The mRNAs
encoding all three RA receptors (Rara,
Rarb, and Rarg) are highly and selectively
expressed in LPMs and SPMs, whereas
mRNAs encoding the TGFb receptors
Tgfbr1 and Tgfbr2 are preferentially ex-
pressed in MG (Figure 6C). Interestingly,
expression of all three retinoic acid recep-
tors is markedly reduced when LPMs are
placed into culture in the presence of M-
CSF or IL-34, whereas the expression of
Tgfbr1 is markedly increased under these
conditions (Figure 6D). Thus, environment
controls the expression of genes responsible for responses to
environment-specific signals.
To investigate the extent to which RA and TGFb influence sub-
set-specific patterns of gene expression, we treated LPMs with
RA or TGFb for 7 days and performed RNA-seq analysis. RA
treatment induced expression of nearly half of the LPM-specific
genes bymore than 2-fold, while inducing about 8%of genes ex-
pressed at similar levels in LPMs and MG (Figure 6E).
Conversely, nearly 50% of the genes induced more than 2-fold
by TGFb in LPMs in culture are preferentially expressed by MG
in vivo, whereas only 4% of the genes expressed at similar levels
in LPMs and MG were induced by TGFb in LPMs (Figure 6F).
Thus, RA and TGFb disproportionately regulate genes that
specify LPM and MG-specific phenotypes, respectively.
We next evaluated the expression of TFs that recognize motifs
identified as putative binding sites for collaborative partners of
PU.1 in LPMs through analysis of strain-specific PU.1 binding.
Remarkably, expression of the majority of TFs best matched to
motifs identified by strains analysis was environment dependent
(Figure 6D). A similar pattern was observed when considering all
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members of each TF family capable of recognizing these motifs
(Figure S4A). RNA-seq analysis further suggested that several
of these factors were inducible by RA. This response was
confirmed under M-CSF treatment conditions for Gata6 and
Rarb, consistent with previous studies (Okabe and Medzhitov,
2014), as well as for Bhlhe40 and Nfe2 (Figures 6G and S4B).
However, expression ofRara,Rarg, andmost of the other factors
illustrated in Figure 6C was not RA inducible. Thus, the environ-
ment modulates in LPMs the expression of collaborative and
SDTFs through both RA-dependent and RA-independent
mechanisms.
Hierarchical Effects of Environment on Macrophage
Enhancer Landscapes
To gain insights into mechanisms underlying effects of environ-
ment on macrophage gene expression, we performed ChIP-
seq analysis for H3K4me2, H3K27ac, and PU.1 in LPMs main-
tained in M-CSF and the presence or absence of RA or TGFb
for 7 days. Transition of LPMs from the peritoneal cavity to a
tissue culture environment containing M-CSF led to a >2-fold
reduction in H3K4me2 and/or H3K27ac at approximately half of
A B
C D
E
Figure 7. Environmental Influence on En-
hancer Landscapes in LPMs and Microglia
(A) Effects of culture environment and RA chronic
stimulation on the enhancer landscape of LPMs.
(B) UCSC browser images displaying effects of
culture environment and RA chronic stimulation on
H3K4me2, H3K27ac, and PU.1 binding at the
Bhlhe40 locus in LPMs.
(C) Effects of culture environment and chronic
stimulation with TGFb on the enhancer landscape
of LPMs.
(D) UCSC browser images displaying effects of
culture environment and chronic stimulation with
TGF-b1 on H3K4me2, H3K27ac, and PU.1 binding
at the Ets1 locus in LPMs.
(E) Hierarchical model for mechanisms by which
the peritoneal environment induces the enhancer
landscape and gene expression signature of
LPMs. See Discussion for details.
See also Table S7.
the enhancer-like regions (Figure 7A).
One-third of these lost enhancer elements
were maintained by RA treatment (Fig-
ure 7A).Of the 302 LPM-specificSEs iden-
tified in Figure 3, 223 (74%) no longer met
SE criteria, indicating a disproportionate
sensitivity to loss of environmental signals.
This pattern is exemplified by the SE asso-
ciated with Bhlhe40, which, in addition to
substantial reduction in the histone signa-
ture of enhancers, also exhibits reduced
PU.1 binding (Figure 7B). Notably,
H3K4me2, H3K27ac, and PU.1 binding
are largely maintained by RA treatment.
Maintenance of LPMs in M-CSF plus
TGFb resulted in marked changes in the
LPM enhancer landscape in comparison to culture in M-CSF
alone, which is consistent with the preferential effects of TGFb
on aMG-specific program of gene expression (Figure 7C). Treat-
ment with TGFb increased the enhancer signature by more than
2-fold at 25% of pre-existing enhancers. Conversely, TGFb
reduced enhancer signatures at 25% enhancer-like elements
that were stable upon transfer to culture in M-CSF. Induced en-
hancers are exemplified by a genomic region in the vicinity of the
Ets1 gene (Figure 7D) that is preferentially expressed in MG and
is highly induced by TGFb. Culture of LPMs in M-CSF results in
appearance of PU.1 binding and H3K4me2 modification, with
TGFb treatment leading to substantial increases in H3K27ac
and a marked increase in gene expression.
DISCUSSION
Mechanisms Underlying Tissue-Specific Enhancer
Selection and Activation
The present studies provide evidence for a hierarchical model in
which the distinct environments of the brain and peritoneal cavity
differentially activate a common set of primed enhancers and
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their target genes that, in turn, promote the selection and activa-
tion of subset-specific enhancer repertoires. The combinatorial
activation of both common and subset-specific enhancers
enables context-dependent regulation of genes required for
specialized functions of MG and RPMs. Aspects of this model
as they pertain to the RA-dependent program of gene expres-
sion specific to peritoneal macrophages are illustrated in Fig-
ure 7E. Common to all macrophage subsets, stimulation of
signaling pathways downstream of the M-CSF receptor by M-
CSF and/or IL-34, which are present in the environment in a
largely tissue-non-specific manner, ensures survival and pro-
motes PU.1 expression (Sarrazin et al., 2009). PU.1 is a critical
LDTFs required for all macrophage subsets that functions to
select common and cell-specific enhancers through collabora-
tive interactions with other TFs. These regions of PU.1 binding
in turn serve as subset-specific sites of action for various types
of SDTFs.
Within the peritoneal cavity, environment-specific signals
control the expression and activities of TFs that act upon primed
enhancers that are common to multiple macrophage subsets
(Figure 7E). A particularly important signal is omentum-derived
RA, which has been shown to be essential for development
and function of LPMs through its activation of RARb and induc-
tion of Gata6 (Okabe and Medzhitov, 2014). We find that all
three high-affinity retinoic acid receptor genes (Rara, Rarb,
and Rarg) are preferentially expressed in the peritoneal cavity
and that this expression requires continual maintenance by
the peritoneal cavity environment. However, only Rarb expres-
sion is preserved by RA treatment in culture, indicating that
expression of Rara and Rarg is under the control of as-yet-un-
identified factors. We speculate that the expression of RARa
and RARg is necessary for full induction of RARb expression
in response to environmental RA and that this positive feedback
loop is important for amplification of the RA signal and activa-
tion of direct RA target genes. These findings imply that at least
two environmental signals are required for initiating the RA-
dependent peritoneal macrophage phenotype, one being RA it-
self and the second being a signal or signals required for RARa
and RARg expression.
Activated retinoic acid receptors primarily function as SDTFs
that act at a common set of primed enhancers established by
PU.1 and other LDTFs that are expressed across macrophage
subsets. Importantly, direct RA target genes include Gata6,
Bhlhe40, and Nfe2, which were identified as putative interacting
partners of PU.1 through analysis of effects of natural genetic
variation. We propose that RAR-dependent induction of these
factors results in collaborative interactions with PU.1 that
drive environment-specific selection of LPM-specific enhancers
(Figure 7E).
Of note, Gata6, Bhlhe40, and Nfe2, as well as all three retinoic
acid receptors, reside in or near peritoneal macrophage-specific
SEs that are lost when LPMs are removed from the peritoneal
cavity. Our findings suggest that an analogous hierarchy oper-
ates in MG, driven in part by TGFb signaling and SMAD TFs.
Although the present studies have focused on PU.1, we expect
that additional macrophage LDTFs function in an analogous
manner to set up macrophage-specific, PU.1-independent
enhancers.
Use of Natural Genetic Variation to Validate and
Discover Collaborative TFs
Here, we demonstrate the use of the natural genetic variation
provided by inbred strains of mice as a powerful means to vali-
date and discover collaborative TFs. By measuring strain-spe-
cific binding of PU.1 in macrophages derived from genetically
diverse strains of mice, we identified motifs for several different
classes of TFs in which strain-specific mutations were highly
correlated with the loss of binding of PU.1 to nonmutated PU.1
recognition motifs. Interestingly, the expression of a significant
fraction of the TFs recognizing these motifs is dependent on
environment.
Many of themotifs identified by analysis of strain-specific bind-
ingof PU.1are recognizedbyTFs that havewell-established roles
in macrophage biology. Some, such as C/EBPa and C/EBPb, are
documented to function as factors that enable collaborative bind-
ing of PU.1 in macrophages (Heinz et al., 2010), supporting the
validity of the approach. Although the biological role of Gata6 in
the development and function of LPMs is established (Okabe
andMedzhitov, 2014;Rosaset al., 2014), thepresent studies sug-
gest that a key molecular function of Gata6 is to collaborate with
PU.1, and likelyothermacrophageLDTFs, todrive theselectionof
LPM-specific enhancers. Bhlhe40 and Nfe2 represent examples
of putative collaborative partners of PU.1 that have not as yet
been linked to macrophage-specific functions. Bhlhe40, also
known as Dec1, Stra13, and Sharp2, has previously been shown
to be inducible by RA and to act as both as a repressor and
activator (Boudjelal et al., 1997; Ivanova et al., 2004), raising the
possibility that it could contribute to selection of LPM-specific en-
hancers, as well as suppress genes that become active when
LPMs are removed from the peritoneal cavity. Nfe2 is a bZip tran-
scription factor that is broadly expressed in the hematopoietic
system and has been established to play important roles in eryth-
ropoiesis and megakaryocyte development (Andrews, 1998).
The present findings provide a rationale for further investigation
of roles of Bhlhe40, Nfe2, and other TFs identified as putative
collaborative binding partners of PU.1.
The use of natural genetic variation as a strategy for identifica-
tion of TFs required for enhancer selection can in principle be
applied to any cell type in which ChIP-seq can be performed
for an index LDTF. In addition, although not a focus of the present
studies, the variation in enhancer selection and activity observed
inmacrophages derived fromdifferent inbred strains ofmicewas
associated with strain-specific differences in LPM and MG gene
expression. Such changes in gene expression are presumably
linked to both molecular phenotypes such as eQTLs and to the
marked phenotypic differences exhibited by these mice that
are influenced by tissue resident macrophage populations,
such as relative susceptibility or resistance to metabolic, cardio-
vascular, infectious, and neurodegenerative diseases (Civelek
and Lusis, 2014; Threadgill and Churchill, 2012). The principle
of collaborative binding, which serves as the basis for the motif
discovery method described here, is directly applicable to inves-
tigating mechanisms by which noncoding variants may exert
phenotypic effects in a cell-type-specific and/or context-depen-
dent manner. In concert, these approaches enable insights into
gene-by-environment interactions and the genetic architecture
of molecular and complex disease traits.
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Tuning Enhancer Landscapes and Gene Expression to
Context-Specific Functions
The present studies reveal that each macrophage subset
uniquely possesses a distinct set of active enhancers, including
subset-specific SEs, which are associated with strong preferen-
tial expression of nearby genes. In LPMs, for example, which
populate a very potent immunogenic environment, Gbp2b and
Alox15 are associated with SE activity, and we note that the pro-
tein products of these genes are critical regulators of immunity,
in particular inflammation and tolerance (Pilla et al., 2014; Uder-
hardt et al., 2012; Yamamoto et al., 2012). In contrast to LPMs,
MG reside in the immune-privileged environment of the brain.
As with LPMs, however, our observations suggest that MG
adopt a unique phenotype that is again strongly contributed by
distinct enhancers and SEs to accomplish tissue-specific func-
tions required for brain homeostasis. For example, SEs in MG
include genomic loci associated with the Cx3cr1 and Gpr56
genes, among others. Interestingly, both genes are highly rele-
vant to brain functions, regulating synaptic pruning and efficient
cortical patterning during brain development (Paolicelli et al.,
2011; Piao et al., 2004). Together, our studies reveal an intricate
relationship between the organization of the genome of tissue
macrophage and their surrounding environment.
Divergent Macrophage Gene Expression in a Common
Environment
Distinct macrophage populations can coexist in a similar envi-
ronment, as illustrated by the copresence of LPMs and SPMs
in the peritoneum. Although these cells are highly concordant
with respect to gene expression and organization of their
enhancer landscapes, consistent with exposure to common
tissue-derived signals, strong points of divergence can nonethe-
less discriminate the two. These observations raise the possibil-
ity that differences in origin and ontology play important roles
in determining these later-stage differences (Perdiguero et al.,
2014; Schulz et al., 2012). Thus, the impact of developmental
history on the regulation of enhancer repertoires and gene
expression of different tissue macrophages remains a funda-
mental open question to be addressed in future studies.
EXPERIMENTAL PROCEDURES
Mice
Seven-week-old C57BL/6J, NOD/ShiLtJ, and SPRET/EiJ male mice were pur-
chased from Jackson Labs and used at 8 to 9 weeks of age. All animal proce-
dures were in accordance with University of California, San Diego research
guidelines for the care and use of laboratory animals.
Microglia Isolation
Mice were anaesthetized with CO2 and quickly perfused intracardially with ice-
cold DPBS. Whole brains were removed and gently mechanically homoge-
nized on ice. Cells were fractionated by Percoll gradient centrifugation, and
microglia-enriched fractions were further purified by cell sorting according to
the scheme described in Figure S1A and Extended Experimental Procedures.
Peritoneal Macrophage Isolation
Following euthanization, peritoneal cells were collected by lavage of the peri-
toneum with ice-cold staining buffer. LPM and SPM subsets were purified
based on relative expression of MHCII and other markers described in Fig-
ure S1B and Extended Experimental Procedures.
Thioglycollate-Elicited and Bone-Marrow-Derived Macrophages
Cultures
TGEMs were harvested by peritoneal lavage with 20 ml ice-cold PBS 4 days
after peritoneal injection of 3ml Thioglycollate broth. Both TGEMs andBMDMs
were cultured as described in Heinz et al. (2010). See also Extended Experi-
mental Procedures.
ChIP-Seq
Macrophages were fixed at room temperature with 1% paraformaldehyde/
PBS containing 1 mM sodium butyrate for 10 min and quenched with glycine.
2.03 105 to 1.03 106 cells were used for ChIP, and samples were processed
as previously described (Heinz et al., 2010), with minor modifications noted in
the Extended Experimental Procedures. Sequencing libraries were prepared
as previously described (Heinz et al., 2010).
RNA Isolation
For RNA-seq, TRIzol (Life Technologies) isolated RNA was either PolyA-
selected (MicroPoly(A) Purist kit, Ambion) or subjected to RiboZero rRNA
removal (Epicenter).
Quantitative PCR, RNA-Seq Library Preparation, and Sequencing
Libraries for RNA sequencing were generated as previously described (Heinz
et al., 2013). See Extended Experimental Procedures for details and qRT-PCR
primer sequences.
Data Analysis
Fastq files from sequencing experiments were mapped to individual genomes
for the mouse strain of origin using default parameters for STAR (Dobin et al.,
2013) (RNA-seq) and Bowtie2 (Langmead and Salzberg, 2012) (ChIP-seq).
NOD/ShiLtJ and SPRET/EiJ custom genomes were generated from invariant
positions of the mm10 sequence with alleles replaced by those reported in
VCF files from the Mouse Genomes Project (Keane et al. 2011). Mapped
data were analyzed with HOMER (Heinz et al., 2010), custom R, and Perl
scripts.
ACCESSION NUMBERS
Raw and processed data are provided in the Gene Expression Omnibus (GEO)
under accession number GSE62826.
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Abstract Although macrophages can be polarized to distinct phenotypes in vitro with individual
ligands, in vivo they encounter multiple signals that control their varied functions in homeostasis,
immunity, and disease. Here, we identify roles of Rev-erb nuclear receptors in regulating responses
of mouse macrophages to complex tissue damage signals and wound repair. Rather than
reinforcing a specific program of macrophage polarization, Rev-erbs repress subsets of genes that
are activated by TLR ligands, IL4, TGFb, and damage-associated molecular patterns (DAMPS).
Unexpectedly, a complex damage signal promotes co-localization of NF-kB, Smad3, and Nrf2 at
Rev-erb-sensitive enhancers and drives expression of genes characteristic of multiple polarization
states in the same cells. Rev-erb-sensitive enhancers thereby integrate multiple damage-activated
signaling pathways to promote a wound repair phenotype.
DOI: 10.7554/eLife.13024.001
Introduction
Macrophages reside in all tissues of the body and play key roles in homeostasis, immunity, and dis-
ease. As immune cells, macrophages serve as sentinels of infection and injury and are active partici-
pants in both innate and adaptive immune responses. Detection of pathogens and tissue damage is
mediated by a diverse array of pattern recognition receptors for pathogen associated molecular pat-
terns (PAMPs) and damage associated molecular patterns (DAMPs), exemplified by the toll-like
receptors (TLRs). Ligation of TLRs initiates profound changes in gene expression that include induc-
tion of chemokines, cytokines, anti-microbial peptides, and other factors that contribute to the
innate immune response and influence adaptive immunity (Ostuni et al., 2013; Lawrence and
Natoli, 2011). This response has been extensively characterized in vitro by treating cultured macro-
phages with specific TLR ligands such as bacterial lipopolysaccharide (LPS), a potent activator of
TLR4 (Kaikkonen et al., 2013; Escoubet-Lozach et al., 2011; Raetz et al., 2006). TLR4 ligation reg-
ulates gene expression through signal transduction pathways culminating in the activation of latent
signal-dependent transcription factors, which include members of the nuclear factor kappa-light-
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chain-enhancer of activated B cells (NF-kB), interferon regulatory factor (IRF), and activator protein 1
(AP-1) families (Medzhitov and Horng, 2009). In macrophages, these factors are primarily directed
to macrophage-specific enhancers that are selected by macrophage lineage determining transcrip-
tion factors, PU.1 and CCAAT-enhancer-binding proteins (C/EBPs) (Heinz et al., 2010). The macro-
phage activation phenotype resulting from selective treatment with LPS, or in some cases a
combination of LPS and interferon g (IFNg), is referred to as M(LPS) or M(LPS+IFNg) activation
(Murray et al., 2014), and is considered vital for the host response to bacterial or viral infection.
Macrophages also play important roles in regulating the resolution phase of inflammation as well
as the repair of tissue damage. These functions are controlled by complex microenvironmental path-
ways that include reductionist signals such as transforming growth factor b (TGFb) and interleukin 4
(IL4). TGFb is generally considered to be an inducer of a ’de-activated’ macrophage or M(TGFb) phe-
notype, although it also acts as a potent chemo-attractant for monocytes and can potentiate their
transition into activated cells (Li et al., 2006). Macrophages respond to TGFb in both an autocrine
and paracrine manner. For example, phagocytosis of apoptotic cells results in increased macro-
phage-mediated secretion of TGFb and subsequent inhibition of inflammatory cytokine production
(Li et al., 2006). In addition to dampening inflammatory responses, secreted TGFb plays key roles in
accelerating wound healing and fibrosis (Schuppan and Kim, 2013). At the transcriptional level,
TGFb signal transduction pathways function primarily in a Mothers against decapentaplegic homolog
(SMAD)-dependent manner through Smad2-, Smad3-, and Smad4-mediated activation, as well as
Smad7-mediated inhibition (Massagué, 2012). Like other signal-dependent transcription factors,
ligation of TGFb receptors causes the localization of Smad3 to genomic loci containing lineage-
determining transcription factors (Mullen et al., 2011).
Regulation of macrophage gene expression by IL4 plays roles in containment of parasitic infec-
tions and in homeostatic functions of adipose tissue. IL4 acts through the IL4 receptor to activate
signal transducer and activator of transcription 6 (Stat6) (Lefterova et al., 2010), which positively
regulates gene expression upon binding to recognition elements in promoters and enhancers of tar-
get genes (Li et al., 2006). IL4 signaling regulates genes that control tissue remodeling, phagocyto-
sis, scavenging, and the arginase pathway. The macrophage activation phenotype resulting from
selective treatment with IL4 is referred to as M(IL4) and is considered vital for the role of macro-
phages in wound repair (Van Dyken and Locksley, 2013).
While M(LPS) or M(LPS+IFNg ), M(TGFb), and M(IL4) macrophage phenotypes are clearly distinct in
vitro, they result from selective activation of specific signaling pathways by strongly polarizing ligands.
In vivo, macrophages encounter diverse combinations of signals that can change over time in
response to physiological or pathological processes such as tissue injury. Recent studies show that
these combinations of signals can influence the transcriptional landscape of macrophages in an input-
specific fashion (Lavin et al., 2014; Ginhoux et al., 2015; Gosselin et al., 2014). However, how com-
plex signals are integrated at the level of transcription and how reductionist stimuli (LPS, TGFb, and
IL4) can be used as a framework to predict how combinations of transcriptional regulators coordinate
immune and tissue repair activities in complex tissue microenvironments remain largely unknown.
The Rev-erb nuclear receptor family consists of two members, Rev-erba (also known as nuclear
receptor subfamily 1, group D, member 1, NR1D1) and Rev-erbb (also known as nuclear receptor
subfamily 1, group D, member 2, NR1D2) (Rev-erbs), that regulate the expression of genes involved
in the control of circadian rhythm (Preitner et al., 2002; Liu et al., 2008; Cho et al., 2012), metabo-
lism (Raspé et al., 2002; Le Martelot et al., 2009; Feng et al., 2011; Solt et al., 2012), and inflam-
mation (Fontaine et al., 2008; Gibbs et al., 2012). Rev-erbs mediate transcriptional repression
through recruitment of the nuclear co-repressor (NCoR) and histone de-acetylase 3 (HDAC3) com-
plex (Yin and Lazar, 2005). Rev-erbs lack the carboxy-terminal (AF2) transactivation domain, which
is required for recruitment of co-activators (Durand et al., 1994). Genome-wide location analysis of
Rev-erba and Rev-erbb in macrophages revealed thousands of binding sites, the vast majority of
which resided at macrophage-specific enhancer-like regions of the genome established by PU.1 and
other macrophage lineage determining factors (Lam et al., 2013). Gain and loss of function experi-
ments indicated that Rev-erbs function to suppress the activities of these enhancers by repressing
enhancer-directed transcription. While these studies provided insights into the functional signifi-
cance of enhancer transcription, the biological consequences of the actions of Rev-erbs at these dis-
tal regulatory elements were not explored.
Eichenfield et al. eLife 2016;5:e13024. DOI: 10.7554/eLife.13024 2 of 30
Research article Genes and Chromosomes
c
Figure 1
a Treatment Effect Effect of Rev-erb DKOb
L
o
g
 2
 F
o
ld
 C
h
a
n
g
e
 (
T
re
a
tm
e
n
t/
C
tr
l)
C
o
m
m
o
n
T
L
R
4
T
L
R
3
T
is
s
u
e
 H
o
m
o
g
e
n
a
te
L
o
g
 2
 F
o
ld
 C
h
a
n
g
e
 (
D
K
O
/W
T
)
TGF
Pam3 
KLA
Poly I:C
IL4
KLA
IFN
Tissue
homogenate
ChIP-Seq
RNA-Seq
AAA
AAA
Experimental Approach 
S
D
T
F
P
o
l 
II
 -4
 0
 4
 -1
 0
 1
T
is
s
u
e
 h
o
m
o
g
 2
4
h
T
is
s
u
e
 h
o
m
o
g
 6
h
P
o
ly
 I
:C
 6
h
 
P
a
m
3
 6
h
K
L
A
 I
F
N
2
4
h
K
L
A
 6
h
IL
4
 2
4
h
 
N
o
 t
re
a
tm
e
n
t
T
G
F
 2
9
h
T
G
F
 9
h
T
is
s
u
e
 h
o
m
o
g
 2
4
h
T
is
s
u
e
 h
o
m
o
g
 6
h
P
o
ly
 I
:C
 6
h
 
P
a
m
3
 6
h
K
L
A
 I
F
N
2
4
h
K
L
A
 6
h
IL
4
 2
4
h
 
P
U
.1
(Treatment/Ctrl) (DKO/WT)
Tie2-Cre +
Rev-erb f/f:Rev-erb f/f
Tie2-Cre -
WT
BMDMs
Rev-erb DKO
BMDMs
e De-repressd Rev-erb DKO genes
# Benjamini # Benjamini
Immune response 74 8.5E-3 6.1E-8
Response to wounding 57 1.8E-2 1.6E-6
Inflammatory response 40 5.0E-2 2.7E-6
Cell adhesion 78 6.8E-2 6.7E-6
Defense response 64 8.8E-2 2.0E-4
Chemotaxis 23 1.0E-1 1.8E-4
Acute inflammatory response 19 8.1E-2 6.9E-3
w/o Tissue homog w/ Tissue homog
Gene Ontology 1.5X UP
98
75
55
103
82
31
23
T
G
F
 2
9
h
T
G
F
 9
h
d
40 30 20 10
-Log 10 p-value (Benjamini corrected)
down-regulated 
genes
GO annotation enrichment analysis
up-regulated 
genes
0 10 20 30 40 50 60
T
ra
n
s
la
ti
o
n
In
fl
a
m
m
a
to
ry
 
re
s
p
o
n
s
e
Im
m
u
n
e
 
re
s
p
o
n
s
e
R
e
s
p
o
n
s
e
 
to
 w
o
u
n
d
in
g
C
e
ll 
c
y
c
le Tissue homog 24h
Tissue homog 6h
TGF  29h
TGF  9h
IL4 24h
Poly I:C 6h
Pam3 6h
KLA + IFN  24h
KLA 6h
Figure 1. Overall impact of Rev-erb DKO on signal-dependent gene expression. (a) Schematic illustrating the experimental approach used in defining
the global transcriptional program in WT and Rev-erb DKO bone marrow derived macrophages (BMDMs). (b) Heatmap showing genes captured by
Figure 1 continued on next page
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Here, we provide evidence that Rev-erbs repress the transcription and function of signal-depen-
dent enhancers that are targets of TLR, IL4, TGFb, and DAMP signaling. Rather than exerting a pat-
tern of repression that reinforces a particular polarization phenotype, Rev-erbs regulate subsets of
signal responsive genes that span those associated with M(LPS) or M(LPS+IFNg ), M(TGFb), and M
(IL4) phenotypes, enriching for functions associated with wound repair. Consistent with these in vitro
observations, deletion of Rev-erbs from the hematopoietic lineage in vivo results in accelerated
wound repair. Unexpectedly, we found that a complex tissue injury signal directs genomic binding
patterns for NF-kB p65 (p65), FBJ murine osteosarcoma viral oncogene homolog (Fos – a member
of the activator protein 1, or AP-1, family), and Smad3 that differ substantially from those observed
following selective treatments with a TLR4 agonist or TGFb. In addition, by analyzing changes in
enhancer signatures, we identified Nrf2 as an additional mediator of the transcriptional response to
the tissue injury signal. While these transcription factors exhibit relatively little co-localization in
response to single polarizing ligands, we observe substantial co-localization and enhancer activation
in response to the complex tissue injury signal, resulting in transcriptional outcomes that are qualita-
tively different than the sum of single polarizing signals. These observations provide insights into
how combinations of signals are integrated at a transcriptional level to result in context-specific pat-
terns of gene expression.
Results
Rev-erb transcriptional activity varies according to polarizing signal
Our previous findings that Rev-erbs regulate transcription from signal-dependent enhancers
(Lam et al., 2013) led us to investigate possible biological roles of Rev-erbs in influencing macro-
phage phenotypes (Figure 1a). To study the phenotypic contribution of Rev-erbs to signal-depen-
dent gene expression in macrophages, we performed RNA-Sequencing (RNA-Seq) of poly(A) mRNA
isolated from wild-type macrophages and those deficient for both Rev-erba and Rev-erbb
(Figure 1a). Rev-erb double knockout (DKO) macrophages were generated from bone marrow dif-
ferentiation of Tie2-Cre Rev-erbaflox/flox Rev-erbbflox/flox (Rev-erb DKO) mice and compared to con-
trol macrophages derived from Cre-negative littermates (WT). Deletion of Rev-erbb exons to
generate a non-functional Rev-erbb mRNA results in marked de-repression of Rev-erba expression
and increased expression of a DNA binding domain deleted form of Rev-erba mRNA (Sud et al.,
2007) (Figure 1—figure supplement 1a–b). Similar effects can be seen following deletion of Rev-
erba exons (corresponding to the DNA-binding domain) with respect to Rev-erbb de-repression
Figure 1 continued
RNA-Seq associated with Rev-erb control after treatment with the indicated ligands compared to the basal state. Genes shown are those more than
1.5-fold differentially expressed in Rev-erb DKO macrophages compared to WT. Data is represented as log2 fold change between the basal state and
treatment (untreated for 6 hr was used for comparison to KLA, Pam3, Poly I:C, TGFb 9 hr, and tissue homogenate 6 hr; untreated for 24 hr was used for
comparison to KLA + IFNg , IL4, TGFb 29 hr, and tissue homogenate 24 hr). Genes were clustered using k-means clustering (k = 10). For untreated
samples, N = 4, for samples treated with Pam3, Poly I:C, KLA or KLA + IFNg , tissue homogenate or TGFb, N = 3, and for samples treated with IL4,
N = 2. The data for this heat map is accessible in Figure 1—source data 1. (c) Heatmap showing genes captured by RNA-Seq as differentially
expressed 1.5-fold in the Rev-erb DKO macrophage compared to WT as indicated. Data is represented as log2 fold change between DKO and WT.
Genes were clustered using k-means clustering (k = 10). For untreated samples, N = 4, for samples treated with Pam3, Poly I:C, KLA or KLA + IFNg ,
tissue homogenate or TGFb, N = 3, and for samples treated with IL4, N = 2. The data for this heat map is accessible in Figure 1—source data 2. (d)
Gene ontology analysis using David (Huang et al., 2009a, 2009b) of genes shown in panel b. (e) Gene ontology analysis using David (Huang et al.,
2009a, 2009b) of genes demonstrating de-repressed expression in Rev-erb DKO macrophages by more than 1.5-fold in all of the conditions combined
(w/o Tissue homog considers de-repressed genes in columns 1–8 of panel c (N = 2315), while w/ Tissue homog considers de-repressed genes in all
columns of panel c (N=2614)).
DOI: 10.7554/eLife.13024.002
The following source data and figure supplement are available for figure 1:
Source data 1. Source data for Figure 1b where each value represents the average normalized log2 fold change between the basal state and treat-
ment state per column.
DOI: 10.7554/eLife.13024.003
Figure supplement 1. .Rev-erb deletion efficiency.
DOI: 10.7554/eLife.13024.004
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Figure 2. Rev-erb DKO bone marrow transplanted animals display enhanced wound closure in a full thickness wound healing model. (a) Wound size
(cm2) as fitted from a linear mixed effects model. Boxes denote the interquartile range and the median, whiskers denote the minimum and maximum
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(Figure 1—figure supplement 1a–b). Reduction of targeted Rev-erb exonic mRNA averaged 90%
for Rev-erba and 80% for Rev-erbb (Figure 1—figure supplement 1c).
Activation of TLR3 with a synthetic double-stranded RNA analog, polyinosinic-polycytidylic acid
(Poly I:C), TLR4 with Kdo2-lipid A (KLA), TLR1/2 with a synthetic triacylated lipopeptide, Pam3CSK4
(Pam3), and co-activation with KLA and IFNg induced characteristic pro-inflammatory gene signa-
tures (Figure 1b and d) in WT macrophages. In contrast, IL4 or TGFb stimulation of macrophages
resulted in the expected alternatively activated and de-activated gene profiles, respectively
(Figure 1b and d).
Comparing the gene expression signature from WT and Rev-erb DKO macrophages, for the
majority of genes, the magnitude of differential expression between WT and Rev-erb DKO macro-
phages varied depending on the polarization state (Figure 1c), in some cases only being observed
under basal conditions, and in other cases only observed in response to a particular stimulus. These
results suggest that the magnitude of differential expression in WT compared to Rev-erb DKO mac-
rophages is highly dependent on polarization state.
Rev-erb deficient animals display enhanced wound healing
Gene ontology analysis of mRNAs exhibiting differential expression (>1.5-fold de-repressed in DKO
macrophages) in at least one of the single polarizing conditions revealed significant enrichment for
genes involved in the response to wounding (Figure 1e). Notably, genetic loss of Cx3cr1 and Arg1
has been shown to hinder efficient wound healing in mice (Campbell et al., 2013; Ishida et al.,
2008), suggesting that mice lacking Rev-erbs in cells of hematopoietic origin might exhibit more
rapid wound healing. To test this hypothesis, we utilized a full thickness wound healing model
(Figure 2a) in mice after bone marrow reconstitution with either WT or Rev-erb DKO bone marrow
(Figure 2—figure supplement 1a). Bone marrow reconstitution efficiency exceeded 94% (Figure 2—
figure supplement 1b). We found from three independent experiments that Rev-erb deficiency in
bone marrow derived hematopoietic cells resulted in accelerated wound closure (Figure 2a–b). This
was especially apparent on days 2–6 post-injury (Figure 2a), consistent with Rev-erb deficiency
resulting in a faster response during the immune phase of wound healing.
Wounds from the Rev-erb DKO chimeric mice displayed greater immune cell infiltration and faster
wound healing progression, characterized by enhanced re-epithelialization and increased granulation
tissue development (Figure 2c), characteristics correlated with an accelerated immune response dur-
ing wound healing. In addition, Rev-erb DKO bone marrow transplanted mice displayed more mac-
rophages at the wound site on day 4 post-injury (Figure 2d), while neutrophil persistence at the
wound site remained similar between WT and Rev-erb DKO transplanted mice (Figure 2e). More-
over, matrigel migration assays show increased extravasation of Rev-erb DKO macrophages when
compared to their WT counterparts (Figure 2f). Flow cytometry analysis of circulating blood leuko-
cytes from WT and Rev-erb DKO bone marrow transplanted animals (Figure 2—figure supplement
1c–d) showed no differences in the populations of Ly6Clow/Ly6Chigh circulating monocytes. These
experiments suggest that the increased migration of macrophages into wounds may be cell autono-
mous changes in transcriptional output.
Figure 2 continued
values excluding outliers, and dots outside of the whiskers denote outlier observations. Data are pooled from three independent experiments as
described in more detail in the Materials and methods. The p-values shown reflect comparisons with a p-value less than 0.05, as determined by the
linear mixed effects model. (b) Macroscopic digital photographs of wound closure in WT and Rev-erb DKO bone marrow transplanted animals. (c)
Histological images of wound healing in WT and Rev-erb DKO bone marrow transplanted animals taken at 2.5x magnification after 2, 4, and 6 days.
Arrowheads show differential re-epithelialization between WT and Rev-erb DKO bone marrow transplanted animals. Abbreviations: g=granulation
tissue, d=dermis. Images representative of two independent animals. (d) Day 4 hematoxylin and eosin (H&E), as well as F4/80 stained histological
images taken at 20x magnification. Images representative of two independent animals. (e) Day 4 hematoxylin and eosin (H&E), as well as Ly6B.2 stained
histological images taken at 20x magnification. Images representative of two independent animals. (f) Migration of WT and Rev-erb DKO macrophages
through matrigel extracellular matrix for 24 hr (**p-value <0.01 two-tailed test, Data represent mean + SD from one of three experiments using 8 wells
with cells pooled from 3 independent mice).
DOI: 10.7554/eLife.13024.005
The following figure supplement is available for figure 2:
Figure supplement 1. . Engraftment efficiency and quantification of circulating blood cells in WT and DKO chimeras.
DOI: 10.7554/eLife.13024.006
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Figure 3. Rev-erb DKO macrophages display increased inflammatory responses to damaged tissue. (a) Schematic illustrating the experimental
approach used comparing the transcriptional profile of in vivo wounds on days 1, 4, 8, or 14 post-wounding with macrophages treated in vitro with
tissue homogenate after 6 or 24 hr. (b) Heatmap showing genes differentially expressed both in the in vivo mouse wound and in macrophages after in
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Rev-erbs integrate macrophage responses to a complex wound signal
Classically, tissue injury of the skin, muscle, or organ systems induces an initial local inflammatory
response, which is followed by subsequent regenerative processes involving macrophages and other
immune cells, as well as mesenchymal stem cells (Novak and Koh, 2013). To devise an in vitro
model of the acute in vivo response to wounding, we prepared a supernatant from homogenized
skin (Figure 3a). This tissue homogenate provides a complex signal derived from components of dis-
rupted cells (damage associated molecular patterns; DAMPs), the skin microbiome (microbial associ-
ated molecular patterns; MAMPs), and factors residing in the extracellular matrix (e.g., TGFb). Tissue
homogenate was used to stimulate WT and Rev-erb DKO macrophages for 6 and 24 hr, followed by
RNA-Seq analysis. The gene expression signature of tissue homogenate-stimulated macrophages
showed both similarities and differences when compared to the responses observed after treatment
with TLR agonists, IL4, or TGFb (Figure 1b).
In parallel, we performed temporal transcriptomic analysis of biopsied wounds during wound
healing and compared them to unwounded skin (Figure 3a). Although myeloid cells represent only a
small fraction of the total cells analyzed in the wound biopsy, 5590 genes exhibited concordant
changes in expression with those observed following stimulation of macrophages with tissue homog-
enate (Figure 3b). Gene ontology analysis of this set of genes indicated significant enrichment for
biological process terms related to the response to wounding, immune response, and cell adhesion
(Figure 3c). Response to wounding was the most highly enriched gene ontology term associated
with genes de-repressed greater than two-fold in Rev-erb DKO tissue homogenate treated macro-
phages (282) followed by immune response and taxis (Figure 3d). De-repressed genes in Rev-erb
DKO macrophages with gene ontology annotations linked to response to wounding and immune
response are indicated in Figure 3e. These results indicate that tissue homogenate induces a Rev-
erb-sensitive program of macrophage gene expression that substantially overlaps with the pattern
of gene expression observed in response to wounding in vivo.
Genes characteristic of alternate polarization states are co-expressed
within individual cells
The approaches used thus far evaluated populations of cells. Genes associated with distinct polariza-
tion states resulting from activation with single ligands but exhibiting co-expression following treat-
ment with tissue homogenate could reflect co-expression at the single cell level or mutually
exclusive expression in subpopulations. To address this question, we performed RT-Q-PCR analysis
of mRNA isolated from single cells maintained under control conditions or treated with tissue
homogenate for 6 hr. We evaluated panels of mRNAs in triplicates corresponding to genes selec-
tively activated by LPS or LPS+IFNg, IL4, TGFb, or tissue homogenate signals, as well as informative
transcription factors and reference genes. After filtering for dead/duplicate cells and eliminating
probes with altered melting curves, data was obtained for 30 genes in 80 control cells and 70
homogenate-treated cells. The distributions of expression values of genes in individual cells under
Figure 3 continued
vitro stimulation with tissue homogenate. Mouse wound genes from Days 1, 4, 8, or 14 post-injury and macrophage tissue homogenate genes at 6 or
24 hr post-stimulation were compared to uninjured in vivo skin or unstimulated controls, respectively. Differentially expressed genes were those
induced or repressed more than 1.5-fold compared to baseline. Genes were clustered using k-means clustering (k = 10). For unstimulated macrophages
for 6 or 24 hr, N = 2, wound samples from Day 1, 8, or 14, N = 2, macrophages stimulated with tissue homogenate for 6 or 24 hr, N = 3, and wound
samples from Day 0, or 4, N = 4. (c) Summary of gene ontology analysis using DAVID (Huang et al., 2009a, 2009b) of overlapping wound healing and
homogenate genes shown in b (N = 5590). Figure 3—source data 1. (d) Summary of gene ontology analysis using DAVID (Huang et al., 2009a,
2009b) of genes de-repressed more than two-fold in Rev-erb DKO macrophages treated with tissue homogenate in comparison to WT macrophages
(maximum de-repression after tissue homogenate treatment for 6 or 24 hr, N = 282). (e) Bar graphs depicting representative genes de-repressed more
than two-fold (in log2 scale) in Rev-erb DKO macrophages after tissue injury (maximum de-repression after tissue homogenate treatment for 6 or 24 hr).
Genes correspond to those associated with response to wounding and immune response categories in panel d. N as described in 3b.
DOI: 10.7554/eLife.13024.007
The following source data is available for figure 3:
Source data 1. Source data for Figure 3b where each value represents the average normalized log2 fold change between the basal state and treat-
ment state per column.
DOI: 10.7554/eLife.13024.008
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Figure 4. Genes characteristic of alternate polarization states are co-expressed within individual cells. (a) Violin plots of expression values for genes in
the indicated categories as determined by single cell RT-Q-PCR from bone marrow derived macrophages treated for 6 hr with vehicle or tissue
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control or tissue homogenate treatment conditions are illustrated in Figure 4a. Cells treated with tis-
sue homogenate were clustered in a binary fashion, according to whether the gene was expressed
or not expressed. Notably, evaluating individual genes by column, a subset from each category of
polarization states is expressed in the majority of cells (e.g., Cxcl1, Dusp4, Cx3cr1, Pf4) (Figure 4b).
Conversely, evaluating the total set of genes across individual cells, genes from each polarization
state can be expressed at similar levels in the same cell (Figure 4c). Of interest, clustering revealed
two main groups that were distinguished by lack of detectable expression of Fos and Rela. Cells
lacking Fos and Rela expression also exhibit reduced expression of subsets of genes in the M(LPS) or
M(LPS+IFNg ), tissue homogenate, and transcription factor categories. Collectively, these findings
indicate that while there is substantial heterogeneity in gene expression at the single cell level,
genes characteristic of M(LPS) or M(LPS+IFNg), M(TGFb), and M(IL4) polarization states can be co-
expressed in individual cells.
Complex signals re-allocate transcription factors to novel genomic loci
To investigate mechanisms underlying effects of tissue homogenate on gene expression, we per-
formed chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-Seq) for his-
tone 3 lysine 27 acetylation (H3K27ac), a histone modification associated with active enhancers and
promoters (Creyghton et al., 2010), after 3 or 6 hr of control or tissue homogenate stimulation.
Treatment with tissue homogenate induced H3K27ac at ~2500 regions after 3 hr and ~5000 regions
after 6 hr (Figure 5a). De novo motif analysis revealed binding sites for Nrf2, AP-1, and NF-kB motifs
as among the most highly enriched sequences in these regions (Figure 5b).
Based on these motif findings, we initially performed ChIP-Seq analysis for p65 and Fos in macro-
phages treated with control or tissue homogenate. In addition, because SMAD motifs are difficult to
retrieve using de novo motif analysis and tissue homogenate stimulation resembled treatment with
TGFb (Figure 1b), we performed corresponding ChIP-Seq analysis of Smad3. In each case, we
observed that tissue homogenate induced a pattern of genomic binding sites that substantially dif-
fered from the pattern resulting from stimulation with the single ligands, KLA (p65 and Fos) or TGFb
(Smad3) (Figure 5c). These binding sites were also highly associated with tissue homogenate-induced
gain of H3K27ac, consistent with their contribution to these changes in active chromatin (Figure 5d).
Examples of the binding patterns of Fos, p65, Smad3, and PU.1 in the vicinity of highly regulated
genes are illustrated in Figure 6a, with responses of corresponding mRNAs to KLA, TGFb, and tissue
homogenate in WT and Rev-erb DKO macrophages shown in Figure 6b. Each genomic location con-
tains numerous binding sites for each factor. PU.1 and Fos exhibit a high degree of constitutive bind-
ing, consistent with roles as pioneering factors that collaborate with each other and other
macrophage lineage-determining factors, but also show quantitative changes in response to KLA
and tissue homogenate. Smad3 and p65 both exhibit strong signal-dependent increases in ChIP-Seq
signal at the majority of their binding sites. We note here that the starting conditions for KLA induc-
tion and tissue homogenate treatment differ, resulting in more constitutive binding of p65 in the
vehicle control for tissue homogenate experiments.
Overall, there is a strong co-occurrence of p65 and Smad3 with pre-existing binding of Fos and
PU.1, consistent with roles of these factors in establishing open regions of chromatin. Despite
exhaustive efforts, we were not successful in determining high-confidence cistromes for endogenous
Rev-erbs in BMDMs. We therefore considered the genomic locations of 7889 high-confidence bind-
ing sites occupied by both Rev-erba and Rev-erbb defined by ChIP-Seq of biotin-tagged proteins in
RAW264.7 macrophages (Lam et al., 2013). For the de-repressed genes in the Rev-erb DKO, such
as Cx3cr1, Mmp9, Arg1, and Socs3 (Figure 6a), strong Rev-erb peaks coincide with at least one
Figure 4 continued
homogenate. Y-axis shows RT-Q-PCR CTs. Higher values indicate lower expression (30: gene product could not be detected). Values are averaged over
3 PCR replicates per gene. (b) Hierarchical clustering with Euclidean distance of single bone marrow derived macrophages treated with tissue
homogenate based on expression (red) or lack of expression (blue) of the genes indicated at the top. Genes with alternating melting curves were
treated as undefined (grey). PCR replicates are shown sequentially (N = 3). (c) RT-Q-PCR expression values for genes indicated above for four
representative cells. Y-axis normalized to (30/CT) – 1. Higher values indicate higher expression (0: gene product could not be detected). Values are
averaged over 3 PCR replicates per gene.
DOI: 10.7554/eLife.13024.009
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Figure 5. Complex transcriptional signals re-allocate transcription factors to novel genomic loci. (a) H3K27ac regions differentially gained upon
treatment for 3 or 6 hr with tissue homogenate compared to treatment for 3 or 6 hr with the vehicle control. The heatmap shows a 6 kb window of
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nearby enhancer-like region occupied by PU.1 and/or Fos, as well as p65 and/or Smad3 (e.g.,
Figure 6a). Furthermore, the majority of Rev-erb binding sites identified in RAW264.7 macrophages
co-localize with binding sites for their obligate co-repressor NCoR in BMDMs, strongly suggesting
that Rev-erbs occupy a similar cistrome in these cells (Figure 6a).
Two observations were unexpected and noteworthy. First, a subset of enhancer-like regions occu-
pied by Smad3 in cells treated with TGFb were occupied by p65 in cells treated with KLA. Under
conditions of stimulation with either KLA or TGFb alone, the expectation is that these regions would
be occupied by one factor, but not the other. However, in the context of tissue homogenate treat-
ment, both factors are simultaneously bound (Figure 6a, yellow boxes). Second, and consistent with
the results presented in Figure 5c, tissue homogenate treatment leads to binding sites for p65 and
Smad3 that are not observed following treatment with KLA or TGFb, respectively (Figure 6a, blue
boxes). Furthermore, many of the new binding sites for p65 co-localize with Smad3 and vice versa.
Consistent with these findings at individual genomic locations, motif analysis of tissue homogenate-
specific SMAD binding sites (from Figure 5c) using TGFb-specific SMAD sites as the background
returned an NF-kB recognition motif as the second most highly enriched motif (Figure 7a).
To investigate whether co-localization of p65 and Smad3 in tissue homogenate-treated cells was
a specific consequence of the complex signal, we performed ChIP-Seq analysis of p65 in macro-
phages selectively treated with TGFb. We observed ~7400 p65 peaks, 5465 of which overlapped
with the 39,825 peaks for Smad3 observed in TGFb-treated cells, representing an overlap with 6% of
the Smad3 peaks (Figure 7b). In contrast, we observed 20,858 p65 peaks and 13,975 Smad3 peaks
in homogenate-treated cells, with p65 co-localizing with 11,379 (82%) of the Smad3 binding sites.
Therefore, the complex tissue homogenate signal drives substantial co-localization of p65 with
Smad3 that is not observed following selective treatment with TGFb. These relationships are further
illustrated for two representative genes, Arg1 and Cxcl2, in Figure 7c, in which yellow shading indi-
cates regions where tissue homogenate induced p65 binding to regions occupied by Smad3 under
either TGFb or tissue homogenate treatment, whereas blue shading indicates regions in which both
p65 and Smad3 binding are selectively observed following treatment with tissue homogenate.
Nrf2 target genes and Nrf2 genomic binding are induced by tissue
damage signals
Unexpectedly, the top enriched motif in tissue homogenate-specific SMAD sites is a binding site for
NFE2L2, also known as Nrf2 (Figure 7a). This was also the top motif recovered from motif analysis
of genomic regions exhibiting a gain in H3K27ac 3 hr following stimulation with tissue homogenate
(Figure 5b). Nrf2 is a latent basic leucine zipper (bZIP) protein that is activated in response to cell
injury and inflammation, and regulates the expression of antioxidant proteins that protect against
oxidative damage (Chen et al., 2015). Evaluation of RNA-seq data from both the in vivo wound
model and tissue homogenate-treated macrophages revealed up regulation of numerous Nrf2 target
genes, including Txn1, Sod2, Hmox1, Prdx6, and Nqo1, suggesting that Nrf2 is activated in macro-
phages as part of the wound response (Figure 7d). We therefore performed ChIP-Seq analysis for
Nrf2 in macrophages before and after tissue homogenate treatment. These experiments demon-
strated that tissue homogenate increased the genome-wide binding of Nrf2 at thousands of geno-
mic locations, a substantial fraction of which were observed to overlap with the tissue homogenate-
induced binding sites for p65, Fos, and Smad3 (e.g., Figure 6a).
Figure 5 continued
normalized H3K27ac tag counts of the 2510 or 5005 homogenate gained regions at 3 or 6 hr, respectively, centered on the nucleosome free region
(nfr). Input shows genomic background at these regions. N = 1. (b) Motifs enriched in the vicinity of gained H3K27ac sites after treatment with tissue
homogenate for 3 or 6 hr using de novo motif enrichment analysis. (c) Comparison of Fos, p65, or Smad3 tag counts at genomic regions that contain
Fos, p65, or Smad3 binding after stimulation with KLA, TGFb, or tissue homogenate. Peaks found to be differentially gained (four-fold more tags) with
KLA or TGFb are colored red, while peaks found to be differentially gained (four-fold more tags) upon tissue homogenate treatment are colored blue.
N = 1. (d) Quantification of H3K27ac, Fos, p65, and Smad3 ChIP-Seq tag counts in the 6 hr vehicle or tissue homogenate treated states centered on
homogenate gained (using HOMER) Fos, p65, or Smad3 binding events. Dashed lines represent ChIP-Seq signal of the vehicle state and solid lines
represent the signal after 6 hr of tissue homogenate stimulation. Blue represents H3K27ac signal, orange represents signal of the respective
transcription factor. N = 1.
DOI: 10.7554/eLife.13024.010
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Tissue damage signals drive co-localization of PU.1, p65, Fos, Smad3,
and Nrf2
To further explore the signal-dependent binding patterns of p65, Fos, Smad3, and Nrf2, we per-
formed unbiased hierarchical clustering using peaks gained after stimulation with tissue homogenate
or single stimuli. This analysis revealed that genomic occupancy of PU.1, Smad3, Nrf2, Fos, and p65
was most similar upon treatment of macrophages with the tissue homogenate signal, whereas pat-
terns of transcription factor binding were more varied upon treatment of macrophages with individ-
ual stimuli (Figure 7e). This co-binding of transcription factors is further emphasized when
comparing the overlap of the investigated transcription factors upon treatment of cells with tissue
homogenate or the vehicle control (Figure 7f and g). This approach demonstrated co-localization of
only 1.4% (893) of peaks in the vehicle state, which increased to 12.05% (7758) overlap when cells
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Figure 6. Locus-specific effects of Rev-erbs and signal-dependent transcription factors. (a) UCSC genome browser images depicting the genomic
regions surrounding Rev-erb target genes, Cx3cr1, Mmp9, Arg1, or Socs3. The image shows the co-localization of PU.1, Rev-erbs, Fos, Nrf2, p65, and
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For unstimulated 6 hr and 24 hr samples, N = 2, samples stimulated with KLA, tissue homogenate for 6 or 24 hr or TGFb for 9 or 29 hr, N = 3.
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were treated with tissue homogenate. This eight-fold increase in co-localization suggests that the
combination of signals present in tissue homogenate induce co-binding of multiple transcription fac-
tors to enhancers that mediate the tissue injury response.
NFkB, Smad, Nrf2, and Rev-erb signaling pathways contribute to the
integrated tissue damage response
Tissue homogenate contains a combination of DAMPs, MAMPs and other factors that have the
potential to activate numerous signaling pathways. While ChIP-Seq experiments documented that
tissue homogenate induces genomic binding of p65, Smad3, and Nrf2, these studies do not estab-
lish functional roles of these factors in the integrated transcriptional response. To address this ques-
tion, we evaluated effects of chemical inhibitors of NF-kB, Smad3, and Nrf2 on gene expression in
tissue homogenate-treated macrophages, using the IKK inhibitor VII to inhibit NF-kB activity, SB-
43154 to inhibit TGFb signaling, and glutathione to block the activation of Nrf2 (Figure 8a–c). These
studies support the idea that each factor contributes to the integrated response to tissue homoge-
nate. For example, activation of Cx3cr1 by tissue homogenate was decreased upon targeting the
NF-kB, TGFb receptor, and Nrf2 pathways, supporting the involvement of all of these pathways in
the regulation of this gene. Conversely, tissue homogenate activation of other genes was more
dependent on specific signal-dependent pathways. For instance, Dusp5 activation was sensitive to
NF-kB inhibition (Figure 8a) while Nptx1 activation was unaffected by NF-kB inhibition (Figure 8a).
Surprisingly, Socs3 activation was sensitive to both inhibition of NF-kB and TGFb receptor signaling
(Figure 8a and b) and Ctla2b was selectively sensitive to inhibition of TGFb receptor signaling
(Figure 8b). Established Nrf2 target genes Txn1 and Hmox1, which were also induced by tissue
homogenate, were repressed by glutathione co-treatment (Figure 8c). Finally, we investigated the
ability of the Rev-erb agonist SR-9009 to influence the responses to tissue homogenate. This agonist
repressed a subset of genes in tissue homogenate-treated macrophages, exemplified by Cx3cr1,
Gpr84, and Pgd (Figure 8d). These results are consistent with these genes being de-repressed in
Rev-Erb DKO macrophages.
Discussion
Rev-erbs have been established to play general roles in the regulation of promoters of ubiquitously
expressed genes such as Bmal that control the circadian rhythm (Preitner et al., 2002; Liu et al.,
2008; Cho et al., 2012). However, the great majority of Rev-erb binding sites in macrophages are
located at cell-specific enhancers, which are selected by macrophage lineage-determining factors
such as PU.1 (Lam et al., 2013). These observations predicted that in addition to cell autonomous
regulation of the circadian rhythm, Rev-erbs would also regulate a macrophage-specific program of
gene expression. Here, using loss of function, transcriptomic, and epigenetic analyses, we demon-
strate that Rev-erbs function to repress a network of genes associated with the response to wound-
ing. Consistent with altered transcriptional responses observed in vitro, loss of Rev-erb expression in
cells derived from the bone marrow compartment resulted in accelerated wound healing in the skin.
As the Rev-erbs are deleted from all hematopoietic lineages in these experiments, further studies
will be required to establish the relative contributions of macrophages and other bone marrow-
derived cells to this phenotype. How this function of Rev-erbs might contribute to normal tissue
homeostasis is as yet unclear. In vivo, Rev-erb expression is circadian (Cho et al., 2012), implying
that the effects on macrophage gene expression observed in the present studies are likely to vary
over the course of the day. Rev-erbs may thus act in a circadian manner to regulate aspects of tissue
macrophage gene expression required for the normal turnover of extracellular matrix, tissue remod-
eling, and wound healing.
By evaluating the consequences of Rev-erb deficiency on macrophage gene expression in
response to distinct polarizing signals in vitro, we found that the consequences of loss of function of
Rev-erbs were dependent on the specific polarizing signal. Consistent with this, Rev-erbs co-localize
with NF-kB p65 and AP-1 family member Fos at enhancers activated by TLR ligands, and with
Smad3 at enhancers activated by TGFb. Although of interest from a mechanistic standpoint, these
findings are of uncertain relevance to functions of macrophages within tissue environments, which
contain a multitude of signaling molecules that are sensed simultaneously. To model the complex
environment associated with acute tissue damage, we treated macrophages with a supernatant of a
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Figure 7. Signal-dependent transcription factors collaborate in response to complex stimuli. (a) Motifs enriched in the vicinity (200 bp) of Smad3
binding sites that are specific to tissue homogenate (induced four-fold), as compared to Smad3 binding sites that are specific to TGFb (induced four-
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skin homogenate. While the specific identities and concentrations of the DAMPs, MAMPs, and other
bioactive molecules in this homogenate are unknown, we provide evidence that the transcriptomic
response of the macrophage to this mixture overlaps significantly with the transcriptional response
observed in a skin wound, thereby validating its use. Through ChIP-Seq experiments, we demon-
strate that this complex signal coordinately induces binding of NF-kB, AP-1, and Smad transcription
factors. Furthermore, de novo motif analysis of activated enhancers led to the unexpected discovery
that the tissue damage signal also acutely activates Nrf2. This finding illustrates the utility of
enhancer analysis to identify transcriptional mediators of unknown environmental factors, providing
a basis for subsequent directed analysis of corresponding upstream signaling pathways. Accordingly,
the use of glutathione to neutralize reactive oxygen species, thus blocking the downstream disrup-
tion of the Kelch-like ECH-associated protein 1 (Keap1)-Cuilin 3 (Cul3) complex required for activa-
tion of Nrf2 (Gorrini et al., 2013; Shibata et al., 2013) provides evidence for its functional
importance in the transcriptional response to the tissue damage signal. Similarly, the use of inhibitors
of NF-kB and TGFb provided corresponding support for functionally important roles of these tran-
scription factors. Of course, there are likely to be many other signaling pathways and downstream
transcription factors involved in the tissue damage response. Furthermore, Rev-erb deficiency likely
modifies both basal and signal dependent transcriptional programs. To distinguish between ’prior’
versus ’post-activation’ roles of Rev-erbs in macrophages during wound healing may require the use
of inducible Cre-expression strategies, as well as measurements of target gene expression in situ in
macrophage infiltrated wounds.
Three additional observations are of particular interest. The first is that the complex signal pro-
vided by tissue homogenate induced co-expression of genes characteristic of distinct macrophage
polarization states within individual cells. Second, we found that the tissue homogenate signal
induced different genomic locations of p65, Fos, and Smad3 than were observed following KLA or
TGFb, respectively, resulting in co-binding at a large number of enhancer-like regions in the vicinity
of tissue homogenate-induced genes. An important implication of these findings is that transcription
factors binding maps are context-dependent and must be interpreted accordingly. We speculate
that the observed co-localization of factors in response to the complex signal enables the appropri-
ate integration of multiple relevant signaling components necessary for the initial acquisition of a
wound repair phenotype (Figure 8e). Third, the present findings may have practical applications
based on the development of small molecules that enhance or inhibit Rev-erb repressive activity
(Solt et al., 2012). Delayed wound healing is observed in a number of pathological contexts, includ-
ing in diabetics (Falanga, 2005; Sen et al., 2009) and in immunocompromised individuals
(Chen et al., 2013; Lin et al., 2011). In these settings, it is possible that Rev-erb antagonists could
be evaluated as a means of enhancing wound repair. Alternatively, a large number of devastating
and largely untreatable diseases are characterized by exaggerated tissue fibrosis, such as idiopathic
pulmonary fibrosis, interstitial renal fibrosis, and liver fibrosis (Schuppan and Kim, 2013). We dem-
onstrate that a Rev-erb agonist can suppress a subset of genes that are de-repressed in the Rev-erb
DKO and are regulated by the complex wound signal. Overall, our findings suggest that Rev-erbs
act to repress a specific combination of genes downstream of multiple signaling pathways that col-
lectively function in an integrated manner to promote the response to wounding (Figure 8e). It will
therefore be of interest to evaluate whether defects in Rev-erb signaling are associated with these
diseases and whether pharmacological modulation of Rev-erb might be of therapeutic benefit.
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fold) using de novo motif enrichment analysis. (b) Venn diagrams depicting overlap of Smad3 and p65 after treatment with TGFb (left) or tissue
homogenate (right). Peaks have a minimal normalized tag count of 16. N = 1. (c) UCSC genome browser images depicting the genomic regions
surrounding genes highly induced by tissue homogenate and not by TGFb. Yellow denotes gain of signal-dependent transcription factor peaks (p65 or
Smad3) after tissue homogenate stimulation that is not seen after treatment with one single polarizing signal. Blue denotes gain of signal-dependent
transcription factor peaks (p65 and Smad3) after tissue homogenate stimulation that is not seen after treatment with either single polarizing signal. (d)
Bar graphs depicting canonical Nrf2 genes induced during stimulation with tissue homogenate (green and blue) or during wound healing (purple and
red). N as described in 3b. (e) Heatmap showing the log2 fold change of transcription factor tag counts at all genomic regions (minimum of 64
normalized tag counts in at least one condition per row) that are differentially gained (four-fold more tags) after stimulation as indicated. N = 1. (f)
Chow-Ruskey Venn diagrams depicting the overlap of all p65, PU.1, Fos, Smad3, and Nrf2 peaks after treatment with vehicle. Peaks have a minimal
normalized tag count of 16. N = 1. (f) Same as (g) but depicting the overlap of all peaks gained after treatment with tissue homogenate. N = 1.
DOI: 10.7554/eLife.13024.012
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Figure 8. Chemical inhibition of multiple signal-dependent pathways results in decreased response to complex tissue homogenate. (a) Box and whisker
plots of expression values for genes as determined by RT-Q-PCR from bone marrow derived macrophages treated with tissue homogenate for 6 hr,
Figure 8 continued on next page
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Materials and methods
Cell culture
Mouse bone marrow derived macrophages were obtained and cultured as previously described
(Heinz et al., 2010). For cytokine stimulation studies, macrophages were cultured in RPMI-1640
(Invitrogen, Waltham, MA) supplemented with 16.7 ng/ml CSF1 (Shenandoah
Biotechnology, Warwick, PA) and 0.5% heat-inactivated fetal bovine serum (FBS)
(Hyclone, Logan, UT) overnight and then stimulated with Pam3CSK4 (300 ng/ml, InvivoGen, San
Diego, CA), polyinosinic-polycytidylic acid (50 ng/ml, GE Healthcare Bioscience, Pittsburgh, PA),
KDO2-Lipid A (100 ng/ml, Avanti Polar Lipids, Alabaster, AL), recombinant interferon g (10 U/ml,
R&D Systems, Minneapolis, MN), interleukin 4 (20 ng/ml, R&D Systems), or tumor growth factor b (1
ng/ml, Cell Signaling, Danvers, MA) for the indicated time points. For ChIP-Seq experiments, cells
treated with TGFb or KLA were compared to untreated cells as a control.
For whole-skin tissue homogenate studies, skin from shaved wild type congenic mice was har-
vested and homogenized in RPMI-1640 supplemented with 0.5% heat-inactivated FBS using a Pre-
cellys 24 tissue homogenizer (6500 RPM, 4  20 s) and metal beads (2.8 mm beads, 2 mL tubes,
Cayman Chemical, Ann Arbor, MI) according to the manufacturer’s instructions. Skin homogenate
was then centrifuged at 4000 RPM for 30 min at 4˚C, and the supernatant filtered through a 0.2 mm
filter (Nalgene, ThermoScientific, Rochester, NY). Approximately 50 ml of tissue homogenate was
collected per mouse. To stimulate macrophages, macrophages were cultured in RPMI-1640 (Invitro-
gen) supplemented with 16.7 ng/ml CSF1 and 0.5% heat-inactivated FBS overnight. The following
morning, the media was switched to either tissue homogenate or vehicle. 16.7 ng/ml CSF1 was
added exogenously to both the homogenate and vehicle treatment conditions. For RNA-Seq repli-
cates using BMDMs (where applicable), bone marrow of several mice were pooled and then cultured
in different wells and processed independently.
For inhibitor experiments, macrophages were generated and cultured as described above, then
pre-treated with 1 mM IKK inhibitor VII (Calbiochem, Billerica, MA), 12.5 mM TGFb RI kinase inhibitor
SB-43154 (Calbiochem), or 5 mM Rev-erb agonist SR-9009 (Burris laboratory) (Lewis et al., 2013) for
1 hr before treatment with tissue homogenate. For anti-oxidant experiments, macrophages were co-
treated with tissue homogenate and 15 mM glutathione (Sigma, St. Louis, MO).
Rev-erb DKO mice and genotyping
Rev-erba and Rev-erbb double floxed mice were generated as previously described (Cho et al.,
2012) and crossed with Tie2-Cre (Lam et al., 2013). Breeding and genotyping were performed as
previously described (Lam et al., 2013). Only males were used for wound healing experiments while
both males and females were used for flow cytometry experiments to enumerate monocyte popula-
tions from peripheral blood. Littermates without the Tie2-Cre transgene were used as WT controls.
All animal procedures were performed in accordance with the University of California, San Diego
research guidelines for the care and use of laboratory animals (Permit Number: S01015).
RNA isolation and RT-Q-PCR
Total RNA was harvested from tissue and cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany)
with in column DNase digestion performed according to the manufacturer’s instructions. DNase-
Figure 8 continued
and pre-treated for 1 hr with vehicle (gray) or 1 mM IKK inhibitor VII (pink). Y-axis shows RT-Q-PCR -(Delta CT), which is normalized to the housekeeping
gene 36B4. Lower values indicate lower expression. N = 8 mice. p-values are shown comparing vehicle versus inhibitor treatment as determined by
unpaired t-test. (b) Same as (a) but with pre-treatment for 1 hr with vehicle (gray) or 12.5 mM TGFb inhibitor SB-43154 (green). N = 8 mice. (c) Same as
(a) but samples were co-treated with tissue homogenate and vehicle (gray) or tissue homogenate and 15 mM glutathione (orange) for 6 hr. N = 6 mice.
(d) Same as (a) but with pre-treatment for 1 hr with vehicle (gray) or 15 mM Rev-erb agonist SR-9009 (blue). N = 6 mice. (e) Working model showing that
signal-specific stimuli (KLA/TGFb/oxidative stress) activate their respective signal-dependent transcription factors, NF-kB, Smads, and Nrf2, which bind
to distinct sets of enhancers and promoters. Tissue damage signal activates all three factors simultaneously, which can co-occupy enhancers and
promoters to generate a transcriptional response that is different than the sum of TGFb, KLA, and oxidative stress mediated signaling. A subset of
these sites that are co-bound and repressed by Rev-erbs are involved in regulating the macrophage response to wounding.
DOI: 10.7554/eLife.13024.013
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treated RNA was used for cDNA synthesis using Superscript III (Invitrogen) according to the manufac-
turer’s instructions.
For the IKK inhibitor VII and TGFb inhibitor experiments, cDNA from biological replicates (N = 8)
were assessed by quantitative polymerase chain reaction using SYBR GreenER Master Mix (Invitro-
gen) or SYBR Fast qPCR Master Mix (Kapa Biosystems, Wilmington, MA) on an Applied Biosystems
7300 Real-time PCR system or Step One Plus. For the glutathione and Rev-erb agonist experiments,
cDNA from biological replicates (N = 6) were synthesized and assessed in technical triplicates by
quantitative PCR using a Fluidigm Biomark HD (Fluidigm, San Francisco, CA). For statistical analysis,
the delta CT was calculated for each biological replicate using 36b4 as the reference gene. Data
were compared statistically using the t-test command in R.
Single Cell RT-Q-PCR and analysis
BMDMs on petri plates were treated for 6 hr with vehicle or tissue homogenate in the presence of
recombinant CSF-1. Following treatment, cells were removed by scraping and captured on a Fluid-
igm 17–25 micrometer C1 Single-Cell Auto Prep Array IFC or a 10–17 micrometer C1 Single-Cell
Auto Prep Array IFC for homogenate or vehicle treated cells, respectively, according to the manufac-
turer’s instructions. IFC positions having a single viable cell were noted and gene specific priming
and pre-amplification was performed using the Fluidigm C1 instrument and the instrument protocol
number 100–4904 H1. After cDNA synthesis, samples were harvested and stored at  20˚C prior to
detection of cDNA using Fluidigm 96.96 Dynamic arrays using the instrument protocol number 100–
9792 A1. cDNA from individual cells was assessed in triplicate using the primers listed below.
For analysis of the data, melting curves of the triplicates were compared and samples with different
melting curves or melting curves with more than one product were defined as NA. Gene products that
could not be detected by Q-PCR were set to a CT of 30. A majority analysis was applied to the tripli-
cates to calculate the average CT per primer pair per single cell (for violin plots [Font-Vizcarra et al.,
2012]). Data was converted into binary data for gene expression heatmap, using 1 for expressed, 0 for
not expressed (CT equals 30) and NA for undetermined. For cases where one sample of the triplicates
had value 1, one had value 0 and one had value NA, NA was used as consensus. The heatmap for sin-
gle cell analysis was created using hierarchical clustering with Euclidian distance in R.
RT-Q-PCR Primers
Gene target Primer sequence
Arg1-Forward TTTTAGGGTTACGGCCGGTG
Arg1-Reverse CCTCGAGGCTGTCCTTTTGA
Cd14-Forward CAGAGAACACCACCGCTGTA
Cd14-Reverse CACGCTCCATGGTCGGTAGA
Cd86-Forward CAGCACGGACTTGAACAACC
Cd86-Reverse CTCCACGGAAACAGCATCTGA
Ctla2b-Forward CTCATGCACCACTAGCCTCC
Ctla2b-Reverse AGCAGGAAGACAGCACTGAA
Cx3cr1-Forward CCATCTGCTCAGGACCTCAC
Cx3cr1-Reverse CACCAGACCGAACGTGAAGA
Cxcl1-Forward ACCCAAACCGAAGTCATAGCC
Cxcl1-Reverse TTGTCAGAAGCCAGCGTTCA
Cxcl2-Forward TGAACAAAGGCAAGGCTAACTG
Cxcl2-Reverse CAGGTACGATCCAGGCTTCC
Cxcl3-Forward ACCCAGACAGAAGTCATAGCCA
Cxcl3-Reverse CTTCATCATGGTGAGGGGCT
Dusp4-Forward CATCGAGTACATCGACGCAG
Dusp4-Reverse ATGAAGCTGAAGTTGGGCGA
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Dusp5-Forward GCACCACCCACCTACACTAC
Dusp5-Reverse CCTTCTTCCCTGACACAGTCAAT
Fos-Forward TTTCAACGCCGACTACGAGG
Fos-Reverse TCTGCGCAAAAGTCCTGTGT
Gpc1-Forward GCCATGGAACTCCGGACC
Gpc1-Reverse GCAGGTGCTCACCCGAGAT
Gpr84-Forward AAACTGGGAACCTCAGTCTCCA
Gpr84-Reverse GCCCAACACAGACTCATGGTA
Hmox1-Forward GAGCAGAACCAGCCTGAACT
Hmox1-Reverse AAATCCTGGGGCATGCTGTC
Hprt-Forward GTTGGGCTTACCTCACTGCT
Hprt-Reverse TCATCGCTAATCACGACGCT
Igsf11-Forward GTGTCGCTGCTCGGTGT
Igsf11-Reverse AGAATGACCTGTTCGGGCTG
Il10-Forward GGTTGCCAAGCCTTATCGGA
Il10-Reverse GGGGAGAAATCGATGACAGC
Il1b-Forward TGCCACCTTTTGACAGTGATG
Il1b-Reverse TGATGTGCTGCTGCGAGATT
Il1r1-Forward GCTGACTTGAGGAGGCAGTT
Il1r1-Reverse CATACGTCAATCTCCAGCGAC
Nptx1-Forward TGGAGAACCTCGAGCAGTACA
Nptx1-Reverse GTCAAGGCGCTCTCGATCTT
Pf4-Forward CCCGAAGAAAGCGATGGAGAT
Pf4-Reverse TTCAGGGTGGCTATGAGCTGG
Pgd-Forward CTCCTCGACTCTGCTTCGTC
Pgd-Reverse GCACAGACCACAAATCCATGA
Polr3c-Forward TCTAAGAAGGGGCGATGGGA
Polr3c-Reverse AGCCTCAGAACTCAGGGTCG
Ptgs2-Forward AGCCAGGCAGCAAATCCTT
Ptgs2-Reverse GGGTGGGCTTCAGCAGTAAT
Rela-Forward CGGATTCCGGGCAGTGAC
Rela-Reverse GAGGGGAAACAGATCGTCCA
Smad3-Forward AAGAAGCTCAAGAAGACGGGG
Smad3-Reverse CAGTGACCTGGGGATGGTAAT
Socs3-Forward TAGACTTCACGGCTGCCAAC
Socs3-Reverse CGGGGAGCTAGTCCCGAA
Spi1-Forward AAGCAGGGGATCTGACCAAC
Spi1-Reverse AGTCATCCGATGGAGGGGC
Thbs1-Forward GACAATTTTCAGGGGGTGCT
Thbs1-Reverse AGAAGGACGTTGGTAGCTGAG
Tnf-Forward GATCGGTCCCCAAAGGGATG
Tnf-Reverse GTGGTTTGTGAGTGTGAGGGT
Tnfrsf12a-Forward CAATCATGGCTTCGGCTTGG
Tnfrsf12a-Reverse CTGCGGCGCCTGGTG
Traf3ip2-Forward CCTGCTCCACCACTTACCTG
Traf3ip2-Reverse TCTAGTTTCTAAGATCGCCACCG
Txn1-Forward AGCCCTTCTTCCATTCCCTC
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Txn1-Reverse GGAAGGTCGGCATGCATTTG
Ube2d2a-Forward AGCTGAGTGGGGCCTCG
Ube2d2a-Reverse TCAATTCCTTGTGGATTCTCTTCA
RNA-Seq
Detailed protocols for RNA-Seq experiments have been previously described (Kaikkonen et al.,
2013; Heinz et al., 2013). Briefly, total RNA was isolated using TRIzol LS (ThermoFisher Scientific)
and resuspended with UltraPure water (ThermoFisher Scientific) supplemented with 1 m/mL SUPER-
ase-In (Ambion) then treated with TURBO DNA-free kit (Ambion). Poly(A) selection was performed
using the MicroPoly(A)Purist kit (Invitrogen) according to the manufacturer’s instructions. Poly(A)
RNA was fragmented using RNA Fragmentation Reagents (Ambion) for 10 min at 70˚C and purified
by running through a Micro Bio-Spin P-30 column (Bio-Rad, Irvine, CA) according to the manufac-
turer’s instructions. 30 ng RNA was utilized for subsequent library preparation.
For the following RNA samples: two replicates of the four day 0 in vivo wound samples, day 1
wound samples, day 4 wound samples, and day 14 wound samples, RNA library preparation was
performed as previously described (Kaikkonen et al., 2013). Fragmented RNA was de-phosphory-
lated using 1 mL T4 polynucleotide kinase (New England Biolabs, Ipswich, MA) and 5 mL 5x PNK
buffer (0.5 M MES, 50 mM MgCl2, 50 mM mercaptoethanol, 1.5 M NaCl, pH 5.5–5.8) supplemented
with 1 m/mL SUPERase-In for 45 min at 37˚C, an additional 1 mL T4 polynucleotide kinase was added
to the reaction, followed by incubated for 45 min, and subsequent heat-inactivation for 5 min at
70˚C and ethanol precipitation overnight with glycogen. The pellet was resuspended in 5.5 mL nucle-
ase free water supplemented with 1 m/mL SUPERase-In and denatured for 5 min at 65˚C. Poly(A)-tail-
ing reaction was performed using 3.75 m E. coli poly(A)-polymerase (New England Biolabs) in 10x
poly(A)-polymerase buffer supplemented with ATP (50:1 molar ratio to RNA) and 1 m/mL SUPERase-
In for 30 min at 37˚C. Reverse transcription was performed using Superscript III (Invitrogen). 8 mL
RNA from the previous reaction, 1 mL 10 mM dNTP and 1 mL of the following oligo with custom
barcodes (underlined and bolded): 5’-Phos CA/TG/AC/GT-GATCGTCGGACTGTAGAACTCT/idSp/
CAAGCAGAAGACGGCATACGATTTTTTTTTTTTTTTTTTTTVN-3’ were incubated for 3 min at 75˚C
and then chilled on ice. 1.7 mL 10x RT buffer, 3 mL 25 mM MgCl2, 1.7 mL 0.1 M DTT, 0.5 mL SUPER-
ase-In, and 0.9 mL Superscript III reverse transcriptase was added to the reverse transcription reac-
tion and then incubated for 30 min at 48˚C. After cDNA synthesis, 2 mL exonuclease I (New England
Biolabs) was added to the reaction and incubated for 30 min at 37˚C. The enzyme was inactivated
and RNA hydrolyzed by adding 1 ml of 2 M NaOH and incubating for 20 min at 98˚C. The reaction
was then neutralized with 1 ml 2 M HCl. The cDNA was run on a 10% TBE-Urea gel (Invitrogen) and
the gel was stained using SYBR gold (ThermoFisher Scientific). cDNA sized ~120–350 nucleotides
were cut, gel purified, and precipitated overnight with ethanol and glycogen. Afterwards, cDNA was
circularized by resuspending precipitated DNA in 10 ml circularization mix (7.5 ml of water, 1 ml 10x
Reaction Buffer (Epicentre, Madison, WI), 0.5 ml of 1 mM ATP (final 0.05 mM), 0.5 ml of 50 mM
MnCl2 (final 2.5 mM), 0.5 ml CircLigase (100 m/ml), (Epicentre)). Circularization was performed for 1 hr
at 60˚C, and the reaction was heat-inactivated for 15 min at 85˚C. Circular single-stranded DNA was
re-linearized by adding 3.3 ml of re-linearization mix (4x mix containing 100 mM KCl and 2 mM DTT)
followed by 1 ml of APE 1 (15 m; New England Biolabs). The reaction was incubated for 45 min at
37˚C; an additional 1 ml APE 1 was added and the reaction was incubated for another 45 min. The
enzyme was inactivated by incubating for 20 min at 65˚C. The cDNA was amplified for 10–14 cycles
using 0.1 ml Phusion polymerase (New England Biolabs), 2 ml 5x HF buffer, 0.2 ml 10 mM dNTP, 1 ml
5 M betaine, 4.7 ml water, and 0.5 ml of the following 10 mM primers: 5’-CAA GCA GAA GAC GGC
ATA-3’ and 5’-AAT GAT ACG GCG ACC ACC GAC AGG TTC AGA GTT CTA CAG TCC GACG-3’.
The subsequent product was then gel purified from a 10% TBE gel (Invitrogen) using the ChIP DNA
Clean & Concentrator Kit (Zymo Research Corporation, Irvine, CA).
For the following RNA-Seq samples: one replicate of no treatment 6 hr, one replicate of no treat-
ment 24 hr, three replicates of polyinosinic-polycytidylic acid treatment 6 hr, two replicates of
Pam3CSK4 treatment 6 hr, one replicate of Kdo2-lipid A treatment 6 hr, one replicate of IL4 treat-
ment 24 hr, and one replicate of Kdo2-lipid A and interferon-g treatment 24 hr, strand-specific RNA
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sequencing libraries were prepared from poly(A) mRNA using a method similar to that previously
described (Wang, 2011) with modifications described herein. Briefly, poly(A) enriched mRNA was
fragmented, in 2x Superscript III first-strand buffer with 10 mM DTT (Invitrogen), by incubation at
94˚C for 9 min, then immediately chilled on ice before the next step. The 10 mL of fragmented
mRNA, 0.5 mL of random primer (Invitrogen), 0.5 mL of Oligo dT primer (Invitrogen), 0.5 mL of
SUPERase-In (Ambion), 1 mL of dNTPs (10 mM), and 1 mL of DTT (10 mM) were heated at 50˚C for
three minutes. At the end of incubation, 5.8 mL of water, 1 mL of DTT (100 mM), 0.1 mL Actinomycin
D (2 mg/mL), 0.2 mL of 1% Tween-20 (Sigma), and 0.2 mL of Superscript III (Invitrogen) were added
and incubated in a PCR machine using the following conditions: 25˚C for 10 min, 50˚C for 50 min,
and a 4˚C hold. The product was then purified with RNAClean XP beads according to manufacturer’s
instructions and eluted with 10 mL nuclease-free water. The RNA/cDNA double-stranded hybrid was
then added to 1.5 mL of Blue Buffer (Enzymatics, Beverly, MA), 1.1 mL of dUTP mix (10 mM dATP,
10 mM dCTP, 10 mM dGTP, and 20 mM dUTP), 0.2 mL of RNAse H (5 m/mL), 1.05 mL of water, 1 mL
of DNA polymerase I (Enzymatics), and 0.15 mL of 1% Tween-20. The mixture was incubated at 16˚C
for 1 hr. The resulting dUTP-marked dsDNA was purified using 28 mL of Sera-Mag Speedbeads
(Thermo Fisher Scientific), diluted with 20% PEG8000, 2.5 M NaCl to final of 13% PEG, eluted with
40 mL EB buffer (10 mM Tris-HCl, pH 8.5), and frozen at  80˚C. The purified dsDNA (40 mL) subse-
quently underwent end repair by blunting, poly(A)-tailing, and adapter ligation as described below.
All other RNA-Seq samples were prepared as described (Heinz et al., 2013). After RNA fragmen-
tation and re-buffering with the Micro Bio-Spin P-30 column (Bio-Rad) according to the manufac-
turer’s instructions, samples were resuspended with 16.5 ml of water. For de-capping using tobacco
acid pyrophosphatase (TAP) (Epicentre), the following was added to the reaction: 2 ml 10x TAP
buffer, 1 ml (20 m) SUPERase-In (Ambion), 0.5 ml TAP; the reaction was then incubated for 2 hr at
37˚C. Samples were then 3’ de-phosphorylated using T4 polynucleotide kinase (New England Biol-
abs); 0.5 ml 10x TAP buffer, 1.5 ml water, 0.5 ml 0.25 M MgCl2, 0.5 ml 10 mM ATP, and 1 mL PNK was
added to the reaction and incubated for 50 min at 37˚C. After de-phosphorylation, samples were
subsequently 5’ phosphorylated using T4 polynucleotide kinase in order to facilitate subsequent
adapter ligation processes; 10 mL 10x T4 DNA ligase buffer, 63 mL water, and 2 mL PNK was added
to the reaction and incubated for 60 min at 37˚C. TRIzol LS was used to quench the reaction and
extract phosphorylated RNA. RNA was resuspended in 4.5 mL water. For indexed library preparation,
the 3’ adapter (0.5 mL 9 mM of a 5’-adenylated sRNA 3’ MPX adapter /5Phos/AG ATC GGA AGA
GCA CAC GTC TGA /3AmMO/ (Integrated DNA Technologies, San Jose, CA)) was heat-denatured
together with the RNA for 2 min at 70˚C, placed on ice, and ligated with 100 m truncated T4 RNA
ligase 2 (K227Q, New England Biolabs) in 10 ml 1x T4 RNA ligase buffer without ATP, containing 20
m/mL SUPERase-In and 15% PEG8000 for 2 hr at 16˚C. Afterwards, 0.5 mL 10 mM MPX_RT primer 5’-
GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC T-3’ (Integrated DNA Technologies,
desalted) was added and annealed to the ligation product by incubating at 75˚C for 2 min, then
37˚C for 30 min, then 25˚C for 15 min. To ligate the 5’ adapter, 0.5 ml 5 mM hybrid DNA/RNA sRNA
5’h adapter 5’-GTT CAG AGT TCT ACA rGrUrC rCrGrA rCrGrA rUrC-3’ (Integrated DNA Technolo-
gies) was ligated to the 5’ end by adding 2 ml T4 RNA ligase buffer, 6 ml 50% PEG8000, 1 ml 10 mM
ATP, 9.5 mL water, and 0.5 ml T4 RNA ligase 1 (New England Biolabs) for 90 min at 20˚C. The reac-
tion was then split in half (15 ml each) and 0.5 mL 10 mM MPX_RT primer was added to one 15 mL
reaction. The reactions were incubated at 70˚C for 1 min, then placed on ice. Reverse transcription
was performed by adding 3 mL 10x RT buffer, 4.5 mL water, 1.5 mL 10 mM dNTP, 3 mL 0.1 M DTT,
1.5 mL RNaseOUT, and 1 mL Superscript III reverse transcriptase, then incubating for 30 min at 50˚C.
The cDNA was amplified for 10–14 cycles using 0.5 mL Phusion polymerase, 10 mL 5x HF buffer, 1 mL
10 mM dNTP, 5 mL 5 M betaine, and 0.25 mL of the following 100 mM primers: 5’-AAT GAT ACG
GCG ACC ACC GAC AGG TTC AGA GTT CTA CAG TCC GAC G-3’ and TruSeq-compatible
indexed primers (e.g. 5’-CAA GCA GAA GAC GGC ATA CGA GAT iii iii GTG ACT GGA GTT CAG
ACG TGT GCT CTT-3’ (desalted, Integrated DNA Technologies, i signifies index nucleotides)). The
subsequent product was then size selected for 175–225 base pair product and gel purified from a
10% TBE gel (Invitrogen) using the ChIP DNA Clean & Concentrator Kit. Libraries were PCR-ampli-
fied for 9–14 cycles, size selected by gel extraction, and quantified using the Qubit dsDNA HS Assay
Kit (Thermo Fisher Scientific).
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ChIP-Seq
Previously published Rev-erba and Rev-erbb ChIP-Seq, and NCoR ChIP-Seq experiments, deposited
as GSE45914 (Lam et al., 2013) and GSE27060 (Barish et al., 2012), respectively, were utilized for
analyses. Detailed protocols for ChIP-Seq experiments have been previously described
(Kaikkonen et al., 2013; Heinz et al., 2010, Heinz et al., 2013; Li et al., 2013). Antibodies against
Fos (sc-7202), Nrf2 (sc-13032x), p65 (sc-372), and PU.1 (sc-352x) were purchased from Santa Cruz
Biotechnology (Dallas, TX), against Smad3 (ab28379) from Abcam (Cambridge, UK), and against
H3K27ac (39135) from Active Motif (Carlsbad, CA). Briefly, for Fos, Nrf2, p65, and Smad3 ChIPs,
macrophages were first cross-linked in 2 mM dissuccinimidyl glutarate (Pierce
20593, Thermo Fischer) in PBS for 30 min, followed by subsequent 1% formaldehyde (Sigma) cross-
linking in PBS for 10 min at room temperature. For H3K27ac and PU.1 ChIPs, cells were cross-linked
using 1% formaldehyde in PBS for 10 min at room temperature. After cross-linking, glycine (Sigma)
was added to a final concentration of 0.2625 M to quench the reaction. Subsequently, cross-linked
macrophages were centrifuged (5 min, 1,200 RPM, 4˚C), washed twice with PBS, and pellets were
snap frozen and stored at  80˚C. For ChIP of H3K27Ac, p65, PU.1, Nrf2 or Smad3, frozen cell pel-
lets were resuspended in cell lysis buffer (10 mM HEPES/KOH pH 7.9, 85 mM KCl, 1 mM EDTA,
1.0% IGEPAL CA-630 (Sigma), 1x protease inhibitor cocktail (Roche, Basel, Switzerland), 1 mM
PMSF). After 5 min lysis on ice, cells were centrifuged (5 min, 4000 RPM, 4˚C), and the supernatant
was removed. The pellet was then resuspended in nuclear lysis buffer (10 mM Tris-HCl, pH 8.0,
100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-deoxycholate, 0.5% N-lauroylsarcosine, 1x pro-
tease inhibitor cocktail, and 1 mM PMSF) and the chromatin was sheared by sonication on wet ice
with a Bioruptor Standard Sonicator (Diagenode, Denville, NJ) for three 15 min cycles each alternat-
ing 30 s on and 30 s off on the high setting. Additional Triton X-100 was added to the sonicated
chromatin to 10% of the final volume and the lysate was cleared by centrifugation (5 min,
14,000 RPM, 4˚C). Input was then saved for subsequent analysis.
For Fos ChIP, pellets were suspended in 50 mM Tris pH 8.0, 60 mM KCl, 0.5% IGEPAL, 1x prote-
ase inhibitor cocktail, and 1 mM PMSF, followed by 10 min of incubation on ice and centrifugation
at 2000 g for 3 min at 4˚C. The pellet was then suspended in 0.5% SDS, 10 mM EDTA, 0.5 mM
EGTA, 50 mM Tris pH 8.0, 1x protease inhibitor cocktail, and 1 mM PMSF. The chromatin suspen-
sion was sheared by sonication on wet ice with a Bioruptor Standard Sonicator for three 15 min
cycles each alternating 30 s on and 30 s off on the high setting, followed by centrifugation for 10
min at 15,000 RPM at 4˚C. The chromatin was diluted 5x with 1% Triton X-100, 2 mM EDTA,
150 mM NaCl, 20 mM Tris pH 8.0, 1x protease inhibitor cocktail, and 1 mM PMSF. An input sample
was saved for subsequent analysis.
Protein A or G Dynabeads (Invitrogen) pre-bound with antibody was added to the diluted cell
lysate overnight at 4˚C. Immunoprecipitated complexes were washed three times with 20 mM Tris/
HCl pH 7.4150 mM NaCl, 0.1% SDS, 1% Triton X-100, 2 mM EDTA, three times with 10 mM Tris/HCl
pH 7.4250 mM LiCl, 1% Triton X-100, 1% sodium deoxycholate, 1 mM EDTA, and two times with Tris-
EDTA plus 0.1% Tween-20 before eluting two times with 50 mL elution buffer (TE, 1% SDS, 30 and 10
min, room temperature). Elution buffer was also added to the input. After pooling the eluted samples,
the sodium concentration was adjusted to 300 mM and cross-links were reversed overnight at 65˚C.
Samples were treated with 0.5 mg/ml proteinase K for 1 hr at 55˚C and 0.25 mg/ml RNase A for 1 hr at
37˚C before DNA was isolated using the ChIP DNA Clean and Concentrator Kit according to the manu-
facturer’s instructions. For library preparation, NEXTflex DNA barcode adaptors (BioO
Scientific, Austin, TX) were ligated to the genomic DNA. Polymerase chain reaction mediated library
amplification was performed and final libraries were size selected on 10% TBE gels (Invitrogen).
High-throughput sequencing and data processing
RNA-Seq and ChIP-Seq libraries were sequenced for 50 cycles on an Illumina Hi-Seq 2000 (Illumina,
San Diego, CA), sequenced for 51 cycles on an Illumina Hi-Seq 4000, or sequenced for 51 cycles on
an Illumina NextSeq 2500 according to the manufacturer’s instructions. ChIP-Seq reads were
mapped to the mouse NCBI37/mm9 (Ferreyra Garrott et al., 2013) assembly using Bowtie
(Langmead et al., 2009), allowing up to two mismatches. RNA-Seq reads were mapped to the
mouse NCBI37/mm9 (Ferreyra Garrott et al., 2013) assembly using Tophat (Trapnell et al., 2009).
Mapped reads were visualized using the UCSC genome browser (Kent et al., 2002) and
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downstream data processing was performed using HOMER (Heinz et al., 2010), and R (Garcı́a-
Oltra et al., 2013).
Genome-wide gene expression analysis with RNA-Seq
RNA-Seq analysis of genome-wide gene expression was performed using HOMER (Heinz et al.,
2010). Differential expression was defined by a fold-change of at least 1.5-fold averaging over repli-
cated datasets. For heatmap analysis, genes were clustered using k-means clustering (k = 10) in R.
Gene ontology analysis was performed using DAVID Bioinformatics Resources 6.7 (Huang et al.,
2009a, 2009b).
ChIP-Seq analysis
Genomic histone acetylation regions and transcription factor peaks were determined with HOMER
using the findPeaks command default parameters of four-fold enrichment over the input, four-fold
enrichment over local background, and normalization to 10 million mapped reads. For transcription
factors, peaks were called using the ’–style factor’ parameter while histone acetylation regions were
called using the ’–style region’ parameter. Histone regions were centered on nucleosome free
regions using the ’–nfr’ parameter. For comparisons, called peaks from different data sets were
merged using the mergePeaks command. Merging of transcription factor peaks or histone regions
was done using the parameter ’–size given’. To obtain differentially bound peaks/regions, tags were
quantified from two data sets using the getDifferentialPeaks command. Peaks/regions were called
as differentially gained if they had a four-fold enrichment of tag counts over the untreated/vehicle
condition and a cumulative Poisson p-value less than 0.001. For heatmap analysis, peaks were clus-
tered using hierarchical clustering in R.
Bone marrow transplantation
Bone marrow harvested from WT and Rev-erb DKO mice was injected via the retro-orbital route into
lethally irradiated (10 Gy) B6.SJL-Ptprca Pepcb/BoyJ (CD45.1) (Jackson Lab, Sacramento, CA) or
C57BL/6J (Harlem (now Envigo), Indianapolis, IN) 8 week old wild type congenic mice. Approxi-
mately 6–7 million bone marrow cells were injected per mouse. Transplanted mice were housed in
autoclaved cages (changed every two days) and supplemented with antibiotics the day before irradi-
ation until two weeks post-transplantation.
Evaluating bone marrow transplant efficiency
To evaluate bone marrow transplant efficiency, whole blood from WT and Rev-erb DKO bone mar-
row transplanted mice was collected through cardiac puncture into EDTA tubes (Becton Dickinson,
Franklin Lakes, NJ). 100 mL whole blood was washed once with PBS and resuspended in 2% FBS in
PBS. Samples were blocked with 1 mL anti-mouse CD16/32 (eBioscience, San Diego, CA, 14-0161-
82) for 15 min at room temperature. The following antibodies were utilized for staining: CD45 (Biole-
gend, San Diego, CA, 103122) and CD45.2 (Biolegend, 109813). Samples were incubated with
directly labeled antibodies for 40 min (4˚C in the dark). Stained cells were washed with 0.1% BSA in
PBS, pelleted (1200 RPM, 5 min, 4˚C), and lysed with hemolysin (Beckman Coulter, Brea, CA) for 20
s. Samples were quenched with 10x PBS, diluted, and gently washed before analysis using a LSR II
flow cytometer (BD Bioscience, San Jose, CA). Unstained and single stains were used for setting up
compensations and gating. Events were first gated on forward and side scatter to determine single
events, before evaluation of other fluorescent markers.
Monocyte enumeration from peripheral blood
Blood was collected from 16 chimeric mice per genotype into 0.5 ml K3 EDTA coated tubes. The
volume of the blood was determined by pipetting and transferred to 5 ml round bottom tubes with
50 ml of Life Technologies (Carlsbad, CA) CountBright Absolute Counting Beads. Erythrocytes were
lysed by addition of 4 ml eBioscience RBC lysis buffer with incubation at 4C for 5 mins. Cells were
collected by centrifugation and the supernatant was carefully removed. Cells were washed once
more and resuspended in buffer containing anti-CD16/CD32 (clone 93, BioLegend) and Zombie
Aqua fixable viability dye (BioLegend). After 10 min, cells were stained with the following 2X anti-
body cocktail: anti-mouse CD11b BD Horizon BUV395 (clone M1/70, BD Biosciences), anti-mouse
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CD19 BD Horizon BUV737 (clone1D3, BD Biosciences), anti-mouse CD115 Brilliant Violet 421 (clone
AFS98, BioLegend), anti-mouse CD90.2 Brilliant Violet 785 (clone 30-H12, BioLegend), anti-mouse
Ly6G FITC (clone 1A8, BioLegend), anti-mouse CD45.2 PE (clone 104, BioLegend), anti-mouse
CD45.1 Alexa Fluor 647 (clone A20, BioLegend), and anti-mouse Ly6C APC/Cy7 (clone HK1.4, BioLe-
gend). After 20 min, cells were washed and counted on a Beckman Colter MoFlo Astrios EQ
equipped with 355 nm, 405 nm, 488 nm, 561 nm and 640 nm lasers. Cells per ml were determined
by following the manufacturer protocol for CountBright Absolute Counting Beads. Cells of interest
were identified by excluding Zombie Aqua that fell within consecutive singlet gates using SSC and
FSC. Donor derived monocytes were identified as CD45.2+, CD19-, CD90.2-, CD115+, Ly6G-, and
CD11b+. Monocytes were further segregated based on expression of Ly6C. To test the dependence
on hematopoietic derived expression of Rev-erb a/b on peripheral blood cell populations we used a
Welch two sample t-test using R.
Wound healing studies
Wound healing studies were conducted 6–10 weeks post-transplantation. Briefly, 15.5 mL tert-amyl
alcohol was added to 25 grams of 2,2,2 tribromoethanol (Sigma Aldrich Chemical) and dissolved
overnight in a dark bottle to generate a stock solution. The subsequent solution was diluted with
PBS, dissolved overnight, and filtered through a 0.2 mm filter to generate a working solution (20 mg/
ml). To achieve anesthesia, 0.4–0.75 mg/g was administered intra-peritoneally. A 3 mm punch biopsy
(Miltex, York, PA) was used to generate four wounds on the dorsal skin of each animal. Wounds
were systematically photographed from a fixed distance daily. For macroscopic analysis, genotypes
were blinded and the size of the wound was analyzed by Adobe Photoshop (San Jose, CA), and nor-
malized to its size on Day 0. Mice were housed singularly throughout the duration of the study.
To assess the contribution of Rev-erb to wound healing, data from three independent experi-
ments were combined and analyzed using a linear mixed effects model (Garcı́a-Gil et al., 2012)
using the R package ’nlme’ (R script: wound model <- lme(’wound size’ ~ ’genotype’ * ’time point’,
random=~1 | ’independent experiment’ /’independent mouse’ /’nested observation’, data=data.file,
na.action=’na.exclude’). Genotype, time point, and their interaction, were modeled as fixed effects,
whereas the observations at wound sites were treated as a random effect nested within the indepen-
dent mouse, which in turn was treated as a random effect nested within the independent experi-
ment, to account for the hierarchical nature of the study design. The numbers of biologically
independent mice per time point are summarized in the below table.
Day WT chimera Rev-erb DKO chimera
0 29 28
1 28 27
2 26 25
3 17 17
4 21 20
5 22 20
6 22 20
7 13 12
8 20 16
9 12 9
10 7 7
11 12 9
12 7 7
Histological analyses
At the indicated time points, mice were euthanized and wounds were harvested using a 6 mm punch
biopsy (Miltex). Harvested wounds were cut along the mid-sagittal plane and paraffin-embedded.
Eichenfield et al. eLife 2016;5:e13024. DOI: 10.7554/eLife.13024 25 of 30
Research article Genes and Chromosomes
Genotypes were blinded for subsequent histological analyses. The first section along the mid-sagittal
plane was utilized for hematoxylin and eosin staining. Subsequent sections were utilized for immuno-
histochemical analysis using the following primary antibodies: biotinylated anti-F4/80 (AbD
Serotec (now Bio-Rad), MCA4978, 1:50 dilution), IgG (Dako, Glostrup Municipality, Denmark), rat
anti-Ly6B.2 (AbD Serotec (now Bio-Rad), MCA771GA, 1:200), and the following secondary antibod-
ies: biotinylated anti-rat (1:500, BD ), as well as HRP-conjugated streptavidin (1:500, Jackson Labora-
tory), Briefly, slides were de-paraffinized and washed three times in 0.1% Tween-20 PBS. Blocking
was performed sequentially using 3% hydrogen peroxide (10 min), 1% BSA in 0.1% Tween-20 PBS
(10 min), 0.1% avidin (10 min), and 0.01% biotin (10 min). Three washes were performed between
each blocking step using 0.1% Tween-20 PBS. Antigen retrieval was performed using proteinase K
(Dako, S3020), followed by three washes and subsequent overnight incubation with the indicated
primary antibodies. After three washes, slides were incubated with the indicated secondary antibod-
ies for 30 min and developed using AEC Peroxidase Substrate Kit (Vector Labs, Burlingame, CA, SK-
4200) according to the manufacturer’s instructions. Counterstaining was performed using Mayer’s
Hematoxylin (Sigma, MHS16), after which samples were mounted in an aqueous gel mount (Vecta-
mount, Vector Labs, H-5501).
In vitro matrigel migration assays
In vitro matrigel migration assays were performed as previously described (Ogawa et al., 2004).
Briefly, macrophages were cultured in RPMI-1640 (Invitrogen) supplemented with 0.5% heat-inacti-
vated FBS (Hyclone) for 24 hr and resuspended at a density of 1 million cells per milliliter. 100 mL of
macrophages was added to the top chamber of a transwell (Corning, Corning, NY) while 650 mL of
media was added to the bottom chamber. Macrophages were allowed to migrate through basement
membrane extract (Corning, 3458) for 24 hr. Afterwards, the wells were briefly washed with PBS,
and migrated macrophages were dissociated from the membrane and incubated with Calcein AM.
Relative fluorescence was measured using a SpectraMax M3 plate reader (Molecular Devices, Sunny-
vale, CA) and the SoftMax Pro software (485 nm excitation, 520 nm emission). A standard curve was
used to convert relative fluorescence to cell numbers.
Sequencing data
All sequencing data used in this manuscript has been submitted to GEO under the accession
GSE72964. This data can be accessed by reviewers through the following link: http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?token=ejixaiswxlqnjiv&acc=GSE72964.
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Abstract 
Cell-specific patterns of gene expression are determined by combinatorial actions of 
sequence-specific transcription factors at cis-regulatory elements. Studies indicate that 
relatively simple combinations of lineage-determining transcription factors (LDTFs) play 
dominant roles in the selection of enhancers that establish cell identities and functions. 
LDTFs require collaborative interactions with additional transcription factors to mediate 
enhancer function, but the identities of these factors are often unknown. We have shown that 
natural genetic variation between individuals has great utility for discovering collaborative 
transcription factors. Here, we introduce MARGE (Mutation Analysis of Regulatory Genomic 
Elements), the first publicly available suite of software tools that integrates genome-wide 
genetic variation with epigenetic data to identify collaborative transcription factor pairs. 
MARGE is optimized to work with chromatin accessibility assays (such as ATAC-seq or 
DNase I hypersensitivity), as well as transcription factor binding data collected by ChIP-seq. 
Herein, we provide investigators with rationale for each step in the MARGE pipeline and key 
differences for analysis of datasets with different experimental designs. We demonstrate the 
utility of MARGE using mouse peritoneal macrophages, liver cells, and human lymphoblastoid 
cells. MARGE provides a powerful tool to identify combinations of cell type-specific 
transcription factors while simultaneously interpreting functional effects of non-coding genetic 
variation. 
 
 
Introduction 
Molecular mechanisms enabling cell-specific transcriptional responses to intra- and extra-
cellular signals remain poorly understood. Genome-wide studies of most lineage-determining 
(LDTF) and signal-dependent transcription factors (SDTF) indicate that the vast majority of 
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their binding sites are in distal intra- and intergenic locations that frequently exhibit 
epigenomic features associated with enhancers (1-6) and are evolutionary well conserved (7-
9). The complement of active cis-regulatory elements bound by LDTFs changes across cell 
types, whereas promoters stay the same. Therefore, these findings introduced the notion that 
enhancers are largely responsible for cell type-specific gene expression (10-12). The 
ENCODE consortium annotated epigenetic features associated with enhancers in several 
different cell lines, primary cells and tissues providing evidence for hundreds of thousands of 
such elements in the human genome (13), greatly exceeding the number of promoters. 
Previous studies of macrophages and B cells provided the basis for a collaborative and 
hierarchical model (14-16). In this model, collaborative binding of two or more LDTFs opens 
up chromatin to establish enhancers (1), enabling cell-specific actions of broadly expressed 
SDTFs (17) (reviewed in (18)). The collaborative nature of LDTFs was further demonstrated 
by analysis of effects of genetic variation in macrophages provided by two inbred strains of 
mice (19).  
Genome-wide association studies, or GWAS (20) have shown that most complex trait-
associated genetic variation is located in non-gene/protein regions of the genome. Such non-
coding variants have the potential to change conserved sequences recognized by LDTFs and 
thereby alter enhancer landscapes between different alleles. These differences could 
manifest between individuals (i.e., between individuals that are each homozygous for 
opposite alleles), or within an individual that is heterozygous for a functional enhancer variant. 
A straightforward mechanism by which enhancer function would be altered by genetic 
variation is where alleles alter the affinity of transcription factors to bind their motifs. 
Consistent with the enhancer model whereby transcription factors collaborate with each other 
to bind DNA motifs, reports have found that allelic variation that mutates DNA binding motifs 
reduces binding of the respective factor while at the same time reducing binding of 
collaborating factors within 100 base pairs (19,21,22). Since the DNA binding motif of the 
partner factor is not mutated, these examples demonstrate a coordinated action of 
transcription factors in accessing DNA. The implication for cell-specific gene regulation is that 
genetic variants altering collaborative factor binding at enhancers will only be functional in the 
appropriate cell type where the correct combinations of transcription factors are expressed. 
The practical implication of these observations is that the particular combinations of factors 
may be discovered with the general strategy in any cell type. In addition to the discovery of 
transcription factors, this method identifies the precise genomic loci where genetic variation 
has a functional role in factor binding that may influence higher order biological processes. 
 To facilitate discovery of novel collaborating transcription factors using the genetic 
variation approach, we developed MARGE (Mutation Analysis for Regulatory Genomic 
Elements). MARGE is a suite of software tools to analyze ChIP-seq, ATAC-seq, DNase I 
Hypersensitivity or other next generation sequencing (NGS) assays where genotyping or 
DNA sequence data is available.  
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MARGE requires two data types: 1) genetic variation, and 2) high-throughput sequencing 
data (ChIP-seq, ATAC-seq, DNaseI-seq). MARGE then integrates these data and provides 
visualization tools to interpret the results. Importantly, MARGE was built to test for functional 
effects of alternate alleles at single nucleotide polymorphisms (SNPs) as well as short 
insertion-deletions (InDels). MARGE performs traditional de-novo motif analysis on genomic 
sequence for each polymorphic allele to identify DNA binding motifs that potentially affect 
transcription factor binding based on sequence analysis alone. The next step is to test 
whether the set of potential variants that mutate a single DNA binding motif are enriched in a 
set of loci where differential binding/accessibility is observed. For this step, MARGE 
associates quantitative measures of binding or accessibility from the ChIP/ATAC/DNaseI-seq 
data with the list of potential mutations in motifs. It analyzes differences in two genotypes by 
comparing the transcription factor binding distribution in relation to motif mutations between 
both genotypes, and also takes advantages of a Linear Mixed Model (LMM) (23,24) to 
compare many different individuals at the same time 
In this report, we apply MARGE and demonstrate its ability to reliably identify known key 
regulators of macrophage lineage. We further apply MARGE to three different ChIP-seq 
datasets from mouse liver cells and also show that MARGE can identify important B cell 
factors in a human PU.1 ChIP-seq dataset from lymphoblastoid cell lines (25). In conclusion, 
MARGE is the first publicly available tool that is created to identify combinations of 
collaborating transcription factors. This approach is agnostic to cell type and can be applied in 
any dataset where genotypes and epigenetic signatures are measured.  
MARGE is based on the ChIP-seq analysis tool HOMER (1) (http://homer.ucsd.edu/homer/) 
and it is an extension to the software used in (19,21). The source code and installation 
package are freely available on GitHub: 
https://github.com/vlink/marge/blob/master/MARGE_v1.0.tar.gz 
 
MATERIAL AND METHODS 
 
Overview 
A schematic outlining the major steps of MARGE is shown in Fig 1. First, MARGE offers a 
complete pipeline to process VCF (Variant Call Format) files (26) and generate individualized 
diploid genomes by extrapolating genetic variants from VCF files and swapping in alternate 
alleles into a reference genome (Fig. 1a-b). Importantly, MARGE is able to analyze 
sequencing data from homozygous (e.g., inbred mouse strains) and heterozygous (e.g., 
human) genomes and includes analysis for Single Nucleotide Polymorphisms (SNPs) as well 
as short Insertion-Deletions (InDels). Because MARGE generates genomes for each 
individual in the VCF file, the investigator can map their sequencing data to the genome with 
all genetic variations by using user-defined mapping software (e.g. bowtie2 (27) or STAR 
(28)) (Fig. 1c). MARGE shifts positions of individual sequence to their corresponding 
reference coordinates for motif analysis and visualization (Fig. 1 d-g). MARGE offers de-novo 
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motif analysis for individualized genomes (Fig. 1g), as well as a new algorithm to identify 
transcription factor binding motifs associated with allele-specific transcription factor binding or 
open chromatin (Fig. 1h). Each step of the MARGE pipeline is discussed below. 
 
Merge, filter, and pre-process VCF files 
The initial step of the MARGE pipeline is to generate a set of high-confidence sequence 
differences between the alleles of interest (Fig. 1a). MARGE allows some basic filtering of 
VCF files by quality scores, however VCFtools (26) provides more sophisticated tools for this 
purpose. For some sequencing projects like the mouse genome project (29), SNPs and 
InDels are annotated in separate files, whereas other projects like the 1000 Genome project 
(30) provides one large file with SNPs and InDels. When SNPs and InDels are provided 
separately, MARGE merges them as a first step. If a combined file is provided then the first 
processing step is skipped. In cases where SNPs overlap deletions or insertions within one 
genomic background the SNP is filtered out and the longer mutation is kept. MARGE also 
simplifies the annotation of the variants per genotype (Fig. 2a). In cases where more than one 
possible mutation occurs in a particular genomic location (e.g. two different genotypes have 
two different mutations in comparison to the reference genome), the mutation is not always 
annotated as the shortest mutation per genotype. As shown in Fig. 2a the genetic variant for 
genotype2 is annotated as GTT -> GTTGTT. MARGE processes each genotype separately 
and therefore calculates the shortest genetic variation for each genotype (in this case T -> 
TGTT). 
 
Generating individualized genomes 
MARGE produces individualized genomes by inserting the alleles from the VCF file into the 
reference genome and generating fasta files, which then can be used to make indices for 
mapping software. For homozygous data, only one genomic sequence is generated. 
Generation of individualized genomes and interpretation of allele-specific mapping for 
heterozygous data requires an additional step. Specifically, alleles at heterozygous sites need 
to be assigned on the same chromosome as neighboring heterozygous alleles. In genetics, 
this is called knowing the phase of the genotypes. Phase is especially important for MARGE 
when variants are in close proximity, because most sequencing reads are between 50-200 
base pairs in length. When multiple SNPs reside in the same read, the correct combination of 
alleles in the genomic index is essential for accurate mapping and downstream interpretation. 
MARGE inherently assumes that all heterozygous data is phased. There are good resources 
for phasing genotypes in human populations. For example, phasing can be achieved using 
BEAGLE (31) or SHAPEIT (32) in conjunction with known haplotype structure of large 
reference populations such as the 1000 Genomes Project. In cases were phasing is not 
easily possible (e.g. F2 generation of inbred mice) loci where mutations overlap within the 
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read length should be excluded from the analysis. 
  
Mapping data to individualized genomes 
Mapping of sequencing experiments to the individualized genome provides better results and 
decreases the possibility of incorrect mapping due to technical bias (Fig. 1c). This is 
especially true in datasets with a large number of differences to the reference. In these cases, 
mapping to the reference can introduce bias and in the case of datasets containing 
heterozygous genotypes can lead to overestimation of allele-specific expression or binding 
(33-35). To assess the effect of individualized genomes on mapping, we used a ChIP-seq 
dataset from inbred strains of mice. This provided a simplified situation since their genomes 
are entirely homozygous and all sequence tags originated from a genome of known 
sequence. Specifically, we used a PU.1 ChIP-seq dataset from three strains of mice 
(C57BL/6J, NOD/ShiLtJ, and SPRET/EiJ) (21). C57BL/6J (C57) is the commonly used 
reference genome and differs to NOD/ShiLtJ (NOD) in about 5 million genetic variants (89% 
SNPs, 11% InDels), whereas SPRET/EiJ (SPRET) provides about 43 million variants (89% 
SNPs, 11% InDels). Mapping of the ChIP-seq data to their respective genomes affected the 
overall mappability of the reads (Fig 2b) and the percentage of uniquely mapped reads (Fig 
2c). The difference in mapping is directly correlated to the number of differences between the 
genomes. After removing all reads that map to multiple locations, peaks were called on all 
datasets separately and compared. Peaks from the C57 ChIP-Seq mapped to C57 and NOD 
genomes show only small differences (Fig. 2d) (about 1% of peaks are unique to either 
genotype), but increasing the number of variation between the genotypes lead to many peaks 
uniquely called in one of the mapped datasets (up to 12%). Also when comparing a PU.1 
ChIP-seq dataset in human lymphoblastoid cell lines (25) mapped to the reference versus the 
individual genomes only about 90% of reads where mapped to the same loci (Supp. Fig. 1a). 
The number of differences between the hg19 reference genome and the individualized 
genomes is smaller than for the mouse data, but still up to 4% of peaks were uniquely called 
on either the dataset mapped to the reference or the individual genome (Supp. Fig. 1b). 
Therefore, mapping the data to the correct individualized genome increases the mapping 
accuracy substantially, leading to a more precise downstream analysis. 
Additional processing for heterozygous data 
Many studies in mice use hybrid mouse strains (F1) generating heterozygous mice from two 
homozygous parents (Fig 1d). Furthermore, all human genomes are heterozygous in many 
loci and due to the advantages in sequencing technology, have become more realistic to 
study genome-wide. To improve mapping for heterozygous data, statistical methods have 
been developed (e.g. WASP (36)). Unfortunately, these methods can only handle SNPs. In 
order to also analyze heterozygous data with InDels, we map our data to two reference 
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genomes corresponding to alternative parental alleles. To effectively analyze heterozygous 
data, allele-specific expression or binding needs to be calculated. For this step, MARGE 
filters all reads with perfect alignment followed by filtering of all reads spanning a variant 
between the two parental strains (Fig 2e). If the heterozygous data is not phased, all regions 
that contain more than one mutation within the length of one read should be excluded from 
the analysis. This procedure makes sure that it is possible to confidently identify the allele of 
origin. To assign allele-specific reads correctly all loci without any variation are annotated with 
half of the perfectly aligned reads, because half of the reads that are sequenced originate 
from allele 1 and the other half from allele 2. For loci with allele-specific sequences, the ratio 
of reads per allele is calculated based on the reads spanning variations. Then the loci are 
annotated with the corresponding ratio of all perfectly aligned reads mapped to this locus. 
 
Shifting to reference coordinates 
A major challenge of mapping data to individual genomes is that the experiments cannot be 
easily compared because of insertions and deletions (Fig. 1e). For example, the 
chromosomal locations between individuals (and across homologous chromosomes within 
heterozygous individuals) do not correspond to each other anymore. Therefore, to be able to 
use external analysis software and to visualize the data in the UCSC genome browser (37), 
we designed MARGE to shift mapped data back to reference coordinates (Fig. 2f). To 
accomplish this, MARGE generates shifting vectors for each genome (or haploid genome in 
the case of human/heterozygous data). Motifs can overlap insertions (M2) and deletions (M1) 
in the reference genome (Fig. 2f). The M2 motif consists of 6 bases, but after shifting the 
length is shrank to 3 bases due to the deletion. Therefore, positional shifting has the potent to 
introduce problems. For example, InDels can cause potential TF binding motifs to disappear 
or appear, which is of interest because these cases likely have functional consequence. 
Another complication of shifting coordinates occurs in the identification of ChIP-seq peaks 
from variable chromosomal sequences (i.e. shifting can cause a loss of peaks). This is 
because ChIP-seq peak calling tools often require a minimum length in order to identify peaks 
and this might not be reached after shifting. To check how frequently a peak was lost, each 
PU.1 ChIP-Seq dataset performed in human lymphoblastoid cell lines (25) was mapped to its 
individual genome and peaks were called with HOMER both before and after shifting. There 
are up to 2 million genetic differences between the reference genome (hg19) and the allele-
specific genomes per individuals, but only up to 11 peaks are lost after shifting (which 
corresponds to less than 0.1% of all peaks) (Fig. 2g, Sup. Table 1). Also when repeating this 
procedure for diverse mouse strains (with more than 40 million genetic differences) only 
about 0.2% of all peaks were lost (Sup. Table 2). Therefore, despite an opportunity for 
difference to emerge in peak calling, we conclude that this phenomenon is very rare and does 
not offset the advantages from more accurate mapping. 
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Data Visualization 
Tools like the Integrative Genomics Viewer (IGV) (38,39) allow visualization of individual 
genomes, but require the user to install the software locally, which is not preferable for data 
sharing. One of the most common software platforms to visualize next-generation sequencing 
data online is the UCSC genome browser (37). Although a powerful tool, it does not allow the 
usage of other genomes than the references. To account for this, after shifting the genomic 
coordinates from the individualized genomes to the reference genome, MARGE can generate 
UCSC genome browser files (e.g. bedGraphs and bigWig files) that take into account 
individual genomic features (Fig. 1f). In addition, MARGE can generate BED (Browser 
Extensible Data) (40) files with all alternate alleles relative to the reference coordinates for 
upload to the genome browser (Fig. 2h). We also provide basic tools to interact with the 
different individual genomes. For example, we make it possible to directly compare the 
number of polymorphisms between different datasets in a table format for either all variants 
(Table 1) or for all private variants (those which can only be found in a particular individual 
compared to all others) (Table 2). More importantly however, MARGE can align nucleotide 
sequences from different individuals or chromosome sequences such as nucleotides or 
protein sequences. This application integrates RefSeq (41) or common gene name 
information to provide alignment for genes of interest, but is also able to extract the sequence 
for every genomic location of interest. This provides a fast and easy way to check for 
differences in genes or non-coding regions for different genetic backgrounds. This also 
simplifies the design of primers or other constructs, because differences can be checked by 
simple alignments of VCF files. To enable some more user-specific analysis, MARGE 
annotates files containing genomic coordinates with all genetic variants and generates files 
with genotype-specific sequences. 
 
De novo motif analysis 
One of the first steps in analyzing ChIP-seq data is motif analysis. The de-novo motif analysis 
software from HOMER (1) was adapted to allow the integration of the individual genomes 
(Fig. 1g). We extended the de-novo motif finding algorithm (1) with a function to extract the 
sequences of the different genotypes as inputs to make sure that the motif finding algorithm is 
applied to the correct sequences and finds the motifs enriched in the sequence of the 
genotype not of the reference. It is possible to use different genotypes for the foreground 
sequences and the background sequences when unique peaks in two different genotypes are 
compared as foreground and background. These extensions make MARGE a powerful tool in 
comparing enriched motifs in two different genotypes.  
 
Motif mutation analysis 
MARGE was primarily developed to determine importance of various nearby transcription 
factor motifs on the binding of a given transcription factor (Fig. 1h). It can analyze 
transcription factor binding profiles for two genomes in a pairwise fashion, but is also able to 
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analyze the binding profiles of many different genomes together (Fig. 3). The first case is 
preferable when two datasets have many genetic differences (e.g. two diverse mouse 
strains), as it may be more cost effective experimentally (pairwise comparison). For the 
analysis of human samples, however, it may be preferable to have more individuals, as the 
number of differences between two human genomes is fewer. In this scenario, a larger 
sample size may be required to achieve statistical power (all-versus-all comparison). MARGE 
uses a list of hand-curated motifs from the JASPAR motif database (42) as default, but also 
allows user-defined input. 
Pairwise comparison 
For the pairwise comparisons, peak files of both genotype alignments are merged and 
annotated with read counts (Fig. 3a). To account for differences between the alleles, the 
individual genome sequence is extracted and scanned with the motif-scanning algorithm 
provided by HOMER. Each motif is analyzed separately. Peaks without the motif that is 
currently scanned for are excluded from the analysis of this particular motif, but are 
considered for other motifs. Therefore, the analysis of every transcription factor motif is done 
on a different number of peaks. The fold change of the normalized read counts between the 
two alleles is calculated. Finally, the distribution of the fold change is calculated for all peaks, 
all peaks with a mutation in the motif of interest in allele1 and all peaks with a mutation in the 
motif of interest in allele2. To ensure that a motif is not just considered allele-specific because 
its log-odd score was slightly below the arbitrarily defined threshold in one of the alleles, 
MARGE extracts the sequence of the potential motif from each allele and calculates the log 
odd score based on the provided position weight matrix (PWM). By default a motif is 
considered missing when the log odd score is smaller or equal to zero, but the user can 
change this value to whatever seems suitable. MARGE also provides the possibility to define 
a motif as missing when its log-odd score in one allele is less than n% of the log-odd score in 
the other allele. To determine the significance of every motif a Student’s t-test is performed 
between the general fold change distribution and the fold change distribution of allele1 and 
allele2, respectively. 
Furthermore, the p-value between the distributions of the two alleles is calculated. This 
procedure is repeated for all transcription factors of interest. All p-values are multiplied by the 
number of comparisons to correct for multiple testing. 
Allele-specific binding can be observed due to the loss of the binding site for the collaborative 
factors or the measured transcription factor itself. Additionally to analyzing every peak with 
the motif of interest, MARGE can analyze only peaks where all loci with differences in the 
motif of the measured TF between genotypes are filtered out. A Student’s t-test is performed 
on the remaining distributions and the p-values are multiplied by the number of comparisons. 
MARGE outputs a motif mutation plot showing the distribution of mutations in relation to the 
fold change for each transcription factor (bottom Fig. 3a, Sup. Fig. 2a). It further outputs a 
density distribution plot for the fold change distribution of all peaks with changes in the motif 
in allele1, allele2, and the background (Sup Fig. 2b). 
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All-versus-all comparison 
In order to perform an all-versus-all comparison on more than two genotypes, peaks are 
called for all genotypes individually (Fig. 3b) and annotated with read counts. In case of 
heterozygous genotypes, peaks should be called on alleles separately and also be annotated 
with allele-specific reads (Fig. 2e). Both alleles are then analyzed as if they were independent 
genotypes. Therefore, when comparing for example 3 heterozygous genotypes, MARGE 
actually analyzes 6 independent samples. All sequences of all genotypes are scanned for the 
motifs of interest. To model the impact of the motif on the binding of the measured factor a 
Linear Mixed Model (LMM) is used. The binding of the measured factor is modeled as the 
fixed effect motif existence or motif score (defined by the user) with random effects locus and 
genotype (Formula 1) with the lme4 package (43) in R (44). 
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To calculate significance for each motif, the drop1 command is used. It compares a model 
including motif score (motif existence, respectively) with a model without motif score (motif 
existence, respectively) and reports the Akaike information criterion (AIC) (45) for the 
difference. To keep the run time reasonable, MARGE implements threading for this 
procedure. 
 
Data mapping 
All data was mapped using bowtie2 (27) with default parameters. The data for the different 
inbred strain of mice and the human data were mapped to the individualized genomes. The 
individualized genomes were generated using bowtie2-build with default parameters. The 
data for C57BL/6J was mapped to the mm10 reference genome from the UCSC genome 
browser (37). The human reference genome was hg19. Uniquely mapped reads are all reads 
that were mapped to only one unique region of the genome.  
To analyze the impact of the genome on the accuracy of the mapping, all mouse ChIP-seq 
data sets in LPMs (21) were mapped to the three strain genomes C57, NOD, and SPRET. 
For the human data (25) all data was mapped against the individualized genome for allele 1, 
allele 2 and the hg19 reference genome. To assess the impact of the mapping on peak 
calling all reads that were mapped to more than one region of the genome were removed. 
 
ChIP-seq analysis 
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All ChIP-seq data sets were analyzed with HOMER after being shifted to reference 
coordinates. Peaks were called using findPeaks with default parameters and –style factor. 
For the LPM data set inputs were used for the peak calling. In case of the liver data and the 
human data no input was available and peaks were called without inputs. After running 
MARGE on the data, the list of significant motifs was reduced and summarized using 
HOMER’s compareMotifs.pl. 
 
Simulation of a data set 
MARGE is based on the model of collaborative binding for TFs and important collaborative TF 
binding motifs therefore should be identified as significant. According to this model a TF can 
only bind if the collaborative factor can bind, too. Applying this idea to two different genotypes 
means that if the motif is missing in genotype1 the binding of the measured factor should be 
lost in genotype1 and be not affected in genotype2 (genotype-specific binding). It further 
means if the motif is found in both genotypes binding should be similar between them 
(genotype-similar binding).  
For the synthetic dataset, ten motifs were randomly chosen and defined as important 
collaborative TF for PU.1 (Tead3, Ventx, and Zic1), somewhat collaborative (Rora, Znf354c, 
and Plag1) and not collaborative (Pax6, Nr4a2, Lin54, and Bhlha15) (Fig. 4a). The genomes 
from three mouse strains (C57BL/6J (C57), BALB/cJ (BALB), and SPRET/EiJ (SPRET)) were 
scanned for the occurrence of all motifs (including PU.1). Next a peak file was generated for 
all genomic locations where the motif of interest was within 200bp of the PU.1 motif. These 
files were merged between two strains (C57 and BALB, C57 and SPRET, BALB and SPRET). 
To model genotype-specific binding, the fold change was randomly chosen to be between 2 
and 10fold. For genotype-similar binding the fold change between the strains was within 1.5 
fold. In all cases the read counts were randomly chosen between 0 and 500. To include 
biological noise in this dataset 85% of peaks with genotype-specific TF binding motifs follow 
the genotype-specific binding for highly collaborative motifs. For somewhat collaborative 
motifs 50% follow this pattern, whereas in the case of not collaborative motifs only 10% of 
peaks with genotype-specific TF motifs also show genotype-specific binding. To model 
genotype-similar binding for all highly collaborative motifs 85% of all peaks with the same 
motif show genotype-similar binding, for somewhat collaborative motifs 50% of the peaks 
have genotype-similar binding, whereas for not collaborative motifs only 10% show genotype-
similar binding. The rest of the peaks show genotype-specific binding randomly assigned to 
one of the two strains. 
 
RESULTS 
MARGE recognizes collaborative motifs in synthetic dataset 
To test the accuracy of the method, a synthetic dataset was generated simulating a ChIP-seq 
experiment using an antibody against PU.1 (for more details see Material and Methods, Fig. 
4a). Ten motifs were randomly chosen and defined as important collaborative TF for PU.1 
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(Tead3, Ventx, and Zic1), somewhat collaborative (Rora, Znf354c, and Plag1) and not 
collaborative (Pax6, Nr4a2, Lin54, and Bhlha15) (Fig. 4a). Data was simulated for three 
different homozygous mouse strains (C57, BALB, and SPRET). Comparing one 
representative of the different motif categories shows that the algorithm is able to detect very 
high significance for Tead3 (defined as highly collaborative), medium significant for Plag1 
(defined as somewhat collaborative) and no significance for Nr4a2 (defined as not 
collaborative) (Fig 4b, Sup. Fig. 2a). In all three comparisons about 50% of all peaks had the 
motif of interest, so the significance is not dependent on the percentage of peaks having the 
motif. The algorithm is able to detect significance for all motifs that were collaborative and 
showed lower or no significance for all non-collaborative motifs (Fig. 4c). PU.1 was almost 
always recognized as a significant motif, which is expected as the peaks were modeled 
according to a PU.1 ChIP-seq experiment. 
 
MARGE analysis output 
In order to learn more about important position in the motif of the candidate transcription 
factor, MARGE offers a motif mutation position analysis (Fig. 4d, Sup. Fig. 3a). Fig. 4d shows 
an example for mutations within the PU.1 motif for the comparison C57 versus BALB on the 
simulated data set for Ventx. Mutations with significant effects on binding are marked by dots, 
whereas stars mark mutations with non-significant effects. Each base is colored differently, so 
it is not only possible to see which positions are mutated (significantly and non-significantly), 
but also to which other base. In the simulated dataset, even highly conserved residues in the 
motif can have mutations without an effect on binding (e.g. Fig. 4d, the highly conserved 
guanine at position 8 has 21 mutations from G->A that are significant but also 5 mutations 
from G->A with no effect). In the simulated data this was inherently part of it due to the 
modeling of biological noise (15% of genotype-specific peaks did show genotype-similar 
binding). It also should be noted that most differences that could be found were InDels (63 
significant versus 10 not significant) or multiple SNPs within one motif (27 significant versus 3 
not significant). MARGE also provides a plot that shows the distribution of the Ventx motif 
around the anchor transcription factor motif PU.1 (Fig. 4e, Sup. Fig. 2b) to see if the motif 
overlaps the anchor TF motif or if it is only randomly distributed within the peak. This plot 
allows the user to explore how the motifs of interest are distributed around the center of the 
peak to get a better understanding of the effect of this motif on the binding of the anchor TF. 
 
Pairwise analysis of mouse data 
To show that the method also works on real data we analyzed data previously published in 
(21) and (46). We assessed PU.1 (a macrophage LDTF) binding in large peritoneal 
macrophages (LPM) in three different inbred mouse strains C57BL/6J (C57), NOD/ShiLtJ 
(NOD), and SPRET/EiJ (SPRET). These strains differ substantially in mutations to each other 
(Table 1). To show the correctness of the method we generated a list of motifs that were 
previously discovered (21) to be involved in the establishment of PU.1 binding in macrophage 
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(PU.1, PU.1-IRF, ETS1, SpiB, CEBP, AP-1, Arid3a). Additionally, we chose some 
transcription factors not expressed in LPMs or with known binding patterns different from 
PU.1 in macrophages. We chose the motifs of Bcl6 (not expressed in LPM, with a known 
function in B cells (47)), NeuroD1 (not expressed in LPM, associated with neurons (48) and 
diabetes (49)), RORgt (not expressed in LPM and mainly associated with thymocytes 
(50,51)), and Gfi1b (not expressed in LPM and associated mainly with neutrophil 
differentiation (52)). 
MARGE could reliably detect motifs that are significantly associated with PU.1 binding, 
independent of the number of peaks containing the motif, or the number of mutations in these 
peaks. For example mutations in CEBP, an important LDTF in macrophages, were detected 
as significantly associated with PU.1 binding (Fig 5a). The plot showing the positions of 
mutations within the motif shows enrichment for mutations in the conserved bases T (bases 2 
and 3) and A (bases 8 and 9) in comparison to the rest of the bases in the motif (Fig. 5b). 
Most causal mutations are due to multiple SNPs or InDels, not merely one single SNP. The 
CEBP motif is distributed closely around the PU.1 motif (where PU.1 is bound) without any 
motifs overlapping the PU.1 binding site (Fig. 5c). Although the peaks are 200 base pairs with 
regard to the reference genome, the sequences analyzed can be longer due to long 
insertions in the different strains resulting in peaks with a size of 300 in this case. Figure 5d 
shows two examples of how SNPs can influence observed PU.1 binding. In the left panel 
PU.1 is only bound in SPRET. A SNP in SPRET in comparison to C57 and NOD adds a PU.1 
binding motif adjacent to an existent CEBP motif resulting in the observed genotype-specific 
binding. The right panel shows how loosing a CEBP binding motif in C57 and SPRET close to 
a PU.1 binding motif existing in all three strains can cause PU.1 binding to be lost. MARGE 
could not find any significant association between motif existence and binding for the motifs 
chosen to provide negative controls (Fig. 5e). Although the number of mutations between two 
genotypes correlates with the significance of the analysis result (due to a bigger sample size), 
even with a low number of genetic variations MARGE was able to detect almost all significant 
motifs. To further test MARGE, we applied it to ChIP-seq experiments in four different strains 
(C57BL/6J (C57), A/J (AJ), CAST/EiJ (CAST), and SPRET/EiJ (SPRET)) for three different 
factors (CEBPa, FOXA1, and HNF4A) in whole liver from (46). CEBPa is an important TF in 
hepatocytes (54,55) (which make up about 70% of all cells in the liver (56)) and 
macrophages. FOXA1 plays important roles for the development and maintenance of the 
liver, mainly in hepatocytes (15,57) and HNF4A is an important liver TF mainly associated 
with hepatocytes (reviewed in (58)). Figure 5f shows an example where the TF binding motifs 
for all three factors were found, but binding could only be observed in AJ, C57, and CAST. 
Binding in SPRET was lost due to the loss of an adjacent RORA motif. After applying MARGE 
to the data, all significant motifs were compared to each other and summarized (compare 
Materials & Methods). In almost all pairwise comparisons for the three different factors the 
measured factor and the two collaborative factors were found as highly significant (Fig. 5g). 
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Nuclear receptors, which play important roles in the liver (reviewed in (59)), were found as 
significant in all three comparisons.  
 
All-versus-all analysis of homozygous mouse data 
To show the correctness of the all-versus-all analysis, we reanalyzed the mouse ChIP-seq 
datasets for CEBPa, FOXA1, and HNF4A from whole liver (Fig. 6a). Almost all motifs that 
were found significant in at least one pairwise comparison were detected as significant in the 
all-versus-all comparisons (compare Fig. 5g and Fig. 6a). Applying the motif score or the 
motif existence in the LMM produced almost the same results, with some motifs differing. The 
motif existence approach should be used with caution since adjusting the threshold that 
defines a sequence as motif can have large impacts on the results. Therefore, the all-versus-
all comparison is able to confirm motifs significantly associated with binding of CEBP, 
FOXA1, or HNF4A in whole mouse liver previously identified by MARGE’s pairwise 
comparisons. To make sure that the all-versus-all comparison is sensitive, we shuffled the 
strain order and repeated the analysis (Fig. 6b). To assess how much the results are 
influenced when very similar strains are shuffled, AJ and C57 were switched, but CAST and 
SPRET were kept at the same position. The further assess robustness of the results, the 
more diverse strains were shuffled with the more similar strains. Furthermore, we used 
completely different mouse genomes (NOD, DBA, PWK, and WSB). The color bar in Figure 
6b shows the number of differences between the strains. When two very similar strains were 
changed (AJ with C57) the results are almost the same and the data sets are clustered 
together. However, as soon as more different strains are switched, the results changed 
dramatically. Motifs that are significant in all comparisons (e.g. NF1) should be counted as 
false positive results. This analysis shows that changing very similar data sets with each other 
does not affect the results, probably because most of the informative loci are found between 
these two strains and the two more diverse strains. 
 
All-versus-all analysis of heterozygous human data 
To show that MARGE is also able to analyze data from several human individuals with a low 
number of mutations, 34 PU.1 ChIP-seq datasets from Waszak at el (25) were analyzed with 
MARGE (listed in Sup. Table 1). The VCF files were downloaded from the 1000 Genomes 
Project (30) and the individual MARGE files and genomes were generated. A bowtie2 (27) 
index was created for each genome (two indices per genotype – one for the complete 
genome containing mutations on allele 1 and one for mutations on allele 2) and the ChIP-seq 
reads were mapped against both indices of the corresponding genotype. Only data sets with 
an overall mappability of 80% were considered in the downstream analysis (22 individuals) 
Peaks were called on all perfectly aligned reads and all peaks were merged and annotated 
allele-specific (320,146 peaks). To see how noise influences the MARGE results, MARGE 
was applied to an unfiltered peak file, as well as a peak file only containing reliable peaks with 
at least 8 reads in at least on individual (16, respectively). The dataset used in this analysis 
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was based on lymphoblastoid cell lines, human B cell lines infected with an Eppstein-Barr 
virus to immortalize them. 
Because the dataset is based on B cells it is not expected that any macrophage specific 
LDTFs are significant, instead B cell specific LDTFs (like PRDM1 also known as BLIMP-1, 
E2A etc.) would be expected to show a significant association with PU.1 binding (60). Figure 
6c shows a UCSC genome browser session for one locus in three different individuals where 
one SNP that causes a loss of a PRDM1 motif close to an ETS factor motif is associated with 
loss of binding of PU.1. Applying the mutation approach systematically to all loci in all 
individuals and then summarizing the motifs, MARGE identified the B cell LDTF PRDM1 as 
highly significant, as well as a motif belonging to the IRF family of transcription factors known 
to play a role in B cells (Fig 6d) and an ETS motif, important for PU.1 binding. DUX4 has 
been previously associated with acute lymphoblastic leukemia (ALL) (61) which is coherent 
with the cancer-like cell type used in this experiment. MARGE was able to identify many other 
important transcription factors for B cells including NUR77 and a KLF binding motif 
(associated with B cell development (62,63)). The more stringent the filtering, the less 
significant motifs could be found. Filtering by 8 reads, about half of the significant motifs could 
be found. But filtering by 16 reads only found PRDM1 as significant. This highlights the 
importance of a good quality data set, because a lot of difference is found in lower bound 
peaks rather than the top peaks. Overall, MARGE was able to find significant motifs 
associated with PU.1 binding in human lymphoblastoid cell lines taking advantage of allele-
specific binding in many individuals.  
 
Discussion 
We developed a powerful tool to efficiently analyze ChIP-seq and other NGS data to 
understand the impact of transcription factor motifs on collaborative binding of transcription 
factors. MARGE is the first publicly available suite of software tools to integrate natural 
genetic variation (including InDels) and NGS binding data and provides complementary 
algorithms to analyze data from different genetic backgrounds in a pairwise manner as well 
as by utilizing a linear mixed model. It further provides many useful tools to directly look at 
genetic differences between different genetic backgrounds. By simulating a dataset and also 
applying MARGE to real world data, we could show that the algorithm works correctly in 
identifying motifs significantly associated with the binding of a measured transcription factor.  
Here, we applied MARGE to ChIP-seq data, which requires a well-working antibody for the 
reference transcription factor. However, MARGE can also be applied to ATAC-seq data or 
DNase I hypersensitivity data, which does not require any previous knowledge. In this case, 
rather than collaborative binding partners for a reference transcription factor, analysis of open 
chromatin would be expected to recover the dominant collaborative factors needed to 
establish open chromatin regions. Therefore, MARGE can potentially be applied to identify 
key regulatory factors in any cell type as long as parallel datasets from genetically diverse 
strains or individuals are available.  
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The algorithm assumes that the binding of the measured factor is only affected by local 
mutations in transcription factor binding motifs. As a result, sequence changes that influence 
binding on a global or long-distance scale in trans will not be detected and introduce noise to 
this. Furthermore, MARGE only analyzes one motif at a time. More complex relationships 
between transcription factors (e.g. the requirement for binding of three factors simultaneously) 
are not considered in the analysis. As in every analysis based on statistical tests, the power 
of discovery is dependent on the number of observations. A greater number of genetic 
variations between two individuals provides a better analysis result and will detect more 
significant motifs. For comparisons with low numbers of genetic variations MARGE offers a 
linear mixed model to increase the power of detection by merging all genetic variation 
between all individuals. This, however, requires substantially more experiments. Furthermore, 
the software is dependent on a list of position-weight matrices for the detection of TF binding 
sites. It is known that TF can bind to very weak motifs that cannot be detected by a motif-
scanning algorithm but play important roles in regulating gene expression (64). However, 
MARGE is dependent on finding motifs based on scanning the DNA for the consensus 
sequence provided by the PWM. This limits the sensitivity of MARGE. Improvements in our 
understanding how to detect motifs in sequence will therefore improve the power of MARGE. 
Similar to de-novo motif finding, also MARGE only detects TF motifs. There are sometimes 
many similar transcription factors capable of binding the same consensus motif, which 
MARGE cannot discriminate. As more TFs and their motifs are characterized, these types of 
analysis will surely improve.  
Genome-wide association studies (GWAS) evaluating common sequence variants associated 
with diverse phenotypes consistently demonstrate that the majority of variants reside in non-
coding regions of the genome (20,65,66). These findings suggest that such variants impose 
risk by altering promoter and enhancer elements that regulate gene expression. Interpretation 
of such variants is currently limited because the genomic location of the regulatory elements 
at which they could potentially exert their effects varies according to cell type. By identifying 
important motif mutations, MARGE can provide a new and unique way to analyze 
transcription factor binding and detect the major collaborative factors involved in the 
establishment of cell-specific enhancer landscapes. With the advances in sequencing 
technology and availability of human samples, MARGE can facilitate the analysis of datasets 
that provide insights into the relationship between non-coding genetic variation and gene 
expression in humans.  
 
Availability 
The MARGE source code and installation package are freely available on GitHub: 
https://github.com/vlink/marge/blob/master/MARGE_v1.0.tar.gz.  
The mouse LPM dataset from (21) was downloaded from the GEO database under accession 
number GSE62826. The data is available at http://genome.ucsc.edu/cgi-
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=vlink&hgS_otherUserSession
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Name=MARGE_LPM_data. The mouse liver data set from (46) was downloaded from 
ArrayExpress Archive (http://www.ebi.ac.uk/arrayexpress/) under accession number E-MTAB-
1414. The data is available at http://genome.ucsc.edu/cgi-
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=vlink&hgS_otherUserSession
Name=MARGE_Liver_data. The human data set from (25) was downloaded from the 
ArrayExpress Archive under accession number E-MTAB-3657. The data is accessible at 
http://genome.ucsc.edu/cgi-
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=vlink&hgS_otherUserSession
Name=MARGE_human_data. 
MARGE is implemented in Perl and R (44). It has been tested on several UNIX systems, 
including CentOS and Debian with Perl version 5.20 and higher and R version 3.3 and higher. 
We provide a script that installs MARGE and allows download of pre-processed mutation data 
from the mouse genome project (29) and the genomes from the 1000 Genome Project used 
in this manuscript. MARGE requires the Perl core modules POSIX, Getopt::Long, Storable 
and threads, as well as the modules Set::IntervalTree (67), and Statistics-Basic (68). It further 
requires the R packages SeqLogo (69), gridBase (70), lme4 (71), and gplots (72). It also 
requires an installed version of gzip. For the motif mutation analysis MARGE requires 
HOMER (1) (http://homer.ucsd.edu/homer/) to be installed and executable. Without a working 
installation of HOMER, MARGE’s functionality is limited to only visualization and annotation of 
the data. 
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Tables and Figures Legends 
Figure 1: Overview of the MARGE pipeline. (A) MARGE merges VCF files for SNPs and 
InDels, offers some basic filtering and split the merged VCF file into separate genotype-
specific mutation files. (B) It then generates individual genomes by inserting the annotated 
mutations in the reference genome per genotype and (C) allows mapping of the experimental 
data sets to the individualized genomes. (D) The data mapped to the individualized genomes 
is then shifted back to the reference coordinates. (E) In case of heterozygous data additional 
processing is necessary. MARGE offers (F) scripts for data visualization including BED files 
for genetic variation per genotype. It further offers (G) de-novo motif analysis for the individual 
genomes to make sure the enrichment analysis is performed on the correct sequence instead 
of the reference. MARGE also offers a new algorithm (H) to associated TF binding motifs with 
genotype-specific binding for pairwise comparisons, as well as comparisons for many 
different individuals (all-versus-all comparison). Taken all of that together MARGE is able to 
identify TF binding motifs that are functionally associated with TF binding. 
 
Figure 2: Details of pipeline: (A) MARGE merges SNP and InDel VCF files and then splits 
the merged file. It finds the shortest annotation for each mutation, changing the original 
annotation from the VCF file. (B) Comparison of the overall mapping efficiency. There is a 
small decrease in overall mappability when data is mapped to the reference. (C) Comparison 
of mapping efficiency for uniquely mapped reads after mapping to different genomes. There is 
an increase in mapping performance when mapped to individualized genomes. (D) 
Percentage of peaks uniquely called to dataset mapped to one genotype versus another. Up 
to 12% of peaks are unique to one genotype. (E) Pipeline for processing heterozygous data: 
Data is mapped to both alleles and shifted back to the reference coordinates. Reads that do 
not uniquely align to the genome are filtered out. Perfectly aligned reads, as well as perfectly 
aligned reads overlapping mutations are filtered out and peaks are called on perfectly aligned 
reads. For each locus without any mutations, the peaks for both alleles are annotated with 
half the reads that mapped to this locus. For each locus with mutations a ratio is calculated 
based on the reads overlapping mutations and then the locus is annotated with the number of 
perfectly aligned reads multiplied by the corresponding to the ratio. (F) Schematic of the 
shifting process: Genomic coordinates of the individual genomes do not concur with the 
reference due to InDels. MARGE shifts the individual coordinates to the reference without 
changing the length of the sequence. (G) Shifting peak coordinates leads to minor loss of 
peaks. 34 PU.1 ChIP-seq data sets were mapped and peaks were called before and after 
shifting. Even with 2 million genetic variants between the reference and the individualized 
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genomes only up to 11 peaks are different. (H) UCSC genome browser shot showing PU.1 
ChIP-seq data in large peritoneal macrophages in 3 different inbred strains of mice (C57, 
NOD, and SPRET). Bed graphs generated by MARGE show genetic differences between the 
strains. The red rectangle shows a zoomed-in area of the UCSC genome browser. 
 
Figure 3: Schematic showing the algorithm for the motif mutation analysis for pairwise 
comparisons or comparisons of a big group of individuals. (A) Pairwise comparison: 
Data is mapped to individual genomes and shifted to reference coordinates. Peaks are called 
per genotype and are subsequentially merged and annotated with the tag counts from the tag 
directories with HOMER. The merged file is iteratively scanned for the TF binding motifs of 
interest. For all peaks containing the current TF motif of interest (marked in green) the binding 
difference between the two genotypes is calculated (fold change). For each TF the fold 
change distribution of all peaks is plotted (more information Sup. Fig. 1a) and a Student’s t-
test is performed on the fold change distribution of all peaks versus all peaks containing a 
mutation in genotype1 (red) (genotype2 (blue), respectively). Further a t-test is performed 
comparing the fold change distribution of all peaks missing the motif of interest in genotype1 
versus genotype2 (purple) and corrected for multiple testing. (B) Motif mutation analysis on 
more than two genotypes: Data is mapped to the individual genomes, shifted back to the 
reference coordinates and peaks are called on each genotype separately and subsequentially 
merged and annotated. Heterozygous data should be annotated with MARGE’s annotation 
function. The merged file is iteratively scanned for the TF motif of interest (marked in green). 
Per TF an output file is generated containing the locus, the binary existence of a motif, the 
motif score and the read counts. This output file is then inserted into a linear mixed model 
(LMM) implemented in R with the package lme4 modeling the binding as dependency of the 
motif score (or motif existence) with random factors Strain and Locus. A p-value is generated 
using the R command drop1 and corrected for multiple testing.  
 
Figure 4: Analysis of a simulated dataset (A) Motifs were defined as important 
collaborative binding (Tead3, Ventx, Zic1), somewhat collaborative (Rora, Znf354a, Plag1) 
and not collaborative (Pax6, Nr4a2, lin54, Bhlha15). Peak files were generated for all loci 
where PU.1 and one of the TF are within 200bp to each other for three mouse strains (C57, 
BALB, and SPRET) and consecutively merged between two strains. For highly collaborative 
TF 85% of the strain specific peaks show strain specific binding (somewhat collaborative: 
50%, not collaborative: 10%). Fold change was randomly chosen to be between 2 and 10 fold 
for differently and to be between 1 and 1.5 fold for similarly bound peaks. Read counts were 
randomly chosen to be between 0 and 500. (B) MARGE correctly identifies the association 
between motif and binding data. Motif mutation distribution plot (Sup. Fig. 2a) for one 
collaborative motif (Tead3) shows a highly significant association between motif mutation and 
binding data (medium significance for Plage1 (somewhat collaborative), no significant for 
Nr4a2 (not collaborative)). (C) Summary heatmap for all analysis on the simulated datasets. 
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MARGE showed high significance for the collaborative TF and less or no significance for non-
collaborative TF binding motifs. (D) Motif mutation position plot for Tead3, showing which 
positions are mutated and associated with different binding (more information Sup. Fig. 3a). It 
furthermore shows that in most cases InDels and multiple SNPs cause significant change in 
binding. (E) TF binding motif distribution of PU.1 and Ventx. Motifs for Ventx are closely 
distributed around the PU.1 binding site (more information Sup. Fig 3b). 
 
Figure 5: Analysis using MARGE’s pairwise-comparison (A) Motif mutation plot for PU.1 
data in LPMs analyzing the impact of mutations in the CEBP binding motif on PU.1 binding. 
Red ticks show mutations in the CEBP motif in C57 (blue for SPRET). Loss of the CEBP 
motifs is significantly associated with strain-specific PU.1 binding. (B) Motif position mutation 
plot for CEBP motif showing the position and effect of mutations in the CEBP motif in relation 
to PU.1 binding. The most conserved positions in the CEBP motif are associated with a loss 
of PU.1 binding. (C) The CEBP motif is distributed closely around the PU.1 motif with a 
depletion of the CEBP motif at the PU.1 binding site. (D) UCSC genome browser shot - Left 
panel: The gain of a PU.1 motif in SPRET adjacent to a CEBP motif results in PU.1 binding 
only in SPRET, but not in C57 or NOD. Right panel: The gain of a CEBP motif in NOD in 
close vicinity to a PU.1 motif results in PU.1 binding only in NOD. (E) Summary heat map of 
multiple testing corrected p-values for TF motifs associated with PU.1 binding. The heat map 
includes some negative control motifs that are not associated with macrophage biology which 
were not identified as significant. (F) UCSC genome browser shot - The loss of a RORA TF 
motif in SPRET causes loss of binding of CEBPa, FOXA1, and HNF4A in SPRET, but not in 
AJ, C57 and CAST. (G) Summary heat map of multiple testing corrected p-values of TF 
binding motifs associated with CEBPa, FOXA1, and HNF4A binding in whole liver. All factors 
reached significance in every pairwise comparison. Nuclear receptors were significantly 
associated with binding of the different factors.  
 
Figure 6: Results of all-versus-all analysis. (A) Summary heatmap of multiple testing 
corrected p-values of all-versus-all analysis of CEBP, FOXA1, and HNF4A ChIP-seq data 
sets from whole liver in AJ, C57, CAST, and SPRET. The analysis confirms the results from 
the pairwise analysis performed in Fig. 5g. The same motifs are highly significance with slight 
variations independent of considering motif score (MS) or motif existence (ME). (B) Summary 
heatmap of multiple testing corrected p-value of the all-versus-all analysis for CEBP, FOXA1, 
and HNF4A ChIP-seq data sets with the original order of the strains and shuffled order of the 
strains to assess sensitivity of MARGE. The color of the boxes correlates to the number of 
mutations (from 0 – white to 50 million – brown). When very similar strains are switched (AJ 
and C57) the MARGE results are clustered together. As soon as more diverse strains are 
switched or different strains are used, the results cluster as outliers to the original data and 
almost all motifs lose significance. (C) UCSC genome browser shot visualizing three human 
PU.1 datasets. The allele-specific loss of a PRDM1 motif close to an ETS motif causes allele-
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specific loss of PU.1 binding. (D) Summary heat map of multiple testing corrected p-values of 
transcription factor motifs significantly associated with PU.1 binding in human lymphoblastoid 
cell. Many TF motifs found to be significantly associated with PU.1 binding are either known 
to play important roles in B cell development and maintenance or cancer. By increasing the 
stringency of peaks included in the analysis (and decreasing the number of observations) the 
number of significant motifs decreases. Only PRDM1 is found as significant when using a 
filter of 16 reads.  
 
Supplemental Figure 1: Effect of mapping ChIP-seq data for human lymphoblastoid 
cell lines. (A) Percentage of reads mapped to the same locus after mapping to individualized 
genotype and reference. Only about 90% of reads mapped to the same locus when 
comparing mapping results for individualized genomes versus the reference. (B) Percentage 
of peaks unique to either the individualized genome of the reference genome hg19. Up to 4% 
of the peaks were called uniquely in either the PU.1 ChIP-Seq dataset mapped to hg19 or the 
individualized genome. 
 
Supplemental Figure 2: Detailed description of the output plots MARGE generates for 
the motif mutation analysis. (A) For each TF of interest MARGE generates this plot. The 
peaks are rank-ordered by most genotype-specific bound in genotype1 to most genotype-
specific bound in genotype2. Genotype1 is color-coded red, whereas genotype2 is color-
coded blue. The left upper corner shows how many mutations could be found in the motifs for 
genotype1 and genotype2. A red tick marks each peak without a TF binding motif of the TF of 
interest, if the motif is missing in genotype1 and a blue tick marks the motif is missing in 
genotype2. All data on the left bottom of the plot show peaks where the binding is very 
specific to genotype1. The right upper corner shows peaks where binding is very specific to 
genotype2. The box plot on the right summarizes the fold change distribution. Grey shows the 
fold change distribution for all peaks having the TF binding motif of interest. Red shows the 
fold change distribution for all peaks missing the TF binding motif of interest in genotype1, 
whereas blue shows the distribution for all peaks missing the TF binding motif in genotype2. 
A Student’s t-test is performed comparing these distributions. The p-value is shown below the 
box plots. Red shows the comparison of the background (grey box) versus the distribution for 
genotype1 (red box), blue shows the comparison of the background (grey box) versus the 
distribution for genotype2 (blue box) and purple shows the comparison between genotype1 
(red) and genotype2 (blue). (B) Kernel density plot for data shown in the motif mutation 
distribution plot. A Gaussian kernel is applied to the fold change distributions for all peaks 
with the motif of interest (black – background), all peaks with missing motifs in genotype1 
(red) and all peaks with missing motifs in genotype2 (blue) and plotted. The p-values are the 
corresponding p-values from the t-test explained above. 
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Supplemental Figure 3: Detailed description of additional output plots provided by 
MARGE. (A) Motif position mutation plot shows the consensus logo of the position-weighted 
matrix (PWM) from the motif. Mutations that affect the TF binding between both genotypes 
are marked by dots, whereas a star marks mutations with no effect. All mutations resulting in 
an adenosine are color-coded green (cysteine are color-coded blue, guanine are yellow and 
thymine are red). The number of InDels and multiple SNPs are reported separately for 
significant changes in binding and no changes. The y-axis shows the frequency for the 
mutations. (B) Motif distance distribution plot. All peaks are centered on their anchor TF 
binding motif and the distribution of the TF of interest is plotted around the TF. Further, a 
genome-wide background is plotted. The right y-axis shows the motif frequency in the 
genotypes, the left y-axis shows the frequency in the background. The distribution of the 
anchor TF is plotted for the background and the genotypes in the order of background (grey), 
genotype1 (dark green), and genotype2 (light green). They should overlap, so only the 
distribution of genotype2 should be visible. For the motif of interest the genome wide 
background is plotted in grey, whereas the distribution for genotype1 is blue and for 
genotype2 is red. The distribution should overlap and only the distribution of genotype2 
should be visible. The x-axis shows the distance of the motif to the center. 
 
Table 1: Overview of all natural genetic variation found in all strain-wise comparisons 
 
Table 2: Overview of all private genetic variation found in in this strain versus all other strains 
 
Supplemental Table 1: Summary of peak numbers before and after shifting for all 34 
individuals from a human PU1 ChIP-Seq dataset. Only up to 11 peaks are lost after shifting, 
which is less than 0.1% of all peaks. 
 
Supplemental Table 2: Summary of peak numbers before and after shifting for mouse data. 
The number of genetic variations is up to 40 million between two strains, and less than 0.1% 
of the peaks are lost after shifting. 
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Strain comparison #SNPs #InDels 
C57BL/6J vs. NOD/ShiLtJ 4,734,324 272,463 
C57BL/6J vs. SPRET/EiJ 40,757,582 2,206,269 
NOD/ShiLtJ vs. SPRET/EiJ 41,033,145 2,302,767 
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Private variation per strain #SNPs #InDels 
NOD/ShiLtJ  2,474,126 160,882 
SPRET/EiJ 38,490,407 2,101,665 
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Abstract	
Non-coding	genetic	variation	is	a	major	driver	of	phenotypic	diversity	and	allows	
investigation	of	mechanisms	that	control	gene	expression.	Here,	we	systematically	
investigate	effects	of	>50	million	variations	from	five	strains	of	mice	on	mRNA,	nascent	
transcription,	transcription	start	sites	and	transcription	factor	binding	in	resting	and	activated	
macrophages.	We	observe	substantial	differences	in	gene	expression	that	are	associated	with	
distinct	molecular	pathways.	Evaluation	of	genetic	variation	provides	evidence	for	roles	of	
~100	transcription	factors	in	shaping	the	binding	of	macrophage	lineage-determining	factors.	
Unexpectedly,	a	substantial	fraction	of	the	strain-specific	binding	of	these	factors	cannot	be	
explained	by	local	mutations.	Integration	of	genomic	features	with	assays	of	chromatin	
interactions	provides	evidence	for	hundreds	of	connected	cis-regulatory	domains	that	are	
associated	with	differences	in	transcription	factor	binding	and	gene	expression.	This	system	
and	the	>250	data	sets	establish	a	substantial	new	resource	for	investigation	of	how	genetic	
variation	affects	cellular	phenotypes.	
	
Introduction	
Mammalian	organisms	are	composed	of	several	hundred	cell	types	that	share	a	common	
genome.	The	development	and	function	of	each	cell	thus	requires	appropriate	selection	of	
promoter	and	enhancer	elements	that	regulate	their	specific	programs	of	gene	expression	
(Heinz	et	al.,	2015;	Levine,	2010;	Shlyueva	et	al.,	2014).	Genome-wide	assessment	of	chromatin	
features	specific	to	enhancers	and	promoters	across	many	cell	types	and	tissues	in	humans	and	
mice	revealed	hundreds	of	thousands	of	enhancer-like	regions,	with	any	particular	cell	type	
exhibiting	on	the	order	of	20,000-30,000	such	elements	(Andersson	et	al.,	2014;	Roadmap	
Epigenomics	et	al.,	2015).	The	general	question	of	how	each	cell	type	selects	its	particular	
repertoire	of	transcriptional	regulatory	elements	is	therefore	central	to	understanding	the	
corresponding	cell’s	development	and	functions.		
	
Investigation	of	mechanisms	underlying	the	selection	of	cell-specific	enhancers	indicate	key	
roles	of	so-called	pioneering	factors	that	have	the	potential	to	recognize	their	binding	motifs	in	
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the	context	of	closed	chromatin	(Soufi	et	al.,	2015)	and	can	therefore	function	as	lineage	
determining	transcription	factors	(Heinz	et	al.,	2015;	Iwafuchi-Doi	and	Zaret,	2014).	However,	
such	factors	only	bind	to	a	small	fraction	of	their	corresponding	recognition	motifs	that	are	
present	within	the	genome,	and	the	same	pioneering	factor	can	bind	to	different	genomic	
regions	in	different	cell	types	(Heinz	et	al.,	2010;	Jin	et	al.,	2011;	Roadmap	Epigenomics	et	al.,	
2015).	Therefore,	additional	mechanisms	are	required	to	specify	their	DNA	binding	patterns	in	
each	cell	type.		
	
Studies	in	macrophages	provided	evidence	for	a	collaborative/hierarchical	model	for	enhancer	
selection	driven	by	macrophage-restricted	combinations	of	lineage-determining	factors	that	
include	PU.1	and	C/EBPα/β	(Heinz	et	al.,	2010).	In	these	studies,	the	pioneering	functions	of	
PU.1	and	C/EBPs	were	suggested	to	be	dependent	on	collaborative	interactions	at	sites	in	the	
genome	containing	closely	spaced	(i.e.	<	~150	bp)	binding	motifs	for	each	factor.	Collaborative	
binding	of	PU.1	and	C/EBPs	was	supported	by	studies	investigating	effects	of	genetic	variation	
in	macrophages	derived	from	C57BL/6J	and	BALB/cJ	mice,	in	which	hundreds	of	strain-specific	
binding	sites	for	each	factor	were	observed	(Heinz	et	al.,	2013).	Strain-specific	mutations	in	the	
recognition	motif	for	PU.1	that	resulted	in	loss	of	PU.1	binding	in	that	strain	also	resulted	in	loss	
of	nearby	C/EBPβ	binding,	despite	intact	C/EBP	recognition	motifs,	and	vice	versa.	While	these	
studies	provided	support	for	a	collaborative	model	of	enhancer	selection,	they	also	indicated	
that	the	majority	of	strain-specific	binding	of	PU.1,	C/EBP	and	P65	could	not	be	explained	by	
mutations	in	their	respective	binding	motifs	(Heinz	et	al.,	2013).	This	discrepancy	raised	new	
questions	regarding	the	determinants	of	the	pioneering	functions	of	factors	such	as	PU.1	and	
C/EBP	and	the	extent	to	which	the	binding	of	these	factors	is	influenced	by	nearby	versus	
distant	genomic	elements.	
	
Additional	motivation	for	elucidating	mechanisms	underlying	general	and	cell-specific	gene	
expression	derives	from	the	importance	of	non-coding	genetic	variation	as	a	determinant	of	
phenotypic	diversity.	While	mutations	in	amino	acid	coding	sequences	that	result	in	altered	or	
loss	of	function	of	essential	proteins	are	well-established	causes	of	monogenic	diseases,	they	
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account	for	a	small	fraction	of	overall	genetic	variation	and	inherited	risk	of	disease.	Genome-
Wide	Association	Studies	(GWAS)	of	diverse	phenotypic	traits,	including	disease	risk,	
consistently	identify	between	80	to	90%	of	the	significant	variants	to	reside	in	non-coding	
regions	of	the	genome,	implying	regulatory	functions	(Farh	et	al.,	2015;	Genomes	Project	et	al.,	
2015;	Hindorff	et	al.,	2009;	Maurano	et	al.,	2012).	Consistent	with	this,	genetic	variation	has	
been	demonstrated	to	directly	affect	transcription	factor	binding	as	an	underlying	determinant	
of	altered	chromatin	states	and	gene	expression	(Farh	et	al.,	2015;	Heinz	et	al.,	2013;	Kasowski	
et	al.,	2010;	Kilpinen	et	al.,	2013;	McDaniell	et	al.,	2010;	McVicker	et	al.,	2013;	Reddy	et	al.,	
2012).	Despite	this	substantial	progress,	interpretation	of	non-coding	genetic	variation	remains	
challenging	for	most	loci	and	it	is	not	yet	possible	to	accurately	predict	gene	expression	from	
genotype.		
	
Here	we	exploit	genetic	variation	provided	by	five	diverse	inbred	strains	of	mice	to	query	
mechanisms	underlying	transcription	factor	binding	and	function.	To	eliminate	confounding	
effects	of	strain-specific	differences	in	tissue	environments	that	are	known	to	influence	
macrophage	phenotypes	in	vivo	(Gosselin	et	al.,	2014;	Lavin	et	al.,	2014),	we	performed	studies	
in	bone	marrow	derived	macrophages	(BMDMs),	in	which	each	strain-specific	population	of	
macrophages	was	established	using	an	identical	M-CSF-dependent	differentiation	protocol.	To	
assess	the	impact	of	genetic	variation	on	signal-dependent	transcription	factor	binding	and	
function,	BMDMs	were	activated	with	Kdo2	lipid	A	(KLA),	a	highly	specific	TLR4	agonist	(Raetz	et	
al.,	2006).	This	system	has	several	experimental	strengths.	BMDMs	are	derived	from	readily	
available	inbred	strains	of	mice	in	which	all	loci	are	homozygous	and	whole	genome	sequences	
are	available	(Keane	et	al.,	2011).	The	five	strains	selected	provide	genetic	variation	ranging	
between	~4.5	million	SNPs	+	InDels,	similar	to	differences	between	any	two	individuals,	to	~50	
million	SNPs	+	InDels,	on	the	order	of	all	such	common	variants	in	the	human	population	
(Genomes	Project	et	al.,	2015).	The	selected	strains	of	mice	have	been	extensively	phenotyped	
and	exhibit	marked	phenotypic	diversity	(Bogue	et	al.,	2017;	Lusis	et	al.,	2016).	Sufficient	cells	
can	be	obtained	for	a	broad	range	of	genomic,	proteomic,	lipidomic	and	functional	assays	and	
can	be	readily	derived	from	crosses	between	strains	and	genetically	modified	mice.	Using	this	
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experimental	system,	we	systematically	evaluate	the	effects	of	SNPs	and	InDels	on	gene	
expression,	nascent	transcription,	open	chromatin,	transcription	factor	binding	and	histone	
modifications	associated	with	primed	and/or	active	regulatory	elements	in	resting	and	
activated	primary	macrophages	(Figure	1A),	generating	more	than	250	genome-wide	data	sets.	
In	parallel,	we	develop	a	general	computational	pipeline	for	assessing	the	significance	of	motif	
mutations	on	transcription	factor	binding.	
	
Given	the	diverse	roles	of	macrophages	in	immunity,	tissue	homeostasis	and	disease	(Hirsch	et	
al.,	2012;	Malm	et	al.,	2015;	Moore	and	Tabas,	2011;	Nguyen	et	al.,	2006;	Williams	et	al.,	2016),	
the	experimental	system,	accompanying	data	and	analytical	pipeline	provide	a	significant	new	
resource	for	investigation	of	the	transcriptional	mechanisms	underlying	macrophage	gene	
expression	and	their	context-specific	functions.		We	observe	striking	effects	of	genetic	variation	
on	nascent	and	mature	mRNA	expression	that	predict	distinct	macrophage	phenotypes	in	each	
mouse	strain.	Differences	in	gene	expression	are	associated	with	order	of	magnitude	greater	
differences	in	transcription	factor	binding.	Leveraging	these	differences,	we	provide	evidence	
supporting	the	hypothesis	that	the	genomic	binding	patterns	of	macrophage	lineage	
determining	transcription	factors	are	influenced	by	a	large	fraction	of	other	transcription	
factors	expressed	in	these	cells.	Although	most	variation	in	nascent	transcription	and	
transcription	factor	binding	is	consistent	with	cis-regulation,	thousands	of	strain-specific	
differences	in	transcription	factor	binding	and	chromatin	features	cannot	be	explained	by	local	
mutations.	Integration	of	strain-specific	genomic	features	indicate	that	they	frequently	reside	in	
highly	interconnected	clusters	that	are	associated	with	strain-specific	gene	expression,	
suggesting	a	domain-wide	regulatory	environment	that	influences	transcription	factor	binding	
and	function.		
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Results	
Genetic	variation	and	mRNA	expression		
The	effect	of	genetic	variation	on	polyadenylated	(polyA)	RNA	expression	was	assessed	in	
BMDMs	derived	from	C57BL/6J	(C57),	BALB/cJ	(BALB),	NOD/ShiLtJ	(NOD),	PWK/PhJ	(PWK)	and	
SPRET/EiJ	(SPRET)	(Figure	S1A)	by	RNA-seq	under	basal	conditions	(notx)	and	following	
stimulation	with	KLA	for	1	hour.	A	minimum	of	two	biological	replicates	was	performed	for	each	
mouse	strain	and	condition,	with	replicates	being	highly	correlated	(Figure	S1B,	S1C).	Pairwise	
comparisons	of	BALB,	NOD,	PWK	and	SPRET	BMDMs	to	C57	BMDMs	indicate	a	progressive	
increase	in	differential	gene	expression	in	resting	cells	(Figure	1B).	Using	a	4-fold	cutoff	and	
false	discovery	rate	(FDR)	of	0.01,	divergent	gene	expression	ranged	from	112	RNA	transcripts	
in	the	BALB	x	C57	comparison	(4,158,340	SNPs	and	240,320	InDels)	to	1,438	RNA	transcripts	in	
the	SPRET	x	C57	comparison	(40,757,582	SNPs	and	2,206,269	InDels)	(Table	S1).	Shared	and	
private	differently	regulated	genes	are	shown	in	Figure	1C.	These	data	show	that	BMDMs,	
despite	being	maintained	in	identical	environments,	exhibit	a	remarkable	diversity	of	gene	
expression.	For	example,	~10%	of	the	expressed	transcriptomes	vary	at	least	4-fold	(FDR	<	0.01)	
without	perturbation	by	KLA.	Upon	KLA	treatment	a	total	of	129	genes	were	regulated	in	any	
strain	by	greater	than	4-fold	at	a	FDR	threshold	of	0.01	(Table	S1).	Although	differences	in	the	
expression	response	across	strains	increased	with	genetic	variation,	there	were	very	few	
qualitative	differences	in	the	response	to	KLA	at	1h.	This	suggests	strong	conservation	of	the	
initial	TLR4	response	between	BMDMs	of	all	strains	(Figure	1C,	D).	The	relationship	of	
transcriptional	variation	as	a	function	of	SNPs	+	InDels	for	all	ten	pairwise	comparisons	is	
indicated	in	Figure	1E.	Notably,	differential	gene	expression	exhibits	a	sharp	rise	for	pairwise	
comparisons	between	C57,	BALB	and	NOD	and	comparisons	of	these	strains	with	PWK.	Addition	
of	genes	differentially	regulated	in	SPRET	leads	to	a	further	but	non-linear	increase	in	divergent	
gene	expression.		
	
Clustering	the	RNA-seq	data	segregates	the	samples	by	strain,	with	KLA	treatment	being	a	
secondary	determinant	(Figure	S1C).	WGCNA	analysis	(Langfelder	and	Horvath,	2008)	identifies	
numerous	differentially	expressed	gene	modules,	many	of	which	are	significantly	enriched	for	
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genes	associated	with	specific	biological	functions	including	autophagy,	metabolism,	cell	cycle	
and	interferon	signaling	(Figure	1C,	Figure	S1D).	To	validate	one	such	module,	we	tested	the	
prediction	that	macrophages	derived	from	SPRET	mice	would	exhibit	defects	in	the	type	I	
interferon	response	following	TLR4	ligation	in	comparison	to	C57	macrophages.	C57	and	SPRET	
BMDMs	in	replicates	were	treated	with	KLA	for	6	hours,	at	which	time	a	robust	Type	I	
interferon	response	is	observed	in	C57	BMDMs	at	the	level	of	mRNAs.	This	is	shown	by	an	
expression	heat	map	of	46	known	interferon	stimulated	genes	(ISGs)	exhibiting	>4-fold	
induction	in	C57	BMDMs	(Figure	1F).	A	subset	of	these	genes,	exemplified	by	Mx1	and	Mx2,	are	
fully	induced	in	SPRET	BMDMs.	However,	37	of	the	46	ISGs	exhibit	>2-fold	less	expression	in	
SPRET	BMDMs	following	KLA	treatment,	exemplified	by	Ccl5	and	Ccl2,	and	40	of	these	ISGs	
exhibit	>	2-fold	less	expression	in	SPRET	BMDMs	under	basal	conditions.	These	findings	suggest	
that	differences	in	the	basal	level	of	activity	of	the	Type	I	IFN	pathway	in	these	macrophages	
determine	its	overall	responsiveness	to	stimulation.	
	
Effect	of	genetic	variation	on	nascent	transcription		
We	performed	whole	genome	run-on	analysis	coupled	to	deep	sequencing	(GRO-seq)	(Core	et	
al.,	2008)	to	more	directly	assess	the	effects	of	genetic	variation	on	nascent	transcription	in	
BMDMs	from	each	strain	under	control	conditions	and	1h	after	treatment	with	KLA.	A	minimum	
of	two	biological	replicates	was	performed	for	each	mouse	strain	and	condition	(Table	S2).	As	in	
the	case	of	polyA	RNA	transcripts,	pairwise	comparisons	of	nascent	gene	body	transcripts	
exhibited	increasing	but	non-linear	strain-specific	differences	with	increasing	degrees	of	genetic	
variation	(Figure	2A).	Strain-specific	GRO-seq	signal	is	exemplified	for	Igf1	in	Figure	2B.	KLA	
treatment	induced	GRO-seq	signal	at	939	genes	>4-fold	with	an	FDR	<0.01	in	BMDMs	from	at	
least	one	strain,	and	repressed	452	genes.	The	larger	effect	of	KLA	signaling	on	nascent	
transcripts	is	consistent	with	the	1	hour	time	point	being	relatively	early	in	the	overall	response	
to	TLR4	signaling,	such	that	many	induced	or	repressed	mRNAs	have	not	yet	reached	changes	
required	to	meet	the	stringent	cutoffs	for	selection.	Clustering	the	GRO-seq	data	sets	indicates	
that	the	KLA	treatment	response	is	the	dominant	variable,	in	contrast	to	strain	background	for	
polyA	transcripts	(Figure	S2A).	As	in	the	case	of	the	RNA	response,	very	few	genes	exhibited	
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divergent	responses	to	KLA	at	the	one	hour	time	point,	exemplified	for	comparisons	of	BALB	
and	SPRET	to	C57	in	Figure	2C.	
	
To	define	sites	of	transcription	initiation,	we	performed	5’GRO-seq,	which	selects	for	the	
capped	ends	of	nascent	transcripts	and	enables	base	pair	resolution	of	RNA	polymerase	(Pol)	II	
start	sites	(Lam	et	al.,	2013).	The	relationship	of	5’GRO-seq	to	GRO-seq	and	H3K27ac	at	the	Igf1	
locus	is	illustrated	in	Figure	2B.	In	addition	to	genic	start	sites,	GRO-seq	and	5’GRO-seq	also	
quantify	RNA	generated	at	enhancers	(eRNAs)	(Hah	et	al.,	2011;	Kaikkonen	et	al.,	2013;	Lam	et	
al.,	2013),	observed	upstream	of	the	Igf1	transcription	start	site	(TSS)	in	Figure	2B.	Because	
polyA	RNAs	can	be	initiated	from	different	promoters	in	a	cell-specific	manner	(Noguchi	et	al.,	
2017),	methods	such	as	5’GRO-seq	are	required	to	annotate	genic	start	sites	within	a	given	cell	
type.	Using	5’GRO-seq,	we	find	about	30%	of	mRNAs	to	be	initiated	further	than	50	bp	from	
RefSeq	annotated	start	sites,	suggesting	utilization	of	alternative	core	promoter	elements	in	
macrophages	and/or	technical	differences	with	respect	to	prior	methods	used	for	start	site	
annotation	(Figure	S2B,	S2C).	Using	5’GRO-seq	annotated	TSS,	we	investigated	the	extent	to	
which	differences	in	nascent	and	polyA	RNA	levels	could	be	explained	by	mutations	within	the	
core	promoter	(-30	to	+20	bp	from	the	TSS),	the	proximal	promoter	region	(-300	to	+50	bp	from	
the	TSS)	and	more	distal	elements.	Figure	2D	shows	the	percentage	of	core	promoter	regions	
containing	mutations	that	exhibit	>4-fold	differences	in	gene	expression	against	the	percentage	
of	core	promoter	regions	with	mutations	that	do	not	exhibit	strain-specific	gene	expression.	For	
comparisons	of	C57	versus	PWK	or	SPRET,	20	-	40%	of	core	promoters	contain	mutations	
regardless	of	variation	in	gene	expression.	For	comparisons	of	C57	versus	BALB	or	NOD,	the	
mutation	frequency	in	core	promoters	of	differentially	expressed	genes	is	10-15%,	in	
comparison	to	5-10%	in	core	promoters	of	similarly	expressed	genes.	Using	the	2-sample	test	
for	equality	of	proportions	with	continuity	correction,	these	values	are	significantly	similar	(p-
value	<1e-12	for	C57	vs.	BALB,	p-value	<1e-3	for	C57	vs.	NOD).		For	the	proximal	promoter,	~	
40%	of	differently	regulated	genes	in	C57,	BALB	and	NOD	BMDMs	contain	sequence	variants	in	
comparison	to	a	25-30%	mutation	frequency	in	the	proximal	promoters	of	similarly	expressed	
genes	(p-value	<	2.2e-16	for	C57	vs.	BALB	and	p-value	=	6.57e-07	for	C57	vs.	NOD,	2-sample	test	
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for	equality	of	proportions	with	continuity	correction)	(Figure	S2D).	Therefore,	the	majority	of	
differences	in	gene	expression	cannot	be	explained	through	variation	within	the	core	or	
proximal	promoter	sequences.		
	
We	next	established	the	relative	contributions	of	local	versus	distal	genetic	variation	on	
differential	expression	of	nascent	and	polyA	RNA	transcripts	by	analyzing	BMDMs	derived	from	
F1	crosses	of	C57,	PWK	and	SPRET	mice.	In	this	context,	differences	between	inbred	parental	
strains	are	likely	a	cis	effect	if	the	difference	between	the	parental	alleles	is	maintained	within	
the	F1	hybrid	(where	there	is	one	copy	of	each	parental	allele).	In	contrast,	if	alleles	that	are	
differentially	expressed	in	the	parental	strains	become	similarly	expressed	in	the	F1	animal,	we	
consider	differential	regulation	in	the	parental	strains	to	be	mainly	due	to	trans	effects.	A	plot	
of	fold	difference	in	allele-specific	reads	of	nascent	gene	body	transcripts	for	a	cross	of	C57	and	
SPRET	mice	versus	the	fold	difference	in	the	parental	strains	is	illustrated	in	Figure	2E.	A	
corresponding	plot	for	a	cross	of	C57	and	PWK	mice	is	shown	in	Figure	S2E.	These	comparisons	
indicate	that	about	80%	of	the	differences	in	nascent	transcripts	are	determined	in	cis	(Figure	
S2F).	When	relaxing	the	threshold	for	cis-regulation	to	a	difference	of	1.5-fold,	90%	of	genes	are	
considered	cis-regulated.	Examples	illustrating	primarily	cis-regulation	are	provided	for	Npy	and	
Plag2g7	for	C57	versus	SPRET	BMDMs	in	Figure	2F.	Collectively,	these	findings	indicate	that	
strain-specific	gene	expression	primarily	results	from	cis-variation	that	is	distal	from	core	and	
proximal	promoter	elements.		
	
Effect	of	genetic	variation	on	LDTF	binding	and	chromatin	signatures		
ChIP-seq	experiments	for	PU.1,	C/EBPβ,	CJUN	and	the	P65	component	of	NFκB	under	resting	
and	KLA-stimulated	conditions	were	performed	in	BMDMs	derived	from	each	mouse	strain.	
Regions	of	open	chromatin	were	assessed	using	the	Assay	for	Transposase-Accessible	
Chromatin,	or	ATAC-seq	(Buenrostro	et	al.,	2013),	and	ChIP-seq	of	dimethylation	of	lysine	4	on	
histone	3	(H3K4me2)	and	acetylation	of	lysine	27	on	histone	3	(H3K27ac)	were	used	as	
surrogates	of	primed/active	and	active	regulatory	regions,	respectively	(Creyghton	et	al.,	2010;	
He	et	al.,	2010).	The	Irreproducible	Discovery	Rate	(IDR)	method	(Li	et	al.,	2011)	was	used	to	
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define	highly	reproducible	peaks	across	replicates	for	the	ChIP-seq	experiments	evaluating	
binding	of	PU.1,	C/EBPβ,	CJUN,	P65	and	the	ATAC-seq	data.	Because	IDR	is	not	applicable	to	
histone	modification	ChIP-seq	experiments,	DESeq2	was	used	(Love	et	al.,	2014)	and	regions	
similar	between	replicates	(p-value	<	0.001)	were	kept.	Examples	of	biological	replicates	and	
correlation	heat	maps	are	provided	in	Figure	S3A	and	S3B.	The	numbers	of	features	identified	
for	each	of	these	assays	in	the	five	strains	of	BMDMs	under	control	and	KLA-treated	conditions	
are	provided	in	Table	S3.		
	
The	effect	of	genetic	variation	on	H3K27ac	ChIP-seq	regions	is	illustrated	for	comparisons	of	
BALB	and	SPRET	BMDMs	to	C57	BMDMs	in	Figure	3A	and	corresponding	comparisons	for	
H3K4me2	are	shown	in	Figure	S3C.	As	in	the	case	of	polyA	and	nascent	gene	body	RNA,	
variation	in	these	features	scale	with	genetic	diversity,	but	to	a	greater	degree.	Extension	of	
these	comparisons	for	ATAC-seq	defined	regions	is	illustrated	in	Figure	3B.	Strikingly,	variation	
in	IDR-defined	open	chromatin	regions	occurs	to	an	order	of	magnitude	greater	extent	than	
polyA	or	nascent	gene	body	RNA	expression.	Genomic	regions	exhibiting	at	least	4-fold	
differences	in	ATAC-seq	tag	counts	range	from	~1650	for	the	comparison	of	C57	and	BALB	to	
~19,700	for	the	comparison	of	C57	to	SPRET.	We	performed	de	novo	motif	analysis	of	distal	
ATAC-seq	peaks	(>3000	bp	from	a	TSS)	associated	with	H3K27ac,	corresponding	to	potential	
enhancer	elements,	in	resting	BMDMs	from	each	strain.	This	analysis	returned	a	consistent	
pattern	of	motifs	for	PU.1,	AP-1	and	C/EBP	as	the	most	highly	enriched	motifs,	followed	by	
motifs	for	USF,	RUNX	and	a	composite	PU.1-IRF	motif	(Figure	3C).	We	then	defined	the	
intersections	of	ChIP-seq	peaks	for	PU.1,	CJUN	and	C/EBPβ	with	distal	ATAC-seq	peaks	
associated	with	H3K27ac.	These	three	factors,	alone	or	in	combination,	were	found	to	occupy	
~85%	of	the	putative	distal	regulatory	regions	of	BMDMs	in	each	strain,	exemplified	for	C57	
BMDMs	in	Figure	3D.	H3K27ac	ChIP-seq	data	was	also	used	to	define	super	enhancers,	which	
are	genomic	regions	that	are	occupied	by	a	high	density	of	active	transcriptional	regulatory	
elements	and	are	associated	with	genes	required	for	cellular	identity	(Whyte	et	al.,	2013).	In	
comparison	to	H3K27ac	patterns	as	a	whole,	H3K27ac	signal	at	super	enhancers	was	generally	
concordant	across	strains	(Figure	3E).		
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The	impact	of	genetic	variation	on	transcription	factor	binding	is	illustrated	for	PU.1	in	Figure	3F.	
As	in	the	case	of	H3K27ac	regions	and	ATAC-seq	peaks,	we	observed	a	striking	graded	
progression	of	strain-specific	binding	as	a	function	of	extent	of	SNPs	and	InDels.	Strain-specific	
binding	of	PU.1	ranged	from	~3,800	peaks	comparing	BALB	and	C57	to	more	than	23,000	peaks	
comparing	SPRET	to	C57,	the	latter	number	representing	nearly	one	quarter	of	the	IDR-defined	
PU.1	binding	sites.	Similar	patterns	were	observed	for	C/EBPβ,	CJUN	and	P65	(Figure	S3D-S3F).	
Thus,	variation	in	transcription	factor	binding	greatly	exceeds	variation	in	gene	expression.	To	
quantify	the	extent	of	cis	versus	trans-regulation	of	binding	for	transcription	factors,	PU.1	ChIP-
seq	experiments	were	performed	in	two	F1	strains	(PWK	x	C57	and	SPRET	x	C57)	in	resting	
BMDMs	and	after	KLA	stimulation	for	1	hour.	Directly	comparing	fold	change	of	allele-specific	
reads	between	parents	and	their	corresponding	fold	change	in	the	F1	strains	indicates	that	
more	than	70%	of	the	peaks	follow	the	parental	pattern	and	are	therefore	considered	to	be	cis-
regulated	(Figure	3G,	Figure	S3G,	S3H),	consistent	with	findings	for	nascent	gene	body	RNA.		
	
We	next	assessed	the	extent	to	which	strain-similar	and	strain-specific	ATAC-seq	and	ChIP-seq	
peaks	exhibit	local	genetic	variation	(+/-	150	bp	of	the	peak	center).	We	considered	
homozygous	variants	that	passed	a	stringent	quality	filter	as	well	as	sequence	variants	meeting	
lower	stringency	criteria	(see	extended	methods	for	details).	For	comparisons	of	C57	to	BALB	
and	NOD	BMDMs,	20-22%	of	the	strain-similar	peaks	contain	SNPs	and/or	InDels	(Figure	3H)	(22%	
-	25%	for	the	more	lenient	definition,	respectively).	These	frequencies	increase	to	71-96%	in	
comparisons	involving	PWK	and	SPRET	BMDMs,	indicating	that	the	great	majority	of	local	
sequence	variants	are	silent.	For	strain-specific	peaks	defined	by	a	>4-fold	cut-off,	comparisons	
of	C57	to	BALB	and	NOD	BMDMs	indicated	that	only	52-59%	of	the	ATAC-seq	peaks	and	64-78%	
of	the	PU.1	ChIP-seq	peaks	contain	local	variants.	Extending	the	strain-specific	cut-off	to	>8	fold,	
76-77%	of	ATAC-seq	peaks	and	76-81%	of	PU.1	ChIP-seq	peaks	contain	local	SNPs	and/or	InDels	
(Figure	3H).	Similar	relationships	are	observed	for	C/EBPβ,	CJUN	and	P65,	although	the	fractions	
of	strain-specific	peaks	containing	mutations	are	somewhat	lower	(Figure	S3I).	While	these	
findings	are	consistent	with	the	expected	effects	of	genetic	variation	on	transcription	factor	
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binding	and	open	chromatin,	they	also	indicate	that	substantial	fractions	of	strain-specific	
differences	in	these	features	cannot	be	explained	by	local	SNPs	or	InDels.	Further	examination	
of	structural	variants	indicates	that	these	regions	frequently	explain	extreme	(i.e.,	all	or	none)	
strain-specific	differences	(Figure	S3J,	exemplified	for	C57	versus	SPRET)	for	regions	without	
mutations,	but	overall	account	for	only	about	2%	-	4%	of	the	features	with	mutations	
exhibiting	>4-fold	differences	between	strains	(Figure	S3K).	
	
Inference	of	an	extensive	network	of	collaborative	transcription	factors	
Prior	observations	that	mutations	in	PU.1	motifs	alter	the	binding	of	nearby	C/EBPβ	and	vice	
versa	(Heinz	et	al.,	2013)	provide	the	basis	for	a	general	approach	for	discovery	of	collaborative	
binding	partners	by	systematic	analysis	of	effects	of	local	motif	mutations.	Here,	we	
qualitatively	advance	this	strategy	by	leveraging	the	diversity	of	five	strains	of	mice,	
simultaneously	assessing	four	transcription	factors	under	basal	and	stimulated	conditions,	and	
developing	a	new	Mutational	Analysis	of	Regulatory	Genomic	Elements	(MARGE)	(Link	et	al.,	
2018)	software	pipeline	to	comprehensively	evaluate	the	relationship	of	motif	mutations	with	
transcription	factor	binding	(see	extended	methods	for	details).	Using	an	input	of	normalized	
ChIP-seq	or	ATAC-seq	data	from	genetically	diverse	samples,	a	library	of	motifs	to	query,	and	
corresponding	genomic	sequence	for	each	sample,	MARGE	utilizes	a	general	linear	mixed	
model	to	calculate	a	p-value	for	whether	mutations	in	a	particular	motif	are	significantly	
associated	with	differential	transcription	factor	binding,	chromatin	accessibility	or	transcription	
initiation.	Because	many	motifs	in	existing	databases	are	highly	redundant	and	are	recognized	
by	the	same	factor	or	family	of	factors,	we	also	generated	a	non-redundant	motif	library	by	
clustering	all	motifs	currently	resident	in	the	JASPER	2016	non-redundant	database	and	
combining	motifs	with	a	Pearson	correlation	coefficient	of	greater	than	0.9.	After	further	
manual	curation	this	exercise	yielded	230	motifs	that	were	used	for	analysis.	
		
We	applied	MARGE	to	systematically	identify	motifs	for	which	disruptions	due	to	mutations	
were	highly	correlated	with	strain-specific	binding	of	PU.1,	C/EBPβ,	CJUN	or	P65	under	control	
and	KLA	treatment	conditions.	A	heat	map	for	a	subset	of	the	most	highly	significant	motifs	is	
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illustrated	in	Figure	4A,	along	with	the	corresponding	motif	name.	The	complete	set	of	
significant	motifs	is	illustrated	in	Figure	S4A.	In	total,	mutations	in	80	motifs	were	found	to	be	
associated	with	strain-specific	binding	of	PU.1,	C/EBPβ,	CJUN	and/or	P65	at	a	p-value	of	less	
than	1e-10	(Table	S4).	These	motifs	could	in	turn	be	associated	with	more	than	100	transcription	
factors	expressed	>	1	transcript	per	million	(TPM)	(Table	S5),	providing	genetic	evidence	for	
functional	roles	of	a	large	fraction	of	the	TFs	expressed	in	BMDMs	as	collaborative	partners	that	
drive	the	selection	of	potential	regulatory	elements.		
	
In	addition	to	consensus	PU.1,	C/EBP,	and	AP-1	motifs,	motifs	for	related	factors	were	also	
amongst	the	most	highly	significant	motifs	identified.	These	included	motifs	for	several	ETS	
factors	(e.g.,	GABPA,	ELK,	ELF),	motifs	for	factors	related	to	C/EBP	(e.g.	DBP)	and	motifs	for	
factors	related	to	CJUN	(e.g.,	ATF,	MAF).	These	motifs	are	more	difficult	to	interpret	because	in	
addition	to	being	high	affinity	binding	sites	for	the	corresponding	factors,	they	are	also	lower	
affinity	binding	sites	for	PU.1,	C/EBPβ	and	CJUN,	respectively.	Analysis	of	PU.1	peaks	containing	
a	single	ETS	motif	that	is	not	a	consensus	PU.1	motif	indicated	that	mutations	within	these	
motifs	significantly	impact	PU.1	binding,	consistent	with	direct	interactions	with	low	affinity	
sites	(Heinz	et	al.,	2013).	However,	many	binding	sites	for	PU.1,	C/EBPβ	and	CJUN	contain	
multiple	iterations	of	ETS,	C/EBP	and	AP-1-like	motifs.	For	example,	about	40%	of	PU.1	peaks	
contain	multiple	iterations	of	related	ETS	motifs.	When	the	motif	with	the	highest	score	for	a	
PU.1	motif	is	masked,	mutations	in	the	remaining	ETS	motifs	remain	significant	as	determinants	
of	PU.1	binding.	Similar	relationships	are	observed	for	DBP	motifs	associated	with	C/EBPβ	peaks	
and	ATF/MAF	motifs	associated	with	CJUN	binding.	These	findings	are	consistent	with	both	
homotypic	and	heterotypic	interactions	and	underscore	the	potential	complexity	of	
combinatorial	interactions	between	members	of	transcription	factor	families	that	recognize	
related	binding	motifs.		
	
Single	factor	interaction	networks	for	PU.1	under	basal	conditions	and	P65	under	KLA-
treatment	conditions	are	illustrated	in	Figure	4B	and	Figure	4C,	respectively.	Corresponding	
networks	for	C/EBPβ	and	CJUN	are	illustrated	in	Figure	S4B	and	Figure	S4C.	In	these	networks,	
	 14	
the	node	sizes	represent	the	fraction	of	PU.1	or	P65	binding	sites	that	contain	the	
corresponding	motifs,	and	the	edge	thicknesses	corresponds	to	the	effect	size	of	motif	
mutations.	The	PU.1	network	illustrates	14	of	the	48	motifs	exhibiting	p-value	<1e-10	
significance	for	PU.1	binding	under	no	treatment	conditions,	while	the	P65	network	illustrates	
15	of	the	60	motifs	exhibiting	p-value	<1e-10	significance	for	P65	binding	following	KLA	
treatment.	For	highly	related	motifs	(e.g.,	ETS	factor	motifs),	the	motif	with	the	largest	effect	
size	is	illustrated.	In	panel	B,	the	PU.1	node	in	red	represents	the	fraction	of	all	PU.1	peaks	
(green)	that	contain	motifs	preferentially	matching	to	the	PU.1	motif	consensus	sequence.	As	
expected,	mutations	in	the	PU.1	motif	and	related	ETS	motifs	have	the	strongest	effect	sizes	on	
PU.1	binding.	Mutations	in	AP-1	motifs	and	C/EBP	motifs	have	the	next	strongest	effect	sizes,	
consistent	with	prior	studies	(Heinz	et	al.,	2013).	In	addition,	mutations	in	motifs	for	more	than	
a	dozen	different	classes	of	transcription	factors	were	significantly	associated	with	strain-
specific	binding	of	PU.1,	including	RUNX,	USF,	DR2,	DBP,	MAF,	MYB,	NRF,	and	E2A	motifs	
(Figure	4B	and	Table	S4).	Mutations	in	NFκB	motifs	have	the	strongest	effect	size	on	P65	
binding,	but	the	NFκB	node	size	indicates	that	the	majority	of	IDR-defined	P65	peaks	lack	
consensus	NFκB	motifs	(Figure	4C).	PU.1/ETS,	AP-1	and	C/EBP	motifs	exhibit	the	next	strongest	
effects	on	P65	binding,	but	mutations	in	motifs	for	many	other	factors	have	significant	effects,	
particularly	NRF2,	RUNX	and	DBP.	While	most	significant	motif	mutations	are	associated	with	
decreased	PU.1	and	P65	binding,	mutations	in	E2A	and	ZEB	motifs	have	the	opposite	effect	
(Figure	4B,	C).		
	
An	integrated	interaction	network	for	PU.1,	C/EBPβ	and	CJUN	under	no	treatment	conditions	is	
illustrated	in	Figure	4D.	In	this	network,	node	sizes	are	the	average	fractional	overlap	of	the	
indicated	motif	with	PU.1,	C/EBPβ	or	CJUN	peaks	and	edges	are	factor-specific	effect	sizes.	This	
network	illustrates	largely	dominant	effect	sizes	of	mutations	in	motifs	for	PU.1,	C/EBP	and	AP-
1	factors	on	each	other’s	binding.	In	most	cases,	motif	mutations	affecting	one	factor	affected	
all	factors,	although	often	with	different	effect	sizes,	exemplified	for	USF.	However,	some	
motifs	exhibited	specific	correlations,	such	as	the	unique	association	of	mutations	in	the	KLF	
motif	with	CJUN	binding	(Figure	4D).	Mutations	in	E2A	motifs	were	associated	with	increased	
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binding	of	PU.1,	C/EBPβ	and	CJUN,	whereas	mutations	in	ZEB	motifs	were	associated	with	
selective	increases	in	binding	of	PU.1	and	CJUN	(Figure	4D).	
	
From	these	analyses,	it	is	possible	to	estimate	the	fraction	of	strain-specific	binding	of	PU.1,	
C/EBPβ,	CJUN	and	P65	attributable	to	local	mutations.	Taking	the	binding	sites	exhibiting	>	4-
fold	differences	in	one	or	more	strains,	mutations	in	the	motifs	for	PU.1,	C/EBP,	AP-1	and	NFκB	
motifs	were	associated	with	22,	10,	8	and	9%,	of	strain-specific	variation,	respectively	(Figure	
4E).	Incorporating	the	additional	motifs	found	significant	by	the	MARGE	analysis	increases	the	
percentage	of	strain-specific	binding	explained	to	70,	50,	65	and	60%,	respectively.	The	fraction	
of	binding	sites	explained	by	MARGE	motifs	is	further	increased	considering	the	500	most	
differential	binding	sites	for	each	factor	(Figure	S4D).	However,	even	at	these	sites,	more	than	
20%	of	strain	specific	binding	of	each	factor	remains	unexplained.	
	
The	interaction	networks	inferred	from	motif	mutations	are	based	on	genomic	regions	in	which	
genetic	variation	results	in	strain-specific	differences	in	transcription	factor	binding.	To	
investigate	the	potential	of	RUNX,	USF	and	NRF	factors	(all	found	to	be	highly	significant	in	the	
MARGE	analysis)	to	function	as	collaborative	binding	factors	for	PU.1,	C/EBPβ	and	CJUN,	we	
performed	ChIP-seq	assays	for	RUNX1	and	USF2	in	C57	BMDMs.	In	addition,	we	analyzed	
previous	ChIP-seq	data	for	NRF2	in	C57	BMDMs	(Eichenfield	et	al.,	2016).	In	each	case	we	
observed	broad	overlap	with	the	genomic	binding	locations	of	PU.1,	C/EBPβ	and	CJUN,	
exemplified	for	overlaps	between	PU.1,	RUNX1	and	USF2	in	Figure	4F.	We	further	investigated	
the	potential	of	these	factors	to	play	roles	in	driving	the	selection	of	the	20%	of	open	regions	of	
chromatin	marked	by	H3K27ac	that	are	not	occupied	by	PU.1,	C/EBPβ,	or	CJUN	(Figure	3D).	
These	analyses	indicated	that	USF2	occupied	more	than	80%	of	these	locations,	primarily	in	
association	with	RUNX1	(Figure	4G).	Thus,	nearly	all	putative	enhancer	elements	in	
macrophages	are	marked	by	combinations	of	only	four	transcription	factors:	PU.1,	C/EBPβ,	
CJUN	and	RUNX1.	The	relationship	of	mutations	in	RUNX1	binding	motifs	to	binding	of	PU.1	and	
RUNX1	is	exemplified	in	Figure	4H	(See	Figure	S4E	and	S4F	for	NRF2	and	USF2),	supporting	a	
role	of	RUNX1	(as	well	as	NRF2	and	USF2)	as	a	collaborative	binding	partners	of	PU.1.		
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Regional	correlation	of	transcription	factor	binding		
The	observations	that	the	majority	of	strain-specific	differences	in	gene	expression	and	
transcription	factor	binding	are	in	cis	but	that	substantial	fractions	of	strain-specific	
transcription	factor	binding	sites	cannot	be	explained	by	local	mutations	led	us	to	investigate	
the	possibility	of	cooperativity	between	distinct	cis-regulatory	elements.	To	investigate	this,	we	
calculated	Pearson	correlation	coefficients	(PCC)	of	normalized	tag	counts	for	transcription	
factor	and	ATAC-seq	peaks	across	the	5	strains	under	basal	and	KLA	treatment	conditions.	Heat	
maps	of	these	values	for	ATAC-seq,	PU.1,	and	C/EBPβ	peaks	along	~6	MB	regions	of	
chromosome	18	are	illustrated	in	Figure	5A,	B	and	C.	In	these	plots,	the	axes	represent	
sequential	locations	associated	with	the	indicated	feature,	with	the	matrix	values	
corresponding	to	correlation	coefficients	defined	by	the	accompanying	scale.	Blocks	of	highly	
correlated	peaks	are	observed	to	diverge	from	the	diagonal.	An	example	of	a	genomic	region	in	
the	vicinity	of	the	Colec12	gene	exhibiting	strain-specific	correlation	of	ATAC-seq,	PU.1,	C/EBPβ,	
CJUN,	H3K27ac	and	GRO-seq	features	is	illustrated	in	Figure	5D.	Within	the	shaded	region	more	
than	a	dozen	high	confidence	PU.1	peaks	exhibit	concordant	changes	in	normalized	tag	counts	
across	the	five	strains.	Similar	concordant	changes	are	observed	for	ATAC-seq,	C/EBPβ,	CJUN,	
H3K27ac	and	GRO-seq	data.	For	reasons	described	further	below,	we	refer	to	these	correlated	
regions	as	connected	regulatory	domains	(CRDs).		
	
As	one	approach	to	define	CRDs,	we	considered	the	minimum	number	of	consecutive	features	
(e.g.,	ChIP-seq	peaks)	that	exceed	a	specific	PCC.	CRDs	for	different	minimal	feature	number	
and	correlation	coefficient	are	illustrated	in	Figure	5E.	No	sharp	inflections	are	observed	that	
provide	a	basis	for	optimization	of	parameters.	CRDs	defined	by	arbitrary	cutoffs	of	a	PCC	
of	>0.8	for	a	minimum	of	4	peaks	result	in	400	-	800	locally	correlated	regions	for	PU.1,	C/EBPβ,	
CJUN	and	P65	ChIP-seq	peaks	and	~4000	locally	correlated	ATAC-seq	regions,	which	contain	
various	combinations	of	CRDs	of	the	other	factors	(Table	S6).	For	CRDs	defined	by	an	n	of	>4	
peaks	and	correlation	coefficient	>0.8,	the	mean	number	of	peaks	within	a	correlated	cluster	
was	6	for	PU.1/	C/EBPβ,	cJUN	and	P65,	and	8	for	ATAC-seq	(Figure	S5A)	and	the	size	of	genomic	
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regions	containing	connected	peaks	ranged	from	1kb	to	5Mb	with	a	mean	length	of	70kb	–	
200kb	(Figure	S5B).	Based	on	the	analysis	of	F1	hybrids,	nearly	all	strain-specific	PU.1	peaks	
associated	with	CRDs	retain	their	parental	allelic	pattern	in	F1	BMDMs,	indicating	that	such	
sites	are	primarily	regulated	in	cis	(Figure	S5C).		
	
CRDs	capture	clusters	of	peaks	that	are	highly	similar	across	all	strain	comparisons,	as	well	as	
clusters	of	peaks	that	exhibit	coordinated	differences	between	strains,	such	as	the	example	
shown	for	Colec12.	Correlated	PU.1	peaks	that	exhibit	preferential	binding	in	C57	or	SPRET	
BMDMs	are	associated	with	corresponding	differences	in	expression	of	the	nearest	gene	in	
comparison	to	CRDs	that	are	strain-similar	(Figure	5F).	Similarly,	correlated	PU.1	peaks	that	
exhibit	significantly	different	binding	in	C57	or	SPRET	BMDMs	(p-value	<	2.2e-16)	are	associated	
with	corresponding	significant	differences	in	local	5’GRO-seq	signal	(p-value	=	2.7e-10	for	C57	
specific	set,	p-value	<	2.2e-16	for	SPRET	specific	set)	in	comparison	to	CRDs	that	are	strain-
similar	(p-value	=	0.72)	(Figure	5F	and	Figure	5G),	as	well	as	significantly	different	gene	
expression	of	the	nearest	expressed	gene	(p-value	=	3.9e-4	for	C57	specific	set,	p-value	=	4.1e-4	
for	SPRET	specific	set,	p-value	=	0.78	for	common	set).	The	same	was	observed	for	ATAC-seq	
peaks	(Figure	S5E).	Overall,	strain-specific	CRDs	were	highly	correlated	with	strain-specific	
patterns	of	5’GRO-seq	signal,	exemplified	for	PU.1	CRDs	in	Figure	5G.	In	contrast,	we	observed	
almost	no	overlap	between	strain-specific	CRDs	and	super	enhancers	(Figure	S5D).		
	
Identification	of	connected	regulatory	domains		
The	observation	of	regionally	correlated	transcription	factor	binding,	open	chromatin,	histone	
signatures	and	gene	expression	raised	the	question	of	the	relationships	of	these	regions	to	DNA	
methylation	and	chromatin	organization.	We	determined	the	patterns	of	DNA	cytosine	
methylation	in	BMDMs	from	C57	and	SPRET	mice	by	performing	bisulfite	sequencing	(Hajkova	
et	al.,	2002).	We	observed	differentially	methylated	regions	at	promoters	and	regulatory	
elements,	as	expected,	but	the	overall	patterns	of	DNA	methylation	were	very	similar	between	
the	two	strains	(Figure	S6A),	including	at	promoters	of	differentially	expressed	genes	(Figure	
S6B,	S6C)	such	as	Colec12,	Npy	and	Igf1	(Figure	S6D).	As	these	BMDMs	are	derived	from	the	
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most	divergent	strains,	differences	in	DNA	methylation	are	unlikely	to	be	major	drivers	or	
consequences	of	CRDs.	
	
We	next	performed	in	situ	Hi-C	assays	(Rao	et	al.,	2014)	in	C57	and	SPRET	BMDMs	to	define	
maps	of	DNA	interactions.	A	Hi-C	contact	matrix	depicting	normalized	contact	frequencies	for	
C57	and	SPRET	BMDMs	for	chromosome	18	is	indicated	in	Figure	6A	(left).	Overall	there	was	a	
high	degree	of	similarity,	with	the	Eigenvalue	of	first	principle	component	(PC1),	correlated	with	
active	or	inactive	regions	of	chromatin,	being	nearly	identical	between	strains.	Strain-similar	
contact	frequencies	and	Eigenvalues	are	illustrated	in	the	vicinity	of	the	Spi1	locus,	encoding	
PU.1	(Figure	6B,	left).	However,	genomic	regions	were	also	observed	exhibiting	markedly	
different	contact	frequencies	that	correlated	with	strain-specific	gene	expression,	exemplified	
by	the	Colec12	locus	(Figure	6B,	right).	The	overall	relationship	of	Eigenvalues	for	PC1	calculated	
for	100	kb	windows	(Figure	S6E)	indicates	a	few	hundred	regions	of	the	genome	in	which	the	
Eigenvalue	reverses	sign,	as	in	the	case	of	Colec12	(Figure	6B	right).	A	small	fraction	of	these	
regions	are	associated	with	strain-specific	differences	in	gene	expression	(Figure	S6F).	However,	
the	great	majority	of	differentially	expressed	genes	reside	in	compartments	associated	with	
similar	PC1	values	in	both	strains.		
	
To	further	investigate	the	relationship	between	correlated	chromatin	features	and	chromatin	
organization	we	identified	topological	associating	domains	(TADs)	from	these	Hi-C	data	sets	
(Dixon	et	al.,	2012).	In	brief,	TADs	are	chromatin	regions	that	are	typically	constrained	by	CTCF	
boundaries	such	that	elements	within	the	TADs	have	coordinated	cis-regulatory	activity.	TADs	
were	also	highly	similar	in	BMDMs	of	C57	and	SPRET	mice	(Figure	S6G),	although	there	were	
frequently	subtle	differences	in	how	adjacent	domains	were	parsed	(e.g.,	Figure	6A,	right).	
Comparison	with	ATAC-seq	and	ChIP-seq	data	indicated	that	nearly	all	locally	correlated	
chromatin	features	reside	within	TADs,	exemplified	by	the	grid	lines	in	Figures	5A,	B	and	C.		
	
To	further	investigate	spatial	relationships	of	locally	correlated	features,	we	performed	
proximity	ligation-assisted	ChIP-seq	(PLAC-seq)	in	C57,	BALB,	NOD,	and	SPRET-derived	BMDMs	
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using	H3K4me3	as	anchor	(Fang	et	al.,	2016).	From	these	data	sets	we	defined	all	significant	
interactions	observed	in	at	least	two	strains	as	a	consensus	set.	We	investigated	the	overlap	of	
significant	interactions	between	and	within	ATAC-seq	CRDs	(Figure	6C).	Almost	50%	of	all	
significant	PLAC-seq	consensus	interactions	are	either	within	or	between	these	features,	with	
an	additional	28%	of	interactions	connecting	correlated	ATAC-seq	peaks	with	other	regions	in	
the	genome.	One	example	of	a	highly	connected	region	of	CRDs	is	exemplified	in	Figure	6D.	
Only	about	20%	of	all	significant	PLAC-seq	interactions	are	not	connected	to	ATAC-seq	CRDs,	
even	though	these	features	only	cover	about	11%	of	the	whole	genome	(Figure	S6H).	Almost	40%	
of	the	correlated	ATAC-seq	peaks	have	11	or	more	significant	interactions	(Figure	S6I).	
Comparing	the	number	of	PLAC-seq	interactions	connected	to	ATAC-seq	CRDs	to	a	size-match	
background	showed	a	highly	significant	enrichment	of	interactions	associated	with	CRDs	(p-
value	<	2.2e-16)	(Figure	S6J).	
	
Discussion	
These	studies	report	systematic	analyses	of	the	effects	of	natural	genetic	variation	on	
transcription	factor	binding,	epigenetic	state	and	gene	expression	in	resting	and	activated	
macrophages.	We	observe	striking	levels	of	variation	across	BMDMs	isolated	from	different	
strains	at	each	level	of	analysis,	with	diversity	of	transcription	factor	binding	greatly	exceeding	
that	of	active	histone	modifications,	nascent	RNA	production	and	mature	transcript	levels.	In	
view	of	the	diverse	roles	of	macrophages	in	immunity,	tissue	homeostasis	and	diseases	
including	atherosclerosis,	diabetes,	cancer	and	neurodegeneration	(Hirsch	et	al.,	2012;	Malm	et	
al.,	2015;	Moore	and	Tabas,	2011;	Nguyen	et	al.,	2006;	Williams	et	al.,	2016)	the	data	sets	
provided	by	these	studies	will	be	substantial	resources	for	advancing	understanding	of	
transcriptional	mechanisms	and	effects	of	genetic	variation.	Differences	in	mRNA	gene	
expression	across	the	five	strains	are	substantial	and	segregate	into	distinct	biological	processes,	
suggesting	substantial	differences	with	respect	to	immune	and	tissue	homeostatic	functions.	
Consistent	with	this,	we	validated	the	prediction	that	SPRET	mice	would	exhibit	altered	Type	I	
interferon	responses	following	TLR4	stimulation.	It	will	be	of	interest	to	determine	whether	the	
degree	of	variation	in	gene	expression	observed	here	in	macrophages	is	a	common	feature	of	
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other	cell	types.	Host	responses	to	pathogens	are	powerful	drivers	of	evolution	of	the	immune	
system,	and	the	unique	histories	of	pathogen	exposure	in	the	five	mouse	strains	used	for	
analysis	may	have	resulted	in	more	substantial	differences	in	immune	cells	than	other	cell	types.	
As	the	general	approach	described	here	can	be	applied	to	any	cell	type,	it	will	be	of	interest	to	
apply	these	methods	to	parenchymal	and	other	cell	types	of	various	organs.	
	
The	measurement	of	nascent	RNA	by	GRO-seq	and	sites	of	transcription	initiation	by	5’GRO-seq	
enabled	estimates	of	the	locations	of	variation	underlying	differences	in	genic	transcription.	By	
using	5’GRO-seq	to	annotate	transcription	start	sites,	we	find	that	mutations	affecting	the	core	
promoter	element	and/or	adjacent	upstream	elements	account	for	less	than	20%	of	divergent	
nascent	gene	expression	among	the	most	closely	related	strains.	Mutations	in	core	promoter	
elements	are	expected	to	be	associated	with	large	effect	sizes	and	therefore	more	likely	to	be	
subject	to	negative	selection.	Conversely,	analysis	of	parental	alleles	in	F1	crosses	of	C57	to	
PWK	or	SPRET	mice	indicates	that	more	than	70%	of	divergent	gene	transcription	is	due	to	cis	
variation.	Thus,	differential	regulation	of	gene	expression	observed	in	these	studies	is	mostly	
due	to	effects	on	distal	regulatory	elements,	consistent	with	recent	studies	across	human	
tissues	(Consortium	et	al.,	2017).	The	availability	of	data	sets	for	mature	and	nascent	RNA	levels	
across	five	diverse	strains	of	mice	will	be	of	value	for	future	exploration	of	how	genetic	
variation	influences	diverse	aspects	of	RNA	processing,	such	as	splicing	and	polyadenylation.		
	
A	primary	motivation	of	the	proposed	studies	was	to	systematically	explore	functional	roles	of	
the	hundreds	of	transcription	factors	that	are	expressed	in	macrophages	in	establishing	the	cis-
regulatory	landscape	of	BMDMs	by	determining	the	consequences	of	mutations	in	their	
respective	DNA	recognition	motifs	on	the	binding	of	a	subset	of	macrophage	lineage	
determining	factors.	We	observed	that	while	mutations	in	the	motifs	for	PU.1,	C/EBP,	CJUN	and	
P65	are	significantly	associated	with	strain-specific	binding,	the	majority	of	these	differences	
are	explained	by	mutations	in	nearby	collaborative	factors.	As	previously	demonstrated,	motif	
mutations	in	PU.1	affect	nearby	binding	of	C/EBPβ	and	vice	versa.	The	present	analyses	of	motif	
mutations	now	extend	these	relationships	to	a	transcription	factor	interaction	network	
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dominated	by	collaborative	interactions	between	PU.1,	C/EBPs,	AP-1,	RUNX	and	USF.	
Altogether,	these	studies	provide	evidence	for	significant	roles	of	>80	motifs,	which	can	be	
assigned	to	106	of	the	248	transcription	factors	confidently	expressed	in	macrophages.	These	
findings	therefore	support	the	hypothesis	that	a	large	fraction	of	the	transcription	factors	
expressed	in	BMDMs	shape	the	DNA	binding	patterns	and	functions	of	macrophage	lineage	
determining	factors.	In	general,	motif	importance	is	correlated	with	expression	levels	of	the	
factor	or	factors	that	recognize	it,	although	there	are	notable	exceptions.	For	example,	E2F	
family	members	are	among	the	most	highly	expressed	transcription	factors	in	BMDMs,	but	
mutations	in	their	recognition	motifs	are	not	associated	with	strain-specific	binding	of	PU.1,	
C/EBPβ	or	CJUN.		
	
Beyond	the	understanding	of	mechanisms	that	account	for	the	genomic	binding	patterns	of	
sequence	specific	transcription	factors,	the	ability	to	predict	whether	such	binding	results	in	an	
increase,	decrease	or	no	change	in	the	activity	state	of	a	cis-regulatory	element	and	a	
corresponding	change	in	nearby	gene	expression	remains	an	elusive	goal.	The	data	sets	
generated	by	these	studies	provide	quantitative	estimates	of	strain-specific	enhancer	activities	
based	on	H3K27ac	and	nascent	RNA	levels.	It	will	therefore	be	of	interest	to	explore	the	
relationships	between	sequence	variants	and	enhancer	activity	states	to	better	understand	
mechanisms	underlying	functional	consequences	of	transcription	factor	binding.	
	
Notably,	substantial	fractions	of	strain-specific	DNA	binding	and	ATAC-seq	sites	are	not	
associated	with	or	cannot	otherwise	be	explained	by	local	DNA	variants.	This	discrepancy	led	to	
the	finding	of	regions	in	the	genome	in	which	transcription	factor	binding,	open	chromatin,	
histone	modifications	and	gene	expression	are	highly	correlated.	Further	investigation	of	these	
regions	using	Hi-C	and	PLAC-seq	analyses	indicated	that	they	primarily	reside	within	TADs	and	
are	highly	intra-	and	inter-connected.	These	studies	thereby	confirm	and	extend	prior	studies	in	
human	lymphoblastoid	cell	lines	demonstrating	both	local	and	distal	control	of	chromatin	state	
(Grubert	et	al.,	2015;	Waszak	et	al.,	2015)	In	particular,	several	independent	lines	of	evidence	
suggest	that	regional	interactions	between	connected	cis-regulatory	elements	influence	
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transcription	factor	binding	independently	of	local	DNA	variants.	An	important	future	goal	will	
be	to	determine	underlying	mechanisms.	Given	the	observation	that	many	connected	
regulatory	domains	are	associated	with	coding	or	non-coding	transcripts,	one	possible	model	is	
that	initiation	of	transcription	from	a	‘bootstrap’	enhancer	or	promoter	enables	RNA	
polymerase	II	to	function	as	a	chromatin	remodeling	factor	that	overcomes	local	barriers	to	
transcription	factor	binding.	In	this	model,	genetic	variants	that	disable	the	initiating	
transcriptional	start	site	would	compromise	transcription	factor	binding	to	the	entire	CRD.	
Importantly,	BMDMs	from	different	strains	of	mice	provide	a	highly	tractable	model	system	
determining	molecular	mechanisms	underlying	regional	control	of	transcription	factor	binding	
and	function.	
	
In	concert,	the	present	studies	reveal	complex	relationships	between	genetic	variation,	
transcription	factor	binding,	epigenetic	state	and	gene	expression,	only	some	of	which	can	be	
currently	explained.	Elucidation	of	the	underlying	mechanisms	will	be	necessary	for	a	better	
understanding	of	how	non-coding	genetic	variation	influences	cellular	phenotype.	Although	
macrophages	from	only	five	strains	of	mice	were	evaluated,	they	collectively	provided	more	
than	50	million	SNPs	and	InDels	for	analysis.	While	many	of	the	major	conclusions	derived	from	
these	studies	can	be	achieved	based	on	the	5-6	million	variants	provided	by	comparisons	of	C57,	
BALB	and	NOD	strains,	the	inclusion	of	PWK	and	SPRET	BMDMs	greatly	increased	statistical	
power	to	detect	both	local	and	regional	transcription	factor	interactions.	This	degree	of	genetic	
variation	and	the	number	of	complementary	genomic	assays	are	not	typically	achievable	in	
studies	of	primary	human	cells.	The	model	system	and	associated	data	sets	provided	by	these	
studies	thus	represent	a	powerful	new	resource	for	investigation	of	the	influence	of	genetic	
variation	on	gene	expression	and	cellular	phenotype.	While	the	positions	of	cis-regulatory	
elements	controlling	gene	expression	in	mice	and	humans	are	poorly	conserved,	the	
mechanisms	driving	cell	specific	gene	expression	are	very	similar	(Cheng	et	al.,	2014;	Stergachis	
et	al.,	2014).	For	example,	a	recent	direct	comparison	of	the	transcription	factor	networks	
driving	mouse	and	human	microglia-specific	gene	expression	indicated	that	they	were	nearly	
identical	(Gosselin	et	al.,	2017).	It	is	therefore	likely	that	general	principles	derived	from	studies	
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of	the	influence	of	genetic	variation	on	gene	expression	in	mice	will	substantially	advance	
efforts	to	understand	the	relationship	of	non-coding	genetic	variation	and	phenotype	in	
humans.		
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Figure	legends		
Figure	1.	Effect	of	genetic	variation	on	mRNA	expression.	A.	Overview	of	experimental	design	
and	main	data	sets.	(notx	=	no	treatment,	KLA	=	KLA	treatment	for	1	hour)	B.	Comparison	of	
RNA-seq	for	polyadenylated	(polyA)	transcripts	in	BMDMs	derived	from	the	indicated	mouse	
strains	under	no	treatment	(notx)	conditions.	Log2(TPM+1)	values	are	plotted	for	BALB,	NOD,	
PWK	and	SPRET	vs.	C57	(TPM	=	transcripts	per	kilobase	million).	The	number	of	SNPs	and	InDels	
for	each	comparison	is	shown	at	the	top.	Transcripts	exhibiting	>2-fold	or	>4-fold	changes	at	an	
FDR	<	0.01	are	color	coded	light	blue	and	dark	blue	respectively.	C.	Clustering	of	differentially	
expressed	genes	determined	by	WGCNA.	Differences	are	indicated	by	z-score.	The	top	
functional	annotations	for	each	cluster	are	determined	by	Metascape	(Tripathi	et	al.,	2015)	and	
are	illustrated	on	the	right	with	the	log	q-value.	(See	Figure	S1	for	modules).	D.	Ratio-ratio	plots	
of	the	fold	response	to	KLA	in	BALB	vs.	C57	BMDMs	(top)	and	in	SPRET	vs.	C57	BMDMs	
(bottom).	Each	point	represents	one	polyA	RNA	transcript.	Dark	blue	dots	show	genes	that	are	
4-fold	reciprocal	regulated,	whereas	green	dots	show	a	4-fold	stronger	response	to	the	KLA	
stimulus	in	one	strain	over	the	other.	E.	Relationship	of	differentially	expressed	genes	to	
number	of	genetic	variation	in	million.	F.	Comparison	of	expression	of	46	primary	interferon	
stimulated	genes	(ISGs)	in	C57	and	SPRET	BMDS	under	no	treatment	conditions	and	following	
KLA	stimulation	for	6h.	The	right	column	represents	the	ratio	of	SPRET/C57	gene	expression	
following	KLA	treatment.	
	
Figure	2.	Effect	of	genetic	variation	on	nascent	transcription.	A.	Comparison	of	GRO-seq	gene	
body	tag	counts	in	BMDMs	derived	from	the	indicated	mouse	strains	under	no	treatment	
conditions.	Log2(tag	counts+1)	values	are	plotted	for	BALB,	NOD,	PWK	and	SPRET	versus.	C57.	
Nascent	transcriptions	exhibiting	>2-fold	or	>4-old	changes	at	an	FDR	<0.01	are	color	coded	
light	blue	and	dark	blue	respectively.	B.	Comparison	of	GRO-seq,	5’GRO-seq	and	H3K27ac	signal	
at	the	Igf1	locus	in	BMDMs	derived	from	each	strain	under	no	treatment	conditions.	C.	Ratio-
ratio	plots	of	GRO-seq	tag	counts	for	KLA/no	treatment	conditions,	comparing	BALB	vs.	C57	in	
the	left	panel	and	SPRET	vs.	C57	in	the	right	panel.	Dark	blue	dots	show	genes	that	are	4-fold	
reciprocal	regulated,	whereas	green	dots	show	a	4-fold	stronger	response	to	the	KLA	stimulus	
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in	one	strain	over	the	other.	D.	Relationship	of	differential	RNA-seq	expression	as	a	function	of	
mutations	between	-30	and	+20	bp	of	the	TSS	defined	by	5’GRO-seq	signal.	E.	Ratio	ratio	plot	of	
gene	body	GRO-seq	tag	counts	in	BMDMs	derived	from	C57	and	SPRET	mice	versus	allele-
specific	tag	counts	in	BMDMs	derived	from	SPRET	x	C57	F1	mice.	F.	GRO-seq	expression	for	Npy	
and	Pla2g7	in	BMDMs	derived	from	C57	and	SPRET	mice	and	allele-specific	tag	counts	in	
BMDMs	derived	from	SPRET	x	C57	F1	mice.	
	
Figure	3.	Effect	of	genetic	variation	on	cis-regulatory	landscapes.	A.	Scatter	plots	of	log2	tag	
counts	for	H3K27ac	ChIP-seq	regions	comparing	BALB	and	C57	(left)	and	SPRET	and	C57	(right).	
Regions	exhibiting	>2-fold	or	>4-fold	different	binding	are	colored	light	blue	and	dark	blue	
respectively.	B.	Scatter	plots	of	log2	tag	counts	for	ATAC-seq	peaks	passing	IDR	comparing	BALB	
and	C57	(left)	and	SPRET	and	C57	(right).	Peaks	exhibiting	>2-fold	or	>4-fold	changes	are	
colored	light	blue	and	dark	blue	respectively.	C.	De	novo	motif	analysis	of	distal	(>3000	bp	from	
TSS)	ATAC-seq	peaks	associated	with	H3K27ac	signal	in	each	strain.	Boxes	display	negative	
log10	p-values	for	enrichment	of	the	corresponding	motif	and	its	rank	order	in	parentheses.	D.	
Pie	chart	indicating	fractions	of	distal	H3K27ac-positive	regions	of	open	chromatin	occupied	by	
PU.1,	C/EBPβ	and/or	CJUN.	E.	Heat	map	of	H3K27ac	tag	density	at	genomic	regions	defined	as	
super	enhancers.	F.	Comparison	of	log2	ChIP-seq	tag	counts	for	PU.1	in	BMDMs	derived	from	
the	indicated	mouse	strains	under	no	treatment	conditions.	Features	exhibiting	>2-fold	or	>4-
fold	changes	are	colored	light	blue	and	dark	blue	respectively	G.	Ratio	ratio	plot	of	PU.1	ChIP-
seq	tag	counts	in	BMDMs	derived	from	C57	and	SPRET	mice	versus	allele-specific	tag	counts	in	
BMDMs	derived	from	C57	x	SPRET	F1	mice.	H.	SNPs	and	InDels	frequencies	in	ATAC-seq	and	
PU.1	peaks	within	300bp	of	the	peak	center	for	the	indicated	strain	comparisons	for	stringent	
VCF	filter	criteria	and	more	relaxed	criteria.	
	
Figure	4.	Transcription	factor	interaction	networks	inferred	from	effects	of	motif	mutations.	A.	
Heat	map	of	a	subset	of	significant	motifs	after	application	of	MARGE	under	control	and	KLA	
treatment	conditions.	For	a	complete	listing,	see	Table	S4.	B.	Top	14	of	60	motifs	correlated	
with	binding	of	PU.1	under	no	treatment	conditions	as	determined	by	motif	mutation	analysis.	
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Node	size	is	fraction	of	PU.1	peaks	containing	the	indicated	motif	and	edge	thickness	is	
proportional	to	the	effect	size	of	motif	mutations.	Nodes	in	red	indicate	motifs	in	which	
mutations	result	in	reduced	PU.1	binding.	Nodes	in	blue	indicate	motifs	in	which	mutations	
result	in	increased	PU.1	binding.	C.	Top	motifs	correlated	with	binding	of	P65	under	KLA	
treatment	conditions	as	determined	by	motif	mutation	analysis.	Node	size	and	edge	thickness	
are	as	defined	in	Panel	B.	D.	Integrated	network	of	collaborative	transcription	factors.	The	top	
15	of	80	motifs	for	which	motif	mutations	affected	binding	of	at	least	one	of	the	three	factors	
are	shown.	Node	sizes	are	average	of	all	three	analyses	and	edge	thickness	is	as	defined	in	
Panel	B.	E.	Fraction	of	strain	specific	binding	of	PU.1,	C/EBPβ,	CJUN	and	P65	explained	by	
mutations	in	their	respective	recognition	motifs	and	by	all	mutations	considered	by	MARGE	
analysis.	Values	are	for	peaks	exhibiting	>4-fold	differences	in	at	least	one	comparison	in	
genomic	regions	containing	local	variants.	F.	Overlap	of	binding	of	PU.1,	RUNX1	and	USF2	under	
no	treatment	conditions	as	determined	by	ChIP-seq	for	each	factor.	G.	Fraction	of	open	
chromatin	marked	by	H3K27ac	and	not	bound	by	PU.1,	CJUN	or	C/EBP	occupied	by	RUNX1,	
USF2	and/or	NRF2.	H.	Relationship	of	mutations	in	RUNX	motifs	on	binding	of	RUNX1	and	PU.1	
in	C57	and	SPRET	BMDMs.	
	
Figure	5.	Regional	correlation	of	ATAC-seq	and	ChIP-seq	peaks.	A-C.	Heat	maps	of	Pearson	
correlation	coefficients	(PCC)	of	PU.1,	C/EBPβ	and	CJUN	peaks,	respectively,	across	the	five	
strains	under	control	conditions	in	a	5	mega	base	window	from	chromosome	18.	Vertical	and	
horizontal	lines	represent	TAD	boundaries	as	defined	by	C57	Hi-C	assays	presented	in	Figure	6.	
D.	Illustration	of	regional	correlation	of	GRO-seq,	ATAC-seq,	PU.1,	C/EBPβ,	CJUN,	and	H3K27ac	
signal	in	the	vicinity	of	the	Colec12	gene.	E.	Percentages	of	PU.1	connected	regulatory	domains	
(CRDs)	based	on	minimum	peak	number	and	minimum	Pearson	correlation	coefficient	(PCC).	F.	
Relationship	of	strain-specific	PU.1	CRDs	to	enhancer	activity	measured	by	5’GRO-seq	and	
expression	of	nearest	gene	measured	by	RNA-seq.	Significance	was	calculated	using	a	two-sided	
t-test.	G.	Heat	maps	for	relative	binding	and	5’GRO-seq	signal	at	PU.1	CRDs.	The	ordering	of	
PU.1	signal	and	corresponding	5’GRO-seq	signal	is	the	same	for	the	two	plots.	
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Figure	6.	Connected	regulatory	domains.	A.	Left:	Hi-C	contact	frequency	maps	for	chromosome	
18	in	BMDMs	derived	from	C57	(lower	left)	and	SPRET	(upper	right)	mice.	The	values	for	the	
PC1	eigenvector	are	shown	at	the	bottom.	Right:	Zoomed-in	view	of	Hi-C	contact	frequency	for	
chromosome	18	visualizing	TAD	boundaries	in	SPRET	and	C57.	B.	RNA-seq,	H3K27ac,	PC1,	and	
Hi-C	contact	loops	in	the	vicinity	of	the	Spi1	locus	(left)	and	the	Colec12	locus	(right).	C	Fraction	
of	significant	consensus	PLAC-seq	interactions	within	ATAC-seq	CRDs,	between	ATAC-seq	CRDs	
and	outside	of	CRDs.	D.	Example	of	ATAC-seq	notx	CRDs	highly	connected	by	PLAC-seq	
consensus	interactions.	
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Supplemental	Figures	
Figure	S1.	A.	(Left)	Bones	were	extracted	from	8	–	12	week	old	female	mice	and	20	million	cells	
were	plated	per	15	cm	dish	in	Media	with	M-CSF	for	7	days.	(Right)	Average	number	of	cells	
extracted	per	mouse	(C57:	14	harvest	(n=53),	BALB:	11	harvest	(n=54),	NOD:	10	harvest	(n=47),	
PWK:	12	harvest	(n=99),	SPRET:	9	harvest	(n=66)).	B.	Comparison	of	polyA	RNA-seq	replicates	
for	C57	in	no	treatment	(left)	and	after	KLA	treatment	for	1h	(right)	(TPM	=	transcripts	per	
kilobase	million).	C.	Clustered	spearman	correlation	matrix	for	different	RNA-seq	replicates	for	
no	treatment	and	KLA	1h.	D.	Gene	dendrogram	and	module	colors	from	WGCNA	analysis.	
	
Figure	S2.	A.	Clustered	spearman	correlation	matrix	for	GRO-seq	replicates	using	tag	counts	
along	gene	bodies	for	no	treatment	and	KLA	1h.	B.	Distance	of	RefSeq	annotated	transcription	
start	sites	(TSS)	and	TSS	defined	by	5’GRO-seq	data	for	C57.	C.	Bar	plot	showing	the	percentage	
of	overlap	between	RefSeq	annotated	TSS	and	TSS	defined	by	5’GRO-seq	signal	for	no	
treatment	and	KLA	1h.	D.	Relationship	of	differential	RNA-seq	expression	as	a	function	of	
mutations	between	-30	and	+20	bp	of	the	TSS	defined	by	5’GRO-seq	signal.	E.	Ratio	ratio	plot	of	
gene	body	GRO-seq	tag	counts	in	BMDMs	derived	from	C57	and	PWK	mice	versus	allele-specific	
tag	counts	in	BMDMs	derived	from	PWK	x	C57	F1	mice.	F.	Boxplot	showing	average	percentage	
of	cis-regulated	genes	between	parental	and	F1	alleles	(FPC	=	PWK	x	C57	F1,	FSC	=	SPRET	x	C57	
F1).	
	
Figure	S3.	A.	Comparison	of	replicates	for	PU.1	notx	ChIP-seq	for	C57	(left)	and	SPRET	(right).	
Grey	dots	are	peaks	called	in	either	replicate,	green	dots	are	peaks	passing	IDR.	B.	Clustered	
spearman	correlation	matrix	for	PU.1	ChIP-seq	replicates	(top	left),	C/EBPβ	ChIP-seq	replicates	
(top	right),	CJUN	ChIP-seq	replicates	(bottom	left),	and	P65	ChIP-seq	replicates	(bottom	right)	
for	all	strains	in	no	treatment	and	KLA	1h	conditions	(KLA	1h	condition	only	for	P65).	C-E.	
Scatter	plots	of	log2	tag	counts	for	H3K4me2	ChIP-seq	regions	(C),	C/EBPβ	ChIP-seq	peaks	(D),	
CJUN	ChIP-seq	peaks	(E)	and	P65	ChIP-seq	peaks	(F)	comparing	BALB	and	C57	(left)	and	SPRET	
and	C57	(right).	Regions	exhibiting	>2-fold	or	>4-fold	different	binding	are	colored	light	blue	and	
dark	blue	respectively.	G.	Ratio	ratio	plot	of	normalized	PU.1	ChIP-seq	tag	counts	in	BMDMs	
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derived	from	C57	and	PWK	mice	versus	allele-specific	tag	counts	in	BMDMs	derived	from	PWK	x	
C57	F1	mice.	H.	Boxplot	showing	average	percentage	of	cis-regulated	transcription	factor	
binding	sites	for	all	loci	with	fold	change	going	in	the	same	direction,	for	all	loci	with	2-fold	
change	(4-fold	change,	respectively)	in	parental	and	F1	alleles	a	I.	SNP+InDel	frequencies	in	
CEBPβ,	CJUN	and	P65	peaks	for	the	indicated	strain	comparisons.	J.	Average	minimum	and	
maximum	tag	counts	per	peak	for	ATAC-seq	(left)	and	PU.1	(right)	with	>4-fold	difference	in	
binding	between	C57	versus	SPRET	without	mutations	that	overlap	or	do	not	overlap	structural	
variances.	K.	Percentage	of	differently	bound	ATAC-seq	and	PU.1	peaks	without	mutations	
overlapping	structural	variances	(left	panel)	and	peaks	with	mutations	overlapping	structural	
variances	(right	panel).	
	
Figure	S4.	A.	Heat	map	of	all	significant	motifs	(p-value	<	1e-10)	after	application	of	MARGE	
under	control	and	KLA	treatment	conditions.	Dendrogram	on	right	shows	clustering	of	
consensus	motifs	by	similarity	based	on	Pearson	correlation	coefficient	(PCC).	On	the	left	
consensus	motif	logos	are	shown.	B.	Top	motifs	correlated	with	binding	of	C/EBPβ	under	no	
treatment	conditions	as	determined	by	MARGE’s	motif	mutation	analysis.	Node	size	is	fraction	
of	C/EBPβ	peaks	containing	the	indicated	motif	and	edge	thickness	is	proportional	to	the	effect	
size	of	motif	mutations.	Nodes	in	red	indicate	motifs	in	which	mutations	result	in	reduced	
C/EBPβ	binding.	Nodes	in	blue	indicate	motifs	in	which	mutations	result	in	increased	C/EBPβ	
binding.	C.	Top	motifs	correlated	with	binding	of	CJUN	under	no	treatment	conditions	as	
determined	by	MARGE’s	motif	mutation	analysis.	Node	size	and	edge	thickness	are	as	defined	
in	Panel	B.	D.	Fraction	of	strain	specific	binding	of	PU.1,	C/EBPβ,	CJUN	and	P65	explained	by	
mutations	in	their	respective	recognition	motifs	and	by	all	motifs	found	significant	by	MARGE	
analysis.	Values	are	for	the	500	most	differently	bound	peaks	containing	local	variants.	E.	
Relationship	of	mutations	in	NRF2	motifs	on	binding	of	NRF2	and	PU.1	in	C57	and	SPRET	
BMDMs	with	intact	PU.1,	C/EBP,	and	AP-1	binding	motifs.	F.	Relationship	of	mutations	in	USF	
motifs	on	binding	of	USF2	and	PU.1	in	C57	and	SPRET	BMDMs	with	intact	PU.1,	C/EBP	and	AP-1	
binding	motifs.	
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Figure	S5.	A.	Bar	plot	showing	the	average	number	of	peaks	within	CRDs	for	different	ChIP-seq	
data	sets	and	treatments	B.	Bar	plot	showing	the	average	length	of	CRDs	in	kilo	bases	(kb)	for	
different	ChIP-seq	data	sets	and	treatments.	C.	Ratio	ratio	plot	of	normalized	PU.1	ChIP-seq	tag	
counts	summed	for	all	peaks	within	CRDs	in	BMDM	derived	from	C57	and	SPRET	mice	versus	
allele-specific	tag	counts	in	BMDMs	derived	from	SPRET	x	C57	F1	mice.	D.	Overlap	of	CRDs	and	
super	enhancers	in	percentage.	CRDs	and	super	enhancers	were	merged	for	different	assays	
and	percentage	of	CRDs	only,	super	enhancers	only	and	overlap	of	both	was	calculated.	E.	
Relationship	of	strain-specific	ATAC-seq	notx	CRDs	to	enhancer	activity	measured	by	5’GRO-seq	
and	expression	of	nearest	gene	measured	by	RNA-seq.	Significance	was	calculated	using	a	two-
sided	t-test.	
	
Figure	S6.	A.	Percentage	of	CpGs	methylated	(mCpG)	at	promoters	(defined	by	RefSeq)	of	all	
genes	for	C57	(green)	and	SPRET	(purple).	B.	Percentage	of	CpGs	methylated	at	promoters	of	
genes	2-fold	differently	expressed	in	C57	vs.	SPRET.	C.	Percentage	of	CpGs	methylated	at	
promoters	of	genes	4-fold	differently	expressed	in	C57	vs.	SPRET.	D.	UCSC	genome	browser	
shot	showing	promoter	methylation	for	highly	differently	expressed	genes	Colce12	(left),	Npy	
(middle)	and	Igf1	(right).	E.	Scatter	plot	of	PC1	Eigenvector	values	comparing	C57	and	SPRET	
derived	from	the	respective	Hi-C	contact	maps.	F.	Expression	values	of	genes	associated	with	
Eigenvector	values	of	the	same	sign	(black)	in	C57	and	SPRET	BMDMs	and	genes	associated	
with	Eigenvector	values	of	opposite	sign	(red).	G.	General	conservation	of	TAD	boundaries	and	
contact	frequency	within	TADs	measured	by	inclusion	ratio	in	BMDMs	derived	from	C57	and	
SPRET	mice.	H.	Fraction	of	genome	covered	by	ATAC-seq	CRDs.	I.	Distribution	of	significant	
PLAC-seq	consensus	interactions	in	ATAC-seq	CRDs.	J.	Comparison	of	overlap	of	significant	
PLAC-seq	interactions	in	ATAC-seq	CRDs	in	comparison	to	size-matched	background	shows	
significant	enrichment	of	PLAC-seq	interactions	in	CRDs.	
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Supplemental	Tables	
Table	S1.	Summary	of	mRNA	expression	Gene	expression	measured	by	RNA-seq	normalized	to	
log2	transcripts	per	million	(TPM)	in	replicates	for	all	expressed	genes	(TPM	>	1)	for	BALB,	C57,	
NOD,	PWK,	and	SPRET	BMDMs	under	control	conditions	(notx)	and	after	KLA	1h	treatment.	
	
Table	S2.	Summary	of	nascent	transcription.	GRO-seq	tag	counts	along	gene	bodies	normalized	
to	10	million	sequenced	reads	in	replicates	for	BALB,	C57,	NOD,	PWK,	and	SPRET	BMDMs	under	
control	conditions	(notx)	and	after	KLA	1h	treatment.	
	
Table	S3.	Summary	of	sequencing	assays.	Number	of	features	(peaks	or	regions)	identified	for	
each	of	assay	(ATAC-seq,	PU.1	ChIP-seq,	CEBPb	ChIP-seq,	CJUN	ChIP-seq,	P65	ChIP-seq,	
H3K27ac	ChIP-seq	and	H3K4me2	ChIP-seq)	in	the	five	strains	of	BMDMs	under	control	(notx)	
and	KLA-treated	conditions	for	1	hour	after	IDR,	as	well	as	the	union	of	features	per	experiment.	
	
Table	S4.	MARGE	analysis	results.	List	of	all	transcription	factor	binding	motifs	found	significant	
in	MARGE	analysis	for	at	least	one	factor	and	treatment	condition.		
	
Table	S5.	Candidate	transcription	factors	for	MARGE	analysis	results.	List	of	all	expressed	
transcription	factors	(TPM	>	1)	which	can	bind	motifs	found	as	significant	by	MARGE	analysis	
including	the	transcription	factor,	its	transcription	factor	family,	as	well	as	RNA-seq	expression	
of	this	factor	in	all	five	strains	and	treatment	(in	TPM).	
	
Table	S6.	Summary	of	CRDs.	List	of	all	CRDs	for	all	assays	and	treatments,	as	well	as	number	of	
CRDs	that	are	strain-specific	and	strain-similar.		
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STAR	Methods	
	
Key	Resources	Table	
	
see	separate	file	(use	template)	
	
Contact	for	Reagents	and	Resource	Sharing	
Further	information	and	requests	for	resources	and	reagents	should	be	directed	and	will	be	
fulfilled	by	the	Lead	Contact,	Christopher	K.	Glass	(ckg@ucsd.edu)	
	
Experimental	Model	and	Subject	Details	
	
Mice	
Female	and	male	breeder	mice	for	C57BL/6J,	BALB/cJ,	NOD/ShiLtJ,	PWK/PhJ,	and	SPRET/EiJ	
mice	were	purchased	from	Jackson	Laboratory.	Mice	were	housed	at	the	UCSD	animal	facility	
on	a	12	h/12	h	light/dark	cycle	with	free	access	to	food	and	water.	All	animal	procedures	were	
in	accordance	with	University	of	California	San	Diego	research	guidelines	for	the	care	and	use	of	
laboratory	animals.	8	–	12	week	old	female	mice	were	used	for	experiments.	For	F1	crosses	
female	C57BL/6J	mice	were	crossed	with	male	PWK/PhJ	and	SPRET/EiJ	and	8	-12	week	old	
female	F1	mice	were	used	for	experiments.	
	
Bone	marrow-derived	macrophage	(BMDM)	culture	
Femur,	tibia	and	iliac	bones	from	the	different	mouse	strains	were	flushed	with	DMEM	high	
glucose	(Corning)	and	red	blood	cells	were	lysed	using	red	blood	cell	lysis	buffer	(eBioscience).	
After	counting,	20	million	bone	marrow	cells	were	seeded	per	15cm	non-tissue	culture	plates	in	
DMEM	high	glucose	(50%)	with	20%	FBS	(Omega	Biosciences),	30%	L929-cell	conditioned	media	
(as	source	of	M-CSF),	100	U/ml	penicillin/streptomycin+L-glutamine	(Gibco)	and	2.5µg/ml	
Amphotericin	B	(HyClone).	After	4	days	of	differentiation,	16.7	ng/ml	mouse	M-CSF	
(Shenandoah	Biotechnology)	was	added	to	the	media.	After	an	additional	2	days	of	culture,	
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non-adherent	cells	were	washed	off	with	room	temperature	DMEM	and	macrophages	were	
obtained	as	a	homogeneous	population	of	adherent	cells	which	were	scraped	and	subsequently	
seeded	onto	tissue	culture-treated	petri	dishes	overnight	in	DMEM	containing	10%	FBS,	100	
U/ml	penicillin/streptomycin+L-glutamine,	2.5µg/ml	Amphotericin	B	and	16.7	ng/ml	M-CSF.	For	
KLA	activation,	macrophages	were	treated	with	10	ng/mL	KLA	(Avanti	Polar	Lipids)	for	1	or	6	
hours.		
	
Method	Details	
	
RNA-seq	library	preparation	
Total	RNA	was	isolated	from	cells	and	purified	using	Quick	RNA	mini	prep	columns	and	RNase-
free	DNase	digestion	according	to	the	manufacturer’s	instructions	(Zymo	Research).	RNA-seq	
libraries	were	prepared	from	poly(A)-enriched	mRNA,	as	previously	described	(Oishi	et	al.,	
2017).	Libraries	were	sequenced	on	HiSeq	4000	or	NextSeq	500.	
	
Crosslinking	for	ChIP-seq	
For	PU.1,	C/EBPβ,	H3K4me2,	and	H3K27ac	ChIP-seq,	culture	media	was	removed	and	plates	
were	washed	once	with	PBS	and	then	fixed	for	10	minutes	with	1%	formaldehyde	(Fischer	
Scientific)	in	PBS	at	room	temperature	and	reaction	was	then	quenched	by	adding	glycine	
(Sigma)	to	0.125M.	
For	CJUN,	P65,	USF2	and	RUNX1	ChIP-seq,	cells	were	cross-linked	for	30	minutes	with	2mM	DSG	
(Pierce)	in	PBS	at	room	temperature.	Subsequently	cells	were	fixed	for	10	minutes	with	1%	
formaldehyde	at	room	temperature	and	the	reaction	was	quenched	with	0.125M	glycine.		
After	fixation,	cells	were	washed	once	with	cold	PBS	and	then	scraped	into	supernatant	using	a	
rubber	policeman,	pelleted	for	8	minutes	at	400xG	at	4°C.	Cells	were	transferred	to	DNA	lobind	
tubes	and	pelleted	at	700xG	for	5	minutes	at	4°C	and	snap-frozen	in	liquid	nitrogen	and	stored	
at	-80°C	until	ready	for	ChIP-seq	protocol	preparation.	
	
ChIP-seq	library	preparation	
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Chromatin	immunoprecipitation	(ChIP)	was	performed	as	described	previously	(Oishi	et	al.,	
2017).	In	brief,	cells	were	resuspended	in	swelling	buffer	(10mM	HEPES/KOH	(pH7.9),	85mM	
KCl,	1mM	EDTA,	0.5%	IGEPAL	CA-630)	with	protease	inhibitors	for	5min	and	then	spun	down	
and	resuspended	in	500µl	lysis	buffer	(50mM	Tris/HCl	(pH7.4),	1%	SDS,	0.5%	Empigen	BB,	
10mM	EDTA)	with	protease	inhibitors,	and	chromatin	was	sheared	using	the	Bioruptor	
(Diagenode).	Lysate	was	diluted	with	750µl	dilution	buffer	(20mM	Tris/HCl,	100mM	NaCl,	0.5%	
TritonX-100,	2mM	EDTA),	1%	was	taken	as	input	DNA,	and	immunoprecipitation	was	carried	
out	overnight	with	Dynabeads	protein	G	bound	to	specific	antibodies	for	PU.1	(Santa	Cruz,	sc-
352X),	C/EBPβ	(Santa	Cruz,	sc-150),	H3K4me2	(Millipore,	07-030),	H3K27ac	(Active	Motif,	
39135),	CJUN	(Santa	Cruz,	sc-1694),	P65	(Santa	Cruz,	sc-372X),	USF2	(Santa	Cruz,	sc-862X)	and	
RUNX1	(Santa	Cruz,	sc-365644).	Beads	were	washed	twice	each	with	wash	buffer	I	(20mM	
Tris/HCl,	150mM	NaCl,	0.1%	SDS,	1%	Triton	X-100,	2mM	EDTA),	wash	buffer	II	(10mM	Tris/HCl,	
250mM	LiCl,	1%	IGEPAL	CA-630,	0.7%	Na-deoxycholate,	1mM	EDTA),	TE	0.2%	Triton	X-100	and	
TE	50mM	NaCl	and	subsequently	eluted	with	elution	buffer	(TE,	2%	SDS).	DNA	was	reverse-
crosslinked	and	purified	using	ChIP	DNA	Clean	&	Concentrator	(Zymo	Research)	according	to	
the	manufacturer's	instructions.	Sequencing	libraries	were	prepared	from	eluted	DNA	by	
blunting,	A-tailing,	adaptor	ligation	as	previously	described	(Heinz	et	al.,	2010)	using	NextFlex	
barcodes	(Bioo	Scientific).	Libraries	were	PCR-amplified	for	12-15	cycles,	size	selected	using	
PAGE/TBE	gels	for	200-400bp	fragments	by	gel	extraction	and	single-end	sequenced	HiSeq	4000	
or	NextSeq	500.	
	
5’GRO-seq	and	GRO-seq		
Nascent	transcription	was	captured	by	global	nuclear	run-on	sequencing	(GRO-seq)	(Core	et	al.,	
2008)	and	nascent	transcription	start	sites	by	5’GRO-seq	(Lam	et	al.,	2013).	Nuclei	were	isolated	
from	BMDMs	using	hypotonic	lysis	[10	mM	Tris-HCl	(pH	7.5),	2	mM	MgCl2,	3	mM	CaCl2;	0.1%	
IGEPAL	CA-630]	and	flash	frozen	in	GRO-freezing	buffer	[50	mM	Tris-HCl	(pH	7.8),	5	mM	MgCl2,	
40%	Glycerol].	3-5	x	106	BMDM	nuclei	were	run-on	with	BrUTP-labelled	NTPs	as	described	
(Duttke	et	al.,	2015)	with	3x	NRO	buffer	[15mM	Tris-Cl	(pH	8.0),	7.5	mM	MgCl2,	1.5	mM	DTT,	
450	mM	KCl,	0.3	U/µL	of	SUPERase	In,	1.5%	Sarkosyl,	366	µM	ATP,	GTP	(Roche),	Br-UTP	(Sigma	
	 40	
Aldrich)	and	1.2	µM	CTP	(Roche,	to	limit	run-on	length	to	~40	nt)].	Reactions	were	stopped	
after	five	minutes	by	addition	of	500	µL	Trizol	LS	reagent	(Invitrogen),	vortexed	for	5	minutes	
and	RNA	extracted	and	precipitated	as	described	by	the	manufacturer.		
	
GRO-seq	library	preparation		
For	GRO-seq,	RNA	pellets	were	resuspended	in	18	µl	ddH2O	+	0.05%	Tween	(dH2O+T)	and	after	
addition	of	2	µl	fragmentation	mix	[100	mM	ZnCl2,	10	mM	Tris-HCl	(pH	7.5)],	incubated	at	70°C	
for	15	minutes.	Fragmentation	was	stopped	by	addition	of	2.5	µl	100	mM	EDTA.	BrdU	
enrichment	was	performed	using	BrdU	Antibody	(IIB5)	AC	beads	(Santa	Cruz,	sc-32323	AC,	lot	
#A0215	and	#C1716),	as	described	in	detail	by	Hetzel	et	al	(Hetzel	et	al.,	2016).	Beads	were	
washed	once	with	GRO	binding	buffer	[0.25×saline-sodium-phosphate-EDTA	buffer	(SSPE),	0.05%	
(vol/vol)	Tween,	37.5	mM	NaCl,	1	mM	EDTA]	+	300	mM	NaCl	followed	by	three	washes	in	GRO	
binding	buffer	and	resuspend	as	25%	(vol/vol)	slurry	with	0.1	U/μL	SUPERase-in.	To	fragmented	
RNA,	500	μL	cold	GRO	binding	buffer	and	40	μL	equilibrated	BrdU	antibody	beads	were	added	
and	samples	slowly	rotated	at	4°C	for	80	minutes.	Beads	were	subsequently	spun	down	at	
1000xG	for	15	seconds,	supernatant	removed	and	the	beads	transferred	to	a	Millipore	Ultrafree	
MC	column	(UFC30HVNB;	Millipore)	in	about	2x	200	μL	GRO	binding	buffer.	The	IP	reaction	was	
washed	twice	with	400	μL	GRO	binding	buffer	before	RNA	was	eluted	by	incubation	in	200	μL	
Trizol	LS	(Thermo	Fisher)	under	gentle	agitation	for	3	minutes.	The	elution	was	repeated	a	
second	time,	120	μL	of	dH2O+T	added	to	increase	the	supernatant	and	extracted	as	described	
by	the	manufacturer.	
For	end-repair	and	decapping,	RNA	pellets	were	dissolved	in	8	µl	TET	[10	mM	Tris-HCl	(pH	7.5),	
1	mM	EDTA,	0.05	%	Tween20]	by	vigorous	vortexing,	heated	to	70°C	for	2	minutes	and	placed	
on	ice.	After	a	quick	spin,	22	µl	Repair	MM	[3	µl	10x	PNK	buffer,	15.5	µl	dH2O+T,	0.5	µl	
SUPERase-In	RNase	Inhibitor	(10	U),	2	µl	PNK	(20U),	1	µl	RppH	(5U)]	was	added,	mixed	by	
flicking	and	incubated	at	37°C	for	1	hour.	To	phosphorylate	the	5’end,	0.5	µl	100	mM	ATP	was	
subsequently	added	and	the	reactions	were	incubated	for	another	45	minutes	at	37°C	(the	high	
ATP	concentration	quenches	RppH	activity).	Following	end	repair,	2.5	µl	50	mM	EDTA	was	
added,	reactions	mixed	and	then	heated	to	70°C	for	2	minutes	before	being	placed	on	ice.	A	
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second	BrdU	enrichment	was	performed	as	detailed	above.	For	library	preparation,	RNA	pellets	
were	dissolved	in	2.75	µl	TET	+	0.25	µl	Illumina	TruSeq	3’Adapter	(10	µM),	heated	to	70°C	for	2	
minutes	and	placed	on	ice.	7	µl	of	3’MM	[4.75	µl	50%	PEG8000,	1	µl	10x	T4	RNA	ligase	buffer,	
0.25	µl	SUPERase-In,	1	µl	T4	RNA	Ligase	2	truncated	(200U;	NEB)]	was	added,	mixed	well	by	
flicking	and	reactions	incubated	at	20°C	for	1	hour.	Reactions	were	diluted	by	addition	of	10	µl	
TET	+	2	µl	50	mM	EDTA,	heated	to	70°C	for	2	minutes,	placed	on	ice	and	a	third	round	of	
BrdUTP	enrichment	was	performed.	RNA	pellets	were	transferred	to	PCR	strips	during	the	75%	
ethanol	wash	and	dried.	Samples	were	dissolved	in	4	µl	TET	[10	mM	Tris-HCl	(pH	7.5),	0.1	mM	
EDTA,	0.05%	Tween	20]	+	1	µl	10	µM	reverse	transcription	(RT)	primer.	To	anneal	the	RT-
primer,	the	mixture	was	incubated	at	75°C	for	5	minutes,	37°C	for	15	minutes	and	25°C	for	10	
minutes.	To	ligate	the	5’	Illumina	TruSeq	adapter,	10	µl	5’MM	[1.5	µl	ddH2O	+	0.2%	Tween20,	
0.25	µl	denaturated	5’TruSeq	adapter	(10	µM),	1.5	µl	10x	T4	RNA	ligase	buffer,	0.25	µl	
SUPERase-In,	0.2	µl	10	mM	ATP,	5.8	µl	50%	PEG8000,	0.5	µl	T4	RNA	ligase	1	(5U;	NEB)]	was	
added	and	reactions	were	incubated	at	25°C	for	1	hour.	Reverse	transcription	was	performed	
using	Protoscript	II	(NEB)	[4	µl	5x	NEB	FirstStrand	buffer	(NEB;	E7421AA),	0.25	µl	SUPERase-In,	
0.75	µl	Protoscript	II	(150U;	NEB)]	at	50°C	for	1	hour.	After	addition	of	30	µl	PCR	MM	[25	µl	2X	
LongAmp	Taq	2X	Master	Mix	(NEB),	0.2	µl	100	µM	forward	primer,	2.8	µl	5M	Betaine	and	2	µl	
10	µM	individual	barcoding	primer],	mixtures	were	amplified	(95°C	for	3	minutes,	[95°C	for	60	
seconds,	62°C	for	30	seconds,	72°C	for	15	seconds]	x13,	72°C	for	3	minutes).	PCR	reactions	were	
cleaned	up	using	1.5	volumes	of	SpeedBeads™	(GE	Healthcare)	in	2.5M	NaCl/20%	PEG8000	and	
libraries	size	selected	on	a	PAGE/TBE	gels	to	160–225	base	pairs.	Gel	slices	were	shredded	by	
spinning	through	a	0.5	ml	perforated	PCR	tube	placed	on	top	of	a	1.5	ml	tube.	150	µl	Gel	EB	
[0.1%	LDS,	1M	LiCl,	10	mM	Tris-HCl	(pH	7.8)]	was	added	and	the	slurry	incubate	under	agitation	
overnight.	To	purify	the	eluted	DNA,	700	µl	Zymogen	ChIP	DNA	binding	buffer	was	added	into	
the	1.5	ml	tube	containing	the	shredded	gel	slice	and	the	Gel	EB,	mixed	by	pipetting	and	the	
slurry	transferred	to	a	ZymoMiniElute	column.	Samples	were	first	spun	at	1000xG	for	3	
minutes,	then	10,000xG	for	30	seconds.	Flow	through	was	removed,	and	samples	washed	with	
200	µl	Zymo	WashBuffer	(with	EtOH).	Gel	remainders	were	removed	by	flicking	and	columns	
washed	by	addition	of	another	200	µl	Zymo	WashBuffer	(with	EtOH).	Flow	through	was	
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removed,	columns	spun	dry	by	centrifugation	at	14,000xG	for	1	minute	and	DNA	eluted	by	
addition	of	20	µl	pre-warmed	Sequencing	TET	[10	mM	Tris-HCl	(pH	8.0),	0.1	mM	EDTA,	0.05%	
Tween	20].	Libraries	were	sequenced	on	an	Illumina	NextSeq	500.	
	
5’GRO-seq	library	preparation		
RNA	pellets	were	resuspended	in	10	µl	TET,	heated	to	70°C	for	2	minutes	and	place	on	ice.	10	µl	
of	dephosporylation	MM	[2	µl	10x	CutSmart,	6.75	µl	dH2O+T,	1	µl	Calf	Intestinal	alkaline	
Phosphatase	(10	U;	CIP,	NEB),	0.25	µl	SUPERase	In	(5U)]	was	added.	Following	incubation	at	
37°C	for	45	minutes,	2	µl	50	mM	EDTA	was	added,	reactions	mixed,	heated	to	70°C	for	2	
minutes	and	place	on	ice.	BrdU	enrichment	was	performed	as	described	for	GRO-seq.	RNA	
pellets	were	dissolved	in	10	µl	TET	and	a	second	round	of	dephosphorylation	and	BrdU	
enrichment	was	performed.	Libraries	were	prepared	as	described	in	(Hetzel	et	al.,	2016).	
Briefly,	libraries	were	done	as	described	for	GRO-seq	with	exception	of	the	3’Adapter	ligation	
step.	Here,	prior	to	3’Adapter	ligation,	samples	were	dissolved	in	3.75	µl	TET	heated	to	70°C	for	
2	minutes	and	placed	on	ice.	RNAs	were	decapped	by	addition	of	6.25	µl	RppH	MM	[1	µl	10x	T4	
RNA	ligase	buffer,	4	µl	50%	PEG8000,	0.25	µl	SUPERase-In,	1	µl	RNA	5'	Pyrophosphohydrolase	
(5U;	RppH,	NEB)]	and	incubated	at	37°C	for	1	hour.	Afterwards,	to	ligate	the	3’	Illumina	TruSeq	
adapter	10	µl	of	3’MM	was	added	[1	µl	10x	T4	RNA	ligase	buffer,	6	µl	50%	PEG8000,	1.5	µl	
ddH2O+T,	0.25	µl	heat-denaturated	Illumina	TruSeq	3’Adapter,	0.25	µl	SUPERase-In,	1	µl	T4	
RNA	Ligase	2	truncated	K227Q	(200U;	NEB)],	mixed	well	by	flicking	and	reactions	incubated	at	
20°C	for	1	hour.	Reactions	were	diluted	by	addition	of	10	µl	TET	+	2	µl	50	mM	EDTA,	heated	to	
70°C	for	2	minutes,	placed	on	ice	and	a	third	round	of	BrdUTP	enrichment	was	performed.	5’	
adapter	ligation,	reverse	transcription	and	library	size	selection	were	performed	as	described	
for	GRO-seq.	Samples	were	amplified	for	14	cycles,	size	selected	for	160–250	bp	and	sequenced	
on	an	Illumina	NextSeq	500.	
	
ATAC-seq	library	preparation		
To	approximately	150k	nuclei	in	22.5	µl	GRO	freezing	buffer,	isolated	as	described	for	GRO-seq	
above,	25	µl	DNA	Tagmentation	buffer	was	added,	reaction	mixed	and	2.5	µL	DNA	
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Tagmentation	Enzyme	mix	(Nextera	DNA	Library	Preparation	Kit,	Illumina)	added.	Mixture	was	
incubated	at	37°C	for	30	minutes	and	subsequently	purified	using	the	Zymogen	ChIP	DNA	
purification	kit	as	described	by	the	manufacturer.	DNA	was	amplified	using	the	Nextera	Primer	
Ad1	and	a	unique	Ad2.n	barcoding	primers	using	NEBNext	High-Fidelity	2X	PCR	MM	for	10	
cycles.	PCR	reactions	were	purified	using	1.5	volumes	of	SpeedBeads	in	2.5M	NaCl,	20%	
PEG8000,	size	selected	using	PAGE/TBE	gels	for	160	–	280	bp	and	DNA	eluted	as	described	for	
GRO-seq.	
	
PLAC-seq	library	preparation	
PLAC-seq	libraries	were	prepared	as	described	in	(Fang	et	al.,	2016).	In	brief,	cells	were	cross-
linked	for	15	minutes	at	room	temperature	with	1%	formaldehyde	and	quenched	for	5	minutes	
at	room	temperature	with	0.2M	glycine.	The	cross	linked	cells	were	centrifuged	at	2500xG	for	5	
minutes.	To	isolate	nuclei,	cross-linked	cells	were	resuspended	in	200	µl	lysis	buffer	(10mM	
Tris-HCl	(pH	8.0),	10mM	NaCl,	0.2%	IPEGAL	CA-630)	and	incubated	on	ice	for	15	minutes.	The	
suspension	was	then	centrifuged	at	2500xG	for	5	minutes	and	the	pellet	washed	by	
resuspending	in	300	µl	lysis	buffer	and	centrifuging	at	2500xG	for	5	minutes.	The	pellet	was	
resuspended	in	50	µl	0.5%	SDS	and	incubated	for	10	minutes	at	62°C.	170	µl	1.47%	TritonX-100	
was	added	to	the	suspension	and	incubated	for	15	minutes	at	37°C.	25	µl	of	10X	NEBuffer	2	and	
100U	MboI	was	added	to	digest	chromatin	for	2	hours	at	37°C	at	1000rpm	rotation.	Enzymes	
were	inactivated	by	heating	for	20	minutes	at	62°C.	Fragmented	ends	were	biotin	labeled	by	
adding	50	µl	of	a	mix	containing	0.3mM	biotin-14-dATP,	0.3mM	dATP,	0.3mM	dTTP,	0.3mM	
dGTP,	and	0.8U/µl	Klenow	and	incubated	for	60	minutes	at	23°C	with	rotation	(500rpm).	Ends	
were	subsequently	ligated	by	adding	a	900	µl	master	mix	containing	120	µl	10X	T4	DNA	ligase	
buffer	(NEB),	100	µl	10%	TritionX-100,	12	µl	10mg/mL	BSA,	10	µl	400U/µl	T4	DNA	Ligase	(NEB,	
high	concentration	formula)	and	658	µl	H2O	and	incubated	for	240	minutes	at	23°C	with	
300rpm	slow	rotation.	Nuclei	were	pelleted	for	5	minutes	at	room	temperature	at	2500XG.	For	
the	ChIP,	nuclei	were	resuspended	in	RIPA	Buffer	(10mM	Tris	(pH	8.0),	140mM	NaCl,	1mM	
EDTA,	1%	Triton	X-100,	0.1%	SDS,	0.1%	sodium	deoxycholate)	with	proteinase	inhibitors	and	
incubated	on	ice	for	10	minutes.	Sonication	was	performed	using	a	Covaris	M220	instrument	
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(Power	75W,	duty	factor	10%,	cycle	per	bust	200,	time	10	minutes,	temperature	7°C)	and	nuclei	
were	spun	for	20	minutes	at	14000rpm	at	4°C.	For	pre-cleaning,	protein	G	sepharose	beads	
were	added	to	the	supernatant	and	rotated	for	3	hours	at	4°C.	5%	of	supernatant	was	taken	as	
input	DNA,	and	to	the	remaining	volume	2.5µg	of	anti-H3K4me3	antibody	(04-745,	Millipore)	
was	added	and	rotated	at	4°C	overnight	for	immunoprecipitation.	0.5%	BSA-blocked	protein	G	
sepharose	beads	was	added	and	the	sample	was	rotated	for	3	hours	at	4°C.	The	sample	was	
centrifuged	at	2000rpm	for	1	minute	and	the	beads	were	washed	three	times	with	RIPA	buffer,	
two	times	with	high-salt	RIPA	buffer	(10mM	Tris	pH	8.0,	300mM	NaCl,	1mM	EDTA,	1%	Triton	X-
100,	0.1%	SDS,	0.1%	deoxycholate),	one	time	with	LiCl	buffer	(10mM	Tris	(pH	8.0),	250mM	LiCl,	
1mM	EDTA,	0.5%	IGEPAL	CA-630,	0.1%	sodium	deoxycholate)	and	finally	two	times	with	TE	
buffer	(10mM	Tris	(pH	8.0),	0.1mM	EDTA).	Washed	beads	were	treated	with	10µg	RNase	A	in	
extraction	buffer	(10mM	Tris	(pH	8.0),	350mM	NaCl,	0.1mM	EDTA,	1%SDS)	for	1	hour	at	37°C,	
and	subsequently	20µG	proteinase	K	was	added	at	65°C	overnight.	ChIP	DNA	was	purified	by	
Phenol/Chloroform/Isoamyl	Alcohol	(25:24:1)	extraction	and	then	ethanol	purification	with	
final	elution	volume.	For	Biotin	pull	down,	20	µL	of	10mg/mL	Dynabeads	My	One	T1	
Streptavidin	beads	washed	with	400	µl	of	1X	Tween	Wash	Buffer	(5mM	Tris-HCl	(pH	7.5),	
0.5mM	EDTA,	1M	NaCl,	0.05%	Tween)	supernatant	removed	after	separation	on	a	magnet.	
Beads	were	resuspended	with	2X	Binding	Buffer	(10mM	Tris-HCl	(pH	7.5),	1mM	EDTA,	2M	NaCl),	
added	to	the	sample	and	incubated	for	15	minutes	at	room	temperature.	Beads	were	
subsequently	washed	twice	with	1X	Tween	Wash	Buffer	and	in	between	heated	on	a	
thermomixer	for	2	minutes	at	55°C	with	mixing	and	once	washed	once	with	1X	NEB	T4	DNA	
ligase	buffer.	To	repair	fragmented	ends	and	remove	biotin	from	unligated	ends,	beads	were	
resuspended	in	88	µl	1X	NEB	T4	DNA	ligase	buffer,	2	µl	25mM	dNTP	mix,	5	µl	10U/µl	NEB	T4	
PNK,	4	µl	3U/µl	NEB	T4	DNA	Polymerase	and	1	µl	5U/µl	Klenow,	incubated	for	30	minutes	at	
room	temperate	and	supernatant	was	discarded	after	separation	on	magnet.	Beads	were	
washed	twice	with	1X	Tween	Wash	Buffer	with	2	minute	incubation	at	55°C	on	a	thermomixer	
with	mixing,	and	afterwards	resuspended	in	100µl	1X	NEB	Buffer	2.	For	dA-tailing,	beads	were	
resuspended	in	90	µl	1X	NEB	Buffer	2,	5	µl	10mM	dATP	and	5	µl5U/µl	Klenow	(exo-,	NEB	
M0212)	and	incubated	for	30	minutes	at	30°C.	Beads	were	then	washed	twice	as	before.	Beads	
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were	subsequentially	washed	in	1X	NEB	Quick	Ligation	Reaction	Buffer	(diluted	from	2X,	NEB	
B2200S).	To	ligate	adapters,	beads	were	suspended	in	50	µl	1X	NEB	DNA	Quick	Ligase	Buffer	
and	3	µl	Illumina	Indexed	adapters	and	2	µl	of	NEB	DNA	Quick	ligase	(M2200)	were	added	
mixed	and	incubated	for	15	minutes	at	room	temperature.	Beads	were	washed	twice	with	1X	
Tween	Wash	Buffer	with	2	minutes	at	55°C	on	a	thermomixer	as	before.	Beads	washed	with	1X	
Tris	Buffer	once	and	resuspended	in	50	µl	of	1x	Tris	Buffer.	KAPA	qPCR	assay	was	performed	to	
estimate	concentration	and	cycle	number	for	final	PCR.	Final	PCR	was	directly	amplified	off	the	
T1	beads	according	to	the	qPCR	results	and	DNA	was	cleaned	with	1X	AMPure	Cleanup	and	
eluted	in	1X	Tris	Buffer	and	sequenced	paired-end.	
	
Bisulfite	Sequencing	
Bisulfite	sequencing	was	performed	as	described	in	(Urich	et	al.,	2015).	DNA	from	C57Bl/6J	and	
SPRET/EiJ	BMDMs	was	isolated	using	the	PureLink	Genomic	DNA	Kit	(Thermo	Fisher	Scientific)	
as	described	by	the	manufacturer.	2	µg	of	gDNA	supplemented	with	0.5%	non-methylated	ʎ-
DNA	(Promega)	was	used	as	input.	DNA	was	fragmented	to	a	200	bp	peak	size	using	the	Covaris	
microTube	sonicator,	size	selected,	end-repaired,	adenylated	and	methylated	adapters	ligated	
exactly	as	detailed	in	Urich	et	al.	Cytosine	to	uracil	conversion	was	performed	with	the	EZ	DNA	
methylation-Gold	kit	(Zymo	Research)	with	450ng	of	adapter-ligated	gDNA	input	as	described	
within.	Following	bisulfite-treated	DNA	purification,	reactions	were	amplified	with	four	cycles,	
purified	using	one	volume	of	AMPure	XP	bead	solution	and	sequenced	on	an	Illumina	NextSeq	
500	for	25	million	and	31	million	reads	for	C57Bl/6J	and	SPRET/EiJ,	respectively.	Conversion	
rates	were	99.69%.	
	
Hi-C	sequencing	
In	situ	Hi-C	was	performed	using	the	Arima-HiC	kit	(Arima	Genomics	Inc)	as	described	by	the	
manufacturer.		
	
Quantification	and	Statistical	Analysis	
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Statistical	details	are	indicated	throughout	the	main	text,	in	the	Figure	legends	and	within	the	
supplemental	Tables	
	
Data	mapping	and	shifting	
Custom	genomes	were	generated	for	BALB/cJ,	NOD/ShiLtJ,	PWK/PhJ,	and	SPRET/EiJ	from	
invariant	positions	of	the	mm10	sequence	with	alleles	replaced	by	those	reported	in	the	VCF	
files	(version	v3)	from	the	Mouse	Genomes	Project	(Keane	et	al.,	2011).	For	C57BL/6J	the	mm10	
reference	genome	from	the	UCSC	genome	browser	was	used.	ChIP-seq,	ATAC-seq,	GRO-seq	and	
5’GRO-seq	data	was	mapped	to	custom	genomes	using	bowtie2	(Langmead	and	Salzberg,	2012)	
with	default	parameters.	RNA-seq	data	was	mapped	to	custom	genomes	using	STAR	(Dobin	et	
al.,	2013)	with	default	parameters.	DNA	methylation	data	was	mapped	to	custom	genomes	
using	Bismark	(Krueger	and	Andrews,	2011)	(bismark	-n	1	-l	40),	Hi-C	data	was	mapped	to	
custom	genomes	using	bowtie2	(Langmead	and	Salzberg,	2012)	with	default	parameters	and	
PLAC-seq	data	was	mapped	to	custom	genomes	using	BWA	(version	0.7.15-r1140)	(Li	and	
Durbin,	2009)	with	default	parameters.	For	visualization	and	data	analysis,	the	strain	genomes	
were	shifted	to	the	positions	of	the	reference	genome	(mm10)	using	MARGE	(Link	et	al.,	2018).	
Deletions	in	the	strains	compared	to	the	reference	were	not	assigned	with	any	reads.	Mapped	
reads	on	insertions	in	the	strain	were	shifted	to	the	last	overlapping	position	between	strain	
and	reference	and	summed	up	at	this	position.	To	overlap	peaks	with	structural	variances	(SV)	
the	SV	file	for	all	strain	comparisons	to	C57	was	downloaded	from	the	mouse	genome	project	
webpage.	
	
Generation	of	consensus	motif	file	
Position	Probability	Matrices	(PPMs)	of	all	pairs	of	DNA	sequence	motifs	were	generated	and	all	
pairwise	combinations	were	aligned	with	Smith-Waterman	algorithm	(Smith	and	Waterman,	
1981)	without	gaps.	For	each	position	in	the	alignment	a	Pearson	correlation	was	calculated.	
Sets	of	motifs	that	had	PPMs	with	a	Pearson	correlation	of	0.9	or	greater	were	merged	by	
iteratively	aligning	each	PPM	within	the	set	and	averaging	the	nucleotide	frequencies	at	each	
position,	similar	to	the	STAMP	approach	(Mahony	and	Benos,	2007).	The	threshold	for	motif	
	 47	
finding	was	set	to	have	a	false-positive	rate	lesser	than	0.001	using	the	Biopython	module	
motifs	(Cock	et	al.,	2009)	with	the	function	distribution.threshold_fpr.	
	
	
IDR	analysis	
Transcription	factor	ChIP-seq	experiments	were	performed	in	two	replicates	with	
corresponding	input	experiments.	HOMER	(Heinz	et	al.,	2010)	tag	directories	were	created	for	
both	replicates	and	both	inputs	and	peaks	were	called	with	HOMER	for	each	tag	directory	with	
relaxed	peak	finding	parameters	(-L	0	-C	0	-fdr	0.9)	and	the	corresponding	input	directory.	For	
ATAC-seq,	no	inputs	were	used,	but	the	size	was	set	to	200bp	(-L	0	-C	0	-fdr	0.9	-minDist	200	-
size	200).	IDR	(Li,	2011)	was	installed	using	Anaconda	3.	To	test	for	reproducibility	between	
replicates,	tag	directories	for	input	and	ChIP-seq	were	pooled	and	pseudo	replicates	were	
generated.	Peaks	were	called	and	IDR	was	run	on	both	replicates	and	considered	good	if	the	
replicate	with	more	peaks	had	less	than	twice	the	number	of	peaks	of	the	other	replicate.	To	
assess	reproducibility	within	one	experiment,	each	replicate	was	randomly	split	into	two	
replicates.	Peaks	were	called	and	IDR	was	run	on	each	pseudo	replicate.	Experiments	were	
considered	self-consistent	if	the	pseudo	replicate	with	more	peaks	had	less	than	twice	the	
number	of	peaks	of	the	other	pseudo	replicate.	After	passing	these	two	quality	control	steps,	
IDR	was	performed	on	replicates	and	all	optimal	peaks	defined	by	IDR	were	used	for	
downstream	analysis.	For	downstream	analysis,	the	pooled	input	and	experiment	tag	
directories	were	used.	
	
Histone	modification	ChIP-seq	quality	control	
IDR	is	not	applicable	for	histone	modification	data.	Therefore,	for	H3K4me2	and	H3K27ac	ChIP-
seq,	peaks	were	called	on	each	replicate	independently	with	HOMER’s	findPeaks	-style	histone,	
8-fold	enrichment	over	the	input	sample	and	normalization	to	10	million	mapped	reads	per	
experiment.	These	peaks	then	were	merged	using	HOMER’s	mergePeaks	–size	given	and	
subsequently	similar	peaks	between	both	replicates	were	identified	using	HOMER’s	
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getDifferentialPeaks	with	the	parameter	–same.	Peaks	that	were	significantly	similar	(p-value	<	
0.001)	were	kept.	
	
ATAC-seq	and	ChIP-seq	analysis	
To	quantify	the	number	of	differentially	bound	transcription	factor	binding	site	and	open	
chromatin,	the	optimal	peak	files	from	the	IDR	analysis	were	merged	between	two	strains	with	
HOMER’s	mergePeaks.	Subsequently	the	merged	file	was	annotated	with	HOMER’s	
annotatePeaks.pl	with	parameters	mm10	–noann	–nogene	and	the	pooled	tag	directories	were	
used.	Peaks	bound	more	than	2-fold	different	between	strains	were	colored	light	blue,	peaks	
bound	more	than	4-fold	different	were	colored	dark	blue.	All	tag	counts	reported	throughout	
the	manuscript	are	normalized	to	10	million	reads	per	sample.	
	
De	novo	Motif	analysis	
To	identify	motifs	enriched	in	peak	regions	over	random	background,	HOMER’s	de	novo	motif	
analysis	(findMotifsGenome.pl)	was	modified	to	account	for	differences	in	the	strain	genomes.	
The	hand-curated	motif	file	was	used	to	compare	enriched	consensus	sequences	with	known	
motifs.	
	
Super	enhancers	
Super	enhancers	were	identified	using	H3K27ac	ChIP-seq	data	in	HOMER	using	the	findPeaks	–
style	super	and	–i<input	sample>	parameters.	
	
	
Network	analysis	
To	calculate	the	effect	size	of	mutations	within	a	motif	on	binding,	the	r.squaredGLMM	function	
of	the	MuMIn	package	(Barton,	2017)	in	R	was	used.	The	marginal	R	value	(sqrt(R2))	was	
multiplied	by	100	and	reported	as	effect	size.	The	network	was	visualized	using	Cytoscape	3.5.1	
(Shannon	et	al.,	2003)	scaling	the	edges	by	effect	size	and	nodes	by	percentage	of	peaks	
containing	the	motif	of	interest	at	least	once.	
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RNA-seq	analysis	
To	compare	strain-specific	gene	expression,	first	HOMER’s	analyzeRepeats	with	the	option	rna	
and	the	parameters	–condenseGenes,	-noadj,	and	–count	exons	was	used	on	two	replicates	per	
strain.	Differential	gene	expression	was	assessed	with	DESeq2	using	HOMER’s	
getDiffExpression.pl	with	the	parameters	–fdr	0.01	and	–log2fold	1	(for	2-fold	differently	
expressed	genes)	or	–log2fold	2	(for	4-fold	differently	expressed	genes).	All	genes	shorted	than	
250bp	were	removed	and	for	the	remaining	genes	the	TPM	(transcript	per	kilobase	million)	
values	were	plotted	and	colored	according	to	fold	change	(2-fold	different:	light	blue,	4-fold	
different:	dark	blue).	For	ratio	ratio	plots	the	TPM	values	of	both	replicates	per	treatment	and	
strain	were	averaged	and	the	induction	of	gene	expression	was	calculated	avg(TPM	
KLA+1)/avg(TPM	notx	+	1)	on	a	log	2	scale.	To	assess	the	difference	in	interferon	response,	46	
genes	associated	with	interferon	response	were	manually	selected	and	the	average	TPM	values	
for	both	strains	and	both	treatments	were	shown	and	used	to	calculate	the	fold	difference	in	
KLA	response.		
	
WGCNA	analysis	
Raw	gene	counts	defined	by	HOMER’s	analyzeRepeats	was	imported	in	R,	processed	with	EdgeR	
version	3.16.5	(Robinson	et	al.,	2010).	Genes	smaller	than	250	bp,	with	less	than	1	count	per	
million	(CPM)	in	at	least	2	samples	were	discarded	and	WGCNA	analysis	(Version	1.61)	
(Langfelder	and	Horvath,	2008)	was	performed	on	the	remaining	genes.	The	coexpression	
network	was	created	using	a	softpower	value	of	20.	Tree	cutting	was	performed	with	PAM	
stage,	minimum	module	size	of	250	genes	and	a	cut	height	of	0.99	(Langfelder	et	al.,	2008).	The	
modules	were	ordered	according	to	number	of	genes,	and	were	assigned	colors	from	the	
‘Spectral’	palette	of	RcolorBrewer	(1.1-2)	(Neuwirt,	2014).	Module	trait	correlations	were	
calculated	using	‘treatment’,	‘strain	combinations’	and	‘treatment	and	strain	interaction’	as	
surrogate	trait	variables.	P-values	based	on	the	correlation	scores	were	FDR	multiple	testing	
corrected	with	the	Stats-package	(Version	4.3.3.2),	and	only	modules-trait	correlated	FDR	<	1E-
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3	were	considered	to	be	significant.	Modules	were	annotated	using	Metascape	(Tripathi	et	al.,	
2015).	
	
GRO-seq	analysis	
To	compare	strain-specific	nascent	transcription	the	level	of	nascent	transcripts	at	the	gene	
bodies	was	assessed	with	HOMER’s	analyzeRepeats	with	the	option	rna	and	the	parameters	–
condenseGenes	–noadj	and	–count	genes	on	two	replicates	per	strain.	Differential	nascent	
transcription	was	assessed	with	DESeq2	using	HOMER’s	getDiffExpression.pl	with	the	
parameters	–fdr	0.01	and	–log2fold	1	(for	2-fold	different	nascent	transcription)	or	–log2fold	2	
(for	4-fold	different	nascent	transcription).	All	genes	shorted	than	250bp	were	removed	and	for	
the	remaining	gene	bodies	the	TPM	values	for	the	pooled	tag	directories	were	used	for	
visualization.	For	ratio-ratio	plots	analyzeRepeats	was	used	with	option	rna	and	the	parameters	
–condenseGenes,	-tpm	and	–count	genes	using	the	pooled	tag	directories	per	strain	and	
treatment.	
	
5’GRO-seq	analysis	
Tag	directories	for	two	replicates	were	pooled	into	one	replicate	to	achieve	more	sequencing	
depth.	5’GRO-seq	signal	was	assessed	with	HOMER’s	findPeaks	–style	tss	using	the	pooled	GRO-
seq	signal	tag	directories	as	input.	5’GRO-seq	peaks	were	merged	between	strains	using	
mergePeaks	and	signal	was	quantified	with	annotatePeaks.pl	with	parameters	–fragLength	1	
and	–strand	+.	To	quantify	the	distance	between	the	5’GRO-seq	signals	and	the	annotated	
transcription	start	sites	(TSS),	the	distances	annotatePeaks.pl	reports	were	used.	
To	determine	the	percentage	of	genetic	variation	within	TSS	affection	gene	expression,	all	TSS	
were	merged	between	all	possible	strains	combinations	with	HOMER’s	mergePeaks	–d	given	-
strand.	These	sites	then	were	centered	and	extended	by	the	respective	distances.	For	TSS	on	
the	negative	strand	the	extension	was	reversed.	The	extended	regions	were	annotated	with	
mutations	from	the	strains.	Furthermore,	the	expression	of	each	gene	was	measured	by	RNA-
seq	read	counts	using	TPM.	Genes	on	chromosome	X	and	chromosome	Y	were	excluded.	All	
genes	with	less	than	4	TPM	were	filtered	out.	For	the	remaining	genes,	the	log2	fold	change	
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was	calculated.	Genes	were	split	into	similarly	expressed	between	strains	(log2	fold	change	
between	-0.5	and	0.5)	and	differently	expressed	(log2	fold	change	greater	than	1	or	less	than	-
1).	The	genes	were	associated	with	the	closest	5’GRO-seq	signal	and	promoter	regions	with	
natural	genetic	variation	were	defined	as	mutated,	whereas	regions	without	any	genetic	
variation	were	defined	as	equal	sequence.	
	
CRD	analysis	
The	optimal	peak	files	from	all	five	strains	were	merged	into	one	large	file	with	HOMER’s	
mergePeaks	and	annotated	with	the	tag	counts	from	the	pooled	IDR	tag	directories.	The	
Pearson	correlation	coefficient	(PCC)	between	all	pairs	of	peaks	was	calculated	with	the	perl	
module	Statistics::Basic	using	the	correlation	sub	function.	To	visualize	the	data,	a	sub	part	of	
the	matrix	was	selected	and	visualized	in	R	with	heatmap.2	from	the	gplots	package.		
To	define	CRDs	4	or	more	consecutive	peaks	with	a	PCC	of	0.8	or	greater	from	each	peak	to	the	
start	peak	was	selected	to	plot	length	and	average	numbers	of	peaks.	To	annotate	the	signal	at	
CRDs	PU.1	or	5’GRO-seq	signal	was	annotated	at	each	original	peak	with	annotatePeaks.	For	
5’GRO-seq	the	parameters	–fragLength	1	and	–strand	+	was	used.	The	signal	of	all	peaks	within	
one	CRD	was	summed	up	to	the	final	signal	at	the	CRDs.	In	order	to	differentiation	between	
highly	similar	and	highly	different	CRDs	between	strains,	the	minimal	and	maximal	binding	
strength	was	defined	by	locus	and	the	difference	between	minimum	and	maximum	was	
calculated	as	(max	–	min)/max.	Loci	with	a	score	greater	than	0.6	were	labeled	as	different,	
whereas	loci	with	a	score	smaller	than	0.5	were	labeled	as	similar.	
	
Hi-C	analysis	
Hi-C	fastq	files	were	mapped	separately	and	HOMER	tag	directories	were	created	with	
makeTagDirectory	<read1>,<read2>	-tbp	1.	Hi-C	interaction	matrices	were	visualized	as	
observed	interactions	versus	expected	with	Juicebox	(Durand	et	al.,	2016)	and	in	the	WashU	
(Zhou	and	Wang,	2012)	genome	browser	as	pairwise	interactions.	PC1	values	were	calculated	
using	HOMER’s	runHiCpca.pl	with	–res	50000	–superRes	100000.	TADs	were	called	with	
HOMER’s	findTADsAndCPs.pl	find	with	parameters	–res	3000	–superRes	15000	for	C57	and	
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SPRET	independently.	To	remove	false	positive	regions,	filterTADsAndCPs.pl	was	used.	To	
compare	TADs	between	strains	the	TADs	were	merged	using	merge2Dbed.pl	and	then	the	
inclusion	ratio	was	quantified	with	findTADsAndCPs.pl	score	with	parameters	TBA.	
The	inclusion	ratio	was	calculated	by	finding	the	average	interaction	counts	as	a	function	of	
distance	for	interactions	within	the	TAD	(intra-TAD)	and	for	interactions	between	the	TAD	and	
the	regions	of	upstream	and	downstream	of	the	TAD	of	the	same	size	(inter-TAD).	To	visualize	
TADs	in	the	matrices	for	the	CRDs	TADbit-analysis	(Serra	et	al.,	2017)	was	used	to	call	TADs	on	
raw	count	interactions	matrices	in	a	100kb	window	generated	by	HOMER.		
	
PLAC-seq	analysis	
PLAC-seq	data	was	preprocessed	with	PrepPlac.sh	script	 from	the	FithiChIP	package	version	1	
(https://github.com/ay-lab/FitHiChIP).	 After	 mapping,	 two	 separate	 alignments	 files	 were	
created	for	short	(<	1	kb)	and	long	(>	10	kb)	range	interactions.	Peak	calling	was	performed	on	
the	 short	 distance	 alignment	 file	 using	MACS2	 (Zhang	 et	 al.,	 2008)	 (version	 2.1.1.20160309).	
BAM	 and	 bed	 peak	 files	were	 used	 as	 input	 for	 FitHiChIP	 to	 calculate	 statistically	 significant	
interactions	between	bin	 size	of	5000	bp.	Significant	 interactions	were	calculated	 for	each	of	
the	strains	 individually.	A	consensus	PLAC-seq	 interaction	set	was	generated	considering	only	
interactions	that	were	identified	in	minimally	two	strains	(Q<0.01).	Overlap	between	CRDs	and	
the	PLAC-seq	consensus	 set	were	 calculated	and	 the	 fraction	of	 intra-CRD,	 inter-CRD,	CRD	 to	
none	 CRD	 region,	 and	 interactions	 without	 CRDs	 were	 calculated.	 A	 5-times	 bigger	 size-
matched	and	peak-matched	background	set	of	consecutive	ATAC-seq	peaks	with	a	PCC	smaller	
than	0.6	was	generated.	Consequentially,	the	number	of	consensus	PLAC-seq	interactions	with	
the	CRDs	and	 the	background	was	 counted	and	 compared	using	 the	Kruskall	Wallis	 between	
group	test.	
	
DNA-Methylation	analysis	
For	analysis	only	CpG	data	was	considered.	To	account	for	additional	CpG	residues	generated	in	
SPRET	due	to	mutations	all	CpGs	present	in	both	strains	were	considered	in	the	downstream	
analysis	and	counted	as	0	when	not	present.	HOMER	tag	directories	were	created	with	
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parameters	–format	bismark	–genome	mm10	–checkGC	–minCounts	0.	The	optimal	number	of	
minCounts	was	assessed	per	experiment	and	tag	directories	were	re-generated	with	
parameters	–format	bismark	–genome	mm10	–checkGC	–minCounts	5	for	C57	and	–minCounts	
7	for	SPRET.	To	assess	the	differences	between	both	strains	the	transcription	start	sites	of	all	
genes	were	annotated	with	the	percentage	of	methylated	CpGs	using	HOMER’s	annotatePeaks	
with	option	tss	and	parameters	–mC.	Subsequently	the	percentage	of	methylated	CpGs	was	
plotted	for	all	gene	promoters,	for	gene	promoters	of	genes	that	are	2-fold	differently	
expressed,	as	well	as	genes	that	are	4-fold	differently	expressed.		
	
MARGE	analysis	
Mutation	Analysis	for	Regulatory	Genomic	Elements	(MARGE)	(Link	et	al.,	2018)	was	used	to	
generate	custom	genomes	and	shift	the	mapped	data	back	to	reference	coordinates.		
To	model	the	impact	of	a	motif	on	the	binding	of	the	measured	TFs,	a	linear	mixed	model	(LMM)	
was	used.	The	binding	of	the	TF	is	modeled	as	the	fixed	effect	motif	existence	with	random	
effects	locus	and	genotype	with	the	lme4	package	(Douglas,	2015)	in	R	(R	Development	Core	
Team,	2016).	To	calculate	significance	for	each	motif,	the	drop1	command	was	used.	It	
compares	a	model	including	motif	score	with	a	model	without	motif	score	and	reports	the	
Akaike	information	criterion	(AIC)	(Akaike,	1973)	for	the	difference.	
	
F1	analysis	
F1	data	was	mapped	to	both	parental	genomes.	Only	reads	without	any	mismatch	were	
considered	for	downstream	analysis.	Tag	directories	were	generated	for	perfectly	aligned	reads	
per	parental	genome,	as	well	as	for	all	reads	that	overlap	loci	with	differences	in	the	parental	
alleles.	All	loci	without	differences	were	discarded.	To	assign	allele-specific	reads,	the	ratio	of	
reads	overlapping	mutations	was	calculated	and	subsequently	all	perfectly	aligned	reads	for	
this	locus	were	multiplied	by	this	ratio	*	10	and	assigned	to	the	parental	genomes.	Loci	
annotated	with	0	reads	in	one	of	the	F1	alleles	were	filtered	out.	For	GRO-seq	analysis,	gene	
bodies	with	less	than	4	tag	counts	in	either	one	of	the	parental	or	F1	alleles	were	filtered	out.	
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For	ChIP-seq	analysis,	loci	with	less	than	16	reads	were	discarded.	To	determine	cis-regulation,	
the	difference	of	fold	change	between	parental	alleles	and	F1	alleles	were	calculated.	
	
Data	visualization	
All	ChIP-seq,	RNA-seq,	GRO-seq,	5’GRO-seq	and	Bisulfite	data	was	visualized	in	the	UCSC	
genome	browser	(Kent	et	al.,	2002).	To	show	interactions	for	Hi-C	and	PLAC-seq,	data	was	
uploaded	to	the	WashU	browser	(Zhou	and	Wang,	2012).	
	
	
Data	and	Software	Availability	
All	raw	data	and	processed	data	files	were	deposited	to	GEO	under	accession	number	
GSE109965.		
	
	
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
PU.1 Santa Cruz Cat#sc-352X 
CEBPb Santa Cruz Cat#sc-150 
H3K4me2 Millipore Cat#07-030 
H3K4me3 Millipore Cat#04-745 
H3K27ac Active Motif Cat#39135 
cJun Santa Cruz Cat#sc-1694 
p65  Santa Cruz Cat#sc-372X 
Usf2 Santa Cruz Cat#sc-862X 
Runx1 Santa Cruz Cat#sc365644 
   
Chemicals, Peptides, and Recombinant Proteins 
DMEM high glucose Corning Cat#10-013-CV 
FBS Omega Biosciences Cat#FB-12 
100X Penicillin/Streptomycin+L-glutamine Gibco Cat#10378-016 
Amphotericin B Hyclone Cat#SV30078.01 
RBC lysis buffer eBioscience Cat#00-4333-57 
mouse M-CSF Shenandoah Biotech Cat#200-08 
Kdo2 Lipid A (KLA) Avanti Polar Lipids Cat#699500P 
Dynabeads Protein G Thermo Fischer Cat#10004D 
Speedbeads GE Healthcare Cat#6515210505025
0 
BrdU Antibody (IIB5) AC beads Santa Cruz Cat#sc-32323 AC 
Millipore Ultrafree MC column Millipore Cat#UFC30HVNB 
Trizol LS Thermo Fischer Cat#10296010 
Dynabeads My One T1 Streptavidin beads Thermo Fischer Cat#65601 
   
Critical Commercial Assays 
ChIP DNA Clean & Concentrator Zymo Research Cat#D5205 
Quick RNA MiniPrep kit Zymo Research Cat#R1055 
PureLink Genomic DNA Kit Thermo Fischer Cat#K182001 
EZ DNA methylation-Gold kit Zymo Research Cat#D5005 
Nextera DNA Library Prep Kit Illumina Cat#FC-121-1030 
NEXTflex® DNA Barcodes Bioo Scientific Cat#NOVA-514104 
Arima HiC kit Arima Genomics Inc NA 
AMPure Cleanup Beckman Coulter CAT#A63880 
   
Deposited Data   
Raw and analyzed data  This paper GEO: 
   
   
Experimental Models: Organisms/Strains 
BALB/cJ Jackson Laboratory Stock No: 000651 
C57Bl/6J Jackson Laboratory Stock No: 000664 
Key Resource Table
 
NOD/ShiLtJ Jackson Laboratory Stock No: 001976 
PWK/PhJ Jackson Laboratory Stock No: 003715 
SPRET/EiJ Jackson Laboratory Stock No: 001146 
   
Software and Algorithms   
Bowtie2 Langmead and 
Salzberg, 2012 
http://bowtie-
bio.sourceforge.net/b
owtie2/index.shtml 
UCSC genome browser Kent et al., 2002 https://genome.ucsc.
edu/ 
STAR Dobin et al., 2013 https://github.com/al
exdobin/STAR 
Bismark Krueger and Andrews, 
2011 
https://www.bioinfor
matics.babraham.ac.
uk/projects/bismark/ 
MARGE In preparation https://github.com/vli
nk/marge 
Irreproducibility Discovery Rate (IDR) Li et al., 2011 https://www.encodep
roject.org/software/id
r/ 
HOMER Heinz et al., 2010 http://homer.ucsd.ed
u/homer/ 
Cytoscape 3.5.1 Shannon et al., 2013 http://www.cytoscap
e.org/ 
TADbit Serra et al. 2017 https://github.com/3
DGenomes/TADbit 
Juicebox Durand et al., 2016 http://www.aidenlab.
org/software.html 
WashU Browser Zhou and Wang, 2013 http://epigenomegate
way.wustl.edu/brows
er/ 
R package: MuMIn  Barton 2017 https://cran.r-
project.org/web/pack
ages/MuMIn/index.ht
ml 
R package: DESeq2 Love et al., 2014 https://bioconductor.
org/packages/releas
e/bioc/html/DESeq2.
html 
R pckage: EdgeR Robinson, McCarthy, 
and Smyth 2010 
http://bioconductor.or
g/packages/release/
bioc/html/edgeR.html 
R-package: WGCNA Langfelder and 
Horvath 2008 
https://labs.genetics.
ucla.edu/horvath/Co
expressionNetwork/
Rpackages/WGCNA/ 
R-package: Dynamic Tree cutting Langfelder, Zhang, and 
Horvath 2008  
https://labs.genetics.
ucla.edu/horvath/Co
expressionNetwork/
BranchCutting/ 
R-package: RcolorBrewer Neuwirt 2014 https://cran.r-
project.org/web/pack
ages/RColorBrewer/i
ndex.html 
 
R-package: gplots  https://cran.r-
project.org/web/pack
ages/gplots/index.ht
ml 
Metascape Tripathi et al. 2015 http://metascape.org 
Perl module: Statistics::Basic Miller 2014 http://search.cpan.or
g/~jettero/Statistics-
Basic-
1.6611/lib/Statistics/
Basic.pod 
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SUMMARY
Macrophages play pivotal roles in both the induction
and resolution phases of inflammatory processes.
Macrophages have been shown to synthesize anti-in-
flammatory fatty acids in an LXR-dependent manner,
but whether the production of these species contri-
butes to the resolution phase of inflammatory re-
sponses has not been established. Here, we identify
a biphasic program of gene expression that drives
production of anti-inflammatory fatty acids 12–24 hr
following TLR4 activation and contributes to downre-
gulation of mRNAs encoding pro-inflammatory medi-
ators. Unexpectedly, rather than requiring LXRs, this
late program of anti-inflammatory fatty acid biosyn-
thesis is dependent on SREBP1 and results in the un-
coupling of NFkB binding from gene activation. In
contrast to previously identified roles of SREBP1 in
promoting production of IL1b during the induction
phase of inflammation, these studies provide evi-
dence that SREBP1 also contributes to the resolution
phase of TLR4-induced gene activation by reprog-
ramming macrophage lipid metabolism.
INTRODUCTION
Failure to resolve endogenous or extrinsic inflammatory stimuli
can lead to a chronic state of low-grade inflammation that results
in cellular dysfunction and tissue damage (Tabas and Glass,
2013). Recent studies have shown that the immune and meta-
bolic systems are highly integrated with one another (Cildir
et al., 2013). For instance, increased infiltration of pro-inflamma-
tory macrophages in adipose tissue, liver, and skeletal muscle
and their release of cytokines that impair local insulin signaling
contribute to insulin resistance (Lumeng et al., 2008; Osborn
and Olefsky, 2012; Tencerova et al., 2015; Varma et al., 2009;
Wynn et al., 2013; Xu et al., 2003). In addition, immune cell func-
tion itself is coordinately regulated with cellular metabolism
(Spann and Glass, 2013). For example, upon inflammatory acti-
vation, macrophages rapidly induce glycolysis through HIF-1a
and NFkB, enabling them to trigger microbicidal activity even
in a hypoxic inflammatory tissue environment (Huang et al.,
2014a; Rodrı́guez-Prados et al., 2010; Tannahill et al., 2013). In
contrast, macrophages display a shift to oxidative metabolism
of glucose and fatty acids and acquire an anti-inflammatory
phenotype in the context of tissue repair and remodeling (Man-
tovani et al., 2013; Rodrı́guez-Prados et al., 2010).
Macrophage activation in response to ligation of TLR4 pro-
vides a paradigm for investigation of molecular mechanisms
that positively and negatively regulate inflammatory responses
(Iyer et al., 2010; Medzhitov and Horng, 2009). TLR4 signaling in-
duces immediate/early gene expression through activation of
latent transcription factors that include members of the NFkB,
IRF, and AP-1 families (Glass and Natoli, 2016; Medzhitov and
Horng, 2009). These factors in turn induce secondary response
genes via the production of type I interferons, TNFa, and other
signaling molecules. Collectively, the immediate/early and sec-
ondary responses drive expression of inflammatory response
genes that support innate immunity and set the stage for adap-
tive immunity. TLR4 signaling also results in downregulation of a
broad program of gene expression, although molecular mecha-
nisms are less well characterized.
Recent lipidomic analysis in macrophages revealed an imme-
diate reduction of fatty acid synthesis in response to TLR4 acti-
vation, followed by an increase in eicosanoid synthesis that was
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Figure 1. Activation of TLR4 Reprograms Macrophage Fatty Acid Metabolism
(A) Pathway maps illustrating omega-3 and omega-7 pathways. The enzymes catalyzing each step are highlighted in blue.
(B) Lipidomic analysis of saturated and unsaturated fatty acids (omega-3, omega-6, omega-7, and omega-9) in thioglycollate-elicited macrophages treated with
KLA for 0, 1, 6, 12, and 24 hr.
(C) Cellular content of omega-3 (DHA and EPA) and omega-7 (9Z-POA) fatty acids in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 12, and
24 hr.
(D) RelativemRNA expression levels for Scd2 and Fads1 determined bymicroarray analysis of RNA from thioglycollate-elicitedmacrophages treated with KLA for
0, 1, 6, and 24 hr.
(E) Heatmap of mRNA expression levels determined by RNA-seq analysis of BMDMs with KLA for 0, 1, 6, and 24 hr (FDR <0.01 and RPKM >0.5).
(legend continued on next page)
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linked to the arachidonic acid pathway and delayed responses
characterized by sphingolipid and sterol biosynthesis (Dennis
et al., 2010). Lipid uptake is activated by chronic (24 hr)
LPS treatment, leading triglycerides to accumulate in lipid drop-
lets within macrophages (Feingold et al., 2012; Huang et al.,
2014b). These changes in lipid metabolism may be linked to
changes in macrophage activity over the time course of the
response to LPS.
Macrophages can also synthesize anti-inflammatory fatty
acids under the control of liver X receptors (LXRs) a and b (Li
et al., 2013; Spann et al., 2012). The LXR pathway is derepressed
following genetic deletion of the nuclear receptor co-repressor
NCoR, leading to increased production of 9Z palmitoleic acid
and polyunsaturated omega-3 and omega-9 fatty acids (Li
et al., 2013). These fatty acids exert anti-inflammatory functions
in macrophages in part by binding to G protein coupled recep-
tors (Oh et al., 2010). NCoR deletion in macrophages conferred
protection of mice from high fat diet-induced inflammation and
insulin resistance (Li et al., 2013). Therefore, it is possible that
anti-inflammatory fatty acids produced by the macrophage act
in an autocrine/paracrine manner to regulate its function auton-
omously, as well as the functions of surrounding parenchymal
cells.
Cholesterol and fatty acid homeostasis are regulated at the
level of transcription by LXRs and SREBPs 1 and 2 (Goldstein
et al., 2006; Hong and Tontonoz, 2014; Horton et al., 2002). Their
roles in cholesterol homeostasis are largely antagonistic.
SREBPs (primarily SREBP2) drive transcriptional programs that
increase cellular cholesterol synthesis and import (Horton
et al., 2002), while LXRs induce expression of genes that mediate
cholesterol efflux and inhibit import (Hong and Tontonoz, 2014).
In contrast, LXRs and SREBPs (primarily SREBP1) function in a
coordinate manner to positively regulate fatty acid biosynthesis.
LXRs directly activate the expression of SREBP1c, and both
LXRs and SREBP1 bind to and activate numerous genes
involved in fatty acid biosynthesis (Repa et al., 2000a; Schultz
et al., 2000). Further, at co-bound genomic loci, SREBP func-
tions in a permissive manner, allowing signal-specific tailoring
of LXR-mediated activation of lipid metabolic gene expression
profiles (Spann et al., 2012), resulting in context-dependent syn-
thesis and output of select lipid species.
LXRs and SREBPs also play important roles in regulating
macrophage activation. LXRs primarily function to inhibit inflam-
matory responses by antagonizing pro-inflammatory transcrip-
tion factors, such as NFkB (Ghisletti et al., 2009; Hong and Ton-
tonoz, 2014), and by activating genes with anti-inflammatory
activities, such as Mer and Abca1 (A-Gonzalez et al., 2009; Ito
et al., 2015). In contrast, SREBP1 has been found to promote
the acute inflammatory response by regulating genes involve in
the production of active Il1b (Im et al., 2011; Reboldi et al.,
2014). Further, the LXR pathway is subject to negative regulation
by TLR4 (Castrillo et al., 2003). This suggests that macrophage
fatty acid synthesis is influenced by TLR signaling via temporal
modulation of LXR activities.
To address the question of whether TLR4 signaling regulates
the production of anti-inflammatory fatty acids, we analyzed
lipidomic data generated by the LIPID MAPs consortium evalu-
ating the temporal response of primary mouse macrophages
to the specific TLR4 agonist Kdo2 LIPID A (KLA) (http://www.
lipidmaps.org/) (Dennis et al., 2010). This analyses revealed
that the intracellular content of anti-inflammatory mono- and
poly- (u-3, u-7, and u-9) unsaturated fatty acids was rapidly
decreased at early time points of TLR4-mediated inflammation;
while the resolution phase was characterized by increased intra-
cellular unsaturated fatty acid levels. This temporal pattern of
changes in specific lipid species was correlated with changes
in mRNAs encoding corresponding biosynthetic enzymes. Un-
expectedly, we found that the late upregulation of unsaturated
fatty acid synthesis was independent of LXR, but was instead
driven by SREBP1. Anti-inflammatory fatty acid synthesis was
compromised in Srebf1/ macrophages at late time points
compared to wild-type (WT) macrophages, concomitant with a
hyper-inflammatory state due to impaired resolution of NFkB
associated activity and gene expression. Supplementation with
exogenous mono- and polyunsaturated fatty acids rescues the
late hyper-inflammatory response in both Srebf1/ macro-
phages and Srebf1/ mice. Collectively, these findings provide
evidence that SREBP1 contributes to resolution of pro-inflam-
matory TLR4 signaling by reprogramming fatty acid metabolism.
RESULTS
TLR4 Signaling Reprograms Macrophage Fatty Acid
Metabolism
To investigate changes in macrophage fatty acid levels
throughout the course of an inflammatory response, we utilized
lipidomic data generated by the LIPID MAPS Consortium
(http://www.lipidmaps.org/) (Dennis et al., 2010). Metabolic
pathways responsible for generation of long chain omega-3 fatty
acids and 9Z palmitoleic acid (9Z-POA) are shown in Figure 1A.
Activation of TLR4 by KLA, a chemically defined substructure of
bacterial lipopolysaccharide (LPS) that is specifically recognized
by Toll-like receptor 4 (Raetz et al., 2006), rapidly and transiently
decreased the cellular content of most fatty acids analyzed (Fig-
ure 1B). Unexpectedly, in addition to the known upregulation
of omega-6 fatty acids, such as arachidonic acid, the cellular
content of anti-inflammatory omega-3, omega-7, and omega-9
fatty acids was also significantly increased during the late inflam-
matory response (12–24 hr after KLA treatment) (Figures 1B and
1C). Based on estimates of cell volume, maximum intracellular
concentrations of DHA are on the order of 10 mM and EPA and
9Z-POA are on the order of 2 mM.
Analysis of microarray data from the same KLA-treated mac-
rophages, generated by the LIPID MAPS Consortium (http://
www.lipidmaps.org/) (Dennis et al., 2010), demonstrated
biphasic expression of genes encoding enzymes involved in
mono-unsaturated and omega-3 polyunsaturated fatty acid
biosynthesis, exemplified by Scd2, Fads1, Acox3, and Elovl5
(F) Functional annotations associated with genes exhibiting KLA repressed-induced temporal expression patterns.
(G) Relative mRNA expression of Scd2 and Fads2 in human monocyte-derived macrophages treated with KLA for 0, 1, 6, and 24 hr.
Values are expressed as mean ± SEM. *p < 0.05 and **p < 0.01.
See also Figure S1.
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Figure 2. Genes Required for Anti-inflammatory Fatty Acid Synthesis Demonstrate Biphasic Temporal Expression Patterns following TLR4
Ligation
(A) Venn diagram of overlap between LXR target genes (GW3965 induced genes >2-fold versus untreated) and KLA repressed-induced genes.
(B) Functional annotations associated with LXR target genes induced by GW3965 treatment.
(C) Scatterplot depicting the relationship between fold change of LXR target genes (GW3965 >1.5-fold versus untreated) comparing RNA-seq data from thio-
glycollate-elicited macrophages treated with GW3965 (18 hr), with or without KLA pretreatment (100 ng/mL for 2 hr).
(D) Functional annotations associated with LXR target genes repressed by KLA treatment.
(E) Scd2, Elovl5, and Fads1 mRNA expression in LXRa/b/ and WT thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 12, and 24 hr.
(legend continued on next page)
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(Figures 1D and S1, available online). To independently confirm
these findings, we performed RNA sequencing (RNA-seq)
throughout a time course of KLA treatment. These experiments
also revealed a common biphasic expression pattern for many
of the genes involved in synthesis of unsaturated fatty acids,
exemplified by Scd1/2, Elovl5, Fads1, Acsl3, and Acox3 (Fig-
ure 1E). This temporal pattern is characterized by an initial tran-
sient reduction within 1–6 hr of TLR4 activation and subsequent
activation in the late phase of the TLR4 response (Figures 1D and
1E). The rapid decrease in lipid species observed at 30 min (Fig-
ure 1B) precedes the decrease in mRNA levels of biosynthetic
genes (Figures 1D and 1E), indicating that the initial phase of
reduced fatty acid levels is determined by post-transcriptional
mechanisms. However, the increase in levels of mono- and poly-
unsaturated fatty acids between 12 and 24 hr is correlated with
increases in mRNA levels of corresponding biosynthetic genes.
Whole transcriptome analysis revealed that among the 22,455
measurable transcripts, 2,993 genes with RefSeq annotations
were reduced >2.0-fold at 6 hr and subsequently increased
2.0-fold at 24 hr after KLA treatment. We define this subset of
KLA-regulated genes as KLA repressed-induced genes. Consis-
tent with temporal changes in macrophage fatty acid content,
the entire set of KLA repressed-induced genes was significantly
enriched for functional annotations linked to lipid metabolism
(Figure 1F). Experiments in KLA-treated human monocyte-
derived macrophages revealed a similar biphasic expression
pattern for genes involved in the synthesis of unsaturated fatty
acids, exemplified by Scd1 and Fads2 (Figure 1G). The temporal
pattern characterized by induction in the late phase of the TLR4
response suggests that the observed temporal dynamics of
specific fatty acid metabolic reprogramming is conserved in
humans. Collectively, these findings indicate that TLR4 signaling
induces a biphasic reprogramming of fatty acid metabolism in
macrophages through transcriptional and post-transcriptional
mechanisms.
Biphasic Expression of Fatty Acid Biosynthetic Genes Is
Independent of LXRs
Many enzymes involved in unsaturated fatty acid synthesis are
products of LXR-regulated target genes (Calkin and Tontonoz,
2012; Hong and Tontonoz, 2014). Because TLR4 activation
can repress LXR induction of gene expression (Castrillo et al.,
2003), it is possible that altered LXR activity could account for
the biphasic pattern of expression observed for genes involved
in mono- and polyunsaturated fatty acid biosynthesis. To
address this possibility, we performed RNA-seq analysis of
RNA recovered from macrophages treated with either vehicle
or the synthetic LXR agonist GW3965. Approximately one fifth
(19.3%) of LXR target genes (GW3965 > vehicle 2-fold) are rep-
resented as KLA repressed-induced genes (Figure 2A). In addi-
tion, gene ontology analysis revealed that both LXR-induced
and KLA repressed-induced genes are enriched for similar func-
tional annotations, including lipid metabolism and fatty acid
metabolic process (Figure 2B). To further examine the extent
to which TLR4-mediated inflammation repressed LXR-depen-
dent gene expression, macrophages were pretreated with
vehicle or KLA, followed by treatment with either vehicle or the
LXR agonist GW3965. RNA-seq revealed that LXR target gene
activation was markedly attenuated by KLA pretreatment
(42%GW3965-induced genes; Figure 2C), consistent with pre-
vious findings (Joseph et al., 2003). These TLR4-compromised,
LXR target genes were significantly enriched for functional anno-
tations linked to lipid transport, lipid localization, and fatty acid
biosynthetic process (Figure 2D). These data suggest that the
macrophage LXR-regulatory program involved in synthesis of
unsaturated fatty acid is repressed in the early phase of TLR4
activation, which could be important for allowing appropriate in-
duction of the inflammatory response.
To assesswhether the repression of LXR activity is required for
the early reduction of unsaturated fatty acid related gene expres-
sion and production following KLA treatment, we took advantage
of LXR-deficient macrophages. The temporal dynamics of TLR4
activation was assessed by expression profiling of KLA treated
macrophages prepared from WT and LXRa/b/ mice (Repa
et al., 2000b). Unexpectedly, qPCR analysis of the temporal
mRNA expression patterns of genes involved in unsaturated
fatty acid synthesis, exemplified by Scd2, Elovl5, and Fads1, re-
vealed similar patterns in LXRa/b/ and WT macrophages (Fig-
ure 2E). We further evaluated effects of TLR4 activation on the
genome-wide location of endogenous LXRs by chromatin immu-
noprecipitation (ChIP)-seq. These studies revealed co-localiza-
tion of LXRs with macrophage lineage-determining factors
PU.1 and AP-1 based on motif co-enrichment (Figure 2F),
consistent with previous studies using tagged LXRs in
RAW264.7 macrophages (Heinz et al., 2010). Further, these
studies revealed an unexpected finding that LXR binding at
KLA repressed-induced loci significantly decreases in the late
phase of inflammation (Figures 2G and S2). Thus, temporal
changes in LXR binding are disassociated from late phase induc-
tion of KLA repressed-induced genes.
TLR4 Signaling Reprograms Enhancer Activities Near
Repressed-Induced Genes
The unexpected finding that LXR is dispensable for late activa-
tion of genes directing fatty acid metabolism prompted us to
analyze the local enhancer landscapes of these genes for
candidate regulators associated with the temporal profile of
repressed-induced genes. To identify enhancers exhibiting tem-
poral activities associated with KLA repressed-induced genes,
we performed ChIP-seq to analyze the dimethylation status of
lysine 4 of histone H3 (H3K4me2), acetylation status of lysine
27 of histone H3 (H3K27ac), and RNA polymerase II (RNA polII)
in naive and KLA-stimulated macrophages. Whereas H3K27ac
and RNA polII correlate positively with active transcriptional ac-
tivity (Creyghton et al., 2010; Kaikkonen et al., 2013), deposition
of H3K4me2 has been demonstrated as an indicator of both pre-
vious and current local transcription (He et al., 2010; Kaikkonen
et al., 2013; Ostuni et al., 2013).
(F) De novo motif analysis of LXR peaks in WT thioglycollate-elicited macrophages.
(G) Normalized distribution LXR ChIP-seq tag density, at enhancers vicinal to KLA repressed-induced genes, in thioglycollate-elicited macrophages treated with
KLA for 0, 1, 6, and 24 hr.
See also Figure S2.
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Consistent with their reduced mRNA levels (Figure 1D),
genomic loci of representative KLA repressed-induced genes,
exemplified by Scd2/3, Acsl3, and Fads1, are associated with
decreased H3K27ac and H3K4me2 during the early phase in-
flammatory response at 1 and 6 hr post-KLA, respectively (Fig-
ure 3A, asterisks). Prior studies revealed that the lineage
determining transcription factor (LDTF) PU.1 is necessary for es-
tablishing macrophage-specific cistromes for signal responsive
transcription factors (Heinz et al., 2010). Centering our analysis
on PU.1-bound regions, we analyzed the temporal pattern of
relevant features at enhancers associated with repressed-
induced genes. Chromatin features of active transcription,
defined by RNA polII and H3K27ac, were decreased during the
early inflammation phase (at 1 hr post-KLA), then subsequently
increased at 6 and 24 hr post-KLA stimulation (Figure 3B), pre-
ceding increased levels of nearby mRNA.
As a more direct analysis of active transcription, we analyzed
global run-on (GRO)-seq data (Kaikkonen et al., 2013) to
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Figure 3. Temporal Dynamics of cis-Regulatory Elements Associated with KLA Repressed-Induced Genes
(A) UCSC genome browser images illustrating normalized tag counts for H3K4Me2 and H3K27Ac at the LXR target genes in BMDMs treated with KLA for 0, 1, 6,
and 24 hr.
(B) Distribution of RNA polII and H3K27Ac tag densities in vicinity of KLA repressed-induced enhancers in BMDMs treated with KLA for 0, 1, 6, and 24 hr.
(C) Distribution of GRO-seq tags at KLA repressed-induced enhancers in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, and 24 hr.
(D) Relative distribution of GRO-seq tags at gene bodies of KLA repressed-induced genes in thioglycollate-elicitedmacrophages treated with KLA for 0, 1, 6, and
24 hr.
(E) Sequence motifs enriched at enhancers associated with KLA repressed-induced genes.
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measure nascent transcript levels at KLA repressed-induced
loci. Consistent with enhancer ChIP-seq data, GRO-seq re-
vealed that nascent RNA transcription at KLA repressed-
induced enhancers follows a similar temporal profile, exhibited
by early transcriptional repression and late response induction
(Figure 3C). Further, GRO-seq analysis revealed a conserved
temporal pattern of transcription at associated KLA repressed-
induced gene bodies (Figure 3D). Collectively, these results sug-
gest that KLA repressed-induced enhancer activity and gene
transcription is transiently inhibited following inflammatory acti-
vation, ensuring decreased unsaturated fatty acid synthesis in
macrophages. This is followed by subsequent late phase induc-
tion of relevant macrophage transcription and gene expression,
culminating in increased unsaturated fatty acid synthesis and
output by macrophages.
To define transcription factors potentially determining this
temporal regulation of KLA repressed-induced genes, we per-
formed motif analysis on enhancers exhibiting the repressed/
induced pattern of chromatin features. As expected, de novo
motif analysis identified motifs for the macrophage LDTFs,
PU.1, C/EBP, and AP-1, as the most highly enriched sequences.
Unexpectedly, an SREBP response element (SRE) was also
highly enriched in repressed-induced associated enhancers
(Figure 3E). Given its role in regulation of fatty acid metabolism
in various cell types, these findings suggested that SREBP1
might be a determinant of late inflammatory phase regulatory dy-
namics leading to induction of genes necessary for unsaturated
fatty acid biosynthesis.
SREBP1 Activity Is Induced during the Resolution Phase
of the Inflammatory Response
We previously demonstrated that LXR and SREBP1 not only co-
localize to representative genes involved in maintaining choles-
terol and fatty acid homeostasis, but their coordinate regulatory
actions can control context-specific expression profiles (Spann
et al., 2012). To investigate the potential relationships of LXR
and SREBP1 in controlling macrophage lipid metabolism
following TLR4 activation, we performed ChIP-seq of SREBP1
and LXR in mouse primary macrophages stimulated with ligands
for LXR and TLR4 for 24 hr. As expected, SREBP1 recruitment
was observed in the enhancers of lipid synthesis-related genes,
as exemplified by Scd2, Acsl3, and Srebf1 following GW3965,
but not desmosterol treatment, which is a potent suppressor
of SREBP processing (Figure 4A). Further, LXR and SREBP1 cis-
tromes exhibited significant overlap when comparing genome-
wide binding profiles (Figures 4A and S3A). The genes associ-
ated with LXR-SREBP1 co-bound sites were enriched for
functional annotations for fatty acid metabolism, fatty acid
biosynthesis, and elongation (Figure S3B). Further, temporal pat-
terns for direct measurement of enhancer activity levels, demon-
strated by H4K5ac and GRO-seq, revealed these LXR-SREBP1
co-bound regions exhibited a coordinate KLA repressed-
induced profile (Figure S3C).
Remarkably, KLA treatment also dramatically increased the
binding of SREBP1 at enhancer-like regions associated with
genes required for mono- and polyunsaturated fatty acid biosyn-
thesis (Figure 4A), consistent with the enrichment of the SREBP
recognition element in repressed-induced enhancers (Figure 3E).
Furthermore, rigorous peak analysis using HOMER defined
peaks along with irreproducible discovery rate (IDR) analysis
identified the top known motif in the KLA-induced SREBP1 cis-
trome as matching the consensus sterol response element (Fig-
ure 4B, top). The sterol response element was independently
identified by de novo motif analysis of IDR-defined SREBP1
binding sites (Figure 4B, bottom). Multiple independent experi-
ments indicated that the late phase KLA induction of SREBP1
binding activity was associated with parallel increased nuclear
levels of mature SREBP1 protein, as determined bywestern blot-
ting (Figure S3D). Intriguingly, the late phase increase in SREBP1
recruitment is specific to KLA repressed-induced associated
promoters and enhancers, as binding is not changed at regions
of solely KLA-repressed genes (Figure 4C).
SREBP1 Drives TLR-Responsive Late Activation of
Repressed-Induced Genes
The observation that SREBP1 was recruited to the genes
involved in unsaturated fatty acid synthesis in the late inflamma-
tory response led us to examine the consequences of Srebf1
deletion in the inflammatory response of macrophages on a
genome-wide scale. We performed RNA-seq analysis of KLA
treated bone marrow-derived macrophages (BMDMs) prepared
from WT and Srebf1/ mice (Shimano et al., 1997) (Figures 5A
and 5B). We identified 2,995 significantly expressed transcripts
with RefSeq annotations exhibiting the KLA repressed-induced
phenotype; characterized by reduced levels of >2-fold at 6 hr
and subsequently increased >2-fold at 24 hr after KLA treatment.
The expression of 1,047 of these genes (35%), in the KLA
repressed-induced group, were significantly reduced at 24 hr
post-KLA treatment in Srebf1/ macrophages compared to
levels in WT cells (Figures 5A and 5B). Both RNA-seq and
qPCR analysis confirmed that Srebf1/ macrophages demon-
strated significant reduction in the expression of genes medi-
ating mono- and polyunsaturated fatty acid biosynthesis, exem-
plified by Scd1/2, Acsl3, Fads1/2, and Acot2, during the
resolution phase of inflammation at 24 hr post-KLA treatment
(Figures 5C and S4A).
We independently confirmed the requirement of SREBP1
in the regulation of these genes by using small interfering
RNAs (siRNAs) specifically targeting Srebf1 or Scap. qPCR anal-
ysis indicated that the Srebf1 knockdownwas sufficient to inhibit
the late phase inflammation induction of unsaturated fatty acid
related gene expressions, exemplified by Scd2 (Figure 5D).
RNA-seq analysis further confirmed that siRNA-mediatedSrebf1
knockdown led to significantly compromised late phase induc-
tion of many genes controlling synthesis of mono- and polyun-
saturated fatty acids, including Acsl3 and Fads1/2, in macro-
phages at 24 hr post-KLA treatment (Figures S4B–S4D).
Further, knockdown of Scap, which is required for SREBP
processing and activation (Horton et al., 2002), resulted in a
similar compromise in late phase induction of gene expression
(Figure 5E).
To gain further insight into the mechanism by which
the repressed-induced gene expression is compromised in
Srebf1/ macrophages, we performed ChIP-seq of H3K27ac
and RNA polII to evaluate local enhancer activity at
KLA repressed-induced loci. Both H3K27ac and RNA polII levels
were markedly decreased at post-KLA 24 hr, in Srebf1/
macrophages, at KLA repressed-induced gene bodies, as
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Figure 4. SREBP1 Is Recruited to Repressed-Induced Enhancers during the Resolution Phase of the Inflammatory Response
(A) UCSC genome browser images illustrating normalized tag counts for SREBP1, LXR, and H3K4Me2, at indicated loci, in thioglycollate-elicited macrophages
treated with vehicle, KLA, GW3965, or desmosterol for 24 hr.
(B) Known and de novomotifs identified in regions bound by SREBP1 in the late inflammatory response. For ChIP-seq peaks used in motif analysis, the peaks for
each SREBP ChIP were identified using Homer, and we calculated the IDR to measure the consistency between replicate experiments for the strength of binding
at each loci and then retained SREBP1 peaks with IDR <0.05.
(C) Distribution of SREBP1 tag densities, at enhancers associated with genes exhibiting either repressed-repressed or repressed-induced temporal expression
patterns, in thioglycollate-elicited macrophages treated with KLA for 24 hr.
See also Figure S3.
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exemplified by Scd2 (Figure 5F). Further, the normal temporal
dynamics, characterized by the late phase increase in both
H3K27ac and RNA polII levels, were globally compromised in
Srebf1/ macrophages when looking at profiles for all KLA
repressed-induced associated enhancers (Figure 5G), consis-
tent with both the deficient late phase expression recovery, as
measured by RNA-seq, and increased late recruitment of
SREBP1 to these enhancers. These results suggest a significant
role for SREBP1 in the late phase induction of repressed-
induced genes that control fatty acid biosynthesis.
To investigate whether signaling through other TLRs would
exert similar effects on SREBP1 target genes, we assessed rele-
vant gene expression levels throughout a time course of
PAM3CSK4 (TLR2 agonist) and Poly(I:C) (TLR3 agonist) treat-
ment, comparing temporal responses in Srebf1/ andWTmac-
rophages. Similar to the temporal dynamics of TLR4 activation,
TLR2 and TLR3 responses of unsaturated fatty acid biosynthetic
genes demonstrated a repressed-induced expression profile
(Figures S4E and S4F) dependent on SREBP1. However, the
induced phase was much more pronounced in the case of
TLR2 activation. This result suggests a predominant role of the
MyD88 pathway, which is used by both TLR4 and TLR2, but
not TLR3, which instead signals primarily through TRIF.
SREBP1 Is Necessary for Resolution of the
TLR-Mediated Inflammation
Previous studies demonstrated that unsaturated fatty acids such
as EPA, DHA, and 9Z-POA have potent anti-inflammatory effects
in macrophages by antagonizing inflammatory signaling through
GPCRs, nuclear receptors, and other mechanisms (Cao et al.,
2008; Li et al., 2013; Oh et al., 2010). To investigate whether
the late phase of expression of genes involved in mono- and
polyunsaturated fatty acid biosynthesis contributes to the reso-
lution phase of TLR4 signaling, we evaluated the temporal
expression profiles of genes that are induced following KLA
treatment in WT and Srebf1/ macrophages. Indeed, RNA-
seq analysis revealed that Srebf1/ macrophages demon-
strated delayed resolution and often exaggerated gene expres-
sion upon TLR4 activation, relative to their WT counterparts
(Figures 6A and 6B). In WT macrophages, 964 significantly ex-
pressed transcripts (with RefSeq annotations) were detected
that were increased >2.0-fold at 6 hr after KLA treatment and
subsequently decreased >2.0-fold at 24 hr post-KLA treatment
(defined herein as KLA induced-repressed genes). There were
247 of these induced-repressed genes that demonstrated signif-
icantly increased expression, at 24 hr post-KLA treatment, in
Srebf1/ macrophages compared to WT (Figures 6A and 6B).
This set of KLA induced-repressed genes had significant enrich-
ment of functional annotations for immune response, regulation
of cytokine production, and inflammatory response (Figure 6C).
qPCR analysis confirmed that inflammatory gene expressions,
as exemplified by Nos2, Cxcl1, Cxcl9, and Il1a, are significantly
increased at 24 hr post-KLA treatment in Srebf1/macrophage
(Figure 6D). Further, siRNA-mediated knockdown experiments
confirmed the requirement of SREBP1 for appropriate resolution
of inflammatory gene expression, as exemplified byCxcl2,Nos2,
Cxcl1, Il1a, Il12b, and Il6 (Figure S5A).
We further assessed relevant pro-inflammatory gene expres-
sion levels throughout a time course of PAM3CSK4 (TLR2
agonist) and Poly(I:C) (TLR3 agonist) treatment, comparing
temporal responses in Srebf1/ andWTmacrophages. Similar
to the temporal dynamics of TLR4 activation, TLR2 and TLR3
responses of pro-inflammatory genes demonstrated an
induced-repressed expression profile (Figures S5E and S5F).
Further, resolution of TLR2- and TLR3-mediated inflammatory
gene expression was drastically compromised in Srebf1/
macrophages, relative to their WT counterparts (Figures S5E
and S5F). Interestingly, Pam3 induced genes showed delayed
resolution, similar to TLR4 response, whereas PolyI:C induced
genes were hyper-responsive throughout the time course.
These results are consistent with a MyD88-dependent induc-
tion of SREBP1 mediating late resolution of TLR2 and TLR4 re-
sponses. The hyper-activation of Ifnb1 and Ifna4 in response to
TLR3 agonist in Srebf1/ macrophages may reflect a different
mechanism.
To further define the SREBP-dependent temporal regulatory
pattern, we analyzed ChIP-seq data for RNA polII in KLA-
treated Srebf1/ and WT macrophages. Normalized tag den-
sity plots at induced-repressed genes revealed increased levels
of RNA polII in Srebf1/ versus WT macrophages (Figure 6E).
The average tag density levels, between Srebf1/ and WT,
demonstrated the most significant differentials at 24 hr post-
KLA (Figure 6E). These distinct patterns are exemplified for
Cxcl2, Nos2, Cxcl1, and Il1a in Figure 6F. Consistent with
ChIP-seq and mRNA expression data, GRO-seq analysis re-
vealed a similarly conserved temporal pattern of transcription
at associated KLA induced-repressed gene bodies (Fig-
ure S5B). These results suggest that the temporal dynamics
of induced-repressed inflammatory genes are regulated via
local enhancer activities driven by KLA responsive transcription
factor complexes.
Given the role of NFkB as a primary driver of TLR4-mediated
responses, we further performed ChIP-seq of the p65 compo-
nent of NFkB to determine whether the increased inflammatory
gene expression, exhibited by Srebf1/ macrophages, was
due to increased p65 recruitment to the induced-repressed
loci. Unexpectedly, the ChIP-seq analysis revealed a strikingly
similar pattern of p65 binding in KLA treated Srebf1/ and WT
macrophages (Figures 6F, S5C, and S5D). Further, the similarity
of p65 binding, comparing Srebf1/ and WT profiles, remains
consistent whether looking at all repressed-induced loci (corre-
lation co-efficient = 0.949817) or the subset of induced-
repressed loci demonstrating the most significant alterations
upon loss of Srebp1 (correlation co-efficient = 0.9438753) (Fig-
ures S5C and S5D). This finding is consistent with previous
studies, suggesting that the repressive actions of unsaturated
fatty acids on NFkB activity are independent of changes in factor
binding (Li et al., 2013).
The gene expression pattern observed in Srebf1/ macro-
phages predicts that the late phase of mono- and polyunsatu-
rated fatty acid production would be compromised in these cells.
We therefore performed lipidomic analysis of KLA-treated
Srebf1/ and WT macrophages to assess changes in fatty
acid levels. Consistent with the altered gene expression pat-
terns,Srebf1/macrophages demonstratedmarked decreases
in unsaturated fatty acid production, as exemplified by DHA,
EPA, and 9Z-POA; with most dramatic differentials, between
Srebf1/ and WT macrophages, occurring at 24 hr post-KLA
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Response
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treatment (Figures 7A and S6A). This late phase-specific
decrease is consistent with the possibility that these anti-inflam-
matory fatty acids contribute to the resolution phase of the TLR4
response.
To further test the link between late phase resolution of inflam-
mation and unsaturated fatty acid output, fatty acid rescue ex-
periments were performed in which exogenous unsaturated fatty
acids were added to KLA-treated Srebf1/ and WT macro-
phages. In these experiments, mono- (9Z-POA) and polyunsatu-
rated (EPA/DHA) fatty acids were supplemented, either alone or
simultaneously, at 12 hr post-KLA treatment to mimic late phase
accumulation. Cells were then harvested at 24 hr post-KLA treat-
ment. Addition of exogenous unsaturated fatty acids led to sig-
nificant reduction of inflammatory gene expression in macro-
phages (Figure 7B). Further, this unsaturated fatty acid-specific
repressive effect was more pronounced in Srebf1/ cells, rela-
tive to their WT counterparts (Figure 7B), consistent with intact
production of these fatty acid species in WT macrophages.
Similar results were observed in siRNA-mediated knockdown
cells (Figure S6B).
To investigate the role of SREBP1-mediated unsaturated fatty
acid output in modulating the inflammatory response in vivo,
Srebf1/ mice were challenged with a sublethal dose of LPS.
Consistent with the increased late phase inflammatory gene
expression patterns observed in the Srebf1/ macrophages
(Figures 6B–6F), circulating cytokine levels of IL-6 and IL-1a re-
mained significantly higher in Srebf1/ mice at 24 hr post-LPS
injection (Figure 7C); thus suggesting a compromised resolution
of inflammation relative to their WT counterparts. In addition,
supplementation of exogenous EPA, prior to the LPS challenge,
protected Srebf1/ mice from an exaggerated inflammatory
response, restoring circulating cytokine levels to those seen in
WT mice (Figure 7C).
DISCUSSION
Emerging evidence suggests that the immune system and
lipid metabolism are coordinately regulated at multiple levels
within the body. Here, we demonstrate a reciprocal relation-
ship between cellular levels of anti-inflammatory fatty acids
and the temporal induction and resolution of pro-inflammatory
gene expression following TLR4 activation (Figure 7D). Anti-in-
flammatory fatty acid levels rapidly fall following KLA treat-
ment, in advance of downregulation of mRNAs encoding cor-
responding biosynthetic enzymes. Given the ability of these
fatty acid species to suppress NFkB-dependent gene expres-
sion, their downregulation is likely to be necessary for a full
TLR4 response. At 12–24 hr following TLR4 ligation, anti-in-
flammatory fatty acid levels rise, concurrent with increased
expression of mRNAs encoding biosynthetic enzymes and
decreased expression of mRNAs encoding pro-inflammatory
mediators.
The mechanisms responsible for downregulation of lipid
biosynthetic genes remain to be established. Repression of
basal LXR-dependent gene expression does not account for
this effect because a similar pattern of gene expression was
observed in LXR double knockout macrophages. Thus, while
TLR signaling blunts the ability of LXR agonists to induce target
gene expression, alternative mechanisms must account for
the observed downregulation. During the initial phase of the
TLR4 response, the p65 component of NFkB is recruited to
many of the enhancer elements associated with the set of
repressed-induced genes. This TLR-induced p65 binding is
associated with loss of both co-activator recruitment and active
chromatin features at these loci, correlating with their loss of
transcriptional activity and expression. Our unpublished results
using an NFkB inhibitor, suggest a requirement for NFkB activ-
ity in mediating the early phase repression of these genes (data
not shown). However, a direct role of p65-containing NFkB
complexes in downregulation of these genes remains to be
established.
Unexpectedly, the late upregulation of mRNAs encoding en-
zymes required for synthesis of anti-inflammatory fatty acids
was independent of LXRs and instead required SREBP1.
Consistent with these findings, ChIP-seq experiments indicated
a reduction of LXR binding to enhancers associated with
repressed-induced genes, but a marked increase in the binding
of SREBP1. This KLA-induced binding of SREBP1 to cis regula-
tory elements at late time points was associated with increases
in the total nuclear content of processed SREBP1. Further,
the late increase in SREBP1 binding was associated with in-
creases in chromatin features associated with active enhancers.
SREBP1 KO macrophages, or macrophages in which siRNAs
were used to knock down SREBP1, displayed compromised
late induction of repressed-induced genes and reduced produc-
tion of anti-inflammatory fatty acids. While our data clearly pro-
vide evidence for a novel role of SREBP1 in transcriptionally
tailoring specific macrophage lipid metabolic output, driving
late phase synthesis of anti-inflammatory unsaturated fatty
acids, the mechanisms controlling both the late phase induction
of SREBP1 recruitment and the SREBP1-target activation
specificity are not entirely clear. An understanding of these
mechanisms could be important in identifying novel targets
for development of SREBP1-centric interventions of various
inflammatory disease states.
Recent studies provided evidence that SREBP-1a is required
for the formation of the inflammasome and secretion of IL-1b in
response to systemic inflammation (such as endotoxic shock)
(Im et al., 2011). Consistent with these findings, we observed
increased secretion of IL-1b protein following KLA treatment of
(C) Relative mRNA expression of Scd2 and Fads2 in WT and Srebf1/ BMDMs treated with KLA for the indicated times.
(D) Relative mRNA expression of Scd2 mRNA KLA-treated thioglycollate-elicited macrophages, transfected with siRNA control or targeting Srebf1.
(E) Relative mRNA expression of Scd2 mRNA KLA-treated thioglycollate-elicited macrophages, transfected with siRNA control or targeting Scap.
(F) Distribution of RNA-seq, H3K27ac, and RNA polII tag densities at the Scd2 locus in WT and Srebf1/ BMDMs treated with KLA for 24 hr.
(G) Distribution of H3K27Ac and RNA polII tag densities in the vicinity of enhancers associated with KLA repressed-induced genes in WT and Srebf1/ BMDMs
treated with KLA for the indicated times.
Values are expressed as mean ± SEM. *p < 0.05 and **p < 0.01.
See also Figure S4.
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Figure 6. Srebf1–/– Macrophages Exhibit a Hyper-inflammatory Phenotype
(A) Scatterplot depicting the relationship between fold change of KLA induced-repressed genes, comparing RNA-seq fromWT versus Srebf1/BMDMs treated
with KLA for 24 hr. The gray dots show all uniquely expressed genes. The red dots represent all KLA induced-repressed genes.
(B) Hierarchical clustering and heatmap of the fold change in expression levels of KLA induced-repressed genes, comparing RNA-seq data from WT and
Srebf1/ BMDMs treated with KLA for 24 hr (FDR <0.01 and RPKM >0.5).
(C) Functional annotations associated with KLA induced-repressed genes.
(D) Relative mRNA expression of inflammatory genes in WT and Srebf1/ BMDMs treated with KLA for the indicated times.
(E) Distribution of RNA polII tag densities at loci of KLA induced-repressed genes WT and Srebf1/ BMDMs treated with KLA for indicated times.
(legend continued on next page)
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Srebf1/ macrophages as compared to WT controls (data not
shown). However, our studies also demonstrated that a subset
of TLR4-responsive, pro-inflammatory genes was hyper-acti-
vated in Srebf1/macrophages at 12–24 hr following KLA treat-
ment. Similar late hyper-inflammatory trends were observed in
Srebf1/ macrophages stimulated with ligands for TLR2 and
(F) UCSC genome browser image illustrating normalized tag counts for RNA-seq, RNA polII, and p65 ChIP-seq at loci of inflammatory genes inWT and Srebf1/
BMDMs treated with KLA for the indicated times.
Values are expressed as mean ± SEM. *p < 0.05 and **p < 0.01.
See also Figure S5.
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Figure 7. SREBP1 Is Necessary for Resolu-
tion of Inflammation by Driving Appropriate
Macrophage Production of Anti-inflamma-
tory Unsaturated Fatty Acids in Late Inflam-
matory Response
(A) Lipidomics analysis of unsaturated fatty acid
(EPA and DHA 9Z-PO) levels in KLA treated WT
and Srebf1/ BMDMs.
(B) Relative mRNA expression of inflammatory
genes in WT and Srebf1/ BMDMs treated with
KLA for 24 hr, with or without supplementation
with the indicated exogenous fatty acids (20 mM)
at 12 hr post-KLA treatment.
(C) Serum levels of cytokines IL-6 and IL-1a, as
quantified by ELISA, in WT and Srebf1/ mice
treated with 5 mg/kg LPS for 0, 1, 3, 6, and 24 hr,
with or without EPA supplementation as indicated.
(D) Model for integrated actions of NFkB, LXRs,
and SREBP1 during the induction and resolution
phases of the TLR4 response.
Values are expressed as mean ± SEM. *p < 0.05
and **p < 0.01.
See also Figure S6.
TLR3; thus indicating that SREBP1 is
genetically required for the normal reso-
lution phase of varied TLR responses in
macrophages. Our findings further sug-
gest that SREBP1-driven synthesis of
anti-inflammatory fatty acids contributes
to this resolution phase. The late TLR4-
mediated increase of these fatty acid
species is compromised in Srebf1/
macrophages, and supplementation of
exogenous anti-inflammatory, both in
cultured macrophages and in vivo, re-
verses hyper-induction of pro-inflamma-
tory gene expression caused by loss of
SREBP1. This is consistent with the pres-
ence of higher concentrations of these
species in WT macrophages. Although
our studies focused on 9Z-POA, DHA,
and EPA, it is possible that additional
anti-inflammatory metabolites of polyun-
saturated fatty acids, such as resolvins
protectins and fatty acid hydroxyl fatty
acids, are also generated by the late
SREBP1-dependent program of gene
expression. Interestingly, loss of SREBP1
results in increased recruitment of RNA polII to a subset of in-
flammatory response genes independent of changes in p65
binding activity. These results are consistent with prior studies
suggesting that DHA, EPA, and 9Z-POA uncouple NFkB binding
from its transcriptional output (Li et al., 2013). Because p65 bind-
ing itself is unchanged, the mechanism of inhibition is unlikely to
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be through alterations in the IkB kinase cascade required for
NFkB activation.
In concert, our findings provide evidence for a role of SREBP1
in promoting resolution of the transcriptional response of macro-
phages to TLR signaling by driving the synthesis of anti-inflam-
matory fatty acids. While we have shown that the SREBP1
pathway also influences resolution following activation of TLR2
and TLR3, the extent to which it is involved in resolution of re-
sponses to other pattern recognition receptors or cytokine-
dependent inflammatory responses remains to be determined.
It will therefore be of interest to investigate this pathway further
with respect to control of the resolution phase of inflammation
in response to infection and injury, as well as in disease contexts
in which inflammation plays a pathogenic role.
EXPERIMENTAL PROCEDURES
Cell Culture
LXRa/b/ and Srebf1/ were generated as described previously (Repa et al.,
2000b; Shimano et al., 1997). These mice were backcrossed to the C57BL/6J
strain formore than ten generations. Mouse thioglycollate-elicitedmacrophages
were isolated frommale 6- to 9-week-old C57BL/6J (Charles River laboratories),
LXRa/b/, and Srebf1/ mice and cultured as previously described (Spann
etal., 2012).Peritonealmacrophageswereharvestedby lavage3daysafter intra-
peritoneal injection of 3 mL of 3% thioglycollate medium (http://www.lipidmaps.
org/protocols/), overnight culture, and adherence selection. Bone marrow from
micewere isolatedby perfusion of themedullary cavity of femurs, tibias, and iliac
bones and cultured in medium containing RPMI-1640, 10% FCS, and 20 mg/mL
M-CSF (R&D) for 6 days.RAW264.7 cells aremaintained in theRPMI-1640media
supplementedwith10%FCS (Hyclone) andusedbetweenpassage5–10. For the
fatty acid rescue experiments, cells were treatedwith fatty acids complexedwith
FA-free low-endotoxin BSA (Sigma, final FA:BSA molar ratio was 5:1).
Animal Study
All mice used in this study have C57BL/6 background. Male, 8- to 11-week-old
Srebf1/ mice and age-matched littermate control were individually housed
in cages in a 12 hr/12 hr light/dark cycle with free access to food and water.
For supplemental EPA administration study, mice were fed with fish meal-
free diet (fish meal-free F1: 4.4% fat; Funabashi Farm) or fish meal-free diet
supplemented with 5% EPA ethyl ester (v/v) for 7 days before single intraper-
itoneal injection of 5mg/kg LPS (n = 5, each group). All animal procedures were
in accordance with research guidelines for care and use of laboratory animals
of Tokyo Medical and Dental University. Temporal changes of serum IL-6 and
IL-1a were quantified by ELISA (R&D).
ChIP-Seq
ChIP from thioglycollate-elicited peritoneal macrophages or BMDMs was per-
formed as described previously (Spann et al., 2012), with modifications as
described in Supplemental Experimental Procedures. ChIP-seq libraries
were prepared from ChIP DNA by blunting, A-tailing, adaptor ligation as previ-
ously described (Heinz et al., 2010) using barcoded adapters (NEXTflex, Bioo
Scientific). Libraries were PCR amplified for 12–15 cycles, size selected by gel
extraction, and sequenced on either a Illumina Genome Analyzer II or HiSeq
2000 for 51 cycles.
RNA-Seq
Total RNA was isolated from cells and purified using RNeasy columns and
RNase-free DNase digestion according to the manufacturer’s instructions
(QIAGEN). RNA-seq libraries were prepared from poly(A)-enriched mRNA,
either as previously described (Kaikkonen et al., 2013) or as detailed in Supple-
mental Experimental Procedures.
High-Throughput Sequencing and Data Analysis
All sequencing was conducted using either Illumina Genome Analyzer II or
HiSeq 2000 sequencers using single-end 50 bp reads. All data were aligned
to the mm9 assembly of the mouse genome, and all subsequent data analysis
was performed using HOMER, and detailed instructions for analysis can be
found at http://homer.salk.edu/homer/ (Heinz et al., 2010). Each sequencing
experiment was normalized to a total of 107 uniquelymapped tags by adjusting
the number of tags at each position in the genome to the correct fractional
amount given the total tags mapped. Sequence experiments were visualized
by preparing custom tracks for the UCSC genome browser. Differentially
expressed genes were identified using HOMER as described previously (Li
et al., 2013). For SREBP1 ChIP-seq analysis, ChIP-seq peaks for each SREBP
ChIP replicate were identified using Homer, and then the strength of binding at
each loci was quantified as the position adjusted reads from the start of the
peak region (Homer peak score). We calculated the IDR to measure the con-
sistency between replicate experiments for the strength of binding at each
loci and retained SREBP peaks with IDR < 0.05. For various ontology analyses,
either HOMER or DAVID Bioinformatics Resources 6.7 was used. The acces-
sion number for the data from previously published GRO-seq and ChIP-seq
experiments is GEO: GSE48759.
Statistical Analyses
Statistical analyses were performed using Graph Pad Prism 5 software. The
images were prepared using Adobe Illustrator CS5 or Photoshop CS5.1.
Data are presented as themean ± SEM. For experiments involving two factors,
data were analyzed by two-way ANOVA followed by Bonferroni post-tests. In-
dividual pairwise comparisons were performed using Student’s t test. p < 0.05
was considered significant.
ACCESSION NUMBERS
The accession number for the sequencing data reported in this paper is GEO:
GSE79423.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2016.11.009.
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Sympathetic innervation of adipose tissue promotes lipolysis and fat 
mass reduction via NE signaling1. In obesity, chronic local inflam-
mation underlies adipose tissue dysfunction, and macrophages have 
been shown to play a central role1,2. The mechanism that links mac-
rophages in white adipose tissue (WAT) to NE remains controversial. 
Some groups have reported that anti-inflammatory adipose tissue 
macrophages (ATMs) in the WAT produce NE to sustain thermogen-
esis and browning. In direct contradiction, other groups have reported 
that ATMs do not express a key enzyme required for NE production 
and that genetic deletion of this enzyme in mouse macrophages has 
no effect on thermogenesis and body weight3–6.
Here we identify a previously undescribed population of SAMs 
that import and degrade NE via specific proteins that are absent from 
ATMs. We found by transcriptional profiling of isolated SAMs that 
neural- and adrenergic-related genes are differentially expressed in 
these cells relative to other macrophage populations. SAMs accumu-
late intracellular NE despite lacking enzymes for NE biosynthesis. 
Using optogenetics, we demonstrate that SNS activity increases NE 
content and the proinflammatory state of SAMs. We functionally 
demonstrate that SAMs import and degrade NE via NE transporter 
(SLC6A2) and degradation enzyme (MAOA), respectively. We fur-
ther demonstrate that SAM-mediated clearance of extracellular NE 
contributes to obesity, as inhibiting NE import by SAMs ameliorates 
obesity, thermogenesis, and browning in mutant obese (ob/ob) mice 
and mice fed a high-fat diet (HFD). Finally, we demonstrate human 
relevance for this mechanism, as we found that SAMs are also present 
in human sympathetic ganglia and express similar molecular machin-
ery as that observed in mice. Thus, the identification of SAMs repre-
sents a new contribution to the ongoing controversy surrounding the 
role of macrophages in thermogenesis and obesity while identifying 
an unforeseen immunological player in noradrenergic homeostasis 
with therapeutic potential for obesity.
RESULTS
Specialized morphology and activation of SNS  
Cx3cr1-expressing cells
Our initial aim was to visualize the in vivo morphology of ATMs using 
two-photon and confocal microscopy in Cx3cr1GFP/+ mice, in which 
macrophages are labeled with GFP. ATMs in fat parenchyma had a 
regular circular shape (Fig. 1a), whereas those located on sympathetic 
1The Howard Hughes Medical Institute (HHMI) and Obesity Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal. 2Department of Cellular and Molecular Medicine, 
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contributed equally to this work. Correspondence should be addressed to A.I.D. (dominan@igc.gulbenkian.pt).
Received 6 May; accepted 12 September; published online 9 October 2017; doi:10.1038/nm.4422
Sympathetic neuron–associated macrophages contribute 
to obesity by importing and metabolizing norepinephrine
Roksana M Pirzgalska1,11, Elsa Seixas1,11, Jason S Seidman2, Verena M Link2,3, Noelia Martínez Sánchez1,  
Inês Mahú1, Raquel Mendes1, Vitka Gres1, Nadiya Kubasova1, Imogen Morris1, Bernardo A Arús1,4,  
Chelsea M Larabee1, Miguel Vasques1,5, Francisco Tortosa6, Ana L Sousa7, Sathyavathy Anandan1,  
Erin Tranfield7, Maureen K Hahn8, Matteo Iannacone9  , Nathanael J Spann2, Christopher K Glass2 &  
Ana I Domingos1,10
The cellular mechanism(s) linking macrophages to norepinephrine (NE)-mediated regulation of thermogenesis have been a topic 
of debate. Here we identify sympathetic neuron–associated macrophages (SAMs) as a population of cells that mediate clearance 
of NE via expression of solute carrier family 6 member 2 (SLC6A2), an NE transporter, and monoamine oxidase A (MAOA), a 
degradation enzyme. Optogenetic activation of the sympathetic nervous system (SNS) upregulates NE uptake by SAMs and shifts 
the SAM profile to a more proinflammatory state. NE uptake by SAMs is prevented by genetic deletion of Slc6a2 or inhibition of 
the encoded transporter. We also observed an increased proportion of SAMs in the SNS of two mouse models of obesity. Genetic 
ablation of Slc6a2 in SAMs increases brown adipose tissue (BAT) content, causes browning of white fat, increases thermogenesis, 
and leads to substantial and sustained weight loss in obese mice. We further show that this pathway is conserved, as human 
sympathetic ganglia also contain SAMs expressing the analogous molecular machinery for NE clearance, which thus constitutes a 
potential target for obesity treatment.
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nerve bundles exhibited profuse pseudopodia that extended over 
a greater surface area (Fig. 1b and Supplementary Fig. 1a,b). 
Furthermore, we observed that sympathetic neuron–associated 
Cx3cr1-GFP+ cells displayed dynamic extensions and retractions 
of dendritiform processes over time (Fig. 1c and Supplementary 
Video 1). In contrast, ATMs surrounding adipocytes displayed mini-
mal temporal plasticity or displacement (Fig. 1c and Supplementary 
Video 2). Using correlative light–electron microscopy on WAT-
derived nerve bundles, we confirmed that Cx3cr1-GFP+ cells extended 
thin pseudopodial processes that enveloped nonmyelinated SNS axons 
(Fig. 1d,e and Supplementary Fig. 1c).
We then investigated whether sympathetic neuron–associated 
Cx3cr1-GFP+ cells were present in other SNS compartments, such as 
paravertebral sympathetic ganglia. Through imaging superior cervical 
ganglia (SCGs) and thoracic chains, we visualized Cx3cr1-GFP+ cells 
that were morphologically similar to those within WAT-derived SNS 
bundles (Supplementary Fig. 2). Owing to the established ex vivo 
explant potential of SCGs, we used them along with WAT-derived 
SNS nerve bundles as model systems for subsequent functional and 
molecular analyses.
SNS Cx3cr1-expressing SAMs exhibit hematopoietic 
characteristics
Because nearly all Cx3cr1-GFP+ cells isolated from sympathetic fibers 
expressed the immune marker CD45 (Supplementary Fig. 3) and 
macrophage marker F4/80 (Supplementary Fig. 4a), we designated 
these cells SAMs. Because of the specialized morphology and loca-
tion of SAMs, we next explored how these cells compared to other 
tissue macrophages and brain microglia. We sorted F4/80+CD45+ 
cells from the following tissues: sympathetic ganglia (SAM ganglia), 
sympathetic nerve fibers from inguinal fat (SAM fibers), neighboring 
subcutaneous fat (sATM), visceral fat (vATM), spleen (SpM), and 
brain (microglia) (Fig. 2a; gating details in Supplementary Fig. 3). 
The relative abundance of CD45highCx3cr1-GFP+ cells was nearly four 
times higher within nerve fibers (SAMs) than in subcutaneous WAT 
(sWAT) (sATMs; Supplementary Fig. 4b).
CD45 is highly expressed in hematopoietic cells but expressed at 
low levels in microglia. Flow cytometric analysis revealed that SAMs 
are CD45medium or CD45high (Supplementary Fig. 3), suggesting 
a hematopoietic origin for these cells. To test this hypothesis, we 
generated chimeras through transplantation of bone marrow from 
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Figure 1 Sympathetic neuron–associated Cx3cr1-GFP+ cells exhibit differentiated morphology for specific association with SNS neurons. (a) Confocal 
images of WAT isolated from a Cx3cr1GFP/+ mouse and stained using lipid stain LipidTOX (blue) and anti-GFP antibody (green). Images are representative 
of five similar experiments. (b) Confocal images of sympathetic nerve fibers in subcutaneous adipose tissue isolated from a cross of TH-cre; LSL-Tomato 
(red) and Cx3cr1GFP/+ (green) mice. Adipocytes were stained using lipid stain LipidTOX (blue). Images are representative of three similar experiments. 
Scale bars in a and b, 50 µm. The boxed regions in the main micrographs in a and b are shown at higher magnification; scale bars, 25 µm. (c) Intravital 
multiphoton visualization of a neural–adipose connection in the inguinal fat pad of a live Cx3cr1GFP/+ mouse; LipidTOX (blue) labels adipocytes. Images 
depict the morphological features and cell dynamics of Cx3cr1-GFP+ cells associated with sympathetic nerve fibers (left) and Cx3cr1-GFP+ cells in 
the parenchyma of subcutaneous fat (right). Images are representative of three similar experiments. Scale bars, 50 µm. Boxed regions in the main 
micrographs are shown at higher magnification at the indicated time points; scale bars, 10 µm. White arrows indicate dendritiform processes over time. 
(d) Confocal images of sympathetic nerve fibers isolated from the inguinal fat pad of a Cx3cr1GFP/+ mouse and stained using anti-TH (red) and anti-GFP 
(green) antibodies. Images are representative of five similar experiments. Scale bar, 50 µm. The boxed region in the main micrograph is shown at higher 
magnification below; scale bar, 25 µm. (e) Correlative confocal and transmission electron microscopy of nerve fibers isolated from the subcutaneous 
fat pad of a Cx3cr1GFP/+ mouse. Shown are an overlay of the GFP fluorescence (green) with the electron micrograph of the same section (upper left; 
the lower left image is a higher-magnification view of the boxed region), the electron micrograph alone (upper middle; the yellow boxed region is shown 
at higher magnification to the right), and the electron micrograph from the lower left with false coloring highlighting Cx3cr1-GFP+ cells (green) and 
sympathetic nerves (red) (lower right). Images are representative of two similar experiments. Scale bars, 2 µm.
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CD45.2 Cx3cr1GFP/+ donors into irradiated CD45.1 recipient mice 
and observed complete repopulation of CD45+ cells derived from the 
CD45.2 Cx3cr1GFP/+ donors (Supplementary Fig. 4c). Eight weeks 
following transplantation, we established that CD45.2+Cx3cr1-GFP+ 
SAMs repopulated sympathetic nerve bundles in WAT, whereas 
microglial repopulation in the brain did not occur (Supplementary 
Fig. 4d). This suggests that SAMs in sympathetic fibers have an origin 
similar to that of other hematopoietic macrophages rather than being 
from a microglial lineage.
SAM expression profile is more macrophage- than glial-like
Considering the association of SAMs with neurons, we asked how 
the gene expression profile of SAMs compared to those of other tis-
sue-resident macrophages and microglia (Fig. 2). We sorted mac-
rophages from various tissues as described above (F4/80+CD45+ 
cells designated as SAM ganglia, SAM fibers, sATMs, vATMs, SpMs, 
and microglia; Fig. 2a and Supplementary Fig. 3) and profiled gene 
expression by low-input RNA-seq (Fig. 2b–f). As expected, SAMs 
highly expressed markers common to both microglia and macro-
phages, such as Adgre1, Csf1r, and Cx3cr1 (Fig. 2b). SAMs expressed 
macrophage-associated genes whose expression was excluded from 
microglia, such as Fn1 and Ciita (Fig. 2b)7. Flow cytometric analysis 
showed that additional macrophage-specific markers whose expres-
sion was excluded from microglia (CD68, Ly6C, major histocompat-
ibility complex II (MHCII), and CD11b) were also highly expressed 
in SAMs (Supplementary Fig. 5a,b). SAMs did not robustly express 
microglial- or glial-specific genes relative to macrophage-specific 
genes (Fig. 2b and Supplementary Fig. 5c)8–17. Expression of the 
Sall1 gene, encoding a key microglial lineage-determining transcrip-
tion factor, was strikingly absent from SAMs18 (Fig. 2b).
Principal-component analysis (PCA) of the RNA-seq data showed 
tight clustering across replicates, indicating low contamination and 
high reproducibility (Fig. 2d). The absence of tyrosine hydroxylase 
(Th) expression in SAMs (Supplementary Fig. 5d) further excluded 
the possibility of contaminating cargo from neighboring cells, as Th 
was highly expressed in adjacent SNS neurons (Fig. 1b,d). PCA indi-
cated that SAMs from fibers and ganglia were closely related, but both 
were distant from microglia and other macrophages (Fig. 2d). This 
was confirmed by phylogenetic analysis (Fig. 2e).
We hypothesized that the increased motility of SAMs (Fig. 1c) 
could indicate an activated, proinflammatory state. Therefore, we 
measured expression of a constellation of pro- and anti-inflamma-
tory markers in SAMs by RNA-seq (Fig. 2c). Relative to other mac-
rophage populations, SAMs highly expressed genes associated with 
macrophage activation, including Cxcl2, Tnf, Socs3, and Il1a (Fig. 2c), 
suggesting a constitutively proinflammatory steady state.
SAMs are phylogenetically distinct from other macrophages
Consistent with the PCA results (Fig. 2d), Pearson correlation anal-
yses of transcript levels indicated differential expression patterns 
across SAMs, sATMs, vATMs, SpMs, and microglia (Supplementary 
Fig. 6a,b). Adipose tissue macrophages (sATMs and vATMs) showed 
similar expression landscapes (R = 0.92) that were distant from those 
of SAMs in fibers (R = 0.63 for sATMs and R = 0.61 for vATMs; 
Supplementary Fig. 6b). The expression landscapes of microglia 
and spleen macrophages were least correlated with other groups 
(Supplementary Fig. 6b).
Gene ontology analyses identified several biological processes 
associated with genes whose expression was enriched in SAMs 
relative to surrounding sATMs (Supplementary Fig. 6c). SAMs 
preferentially expressed genes involved in synaptic signaling, cell–
cell adhesion, and neuron development (Supplementary Fig. 6c), 
suggesting that these cells fulfill an intrinsic role in local neuronal 
maintenance. Taken together, these data demonstrate divergent gene 
expression patterns in SAMs and ATMs, constituting within-tissue 
macrophage specialization.
SAMs import and degrade but do not synthesize NE
We next examined specific transcripts corresponding to the genes 
with divergent macrophage expression. The aforementioned popula-
tions of macrophages were sorted (Fig. 2a and Supplementary Fig. 3) 
for transcriptome analysis via low-input RNA-seq. Considering the 
gene ontology results (Supplementary Fig. 6c) and spatial proxim-
ity of SAMs to nerves (Fig. 1), we hypothesized that there would be 
differential expression of neurotransmitter receptors, transporters, 
or catalytic enzymes among these macrophage populations (Fig. 2f). 
In agreement with the Immunological Genome Project (ImmGen) 
database, we detected abundant expression of the Adrb2 gene encod-
ing β2 adrenergic receptor in all macrophage populations (Fig. 2f), 
which was confirmed by qRT–PCR (Supplementary Fig. 6d).
However, SAMs were the only population that expressed Slc6a2, 
the gene encoding the NE transporter (Fig. 2f). Similarly, Maoa was 
highly expressed in SAMs relative to the other macrophage types 
(Fig. 2f). Both results were validated by qRT–PCR (Fig. 2g,h and 
Supplementary Table 1). As SLC6A2 imports and MAOA degrades 
NE, we also tested for the presence of NE and detected it through 
enzyme-linked immunosorbent assay (ELISA) in sorted SAMs (Fig. 
2i and Supplementary Fig. 6e). In agreement with our results, nei-
ther Slc6a2 nor Maoa was substantially expressed in any macrophage 
population listed in the ImmGen database. Furthermore, we validated 
SLC6A2 and MAOA protein expression by immunofluorescence in 
SNS nerve fibers and SCG cryosections from Cx3cr1GFP/+ mice (Fig. 
2j,k). Representative photomicrographs show that GFP-expressing 
SAMs were double positive for membrane-bound SLC6A2 (Fig. 2j) 
and mitochondria-bound MAOA (Fig. 2k).
As SAMs, but not the other macrophage types assessed, possess 
the molecular machinery for import (Fig. 2f,g,j) and degradation 
(Fig. 2f,h,k) of NE, as well as considerably more NE than other macro-
phages (Fig. 2i and Supplementary Fig. 6e), we tested the possibility 
that SAMs synthesize NE. Through qRT–PCR of sorted SAMs, we 
did not detect expression of Th, which encodes an enzyme necessary 
for NE biosynthesis (Supplementary Fig. 5d). Taken together, these 
results indicate that SAMs have the molecular machinery for import-
ing and degrading NE but not for biosynthesis of it.
To explore the responsiveness of SAMs to NE, we optogenetically 
stimulated sympathetic neurons in SCG cultures from mice produced 
by crossing Th-cre mice with loxP-STOP-loxP (LSL)-ChR2-YFP mice1, 
which allowed us to visualize sympathetic neuron–macrophage 
interactions ex vivo (Fig. 3a,b). After optogenetic stimulation, we 
measured the NE content of sorted CD45+F4/80+ cells. SAMs from 
channelrhodopsin-2 (ChR2)+ cultures exhibited significantly higher 
NE levels (Fig. 3c) that were proportional to NE availability in the 
culture medium (Fig. 3d). NE release by ChR2+ neurons was sig-
nificantly higher than that from ChR2− neurons (Fig. 3d). Uptake of 
NE by SAMs was prevented by pharmacological blockade of SLC6A2 
using the pharmacological inhibitor nisoxetine, despite the significant 
increase of NE in the culture medium (Fig. 3c,d).
To validate our optogenetic findings with a physiologically relevant 
stimulus, we activated SNS explants with acetylcholine (ACh), which is 
presynaptically released from spinal cord neurons to innervate SCGs. 
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ACh-treated CD45+F4/80+ cells sorted from SCG explants con-
tained significantly higher levels of NE than vehicle-treated controls 
(Fig. 3e). We validated that blockade of the NE importer SLC6A2 by 
nisoxetine prevented NE accumulation in SAMs (Fig. 3e). Co-incubation 
with ACh and nisoxetine further abolished NE uptake (Fig. 3e), 
despite the substantial increase in extracellular NE levels in the 
culture medium (Fig. 3f). These results, along with the negligible 
expression levels of Chrna1 (AChR) in SAMs (Supplementary Fig. 7a; 
also validated by qRT–PCR in Supplementary Fig. 7b), exclude a role 
for acetylcholine receptors (AChRs) in mediating NE import.
Next, we assessed the effect of blocking MAOA on NE content in 
CD45+F4/80+ cells (Fig. 3e). Treatment with the MAOA inhibitor 
SAM
sorting
a
f g h
b
c d e
DIC
Blue laser light
Th-cre; ChR2
SAM
S
S
C
104
103
102
101
100
0 20 K 40 K 60 K
FSC
103
102
101
0
0 101 102 103
SAM
ganglia
F
4/
80
 (
A
le
xa
 F
lu
or
 6
47
)
ChR2
SLC6A2-block
–
–
+
–
+
+
* * ****
****
ChR2
SLC6A2-block
–
– –
+
+
+
****
****
* **
** ****
B6
Slc6a2–/–
B6
Slc6a2–/–
200
150
100
50
0
ACh
SLC6A2-block
MAOA-block
–
–
–
–
–
– –
–
–
–
–
–
+
+
+
+
++
2,000
1,500
1,000
500
0
ACh
N
E
 (
pg
/m
l)
SLC6A2-block
MAOA-block
–
–
– –
–
–
–
– –
–
–
–
+
+
+
+++
Tnfa ll1 ll4ra
15
10
5
0
ChR2 – + ChR2 – + ChR2 – + ChR2 – +
2.5
2.0
1.5
1.0
0.5
0.0
Arg1
18
16
14
12
10
8
R
el
at
iv
e
qu
an
ti
ca
tio
n 
(A
U
)
R
el
at
iv
e
qu
an
ti
ca
tio
n 
(A
U
)
15
10
5
0
R
el
at
iv
e
qu
an
ti
ca
tio
n 
(A
U
)
R
el
at
iv
e
qu
an
ti
ca
tio
n 
(A
U
)
N
E
 (
pg
)/
1,
00
0 
ce
lls
*
*
**
**
*
*
300
200
100
0
N
E
 (
pg
/m
l)
N
E
 (
pg
)/
1,
00
0 
ce
lls
60
40
20
0
GFP
CD45.2 PE
Figure 3 SAMs import and metabolize norepinephrine via SLC6A2 and MAOA, respectively, to regulate extracellular norepinephrine availability.  
(a) Representative images of ex vivo SCG explant cultures. Top, the area of the sympathetic ganglia is represented using the reflected-light differential 
interference contrast (DIC) channel. Bottom, Cx3cr1-GFP+ cells in the same explant culture (GFP channel). Images are representative of 20 similar 
experiments. Scale bar, 100 µm. (b) Schematic representation of optogenetic activation of sympathetic SCG explant culture (left) followed by CD45.2 
(PE)+F4/80 (Alexa Fluor 647)+ cell sorting (right). FSC, forward scatter; SSC, side scatter. (c) NE content in CD45.2+F4/80+ cells isolated from SCG 
explant cultures from Th-cre; LSL-ChR2-YFP and LSL-ChR2-YFP mice after optogenetic activation. Each data point represents tissues pooled from six 
mice. n = 3–7 experiments. The following numbers of cells were used in NE assays (run in duplicate): 189 ± 30 from Th-cre; LSL-ChR2-YFP SCG (n 
= 7), 126 ± 21 from LSL-ChR2-YFP SCG (n = 6), and 159 ± 19 from Th-cre; LSL-ChR2-YFP SCG stimulated with SLC6A2 blocker (n = 3). (d) Ex vivo 
NE release upon optogenetic stimulation of SCG explants isolated from Th-cre; LSL-ChR2-YFP and LSL-ChR2-YFP mice. Each data point represents 
medium collected from one explant culture. n = 7 per group. (e) NE content in CD45.2+F4/80+ cells isolated from the SCG of either B6 or Slc6a2−/− 
mice and then incubated with ACh, ACh and SLC6A2 blocker, ACh and MAOA blocker, or culture medium. Each data point represents tissues pooled 
from six mice. n = 3–7 experiments. The following numbers of cells were used in NE assays (run in duplicate): 364 ± 128 from B6 SCG (n = 7), 238 
± 55 from Slc6a2−/− SCG (n = 3), 216 ± 58 from B6 SCG incubated with ACh (n = 7), 201 ± 63 from Slc6a2−/− SCG incubated with ACh (n = 3), 196 
± 18 from B6 SCG incubated with ACh and SLC6A2 blocker (n = 5), and 133 ± 11 from B6 SCG incubated with ACh and MAOA blocker (n = 7). (f) Ex 
vivo NE release from the SCG of either B6 or Slc6a2−/− mice after incubation with ACh, ACh and SLC6A2 blocker, ACh and MAOA blocker, or culture 
medium. Each data point represents medium collected from one explant culture. n = 7 per group. (g) Expression of mRNA as determined by qRT–PCR 
relative to Gapdh expression for proinflammatory genes (Tnfa and Il1) in CD45.2+F4/80+ cells isolated from SCG explant cultures from Th-cre; LSL-
ChR2-YFP (blue) and LSL-ChR2-YFP (black) mice. Prior to cell sorting, SCG explants were optogenetically stimulated. n = 3–4 experiments (for Tnfa, 
n = 4, P = 0.0467; for Il1, n = 3, P = 0.011). (h) Expression of mRNA as determined by qRT–PCR relative to Gapdh expression for anti-inflammatory 
genes (Il4ra and Arg1) in CD45.2+F4/80+ cells isolated from SCG explant cultures from Th-cre; LSL-ChR2-YFP (blue) and LSL-ChR2-YFP (black) mice.  
Prior to cell sorting, SCG explants were optogenetically stimulated. n = 3–4 experiments (for Il4ra, n = 3, P = 0.0257; for Arg1, n = 4, P = 0.0497). 
Data in c–h were analyzed by two-tailed unpaired Student’s t-test and are shown as average ± s.e.m. *P < 0.05, **P < 0.01, ****P < 0.0001.
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clorgyline was sufficient to nearly double intracellular NE levels in 
SAMs (Fig. 3e). In agreement with this finding, clorgyline increased 
NE levels in the medium (Fig. 3f), to which neuronal MAOA expres-
sion may also contribute. Genetic ablation of Slc6a2 (in SCG cul-
tures isolated from Slc6a2−/− mice) prevented NE uptake by SAMs 
regardless of NE availability in the culture medium (Fig. 3e,f). Finally, 
ATMs cultured in vitro with NE did not accumulate intracellular NE 
(Supplementary Fig. 7c), further demonstrating the specificity of 
NE uptake by SAMs. Altogether, our results indicate that Slc6a2 is 
required for NE accumulation in SAMs.
We further probed whether the availability of NE, which can 
be manipulated in vivo by optogenetic activation of SNS neurons, 
changes the inflammatory profile of SAMs. We found that optogenetic 
stimulation of SCG explants correlated with an increase in proinflam-
matory gene expression, as measured by changes in expression of 
Tnf (Tnfa) and Il1a (Il1) (Fig. 3g), and a decrease in the expression 
of anti-inflammatory genes, as measured by changes in expression 
of Il4r (Il4ra) and Arg1 (Fig. 3h).
SAMs are recruited and activated in obesity
We next used two mouse models to characterize the effect of obes-
ity on tissue-specific functions of SAMs. In total, we employed four 
experimental groups: HFD, Lep (Leptin)-deficient (ob/ob), normal 
diet (ND), and 24-h-fasted ND mice. Flow cytometric analysis dem-
onstrated that both obesity models (HFD and ob/ob) exhibited sig-
nificantly higher percentages of SAMs than lean mice (ND) (Fig. 4a 
and Supplementary Fig. 8a). Furthermore, the acute metabolic chal-
lenge of fasting did not result in upregulation of SAMs, suggesting an 
obesity-specific causation of elevated macrophage content in sympa-
thetic fibers (Fig. 4a and Supplementary Fig. 8a). Within the F4/80+ 
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Figure 4 Obesity-induced accumulation of SAMs. (a) Representative histograms showing percentages of F4/80 (Alexa Fluor 647)+ cells in sympathetic 
nerve fibers (left), subcutaneous adipose tissue (middle), and spleen (right) in mice that were genetically obese (ob/ob; black), obese due to HFD (red), 
ND fed (blue), or fasted for 24 h (green). CD45.2 (PE)+ cells were gated. Histograms are representative of four independent experiments. HFD no Ab, 
cells without antibody staining harvested from mice fed a HFD. Black lines indicate the region defining F4/80+ cells. (b) Percentages of F4/80 (Alexa 
Fluor 647)+CD11c (FITC)+ cells in sympathetic nerve fibers (left), subcutaneous adipose tissue (middle), and spleen (right) in mice that were genetically 
obese (ob/ob; black), obese due to HFD (red), ND fed (blue), or fasted for 24 h (green). CD45.2 (PE)+ cells were gated. n = 4 experiments per group. Each 
data point represents one experiment. (c) Expression of mRNA as determined by qRT–PCR relative to Gapdh expression for proinflammatory genes (Tnfa 
and Il1) in CD45.2+F4/80+ cells in sympathetic nerve fibers (SAMs), subcutaneous adipose tissue (ATMs), and spleen (SpMs) isolated from mice that 
were fed either ND (blue) or HFD (red). n = 4 experiments per group. Each data point represents tissues pooled from ten mice. (d) Expression of mRNA 
as determined by qRT–PCR relative to Gapdh expression for anti-inflammatory genes (Arg1 and Il10) in CD45.2+F4/80+ cells including SAMs, ATMs, 
and SpMs isolated from mice that were fed either ND (blue) or HFD (red). n = 4 experiments per group. Each data point represents tissues pooled from 
ten mice. (e) Heat map showing the expression of pro- and anti-inflammatory genes as determined by the qRT–PCR analyses in c and d. Data in b were 
analyzed by one-way ANOVA followed by Bonferroni multiple-comparisons test with ND as the control group. Data in c and d were analyzed by two-tailed 
unpaired Student’s t-test. Data are shown as average ± s.e.m. **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not significant.
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SAM fraction from HFD and ob/ob mice, we noted a high frequency 
of CD11c+ cells (Fig. 4b), which are hallmarks of inflammation and 
insulin resistance in human obesity19. In contrast to SAM accumula-
tion in SNS nerve fibers dissected from WAT, SAMs did not accumu-
late in SCG, which innervates neck structures such as salivary glands 
(Supplementary Fig. 8b).
The differential distribution of macrophages under conditions 
of obesity suggests that cytokine levels are also sensitive to obes-
ity. Comparison of the anti- and proinflammatory gene profiles 
of SAMs, ATMs, and SpMs (Fig. 4c–e) revealed that obesity correlated 
with higher levels of proinflammatory genes (i.e., Tnfa or Il1; Fig. 4c,e) and 
lower levels of anti-inflammatory genes (i.e., Arg1 or Il10; Fig. 4d,e).
To determine whether local proliferation contributes to SAM accu-
mulation, we measured the proliferation marker Ki-67 in SAMs by flow 
cytometry (Supplementary Fig. 8c,d). We observed that obesity (in 
the HFD and ob/ob models) did not substantially increase Ki-67+ SAM 
percentage, whereas (in accordance with previous reports20) obesity 
increased Ki-67+ ATMs from sWAT (Supplementary Fig. 8d).
Slc6a2 deletion in SAMs rescues obesity
We probed how ablating Slc6a2 in SAMs affects obesity-associated 
pathology. We considered a Cre–loxP approach, but the established 
macrophage Cre lines (Cx3cr1-cre21,22 and LyzM-cre23) would not 
allow for specificity of ablation to SAMs. We thus took advantage of 
the cell-type specificity of Slc6a2 expression, which is high in SAMs 
but negligible in other macrophage and hematopoietic cell popula-
tions (Fig. 2b,g and ImmGen24). We validated that there was not 
another population of hematopoietic origin expressing Slc6a2 aside 
from SAMs; a rare population of CD45+F4/80− cells was present 
in SCG (Supplementary Fig. 9a) but did not express SLC6A2 
(Supplementary Fig. 9b). SAM-specific genetic ablation of Slc6a2 
was achieved through bone marrow transfer from Slc6a2−/− mice25 
into genetically obese ob/ob recipients (ob/ob-Slc6a2−/−; Fig. 5a). 
Control chimeras consisted of ob/ob mice (ob/obCtrl) that received 
a bone marrow transfer from B6 CD45.1 mice. Chimeras recovered 
for 9 weeks following transplant to allow irradiation-induced inflam-
mation to subside.
As cold temperature is a robust driver of SNS activity, we challenged 
mice for 2 h at 4 °C and observed that ob/ob-Slc6a2−/− chimeras displayed 
superior capacity for maintaining body temperature as compared to con-
trol ob/obCtrl chimeras (Fig. 5b). These thermogenic effects were accom-
panied by significant upregulation of NE levels in serum (Fig. 5c), rescue 
of BAT morphology (Fig. 5d), and browning of white fat, as measured by 
Ucp1 mRNA and uncoupling protein 1 (UCP1) levels (Fig. 5e–g).
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Figure 5 Loss of Slc6a2 function in SAMs rescues the thermogenic capacity of ob/ob mice. (a) Schematic representation of bone marrow transplant 
from either Slc6a2−/− or control B6 (CD45.1) mice into genetically obese ob/ob mice (ob/ob-Slc6a2−/− and ob/obCtrl chimeras, respectively). (b) Rectal 
temperature of ob/obCtrl (black) and ob/ob-Slc6a2−/− (green) chimeras was measured at room temperature (RT) and after 2 h of cold challenge (4 °C). 
Each data point represents one mouse. n = 4 ob/ob-Slc6a2−/− mice and n = 6 ob/obCtrl mice. *P = 0.025, ****P < 0.0001. (c) Serum levels of NE 
in ob/obCtrl (black) and ob/ob-Slc6a2−/− (green) chimeras were measured at room temperature and after 2 h of cold exposure (4 °C). Each data point 
represents one mouse. n = 4 mice per group for ob/ob-Slc6a2−/− mice and n = 5 mice per group for ob/obCtrl mice. *P = 0.022, **P = 0.0072.  
(d) Optical micrographs of BAT removed from ob/ob chimeras following 2 h of cold challenge (4 °C) and stained with H&E. Left, BAT from an ob/obCtrl 
chimera. Right, BAT from an ob/ob-Slc6a2−/− chimera. Images are representative of fat organs collected from four ob/obCtrl and six ob/ob-Slc6a2−/− 
mice. (e) Expression of mRNA for Ucp1 as determined by qRT–PCR relative to Gapdh expression in BAT (left) and sWAT (right) dissected after 2 h of 
cold challenge (4 °C). Each data point represents one mouse. n = 4 ob/ob-Slc6a2−/− mice (green) and n = 5 ob/obCtrl mice (black). *P = 0.0269,  
**P = 0.0015. (f) Optical micrographs of BAT dissected from ob/obCtrl (left) and ob/ob-Slc6a2−/− (right) chimeras following 2 h of cold challenge  
(4 °C) and stained with anti-UCP1 antibody. Images are representative of fat organs collected from four ob/obCtrl and six ob/ob-Slc6a2−/− mice.  
(g) Optical micrographs of sWAT dissected from ob/obCtrl (left) and ob/ob-Slc6a2–/– mice (right) following 2 h of cold challenge (4 °C) and stained with 
anti-UCP1 antibody. Images are representative of fat organs collected from four ob/obCtrl and six ob/ob-Slc6a2−/− mice. (h) Average adipocyte diameter 
quantified from optical micrographs of sWAT and BAT from ob/ob chimeras following 2 h of cold challenge (4 °C). Measurements  
are representative of four (ob/ob-Slc6a2−/−) and six (six ob/obCtrl) independent micrographs. 18–34 measurements were obtained per micrograph.  
n = 169 cells for ob/obCtrl sWAT, n = 120 cells for ob/ob-Slc6a2−/− sWAT, n = 180 cells for ob/obCtrl BAT, n = 120 cells for ob/ob-Slc6a2−/− BAT. ****P 
< 0.0001. (i) Body weight change (top) and daily food intake (bottom) of ob/obCtrl (n = 4 mice) and ob/ob-Slc6a2−/− (n = 6 mice) chimeras monitored 
for 7 weeks following 2 weeks of food intake normalization (0.06 g of food per 1 g of body weight per day; gray shading) that started 9 weeks after 
bone marrow transplant. The yellow triangle indicates when irradiation was performed. *P < 0.05. (j) Blood plasma nonesterified (free) fatty acid (FFA) 
concentration in ob/obCtrl and ob/ob-Slc6a2−/− chimeras measured 8 weeks after bone marrow transplant before and while mice were under a regimen 
of 0.06 g of food per 1 g of body weight per day. n = 5 mice per group. **P = 0.0022. Data in b, c, e, h, and j were analyzed by two-tailed unpaired 
Student’s t-test and in i by multiple t-tests (one Student’s t-test per row with correction for multiple comparisons using the Holm–Sidak method). Data 
are shown as average ± s.e.m. Scale bars in d, f, and g, 100 µm. 
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Transplant of bone marrow from Slc6a2−/− mice into ob/ob mice 
prevented obesity-induced hypertrophy of both BAT and WAT 
adipocytes (Fig. 5h) but did not affect total body weight (Fig. 5i). 
Because food-restriction challenge drives SNS activity and mobi-
lizes lipid stores from adipose tissue, we normalized the daily food 
intake of the ob/ob chimeras for 2 weeks (Fig. 5i,j). After a dieting 
challenge, ob/ob-Slc6a2−/− mice lost nearly 30% of their body weight 
relative to their original body weight, after which their body weight 
was stable for up to 16 weeks, even after they were given ad libitum 
access to food (Fig. 5i). We also found that ob/ob-Slc6a2−/− mice 
exhibited higher lipid mobilization during food restriction relative to 
controls (Fig. 5j).
We analyzed wild-type B6 chimeras reconstituted with bone mar-
row from Slc6a2−/− mice relative to CD45.1 controls (B6-Slc6a2−/− 
and B6Ctrl chimeras, respectively) (Supplementary Fig. 9c). SAMs 
from B6-Slc6a2−/− chimeras did not accumulate NE (Supplementary 
Fig. 9d). In accordance with the results from ob/ob chimeras (Fig. 5), 
B6-Slc6a2−/− chimeras also exhibited increased serum levels of NE, 
thermogenesis, and lipolysis, as well as marked weight loss, relative 
to control mice (Supplementary Fig. 9e–i). Upon challenge with 
HFD, we observed weight-gain prevention in B6-Slc6a2−/− but not 
B6Ctrl mice (Supplementary Fig. 9g). These results indicate a notable 
anti-obesity effect of SAM-specific Slc6a2 ablation.
SAMs are in BAT and act as a NE sink
In light of the enhanced thermogenic capacity of ob/ob-Slc6a2−/− 
chimeras, we questioned whether SAMs are present in BAT 
(Supplementary Fig. 10). BAT did contain Cx3cr1-GFP+ cells (in 
accordance with a previous report19) that exhibited a morphology 
intermediate to those of SAMs (multiple pseudopodia) and ATMs 
(round) (Supplementary Fig. 10a as compared to Fig. 1c). Some 
of these cells appeared to make close contacts with thin TH+ axons 
(Supplementary Fig. 10a). Because TH+ nerve fibers in BAT are too 
delicate for dissection, we sorted macrophages from whole BAT for 
qRT–PCR analysis. Slc6a2 and Maoa were expressed in BAT macro-
phages, although at lower levels than in SAMs isolated from dissected 
SNS nerve bundles in sWAT or SCG (Supplementary Fig. 10b,c). We 
also detected the presence of NE in BAT macrophages, although at 
lower levels than SAMs (Supplementary Fig. 10d). The lower levels 
of Slc6a2, Maoa, and NE content may reflect a dilution of BAT SAMs 
by BAT ATMs, as mixed (as opposed to isolated) populations were 
analyzed.
Finally, we used LyzM-cre; Csf1r-LSL-DTR mice with condi-
tional expression of diphtheria toxin receptor (DTR) on macro-
phages to test whether macrophages serve as a sink for NE. After 
validating ablation of macrophages (Supplementary Fig. 11a,b), we 
observed a significant increase of NE in sWAT of LyzM-cre; Csf1r-
LSL-DTR mice relative to Csf1r-LSL-DTR controls (Supplementary 
Fig. 11c). Note that, owing to constant hematopoietic input, it is prac-
tically impossible to completely deplete macrophages. This limitation 
notwithstanding, these results are consistent with a model in which 
macrophages act as a sink for NE.
Human sympathetic ganglia also contain NE-degrading SAMs
Finally, we asked whether SAMs exist in humans. We obtained nine 
human excisional biopsies of SNS or thoracolumbar ganglia that were 
collected during sympathectomy and/or gangliotomy. We stained tis-
sue sections with H&E (Fig. 6a,b) or an antibody against CD68, a 
human macrophage marker, and identified the presence of macro-
phages in SNS tissues (Fig. 6c,d and Supplementary Fig. 12).
We next determined whether SAMs in human sympathetic 
ganglia also contain the machinery for uptake and degradation 
of NE (Fig. 6e,f and Supplementary Fig. 12). The CD68 macro-
phage marker colocalized with staining for SLC6A2 (Fig. 6e and 
Supplementary Fig. 12a) and MAOA (Fig. 6f and Supplementary 
Fig. 12b). Both SLC6A2+ and MAOA+ neurons existed, but the 
background levels were low relative to control human gut-associated 
lymphoid tissue (GALT) samples that also contained CD68+  
macrophages (Supplementary Fig. 12c,d).
DISCUSSION
SAMs are a previously undescribed population of SNS-resident mac-
rophages that import and degrade NE. To fulfill their function, SAMs 
express a dedicated molecular machinery that is, as best we can tell, 
absent from neighboring macrophages and other known macrophage 
populations (shown by our data and the ImmGen database). In SAMs, 
NE is imported by SLC6A2 and degraded by MAOA. This is a specialized 
a b
dc
CD68 SLC6A2 CD68 MAOAfe
Figure 6 SAMs in the human sympathetic nervous system. (a,b) Optical 
micrograph of human ganglia from the thoracolumbar region stained 
with H&E (a) and a higher-magnification image (b). (c,d) Optical 
micrograph of human ganglia from the thoracolumbar region stained 
with an antibody against CD68 (c) and a higher-magnification image 
(d). (e) Optical micrograph of human ganglia from the thoracolumbar 
region stained with antibodies against CD68 and SLC6A2. Red arrows 
indicate CD68+SLC6A2+ regions. Pink arrows indicate SLC6A2+ regions. 
(f) Optical micrographs of human ganglia from the thoracolumbar region 
stained with antibodies against CD68 and MAOA. Red arrows indicate 
CD68+MAOA+ regions. Pink arrows indicate MAOA+ regions. Boxed regions 
in e and f represent higher-magnification images of the main micrographs. 
Scale bars: 1 mm (a,c), 100 µm (b,d), and 50 µm (e,f); for boxed regions, 
25 µm. Images in a–f are representative of nine different human samples.
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molecular mechanism for NE uptake with a role that is not fulfilled by the 
canonical phagocytic mechanisms generally present in macrophages26.
Unlike most other neurons, which exclusively release neuro-
transmitter at a terminal synapse, SNS neurons also release NE via 
varicosities distributed along axons that can extend for tens of cen-
timeters27. SAMs possibly serve to prevent NE spillover into the 
bloodstream or neighboring tissues when SNS activity is high. Indeed, 
we demonstrate that, when SNS neurons are optogenetically acti-
vated, SAMs import increased levels of NE and become more polar-
ized toward a proinflammatory phenotype. In this regard, NE can be 
considered a noxious stimulus that must be locally delivered in a con-
trolled manner to a target tissue. Chronic and excessive systemic NE 
in serum, such as the levels present under chronic stress conditions or 
in medullary adrenal tumors, leads to hypertension and cardiopathy 
due to direct action in cardiovascular tissues28.
The activated polarization state of SAMs is consistent with a model 
in which these cells play a tissue-protective role by acting as a sen-
tinel and scavenger of surplus levels of an endogenous neurotrans-
mitter (i.e., NE) that, if released in excess from varicosities, could 
potentially be harmful. Tissue-protective immune cells have been 
documented in the brain and other, non-neuronal systems29–34. For 
instance, muscularis-resident macrophages in the gut induce rapid 
tissue-protective responses to potentially pathogenic insults via β2 
adrenergic receptor signaling35. This mechanism and our study 
indicate specialization of macrophage populations for fulfillment of 
tissue-specific tasks in response to neuronal cues. Divergent gene 
expression landscapes across populations of resident macrophages 
isolated from different tissues support the idea of local macrophage 
adaptations22,36,37. In this study, we use transcriptional data to 
molecularly characterize SAMs alongside other macrophage popu-
lations. Our results suggest that macrophages associated with the 
SNS have specialized molecular programs, whose exploration might 
give further insight into mechanisms underlying SNS macrophage–
neuron communication.
Although SAMs express common microglial genes and reside in 
proximity to nerve cells, SAM pseudopodia are morphologically 
distinct from the finely branching ramifications of resting micro-
glia38,39. Moreover, SAMs are seemingly of hematopoietic origin, 
as suggested by our bone marrow chimera studies and their high 
expression of CD45 and macrophage markers. Future tracing studies 
are necessary to definitively determine SAM origin. To our knowl-
edge, no reports exist on NE uptake by microglia, and we verified that 
the machinery for NE uptake is not expressed in these cells. In this 
regard, only one study has reported that NE can trigger microglia to 
import and degrade amyloid but not NE itself40. Neurotransmitter 
uptake has primarily been studied in astroglia, which are 
CX3CR1− (ref. 41).
Chimeric models require irradiation that generates inflammation. 
However, if given adequate recovery time (8 weeks), recruited mac-
rophages dissipate from the brain, as represented in our chimeras by 
minimal residual Cx3cr1-GFP+ microglia (0.06%). SAMs persist at 
levels that greatly surpass background irradiation-induced macro-
phage recruitment, and regenerated SAMs are seemingly identical to 
those in non-irradiated mice.
We show low expression of several astroglial markers in SAMs, rais-
ing the possibility of a hybrid peripheral cell type that unites some of 
the features of macrophages and glia. Alternatively, genes expressed in 
common by glial cells and SAMs may be attributable to the proximity 
of SAMs to neuron-derived signals, analogous to the observation that 
microglia, astrocytes, and neurons share the expression of certain 
central nervous system–specific genes7,42. An alternative model is 
that SAMs share the lineage of satellite glial cells (SGCs), which are 
derived from embryonic neural crest11 and also express canonical 
astroglial markers43. However, SGC import or degradation of NE has 
not been reported44.
Our study may fill a gap in the literature by demonstrating a cellular 
and molecular mechanism alternative to the proposed existence of 
NE-producing macrophages in WAT3. In this regard, our findings are 
consistent with other reports4–6, as we did not detect the NE biosyn-
thetic machinery in SAMs nor in ATMs. The identification of SAMs 
sheds new light on this recent controversy by documenting how a 
particular population of macrophages can contain NE in the absence 
of its biosynthesis. We also document that BAT macrophages contain 
similar molecular machinery to that in SAMs for NE uptake, extend-
ing and validating the findings of our colleagues21. SAMs may play 
a tissue-protective role through regulation of regional NE levels by 
serving as a local sink that prevents the dangerous effects of chroni-
cally increased levels of systemic NE.
In sharp contrast to the anti-inflammatory state of intestinal nerve–
associated Cx3cr1-GFP+ macrophages35, SAMs exhibit a proinflamma-
tory profile at steady state. This could be due to the constitutive presence 
of a danger signal—namely, NE. Whether this polarization is caused 
by NE import or by adrenergic signaling remains to be established. In 
this regard, polarization of enteric-associated macrophages has been 
linked to activation of β2 adrenergic receptor, which is also expressed in 
SAMs35. Regardless, our core message is relevant: SAMs are proinflam-
matory and act as a NE sink, and blocking NE uptake has an antiobesity 
effect. Our results support a model whereby SAMs pathologically accu-
mulate in the SNS nerves of obese subjects in an organ-specific manner, 
thus explaining why we detect SAM accumulation in the WAT-associ-
ated SNS but not in SCG, which innervates salivary glands and other 
neck structures. The NE-scavenging role of SAMs may have become 
evolutionarily maladaptive, as in the past obesity was not a common 
physiological stress to which humans had to adapt. In modern times, the 
prevalence of overnutrition has created a need for increased lipolysis-
inducing NE signaling to maintain fat stores, which is obstructed by the 
‘original’ function of SAMs to limit NE levels.
Reduced NE availability in the adipose tissue is linked to blunted 
lipolysis and obesity. Very recently, our colleagues have shown that 
ATMs degrade NE during aging45. Whether this observation is also 
associated with the accumulation of SAMs in fat, as we observed in 
the two mouse models of obesity, remains to be established.
Our results demonstrate that SAM-specific Slc6a2 ablation rescues 
BAT and adaptive thermogenesis in obese ob/ob mice, which in turn 
leads to sustained weight loss and lipid mobilization. We determine 
that blocking NE import into SAMs mitigates the recidivism of obes-
ity that is typical after dieting. Overall, our results identify SAMs as a 
potential new molecular and cellular target for obesity therapy.
METHODS
Methods, including statements of data availability and any associated 
accession codes and references, are available in the online version of 
the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
General experimental approaches. No samples, mice, or data points were 
excluded from the reported analyses. Samples were not randomized to experi-
mental groups. Analyses were not performed in a blinded fashion. More 
detailed information can be found in the Life Sciences Reporting Summary.
Antibodies, stain reagents, and drugs. Antibodies were obtained from the fol-
lowing vendors: anti-F4/80–Alexa Fluor 647 (BioLegend, catalog no. 123122, 
clone BM8), anti–human CD68 (Dako, catalog no. M 0876, clone PG-M1), anti–
human NE transporter (NET) (MAb Technologies, catalog no. NET17-1, clone 
3-6C1 sc H10), anti-MAOA (Abcam, catalog no. ab126751, clone GR155892-5), 
anti-TH (Pel-Freez Biologicals, catalog no. P40101-150, lot 16736), anti-GFP 
(Abcam, catalog no. ab13970, lot GR279236-1), anti-TH (Aves Lab, catalog no. 
TYH, lot TH1205), anti-GFP (Invitrogen, catalog no. A11120, lot 1563696), 
anti-GFP (Abcam, catalog no. ab6556, lot GR292567-1), goat anti–chicken IgY 
(H+L) secondary antibody, Alexa Fluor 488 (Molecular Probes/Thermo Fisher 
Scientific, catalog no. A-11039, lot 1759025), goat anti–rabbit IgG (H+L) cross-
adsorbed secondary antibody, Alexa Fluor 594 (Molecular Probes/Thermo 
Fisher Scientific, catalog no. A-11012, lot 1704538), anti-Ly6c–eFluor 405 
(eBioscience, catalog no. 48-5932-82, clone HK1.4, lot 4306743), anti-CD11c-
PE (BD Pharmingen, catalog no. 553802, clone HL3, lot 47030), anti-CD45.2-
PE (BioLegend, catalog no. 109808, clone 104.2), anti-CD45.2-FITC (obtained 
from S. Kimura (Memorial Sloan Kettering Cancer Center); clone 104.2), anti-
CD11b-FITC (ATCC, catalog no. TIB-128, clone M1/70), anti-MHCII-Bio 
(clone M5/114, ATCC, catalog no. TIB-120), SAv-APC/Cy7 (BioLegend, catalog 
no. 405208, lot B215107), anti-Ki-67-Alexa488 (BD Biosciences, catalog no. 
558616, clone B56, lot 7138687), IgG-Alexa488, isotype control (BD Biosciences, 
catalog no. 557782, lot 7102576), anti-Siglec-F-BV421 (BD Biosciences, cata-
log no. 562681, lot 7047598), anti-CD68 (Bio-Rad, catalog no. MCA1957GA, 
clone FA-11), goat anti–rat IgG (H+L) cross-adsorbed secondary antibody, Alexa 
Fluor 594 (Invitrogen, catalog no. A-11007), goat anti–chicken IgY (H+L), 
Alexa Fluor 647 (Abcam, catalog no. ab150171), goat anti–rabbit IgG (H+L), Alexa 
Fluor 488, (Abcam, catalog no. ab150077), goat anti–mouse IgG (H+L), Alexa 
Fluor 488 (Sigma, catalog no. SAB4600387), anti–mouse IgG (whole molecule), Cy3 
(Sigma, catalog no. C0992), rabbit anti-UCP1 (Abcam, catalog no. ab10983, 
lot GR249119-8), mouse anti-NET (MAb Technologies, catalog no. NET05-2, 
clone 2-3 B2 sc D7). SYTOX Blue dead cell stain (Molecular Probes/Thermo 
Fisher Scientific, catalog no. S34857, lot 1851462) was used to exclude dead 
cells. HCS LipidTOX Deep Red Neutral Lipid Stain (Molecular Probes/Thermo 
Fisher Scientific, catalog no. H34477) and HCS LipidTOX Red Neutral Lipid 
Stain (Molecular Probes/Thermo Fisher Scientific, catalog no. H34476) were 
used to stain lipids.
Acetylcholine chloride, nisoxetine hydrochloride, clorgyline, and NE were 
purchased from Sigma-Aldrich.
Mice. Cx3cr1GFP/+ mice (Cx3cr1tm1Litt/LittJ; stock no. 008451), Th-cre mice 
(stock no. 008601), GFP-L10 mice (stock no. 024750), LysM-cre mice (stock no. 
004781), LSL-ChR2-YFP mice (stock no. 012-569), LSL-tdTomato mice (stock 
no. 007909), ob/ob mice (stock no. 000632), and Csf1r-LSL-DTR mice (stock no. 
024046) were purchased from the Jackson Laboratory (JAX). NETP/P (Slc6a2−/−) 
mice were kindly provided by M. Hahn (Vanderbilt University). B6 (C57BL/B6J) 
and B6-CD45.1 mice were purchased from Charles River and were bred and 
maintained at Instituto Gulbenkian de Ciência. Both males and females were 
used in this study. Mice were 4–10 weeks old (for details, see the Life Sciences 
Reporting Summary). Animal procedures were approved by the ethics com-
mittee of Instituto Gulbenkian de Ciência.
Immunofluorescence and confocal microscopy. Tissues were dissected and 
fixed in 4% paraformaldehyde for 2 h (at room temperature (RT), with agitation). 
For images in Figure 2j,k, we employed frozen sections and the fixation step was 
followed by cryoprotection in 30% sucrose (Alfa Aesar). 16-µm sections were 
obtained in a Leica Cryostat CM3050 S. Both frozen sections and whole-mount 
tissues were incubated in a blocking and permeabilization solution (3% BSA, 2% 
goat serum, 0.1% Tween, and 0.1% sodium azide in 1× PBS) for 1 h at RT with 
(whole mounts) or without (frozen sections) agitation. Incubations with primary 
antibodies were performed overnight at 4 °C with (whole mounts) or without 
(frozen sections) agitation. The following dilutions of primary antibodies were 
used: anti-GFP (1:500), anti-TH (1:1,000), anti-SLC6A2 (1:500), anti-MAOA 
(1:100). Incubation with secondary antibodies was performed for 1–2 h at RT, 
with or without (in the case of frozen sections) agitation. Z-series stacks were 
acquired on a Leica TCS SP5 confocal inverted microscope. Analysis and quan-
tification of images were performed in Fiji.
In vivo two-photon microscopy. Mice aged 2 months were kept anesthetized 
with 2% isoflurane. During surgery, body temperature was maintained at 37 °C 
with a warming pad. After application of local anesthetics (lidocaine), a sagittal 
incision of the skin was made above the suprapelvic flank to expose the subcu-
taneous inguinal fat pad. An imaging chamber was custom-built to minimize 
fat movement. Warm imaging solution (in mM: 130 NaCl, 3 KCl, 2.5 CaCl2, 
0.6 MgCl2.6H2O, 10 HEPES without sodium, 1.2 NaHCO3, 10 glucose, pH 
7.45 with NaOH) (37 °C) mixed with a fat dye (LipidTOX) was applied to 
label adipocytes, maintain tissue integrity, and allow the use of an immersion 
objective. Imaging experiments were performed under a two-photon laser- 
scanning microscope (Ultima, Prairie Instruments). Live images were acquired at 
8–12 frames per second at depths below the surface ranging from 100–250 mm, 
using an Olympus 20× 1.0 N.A. water-immersion objective with a laser 
tuned to a wavelength of 810–940 nm and emission filters at 525/50 nm and 
595/50 nm for green and red fluorescence, respectively. Laser power was adjusted 
to be 20–25 mW at the focal plane (maximally 35 mW), depending on the 
imaging depth and levels of GFP expression and LipidTOX spread. Analysis 
and quantification of images were performed in Fiji.
Electron microscopy. Fresh tissue was perfused with 2% paraformaldehyde 
(Electron Microscopy Services (EMS)) and 0.2% glutaraldehyde (EMS) in 0.1 M 
phosphate buffer (PB; pH 7.4). After perfusion, fibers were isolated and immer-
sion fixed for 2 h at RT in the same fixative. For quenching of autofluorescence 
from free aldehydes, nerves were washed with 0.15% glycine (VWR) in PB for 
10 min at RT.
Correlative light–electron microscopy. After fixation, fibers were stabilized 
with 0.1% tannic acid (EMS) and embedded in 2% agarose (Omnipur) before 
cryoprotection in 30% sucrose (Alfa Aesar) overnight at 4 °C. Embedded sam-
ples were placed in optimal cutting temperature (OCT) compound (Sakura) 
and plunge frozen in liquid nitrogen. 10-µm sections were obtained in a Leica 
Cryostat CM3050 S and placed on cover glasses coated with 2% (3-aminopropyl) 
triethoxysilane (Sigma-Aldrich) in acetone. Light microscopy imaging was 
performed in a Leica SP5 Live microscope after mounting the sections with 
PB. For electron microscopy processing, samples were washed ten times with 
PB and post-fixed in 1% osmium tetroxide (EMS) with 1% potassium hexacy-
anoferrate (Sigma-Aldrich) in PB for 30 min on ice. Dehydration was done in 
a graded ethanol series of 30%, 50%, 75%, 90%, and 100% ethanol for 10 min 
each. EPON resin (EMS) was used for embedding. 70-nm serial sections were 
obtained in a Leica EM UC7 and stained with 1% uranyl acetate and lead citrate 
for 5 min each. Electron microscopy images were acquired on a Hitachi H-7650 
operating at 100 kV.
Single-cell suspension. Tissues were dissected from ten mice. Spleen, brain, 
visceral fat, and subcutaneous fat were excised and digested for 30 min with col-
lagenase (Sigma) at 37 °C with shaking. Sympathetic nerve fibers were isolated 
from subcutaneous adipose tissues and digested for 30 min with hyaluronidase 
(Sigma) at 37 °C with shaking, washed, and further digested with collagenase 
for 15 min. SCGs were dissected and digested with collagenase for 10 min, 
washed, and further digested with trypsin (Biowest) for 30 min at 37 °C with 
shaking. Cell suspensions were filtered through a 70-µm sieve and centrifuged 
at 450g for 5 min.
Flow cytometry. Flow cytometry data were acquired on an LSR Fortessa X-20 
SORP (Becton-Dickinson), FACSCalibur (Becton-Dickinson), or CyAn ADP 
(Beckman Coulter) and analyzed using the FlowJo software package (Tree Star). 
Macrophages were sorted as live CD45 and F4/80 double-positive cells using a 
FACSAria IIu high-speed cell sorter (Becton Dickinson) or MoFlo High-Speed 
Cell Sorter produced by Dako Cytomation (now owned by Beckman Coulter).
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Bone marrow chimeras. B6-CD45.1 mice (aged 8–10 weeks), B6 (C57BL/6J) 
mice (aged 8–10 weeks), and ob/ob mice (aged 8–10 weeks) were lethally irradi-
ated (900 rad, 3.42 min, 137Cs source) (Gammacell 2000) and reconstituted with 
bone marrow cells from Cx3cr1GFP/+ mice (aged 6 weeks), Slc6a2−/− mice (aged 
6–8 weeks), B6 mice (aged 6–8 weeks), or B6-CD45.1 mice (aged 6–8 weeks). 
B6-CD45.1 mice and B6 mice were reconstituted with 5 × 106 total bone marrow 
cells, and ob/ob mice were reconstituted with 3 × 107 total bone marrow cells. 
Chimerism was assessed 8 weeks after reconstitution using flow cytometry.
Low-input RNA-seq library preparation. Sequencing libraries were prepared 
according to the Smart-seq2 method46 with some modifications. 1,715 ± 115 
cells from nerve fibers, 1,534 ± 85 cells from superior cervical ganglia, and 5,000 
cells from other tissues (visceral fat, subcutaneous fat, spleen, and brain) were 
isolated as live CD45+F4/80+ cells in TRIzol (Thermo Fisher) and were used as 
starting material. RNA was extracted with the Direct-zol MicroPrep kit (Zymo 
Research) with on-column DNase I treatment. 10 µl of purified RNA was mixed 
with 5.5 µl of SMARTScribe 5× First-Strand Buffer (Clontech), 1 µl of poly(T) 
primer for reverse transcription (2.5 µM; 5′-AAGCAGTGGTATCAACGCAGA
GTAC(T30)VN-3′), 0.5 µl of SUPERase IN (Ambion), 4 µl of dNTP mix (10 mM; 
Invitrogen), 0.5 µl of dithiothreitol (DTT) (20 mM; Clontech), and 2 µl of 
betaine solution (5 M; Sigma), and samples were incubated at 50 °C for 3 min. 
3.9 µl of first-strand mix, containing 0.2 µl of 1% Tween-20, 0.32 µl of MgCl2 
(500 mM), 0.88 µl of betaine solution (5 M; Sigma), 0.5 µl of SUPERase IN 
(Ambion), and 2 µl of SMARTScribe Reverse Transcriptase (100 U/µl; Clontech), 
was added, and samples were incubated with one step at 25 °C for 3 min 
and one step at 42 °C for 60 min. 1.62 µl of template-switch (TS) reaction mix 
containing 0.8 µl of biotin-TS oligonucleotide (10 µM; biotin-5′-AAGCAGT
GGTATCAACGCAGAGTACATrGrG+G-3′), 0.5 µl of SMARTScribe Reverse 
Transcriptase (100 U/µl; Clontech), and 0.32 µl of SMARTScribe 5× First-Strand 
Buffer (Clontech) was added, and samples were then incubated at 50 °C for 2 min, 
42 °C for 80 min, and 70 °C for 10 min. 14.8 µl of second-strand synthesis, 
preamplification mix containing 1 µl of preamplification oligonucleotide (10 µM; 
5′-AAGCAGTGGTATCAACGCAGAGT-3′), 8.8 µl of KAPA HiFi Fidelity Buffer 
(5×; KAPA Biosystems), 3.5 µl of dNTP mix (10 mM; Invitrogen), and 1.5 µl of 
KAPA HiFi HotStart DNA Polymerase (1U/µl; KAPA Biosystems) was added, and 
samples were amplified by PCR: 95 °C for 3 min, 8 cycles at 98 °C for 20 s, 67 °C for 
15 s, and 72 °C for 6 min, and a final extension step at 72 °C for 5 min. The synthe-
sized double-stranded DNA (dsDNA) was purified using Sera-Mag SpeedBeads 
(Thermo Fisher Scientific) with final concentrations of 8.4% PEG 8000 and 1.1 M 
NaCl and then was eluted with 13 µl of UltraPure water (Invitrogen). The prod-
uct was quantified by Qubit dsDNA High Sensitivity Assay Kit (Invitrogen), 
and libraries were prepared using the Nextera DNA Sample Preparation Kit 
(Illumina). Tagmentation mix containing 11 µl of 2× Tagment DNA Buffer and 
1 µl of Tagment DNA Enzyme was added to 10 µl of purified DNA, and samples 
were then incubated at 55 °C for 15 min. 6 µl of Nextera Resuspension Buffer 
(Illumina) was added, and samples were incubated at RT for 5 min. Tagmented 
DNA was purified using Sera-Mag SpeedBeads (Thermo Fisher Scientific) with 
final concentrations of 7.8% PEG 8000 and 0.98 M NaCl and then eluted with 25 µl 
of UltraPure water (Invitrogen). Final enrichment amplification was performed 
with Nextera primers, adding 1 µl of Index 1 primers (100 µM; N7xx), 1 µl of 
Index 2 primers (100 µM; N5xx) and 27 µl of NEBNext High-Fidelity 2× PCR 
Master Mix (New England BioLabs) and then amplifying samples by PCR: 72 °C 
for 5 min, 98 °C for 30 s, and 8–13 cycles of 98 °C for 10 s, 63 °C for 30 s, and 72 °C 
for 1 min. Libraries were size selected, quantified by Qubit dsDNA HS Assay 
Kit (Thermo Fisher Scientific), and pooled and sequenced on a NextSeq 500 
(Illumina) for 76 cycles at a depth of 25 to 30 million single-end reads per sample. 
To normalize for genomic DNA contamination, which occurred in some 
samples due to incomplete DNA removal during RNA isolation, the average 
intronic noise per base pair in all intronic regions per gene was calculated. The 
exonic reads were then normalized by subtracting the background noise per base 
pair for the complete length of the exonic regions. Genes without introns were not 
normalized, as these genes are the minority of genes and are typically short (code 
available at https://github.com/vlink/DNA_contamination/).
Fastq files from sequencing experiments were mapped to the mouse mm10 
genome using default parameters for STAR47. Mapped data were analyzed with 
HOMER48 and custom R and Perl scripts.
Superior cervical ganglion explant cultures. SCGs were removed from mice 
aged 4–6 weeks under a stereomicroscope and placed in DMEM (Invitrogen, 
Carlsbad, CA, USA). Ganglia were cleaned from the surrounding tissue capsule 
and transferred into eight-well tissue culture chambers (Sarstedt, Nümbrecht, 
Germany) that were previously coated with poly-d-lysine (Sigma-Aldrich, 
Steinheim, Germany) in accordance with the manufacturer’s instructions. 
Ganglia were then covered with 5 µl of Matrigel (BD Bioscience, San Jose, CA, 
USA) and incubated for 7 min at 37 °C. DMEM without phenol red (Invitrogen) 
supplemented with 10% FBS (Invitrogen), 2 mM l-glutamine (Biowest, 
Nuaillé, France), and nerve growth factor (Sigma-Aldrich) was subsequently 
added. 12 SCG explant cultures were prepared per condition. SCGs were cul-
tured for a minimum of 24 h before further manipulation. The stimulation 
protocol in Figure 3 was performed for 2 h with the following concentrations 
of drugs: 10 mM acetylcholine chloride, 100 nM nisoxetine hydrochloride, and 
100 µM clorgyline.
NE measurements after optogenetic stimulation ex vivo. Depolarization of 
sympathetic neurons in Th-cre; LSL-ChR2-YFP explant cultures was performed 
on a Yokogawa CSU-X Spinning Disk confocal microscope using the 488-nm 
laser line pointing at the region of interest (ROI) for 200 µs. Stimulation was 
repeated seven times using 40% laser intensity. NE content in the SCG explant 
culture medium and in sorted CD45+F4/80+ cells was determined by NE ELISA 
kit (Labor Diagnostika Nord, Nordhorn, Germany, catalog no. BA E-5200). The 
same procedure was performed for LSL-ChR2-YFP control mice.
NE measurements in macrophages from sWAT. CD45.2 (PE)+F4/80 (Alexa 
Fluor 647)+ cells from sWAT were sorted as live cells and incubated with 2 µM 
NE for 2 h using the same culture conditions as those used for SCG explant 
cultures. Afterwards, cells were washed twice with 1× PBS, and NE content was 
measured by NE ELISA kit (Labor Diagnostika Nord, Nordhorn, Germany, 
catalog no. BA E-5200).
qPCR. Total RNA from sorted cells was isolated using the RNeasy Plus Micro Kit 
(Qiagen, catalog no. 50974034). Total RNA from adipose tissues was isolated with the 
PureLink RNA Mini Kit (Ambion, Life Technologies, catalog no. 12183025). cDNA 
was reverse transcribed using SuperScript II (Invitrogen) and random primers 
(Invitrogen). qPCR was performed using SYBR Green (Applied Biosystems) in 
ABI QuantStudio 7 (Applied Biosystems). The Gapdh housekeeping gene was 
used to normalize samples. We used the following formula to calculate relative 
expression levels: RQ = 2−∆Ct × 100 = 2−(Ct gene of interest − Ct Gapdh) × 100.
The primers used were as follows: Lpl-forward, 5′-CAGCTGGGCCTAACTT 
TGAG-3′; Lpl-reverse, 5′-CCTCTCTGCAATCACACGAA-3′; Pnpla2-forward, 
5′-CACTTTAGCTCCAAGGATGA-3′; Pnpla2-reverse, 5′-TGGTTCAG TAG 
GCCATTCCT-3′; Gfap-forward, 5′-CCAGCTTCGAGCCAAGGA-3′; Gfap-
reverse, 5′-GAAGCTCCGCCTGGTAGACA-3′; Gap43-forward, 5′-AGCC 
AAGGAGGAGCCTAAAC-3′; Gap43-reverse, 5′-CTGTCGGGCA CTTTCC 
TTAG-3′; Ucp1-forward, 5′-GTGAAGGTCAGAATGCAAGC-3′; Ucp1-reverse, 
5′-AGGGCCCCCTTCATGAGGTC-3′; Slc6a2-forward, 5′-CAGGCACCT 
CCATTCTGTTT-3′; Slc6a2-reverse, 5′-GCGGCTTGAAGTTGATGATG 
CTG-3′; Maoa-forward, 5′-GCCCAGTA TCACAGGCCAC 3′; Maoa-reverse, 
5′-GTCCCACATAAGCTCCACCA-3′; Chrm1-forward, 5′-CA GTCCCAACAT 
CACCGTCTT-3′; Chrm1-reverse, 5′-GAGAACGAAGGAAACCAACCAC-3′; 
Chrm2-forward, 5′-TGTCTCCCAGTCTAGTGCAAGG-3′; Chrm2-reverse, 
5′-CATTCTGA CCTGACGATCCAAC-3′; Chrm4-forward, 5′-GCCTTCATCC 
TCACCTGGAC-3′; Chrm4-reverse, 5′-AGTGGCATTGCAGAGTGCAT-3′; 
Chrm5-forward, 5′-CCA TGGACTGTGGGAAGTCA-3′; Chrm5-reverse, 
5′-CAGCGTCC CATGAGGATGTA-3′; Chrna2-forward, 5′-CTCCCATCCT 
GCTTTCCAG-3′; Chrna2-reverse, 5′-GTTTGAACAGGCGGTCCTC-3′; 
Chrna3-forward, 5′-GCGAACAGGTCACAGTTTATG-3′; Chrna3-reverse, 
5′-GCATTTT TCTCTGGGTTTTCA-3′; Chrna5-forward, 5′-CGCTCTTCT 
TCCACACACAA-3′; Chrna5-reverse, 5′-TAGGTCCACCGTCTTTCTCG-3′; 
Chrna6-forward, 5′-CTTTGTCACGCTGTCCAT-3′; Chrna6-reverse, 5′-
GCCTCCT TTGTCTTGTCC-3′; Chrna7-forward, 5′-ACAGTACTTC 
GCCAGCACCA-3′; Chrna7-reverse, 5′-AAACCATGCACACCAATTCA-3′; 
Chrna9-forward, 5′-ACAAGGCCACCAACTCCA-3′; Chrna9-reverse, 
5′-ACCAACCCACTCCTCCTCTT-3′; Chrna10-forward, 5′-TCTGACCTCA 
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CAACCCACAA-3′; Chrna10-reverse, 5′-TCC TGTCTCAGCCTCCATGT-3′; 
Chrnb2-forward, 5′-GGGCAGGCA CACTATTCTTC-3′; Chrnb2-reverse, 
5′-TCCAATCCTCCCTCACACTC-3′; Chrnb3-forward, 5′-CTCCTCAGACATT 
GGTTCCAAGG-3′; Chrnb3-reverse, 5′-AATGAGG TCAACCATGGT-3′; 
Chrnb4-forward, 5′-TCTGGTTGCCTGACATCGTG-3′; Chrnb4-reverse, 5′-
GGGTTCACAAAGTACATGGA-3′;Adrb2-forward, 5′- GGTTATCGTCCTGG
CCATCGTGTTTG-3′; Adrb2-reverse, 5′-TGGTTCGTGAAGAAGTCACAGC
AAGTCTC-3′; Th-forward, 5′-GGTATACGCCACGCTGAAGG-3′; Th-reverse, 
5′- TAGCCACAGTACCGTTCCAGA-3′; Tnfa-forward, 5′- ATGAG CACAGA 
AAGCATGATC-3′; Tnfa-reverse, 5′-TACAGGCTTGTCACTCGAATT-3′; Il10-
forward, 5′-GCTCTTACTGACTGGCATGAG-3′; Il10-reverse, 5′-CGCAG 
CTCTAG GAGCATGTG-3′; Il1-forward, 5′- GAAGAAGAGCCCATCCT 
CTG-3′; Il1-reverse, 5′- TCATCTCGGAGCCTGTAGTG-3′; Il4ra-forward, 
5′-TGACCTCACAGGAACCCAGGC-3′; Il4ra-reverse, 5′-GAACAGGC 
AAAACAACGGGAT-3′; Gapdh-forward, 5′-AACTTTGGCATTGTGGA 
AGG-3′; Gapdh-reverse, 5′-ACACATTGGGGGTAGGAACA-3′.
Functional studies. We measured rectal temperature with an electronic ther-
mometer (Precision) when the mice were housed both at RT and at 4 °C with 
ND food and water ad libitum.
Free fatty acids were measured in blood plasma using the Free Fatty Acid 
Quantitation Kit (Sigma-Aldrich, catalog no. MAK044-1KT).
Serum levels of NE were determined by NE ELISA kit (Labor Diagnostika 
Nord, Nordhorn, Germany, catalog no. BA E-5200).
High-fat diet challenge. When B6 mice reached 8 weeks of age, we replaced ND 
with HFD (Ssniff, Spezialdiäten, Soest, Germany, catalog no. D12492). Analyses 
in Figure 4 were performed when mice achieved a 40% increase in body weight 
after 3 months of a HFD.
Intracellular staining for Ki-67. Cells were surface-stained for 30 min. 
Subsequently, cells were washed and fixed with fixation and permeabilization 
buffer (eBioscience) and then permeabilized with permeabilization buffer (eBio-
science). Following this process, cells were intracellularly stained with anti-Ki-67 
or isotype control.
Histopathological and immunohistochemical analyses. Human and mouse tis-
sues were fixed in buffered formalin, and inclusion in paraffin was done accord-
ing to standard technical procedures. Histochemical and immunohistochemical 
studies were performed on formalin-fixed and paraffin-embedded (FFPE) tissue 
sections. Sections were 2 µm (human ganglia) or 3–6 µm (mouse tissues) thick 
for H&E or were 4 µm thick for immunohistochemical studies. The following 
markers were used for immunohistochemistry: aminoethylcarbazole (AEC) and 
3,3′-diaminobenzidine (DAB) according to the usual technical procedure for 
the marker. For the immunohistochemical studies, sections underwent antigenic 
recovery before incubation with primary antibodies: anti-CD68 (Dako, clone 
PG-M1; dilution 1:150) anti–human SLC6A2 (MAb Technologies, clone 3-6C1 
sc H10; dilution 1:1,000), anti-MAOA (Abcam, clone GR155892-5; dilution 
1:50), and anti-UCP1 (Abcam; dilution 1:500). Human tissues were analyzed 
under an optical microscope (Nikon Eclipse 50i), and iconography microscopic 
images were captured using a coupled digital camera (DS Camera Control Unit 
DS-L2). Mouse tissues were analyzed using a Leica DM LB2 microscope, and 
images were captured with a Leica DFC 250 camera.
Diphtheria toxin–mediated macrophage depletion. We used LysM-cre; LSL-
Csf1r-DTR mice for this experiment and LSL-Csf1r-DTR mice as controls. 
Animals received injections of diphtheria toxin (DT) from Corynebacterium 
diphtheria (Calbiochem) once daily for four consecutive days. The first dose was 
500 ng of DT in PBS per 20 g of body weight followed by three doses of 250 ng 
of DT in PBS per 20 g of body weight. Depletion was assessed by flow cytometry 
12 h after the fourth injection. NE levels in adipose tissues were assayed by NE 
ELISA kit (Labor Diagnostika Nord, Nordhorn, Germany, catalog no. BA E-
5200). Protein concentration was determined by the Bradford method.
Statistics. Statistical analyses were performed with GraphPad Prism software 
(San Diego, CA) using unpaired Student’s t-test (two-tailed) when two groups 
were being compared or one-way ANOVA when several groups were being 
compared. One-way ANOVA was followed by Tukey’s multiple-comparisons 
test, except for the data in Figure 4b and Supplementary Figure 8a, where it 
was followed by Bonferroni multiple-comparisons test with one group indicated 
as a control group. P < 0.05 was considered statistically significant. Data are 
represented as mean ± s.e.m. Sample size was predetermined based on previous 
studies (for more information, see the Life Sciences Reporting Summary). Data 
displayed normal variance.
Data availability. The RNA-seq data sets are available at GSE103847. 
The data that support the findings herein presented are available from the corre-
sponding author upon reasonable request. A Life Sciences Reporting Summary 
is available.
46. Picelli, S. et al. Smart-seq2 for sensitive full-length transcriptome profiling in single 
cells. Nat. Methods 10, 1096–1098 (2013).
47. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 
15–21 (2013).
48. Heinz, S. et al. Simple combinations of lineage-determining transcription factors 
prime cis-regulatory elements required for macrophage and B cell identities. Mol. 
Cell 38, 576–589 (2010).
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206 Chapter 5
Discussion
In this chapter, I will discuss the findings of chapters 1 to 5 and answer the overarching
question of my thesis how the enhancer landscape in macrophages get selected and reg-
ulated in order to control gene expression. To answer this general question, I addressed
three main points:
• What are the epigenetic mechanisms that are responsible for tissue–specific functions?
• How do complex stimuli change the epigenetic landscape of macrophages in compar-
ison to single stimuli?
• How does natural genetic variation influence the epigenetic landscape and gene ex-
pression in macrophages?
Furthermore, I will put the answer of these questions in the bigger context of current
scientific discoveries, as well as point out new challenges and questions based on these
findings. Finally, I will give a short overall conclusion.
Epigenetic mechanisms for tissue–specific functions
As discussed in the General Introduction, enhancers are bound by lineage–determining
transcription factors (LDTFs), as well as signal–dependent transcription factors (SDTFs),
and play an important role in the regulation of gene expression. It has been shown that
PU.1 in combination with C/EBP establishes macrophage–specific enhancers, whereas
PU.1 in combination with E2A and OCT–2 establishes enhancers specific to B cells (Heinz
et al. (2010)). This provides a model for how cell type–specific enhancers are established.
However, it does not account for the influence of tissue–specific environments on the en-
hancer landscape. We studied macrophages from different tissues to address this question
(Gosselin, D., Link, V. M., Romanoski, C. E. et al. (2014)) (Chapter 1). We found an
astonishing amount of gene expression differences in macrophages from very different en-
vironments of the body (i.e. the brain versus the peritoneal cavity). Different macrophage
populations from the same biological environment show more similar gene expression pro-
files, but still experience differences. By evaluating the signature of primed and active
enhancers in these different macrophage populations, we find a mostly shared histone
modification profile at promoters, but vastly different signatures at enhancers. The his-
tone modification signature at enhancers correlates well with the expression of the nearest
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gene, confirming that enhancers are the main drivers of cell type–specific gene expression.
Motif enrichment analysis of cell type–specific enhancers showed a general enrichment of
the macrophage–specific transcription factor (TF) PU.1. However, the collaborative fac-
tors in the cells from different environments varied substantially (e.g. an enrichment of
the GATA consensus binding motif in macrophages from the peritoneal cavity and an
enrichment for myocyte enhancer factor-2 (MEF2) and mothers against decapentaplegic
homolog (SMAD) consensus motifs for microglia – macrophages isolated from the brain).
These vastly different collaborative binding partners for PU.1 were conserved in different
mouse strains. To address the influence of the environment in more detail, cells were
taken out of the brain and the peritoneal cavity and cultured for 7 days. Interestingly, the
majority of cell type–specific genes were significantly downregulated after 7 days in cul-
ture, and many cell type–specific enhancers were lost. Culturing the cells for 7 days with
supplemental transforming growth factor beta (TGFβ) and retinoic acid to mimic an in
vivo environment more closely restored gene expression of about half of the environment–
dependent genes. This shows that the environment has a big influence on gene expression
of different macrophage subpopulations. Furthermore, the environment the cells are ex-
posed to is a complex combination of different signals and we have not yet managed to
appropriately mimic it in vitro.
This study was co–published with a complementary study by Lavin et al. (2014). The
authors independently confirmed the importance of MEF2 and SMAD for the enhancer
landscape of microglia, as well as the importance of GATA for macrophages from the
peritoneal cavity. Furthermore, the authors included monocytes and neutrophils in their
analysis and showed that even between different cell types, the histone modifications at
promoters are strikingly similar, but the patterns at enhancers are widely different. The
authors used a different approach to evaluate the importance of the tissue environment
on the enhancer landscape than we did. Instead of culturing the cells for 7 days, they
depleted all immune cells from CD45.2 host mice and injected CD45.1 donor cells that
allows tracking of the donor cells. After four months, the authors isolated macrophages
from the lung, brain, kidney and peritoneal cavity and assessed the enhancer landscape
of CD45.1 cells. They showed a striking similarity between the enhancer landscape of the
original macrophages and the enhancer landscape of the CD45.1 macrophages. To further
test the influence of the environment, the authors isolated macrophages from the peritoneal
cavity and transferred them into the lung of a host mouse. After 15 days of differentia-
tion the authors isolated the implanted macrophages and compared them to original lung
macrophages. Interestingly, they adapted an enhancer landscape resembling the landscape
of cells from this environment more closely than their original landscape. This shows that
macrophages are not only influenced by their environment during differentiation, but they
keep their plasticity and are able to adapt to their new host tissue.
These two papers showed the influence of the tissue–environment on the epigenetic land-
scape of macrophages independently. This work underlined the need for a deeper under-
standing of the influence of the tissue environment on cells.
Another study by Roberts et al. (2017) studied the influence of the tissue environment
on the ability of macrophages to clear apoptotic cells. They found several populations of
Discussion 209
macrophages including peritoneal macrophages and lung macrophages were able to engulf
apoptotic cells, but lose this ability after removal from the tissue environment and putting
them in culture. Cultured bone marrow–derived macrophages (BMDMs) that were im-
planted in either the peritoneal cavity or lung gained the ability to clear cells after several
weeks in the tissue environment. Furthermore, the authors showed that the TFs Krüppel-
like Factor (KLF) 2 and KLF 4 were involved in this process. We (Gosselin, D., Link, V.
M., Romanoski, C. E. et al. (2014)), as well as Lavin et al. (2014) found KLF to be a TF
important for macrophages from the peritoneal cavity.
The influence of the tissue envrionment was further shown by studying the transformation
of circulating monocytes into Kupffer cells after niche availability (Scott et al. (2016)).
After cell–specific depletion of Kupffer cells, the liver is repopulated by circulating mono-
cytes about 48 hours after depletion. After 15 days in the liver, the infiltrated monocytes
were not distinguishable from embryonic derived Kupffer cells by fluorescence activated cell
sorting (FACS) and the most Kupffer cell–specific genes were expressed in the infiltrating
monocytes. They also gained the capacity to self–renew, something that was believed to
require genetic engineering of monocytes. This work is another powerful example of the
influence of the tissue–environment on the gene expression profile of cells.
Interestingly, when we studied macrophages at sympathetic nerve bundles we found a
previously undescribed population of sympathetic neuron-associated macrophages (SAMs)
(Pirzgalska et al. (2017)). These macrophages populate a unique niche in the body and
possess the ability to uptake norepinephrine, as well as synthesize it by expression of solute
carrier family 6 member 2 (Slc6a2) and monoamine oxidase A (MAOa). The expression of
these two genes was shown by RNA–seq, as well as quantitative polymerase chain reaction
(qPCR), and neither Slc6a2 nor MAOa were substantially expressed in any macrophage
population listed in the ImmGen database (Heng et al. (2008)). It is not clear which en-
vironmental signals produce the expression of this machinery, but this small population of
macrophages is another impressive example of how the environment can influence pheno-
types of cells.
The origin of most tissue–resident macrophages is not completely clear. Studies showed
that most macrophages are derived from erythromyeloid progenitors (EMPs) directly from
the yok sac (Perdiguero et al. (2015)), but other studies showed evidence that tissue–
resident macrophages are derived from classical hematopoietic stem cells with the exception
of microglia and epidermal Langerhans cells (Sheng et al. (2015)). Although there is some
controversy about the origin of tissue–resident macrophages, Mass et al. (2016) reported
that EMPs are detected around embryonic day 8.5, start populating the liver at embryonic
day 9.5 and populate the rest of the embryo by embryonic day 10.25. During this time all
cells express a common macrophage–core program that is different from other cell types
populating the embryo. Genes upregulated during this phase include colony stimulating
factor 1 receptor (Csf1r), Maf, Basic leucine zipper transcriptional factor ATF–like (Batf)3,
and PPARγ. At the same time, macrophages populating different tissues in the embryo
start to lose expression of tissue–specific macrophage genes (e.g. T–cell immunoglobulin
and mucin domain containing 4 (Timd4) expression is lost in all sub–populations except
for Kupffer cells), as well as upregulate their respective signature genes (e.g. spalt like
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transcription factor (Sall)1 and Sall3 in microglia, nuclear receptor subfamily 1, group H,
member 3 (Nr1h3), DNA-binding protein inhibitor (Id)1, and Id3 in macrophages populat-
ing the liver and aryl hydrocarbon receptor (Ahr) in macrophages in the limb). This study
suggests that tissue–specificity is established early on in embryogenesis, but it is based on a
common macrophage core expression profile, explaining the high plasticity of macrophages
even after fully differentiating.
A great model to study the influence of the changing tissue–environment over different
developmental stages are microglia, because the brain–blood barrier is formed early in de-
velopment. From this point on, there is no infiltration of other monocytes into the brain
and the only immune cells are microglia. Matcovitch-Natan et al. (2016) studied the change
in microglia during development of the brain and how these cells adapt to changes in envi-
ronment. They showed that microglia undergo three main temporal developmental stages
with different TFs and genes expressed at every stage (e.g. genes associated with cell cycle
and differentiation were expressed in the first stage, whereas genes involved in neuronal de-
velopment were expressed in a later stage). The authors also showed that the dynamics of
the epigenetic landscape in microglia overlapped well with microglia gene expression across
developmental stages. Furthermore, they showed that disturbance of microglia develop-
ment due to viral infection shifts the cell toward a more advanced developmental stage,
potentially explaining the influence of viral infections on brain development. This work
suggested that not only the tissue–environment itself is influencing the enhancer landscape,
but also changes during development play important roles.
Adam et al. (2015) showed that super enhancers (SEs) in transitamplifying cells (TACs)
are different than SEs in hair follicle stem cells (HFSs), with TAC–specific genes exhibit-
ing TAC–specific SEs and vice versa. They also found an enrichment of TAC–specific and
HFS–specific TF binding motifs in their respective SEs. Furthermore, SEs specific to HFS
genes were lost in vitro, but were restored after engraftment of these cells into donor mice.
Interestingly, the authors also found new SEs in vitro that were close to genes implicated
in wound healing, pointing out the plasticity of cells.
Many studies have focused on the influence of the environment on the epigenetic landscape
in mice. However, to ultimately understand the influence of the tissue environment on hu-
man disease, it is necessary to study human cells directly. With the decrease of sequencing
cost and the lower requirement of cells for next–generation sequencing assays, theses stud-
ies became more feasible to do.
Much of the research focuses on the role of microglia in neurodegenerate diseases. One
of the first studies to evaluate the environment on the TF network in human microglia
was performed by Gosselin et al. (2017). The authors reported gene expression data from
healthy brain tissue of 19 individuals including different sexes, ages and disease diagnosis.
They identified a common mRNA profile in human microglia. Many of these genes have
been previously associated with neurodegenerative diseases. They identified consensus
binding motifs in microglia enhancers, confirming the previously reported roles of MEF2
and SMAD in mouse microglia biology. However, they also showed substantial differences
in the expression of many TFs between mouse and human, most notably the lack of ex-
pression of SALL2, SALL3, as well as SMAD1 in human microglia. By culturing human
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microglia for 7 days, they observed a similar effect on the epigenetic landscape, as well as
the transcriptome, than previously observed in mice (Gosselin, D., Link, V. M., Romanoski,
C. E. et al. (2014)). Interestingly, many genes downregulated in culture were upregulated
during microglia development. Furthermore, the expression of about half of the genes that
were highly expressed in microglia and also associated with neurodegenerative disease were
impacted by a transition of the cell from the in vivo environment into culture.
We published one of the first studies (Gosselin, D., Link, V. M., Romanoski, C. E. et al.
(2014)) demonstrating the importance of the tissue environment for the regulation of the
epigenetic landscape of cells and subsequentially the regulation of gene expression. This
study was an important first step to realize that studying cells in culture is not sufficient
in order to understand regulation in vivo. More studies have been published since that
(e.g. Roberts et al. (2017), Scott et al. (2016), Pirzgalska et al. (2017)), underlining the
importance of the tissue environment, as well as demonstrating the plasticity of cells and
their ability to adapt to new environments. These initial studies were performed in mice
and built an important first step in deciphering the influence of the tissue environment on
gene regulation. In recent years studies in human became more feasible and are now seen
as crucial tools in order to understand the interplay between tissue environment, regulation
of gene expression and disease.
The influence of complex stimuli on the epigenetic land-
scape in macrophages in comparison to single stimuli
Macrophages are innate immune cells and respond to diverse inflammatory signals, as
well as damage–associated molecular patterns (DAMP) or microbe–associated molecular
patterns (MAMP). In order to understand the regulation of macrophages after stimula-
tion, studies often utilize bone marrow–derived macrophages (BMDMs), or thioglycollate–
elicited peritoneal macrophages (TGEMs) and stimulate them with diverse inflammatory
signals (e.g. TLR4 agonists, IFNγ, TNF) or alternate activation signals like IL–4 or IL–13.
However, very little is known about in vivo responses to stimuli, where cells experience
more than one signal at a time. This is challenging to study, because of the low num-
bers of cells that experience the signal. To simulate a more closely assembling in vivo
environment, we (Eichenfield, D. Z., Troutman, D. T., Link, V. M. et al. (2016)) stimu-
lated BMDMs with homogenized skin (tissue homogenate) to mimic a wound environment
(Chapter 2). Comparing the transcriptome of BMDMs stimulated with tissue homogenate
showed marked differences from BMDMs stimulated with single stimuli like polyinosinic–
polycytidylic acid (Poly I:C) for activation of TLR3, Kdo2–lipid A (KLA) for activation
of TLR4, Pam3CSK4 - a synthetic triacylated lipopeptide (Pam3) for activation of TLR1
and TLR2, or a co–activation with KLA and IFNγ to induce pro–inflammatory gene sig-
natures, as well as IL–4 or TGFβ to achieve alternately activated and de–activated gene
profiles. Cells from in vivo wounds were extracted and RNA–seq was performed. The
transcriptome profile of cells from the wound overlapped mostly with the transcriptome
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profile of BMDMs stimulated with tissue homogenate, showing that tissue homogenate is a
good way to mimic a wound environment and present a cell with several different stimuli at
the same time (DAMP, MAMP, as well as factors residing in the extracellular matrix like
TGFβ). To better understand the regulation of gene expression after tissue homogenate
exposure, we performed ChIP–seq for the LDTFs PU.1 and FOS, for the KLA–induced
factor P65, the TGFβ–induced factor SMAD3, and the histone activation mark H3K27ac
under vehicle and tissue homogenate treated conditions. We found that binding of the
factors was highly associated with tissue homogenate induced active enhancers. We over-
all observed a strong co–occurrence of P65 and SMAD3 at sites already bound by FOS
and PU.1. Additionally, these sites overlapped with binding of REV-ERB, a factor in-
volved in wound healing. Interestingly, we found enhancers that were bound by SMAD3
after TGFβ treatment, bound by P65 after KLA treatment and bound simultaneously by
both factors after tissue homogenate stimulation. Tissue homogenate treatment estab-
lished binding sites for P65 and SMAD3 that were not observed following treatment with
KLA or TGFβ, respectively, and also showed binding of REV–ERB. Therefore, the com-
plex tissue homogenate signal drove substantial co–localization of P65 with SMAD3 that
was not observed following selective treatment with single stimuli. We furthermore found
nuclear factor (erythroid–derived 2)–like (NRF)2 as the most enriched TF binding motif
at SMAD binding sites after tissue homogenate treatment. ChIP–seq experiments demon-
strated that tissue homogenate increased the genome–wide binding of NRF2 at thousands
of genomic locations, a substantial fraction of which were observed to overlap with the
tissue homogenate induced binding sites for P65, FOS, and SMAD3. We found an eight–
fold increase in co–localization of these four factors at enhancers after tissue homogenate
treatment suggesting that the combination of signals present in tissue homogenate induce
co–binding of multiple TFs to enhancers that mediate the tissue injury response. This
study provides first insights into how more complex stimuli regulate gene expression that
cannot be observed under single stimuli. This stressed the importance of studying epi-
genetic regulation in cells that experience more complex signals. With the advances in
technology it will become more and more feasible to study cells from in vivo environments
directly under healthy and diseased states.
In cancer, mutations often cause dysregulation of gene expression programs in cells, lead-
ing to changing signals in the cell’s environment. Therefore, tumors provide a good model
to study how several different stimuli together influence the epigenetic landscape in cells.
Roe et al. (2017) developed an in vitro model that closely mimics the in vivo environment
of healthy cells and metastatic cancer cells. Comparing these, the authors found several
thousand enhancers gained in the cancer cells that were also mostly present in human
metastatic cells. The authors were able to show that the expression of the TF FOXA1
was increased in tumor cells and further elevated in metastatic tumor cells. FOXA1 is a
pioneer TF that was bound to the newly gained enhancers in metastatic cells in collabora-
tive binding with the upregulated TFs GATA binding factor–5 (GATA5), BATF2, paired
mesoderm homeobox protein 2 (PRRX2), and PAX9. The authors conclude that their
findings suggest that a FOXA1–dependent enhancer reprogramming promotes progression
of the cancer and metastasis in vivo.
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Yang et al. (2015) also studied the influence of a unique tumor–environment in squamous
cell carcinoma (SCC) on the epigenetic landscape of stem cells in vivo. By analyzing super
enhancers (SEs) in healthy cells in comparison to tumor cells, the authors found many
different SEs. They found an enrichment of SOX binding sites in tumor–related SEs, as
well as AP–1 binding sites. Surprisingly, they also found E-twenty-six (ETS) consensus
sites as enriched in tumor–associated SEs, although ETS proteins have not been previously
implicated in SCC. However, they also showed new SEs at the ETS domain–containing
protein 3 (ELK3) and ETS2 genes and provided evidence that these factors drive hyper
proliferation and SCC progression, as well as that ELK3 and ETS2 expression correlates
with poor prognosis in human SCCs.
Our previous study demonstrated in vitro the importance to study the regulation of com-
plex stimuli. Therefore, using the tumor environment to understand regulation of the
epigenetic landscape is a logical step forward. Cancer is not only one of the most deadly
diseases in the world, but it also provides a unique insight into how complex signals affect
the enhancer landscape of cells.
Much works has been put into understanding how immune cells get activated and respond
to different signals in the surrounding environment. However, to maintain a healthy tissue
homeostasis, cells need to go back to their unstimulated state after the signal is resolved.
Macrophages are good models to study this, because they respond to different signals, like
inflammation or tissue injury, but they also return to baseline after the signal is resolved.
It has been shown that macrophages synthesize anti–inflammatory fatty acids in an LXR–
dependent manner after TLR4 stimulation (Oh et al. (2010), Spann et al. (2012), Li et al.
(2013a)), but whether the production of these species contributes to the resolution phase
of inflammatory responses has not been established. We (Oishi et al. (2017)) demonstrated
a reciprocal relationship between levels of anti–inflammatory fatty acids and the expres-
sion of pro–inflammatory genes after TLR4 activation. Anti–inflammatory fatty acids that
have the ability to suppress NF–kB are rapidly downregulated following stimulation of
BMDMs with KLA and activation of the TLR4 response. However, 12 – 24 hours after
stimulation, fatty acid levels rise again, initiating the resolution phase. The upregulation
of anti–inflammatory fatty acids was independent of LXR, but instead sterol regulatory
element–binding protein 1 (SREBP1)–driven. SREBP1 binding in the resolution phase
is correlated with increased enhancer activity at its binding sites. Furthermore, SREBP1
knockout mice lack the ability to induce the production of fatty acids. Therefore, we show
that SREBP1 and the production of anti–inflammatory fatty acids play crucial roles in the
resolution of the inflammatory response of macrophages.
This important mechanism was recently confirmed by Körner et al. (2018) who showed
a decrease of inflammation in sepsis after treating mice with omega–3 lipid emulsions.
They observed a significant reduction in pro–inflammatory macrophages and an increase
in alternately activated macrophages. Although the authors did not study the underlying
transcriptional mechanisms for their observation, it seems plausible that the omega–3 fatty
acids activate the same pathways as SREBP1. Furthermore, the authors observe an in-
creased level of IL–10 and TGFβ. These cytokines are known to induce anti–inflammatory
gene expression programs in macrophages.
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In summary, complex in vivo stimuli might activate TF binding programs that cannot be
observed in tissue cultures using single stimuli. We provided substantial evidence for this
by using a signal mimicking an in vivo wound environment and observe combinations of
TFs binding at enhancers that cannot be observed following single stimuli. Especially in
the context of tissue–environment, it is important to analyze the response of tissue–resident
cells to signals rather than removing them from their natural environment and stimulate
them with single stimuli in vitro. However, this does not mean that tissue–culture studies
with single stimuli are obsolete. In order to understand the precise molecular mechanisms
at play, these studies can provide unprecedented insight into the effect of TF binding on
the expression of genes. Only in vitro studies allow a controlled environment to under-
stand signal processing. Using this controlled environment we were able to show that the
resolution phase in macrophages after stimulation is partly regulated by SREBP1, in an
LXR–independent manner. This new finding helps to understand how macrophages reach
baseline gene expression again, after exposure to an acute inflammatory signal. To more
precisely understand regulation of cells during disease, however, studying the cells in their
natural environment during health and diseases states is absolutely essential.
The influence of natural genetic variation on the epi-
genetic landscape and gene expression in macrophages
It has been a long–standing goal in biomedical research to understand the interplay be-
tween gene expression and disease. After sequencing the human genome (International
Human Genome Sequencing Consortium (2001), Venter et al. (2001)), genome–wide asso-
ciation studies (GWAS) became possible, which allow the association of single–nucleotide
polymorphisms (SNPs) to human traits or disease phenotypes. Most GWAS focused on
common diseases like cancer (e.g. Broderick et al. (2007), Hunter et al. (2007), Eeles
et al. (2008), Shiraishi et al. (2016)), type II diabetes mellitus (Diabetes Genetics Initia-
tive et al. (2007), Scott et al. (2007), Hara et al. (2014)), neurodegenerative disease (Fung
et al. (2006), Simon-Sanchez et al. (2007), Reiman et al. (2007), Vojinovic et al. (2015)),
heart disease (Larson et al. (2007), Wellcome Trust Case Control Consortium (2007), Wang
et al. (2016)), or auto–immune diseases (Yamazaki et al. (2005), Rioux et al. (2007), Raj
et al. (2016), Sulem et al. (2011)). However, it is becoming clear that most SNPs associ-
ated with traits can be found in non–coding regions of the genome, rather than in coding
sequences. This makes an interpretation of the results often times very hard. This also
means that most consequential genetic variation is within regulatory regions of the genome
rather than in coding regions that translate into proteins. To understand how these SNPs
affect the host, a detailed knowledge of the affected cell type, as well as the epigenetic
landscape within this cell type is necessary. Therefore, the research focus has shifted to
understanding the direct influence of genetic variation on gene expression by epigenetically
profiling different tissues and activation states.
One early study in humans investigated the relationship between common genetic polymor-
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phisms and differences in gene expression in endothelia cells at baseline and after exposure
to an oxidized phospholipid species to induce early atherosclerotic lesions (Romanoski
et al. (2010)). The authors found significant interactions between genotype and response
to phospholipids for about one–third of the most highly regulated genes. Much of this
regulation is dependent on distal regulatory elements. This study therefore showed that
genetic variation in non–coding regions of the genome can affect gene expression and alter
the response to stimuli.
At about the same time another study (Kasowski et al. (2010)) investigated the influence
of genetic variation on TF binding and gene expression in ten human samples at baseline.
The authors showed that 7.5% of NF–kB binding sites and 25% of RNA polymerase II
(Pol II) binding sites differed significantly between at least two individuals and that these
binding sites were enriched for SNPs affecting the underlying binding motif. About 30%
of differences in NF–kB binding could by explained by SNPs, however that also means
70% of differences in binding remained elusive. The authors observed a correlation be-
tween differences in binding and gene expression, but binding differences greatly exceeded
transcriptome differences, hinting to a potential buffering system in the cells. TF binding
itself, however, is often not sufficient for biological output. A better measurement is chro-
matin accessibility which can be measured by DNase I hypersensitivity sites sequencing
(DNase–seq) and usually correlates well with nearby gene expression. Degner et al. (2012)
performed DNase–seq in 70 Yoruba lymphoblastoid cell lines and showed that common
genetic variants affect chromatin accessibility at thousands of hypersensitive regions across
the human genome. They found that causal variants often lie within or very near to hy-
persensitivity regions, often affecting the binding affinity of TFs. Therefore, measuring
chromatin accessibility rather than TF binding might be a better way to study the impact
of genetic variation on gene expression.
An even more direct readout of chromatin activity is measuring histone modifications. As
discussed in the General Introduction, activity of enhancers and promoters can be directly
measured by histone marks. In 2013, Science published three back–to–back articles that
investigated the effect of natural genetic variation on histone modifications (Kilpinen et al.
(2013), McVicker et al. (2013), Kasowski. et al. (2013)). Kilpinen et al. (2013) investigated
differences in histone modifications, TF binding and gene expression in two parent–offspring
trios, as well as eight unrelated individuals. They found that allele–specific activity across
all regulatory layers is largely transmitted from parents to children. Their studies also
suggest that TF binding, histone modifications, and transcription operate within the same
allelic framework. Changes in TF binding showed correlation with gene expression, whereas
changes in histone modifications did not, suggesting that changes in TF binding are often
causal to changes in gene expression. This finding was supported by McVicker et al. (2013)
who found that histone modifications are directed by sequence–specific TFs and that ho-
mozygous high–expression genotypes are more enriched in DNase I hypersensitivity and
active histone marks, as well as depleted in repressive histone marks than heterozygous
sites or homozygous low–expression genotypes. Therefore, their study suggests that single
genetic variants can affect multiple aspects of chromatin states including histone activity
marks, DNase I hypersensitivity and chromatin accessibility. Interestingly, Kasowski. et al.
216 Discussion
(2013) showed that despite the strong relationship between genetic variation and histone
activity, there is not always an effect on gene expression. They suggest that variability in
several enhancers is necessary to affect gene expression. They also found many genes that
were equally expressed, but had one differentially activated enhancer, further supporting
their hypothesis that several enhancers together regulate gene expression.
The observation that regions of differentially bound TFs have more impact on gene ex-
pression than differences in histone modifications, as well as the fact that only about 30%
of the binding differences can be explained by direct mutations of the TF binding mo-
tif, raised the question how the majority of differently bound TFs are regulated. Heinz
et al. (2013) tried to answer this question by studying binding of LDTFs and SDTFs in
macrophages from two commonly used inbred mouse strains. They observed that only a
fraction of TF binding could be explained by mutations in the respective consensus motif,
however mutations in nearby TF motifs of collaborative factors increased the percentage
of explained binding differences to about 60%. This was especially notable for the SDTF
NF–kB, where only about 10% of differential binding could be explained by differences
in the NF–kB motif, which increased to 35% when considering the binding motifs of the
LDTFs PU.1 and C/EBP. Interestingly, the authors also showed that mutations in less
conserved nucleotides in the consensus binding motif have less impact on TF binding than
mutations in highly conserved residues. Furthermore, they showed that by swapping the
enhancer sequence from one strain into the other, they also swapped the binding profile at
this locus.
Although this study improved the number of loci that could be explained, a lot of differ-
ential binding remained unexplained. This led me to think that by only looking at three
TFs a big part of the collaborative factors and motifs were missed, accounting for the
gap in explaining the binding profiles. To address this question we developed Mutation
Analysis for Regulatory Genomic Elements (MARGE) (Link et al. (2018b)), a software
pipeline that allows the analysis of TF binding in several individuals at the same time by
leveraging a linear mixed effects model. To avoid biases due to mapping errors caused by
natural genetic variation, MARGE allows mapping of the data to custom made genomes,
as well as shifting the data to the respective reference coordinates for downstream analysis.
The software can analyze every kind of TF binding, open chromatin or enhancer activity
data. To investigate the effect of natural genetic variation, each locus is annotated with
all possible motifs. The binding of each factor is then modeled as the fixed effect motif
existence/score with random effects locus and genotype for each motif. Motifs that impact
binding of the factor will therefore show a significant association between the motif exis-
tence and the binding of a factor.
To investigate the scope of TFs that are involved in collaborative binding in macrophages,
we took advantage of the big number of natural genetic variation between commonly used
laboratory mouse strains and wild–derived mice (Link et al. (2018a)). We observed sub-
stantial strain–specific differences in gene expression in which increased genetic differences
between mouse strains led to a substantial but non–linear increase in divergent gene ex-
pression. This was observed on the level of mRNA, as well as on the level of nascent
transcription. The majority of the effects of genetic variation on nascent transcription
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map to distal cis–regulatory elements, which was shown by using filial 1 hybrid (F1) mice.
By applying MARGE to the TF binding data sets of four TFs in five different strains of
mice, we found evidence for roles of about 100 TFs, increasing the percentage of explained
differential binding sites to 70%. By only considering the 500 most differently bound loci,
this fraction increased further to up to 90%. However, a substantial fraction of the strain–
specific binding of these factors cannot be explained by local mutations. Investigation of
the basis for this discrepancy led to the identification of highly interconnected clusters of
TFs that reside within topologically associating domains (TADs). These connected reg-
ulatory domains (CRDs) are highly associated with strain–specific TF binding, enhancer
activity, as well as nearest gene expression. They additionally show significant enrichment
in three–dimensional interactions, further supporting the notion that CRDs present a new
and important layer of transcriptional regulation.
Recently, two studies made similar observations. Waszak et al. (2015) profiled histone mod-
ifications, binding of PU.1 and Pol II, as well as gene expression in lymphoblastoid cell lines
from 47 whole–genome sequenced individuals and observed coordinated chromatin varia-
tion across individuals, which they named variable chromatin modules (VCMs). VCMs
were enriched for TF bound regions and in the majority of cases causal for observed changes
in gene expression. Cheng et al. (2017) performed ATAC–seq, as well as gene expression
profiling of T–cells from 105 healthy donors at basal state and after in vitro stimulation.
They observed co–accessible ATAC–seq peaks across loci at kilobase and megabase scales,
consistent with three dimensional chromosome organization patterns. They furthermore
found enrichment for significant associations between gene expression and co–accessibility
of ATAC–seq peaks.
Cheng et al. (2017) found enrichment of co–accessible ATAC–seq peaks in super enhancers
(SEs), whereas we found CRDs to be distinct from SEs. This led to the conclusion that
CRDs and co–accessible ATAC–seq peaks are different biological phenomena. However,
the concept of chromatin accessibility that is concordantly regulated over several loci, as
well as within TADs seems to be a powerful biological regulatory mechanism to control
gene expression.
It is important to keep in mind that the effect of genetic variation on gene expression is
dependent on the cell type (Ackermann et al. (2013)). SNPs that are completely silent in
one specific cell type and do neither affect chromatin states nor gene expression can have
dramatic effects in another cell type. Furthermore, many SNPs are silent in basal state
and are associated with different responses to stimuli. Lee et al. (2014) showed that of
264 loci with genetic variants associated with changes in gene expression in human den-
dritic cells, 121 of them were only observed after one or more stimuli without any effect
at basal state. This study underscored the need to study genetic variation in different cell
types and under different stimuli in order to capture the whole impact of these variants on
gene expression. More efforts have been put into studying the relationship between genet-
ics and environment, in developing new computational methods (Knowles et al. (2017)),
as well as in discovering the impact of natural genetic variation on gene expression be-
tween different tissues and stimuli (Li et al. (2017), Chen et al. (2016)). However, many
questions remain unanswered and more effort is needed in order to understand the exact
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mechanisms that regulate gene expression. Our work provided evidence that about 100
TFs confidently expressed in macrophages are involved in establishing the epigenetic land-
scape. This work should be expanded to other cell types to decipher the regulation of
enhancers on a organism–wide scale. Furthermore, we provided evidence for an additional
layer of transcriptional regulation by discovering connected regulatory domains (CRDs).
This phenomenon has been undescribed so far and the underlying regulatory mechanisms
remain unclear. Uncovering these mechanisms will provide the next step in understanding
how enhancers regulate gene expression.
Conclusion and further directions
This thesis studied the regulation of the epigenetic landscape and subsequentially gene
expression in different macrophages from different tissues and after exposure to different
stimuli. Furthermore, we investigated the effect of natural genetic variation on mRNA
expression, nascent transcription, TF binding, as well as histone modifications. We and
others showed the influence of the tissue environment on the epigenetic landscape of the
cell. With these studies we showed that the impact of the environmental factors plays a
crucial role for cell identity and tissue culture systems are not sufficient to model these
complex interactions. Furthermore, a cell experiences different signals at the same time,
so studying regulation of gene expression in vitro using a single stimuli allows to study
basic mechanisms, but does not even closely cover the processes observed in vivo. We
showed that studying natural genetic variation is a powerful tool to learn more about
regulation of TF binding and the epigenetic landscape. By studying it we further discovered
a new layer of transcriptional regulation. In order to gain additional insight into the
selection of enhancers, we developed Mutation Analysis for Regulatory Genomic Elements
(MARGE), a new software that analyzes the effect of natural genetic variation on TF
binding. With this software, we found evidence for the involvement of 100 confidently
expressed TFs in macrophages in the selection of enhancers. However, this study was
performed in vitro in order to minimize differences in gene expression and the epigenetic
landscape due to different in vivo signals. This strategy proved to be useful in uncovering
the scope of TFs involved in collaborative binding, as well as the impact of genetic variation
on gene expression. However, this study allows only limited conclusion for the detailed
mechanisms observed in vivo. To really uncover the regulation of gene expression, these
strategies need to be combined. The next steps in advancing our current knowledge is
to study different populations of in vivo cells from different individuals at baseline and
after exposure to several different stimuli. Efforts are ongoing in the Glass laboratory and
many other laboratories to set up systems and study the gene environment interaction in
more detail. Cancer systems might provide a powerful resource, as the tumor environment
differs substantially from healthy tissue. With the decreasing demand for cells to run NGS
assays, as well as the better collaboration between surgeons and researchers, these studies
become more and more feasible. Recently, several groups, including us, have described
new layers of transcriptional regulation by showing correlated regions of open chromatin
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or TF binding. The underlying mechanisms for this phenomenon are completely unknown
yet. Several possible explanations are plausible. For example, it is possible that one SNP
causes the disruption of Pol II, which then in turn cannot remodel the chromatin anymore
and the binding sites remain inaccessible for the TFs. Another possible explanation is that
rearrangement of chromatin due to long non–coding RNAs can remodel the nucleosomes
and therefore make the binding site accessible. More research will be necessary in the
future to understand these large–scale differences that seem to have the biggest impact on
gene expression.
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Glossary
Ahr aryl hydrocarbon receptor.
AP–1 activator protein 1.
ATAC–seq assay for transposase–accessible chromatin us-
ing sequencing.
Batf Basic leucine zipper transcriptional factor
ATF–like.
BMDM bone marrow–derived macrophage.
C/EBP CCAAT-enhancer-binding protein.
CAGE cap analysis of gene expression.
cDNA complementary DNA.
ChIP–chip chromatin immunoprecipitation coupled with
microarrays.
ChIP–seq chromatin immunoprecipitation coupled to
massively parallel sequencing.
CRD connected regulatory domain.
Csf1r colony stimulating factor 1 receptor.
Cx3cr1 CX3C chemokine receptor 1.
DAMP damage–associated molecular patterns.
DNA deoxyribonucleic acid.
DNase I deoxyribonuclease I.
DNase–seq DNase I hypersensitivity sites sequencing.
EBF1 early B–cell factor 1.
ELK3 ETS domain–containing protein 3.
EMP erythromyeloid progenitor.
eRNA enhancer RNA.
EST expressed sequence tag.
ETS E-twenty-six.
F1 filial 1 hybrid.
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FACS fluorescence activated cell sorting.
FAIRE formaldehyde–assisted isolation of regulatory
elements.
FOXA1 forkhead box protein A1.
GATA5 GATA binding factor–5.
GRO–seq global run-on sequencing.
GWAS genome–wide association studies.
H3K27ac acetylation of histone H3 lysine 27.
H3K27me3 trimethylation of histone H3 on lysine 27.
H3K4me1 monomethylation of histone H3 lysine 4.
H3K4me2 dimethylation of histone H3 lysine 4.
H3K4me3 trimethylation of histone H3 lysine 4.
HDAC3 histone deacetylase 3.
HFS hair follicle stem cell.
HOMER Hypergeometric Optimization of Motif En-
Richment.
Id DNA-binding protein inhibitor.
IFNγ interferon gamma.
IL interleukin.
IRF interferon regulatory factor.
KLA Kdo2–lipid A.
KLF Krüppel-like Factor.
LDTF lineage–determining transcription factor.
LPS lipopolysaccharide.
LXR liver X receptor.
MACS2 Model–based Analysis of ChIP–Seq 2.
MAMP microbe–associated molecular patterns.
MAOa monoamine oxidase A.
MARGE Mutation Analysis for Regulatory Genomic
Elements.
MEF2 myocyte enhancer factor-2.
Mmp9 matrix metallopeptidase 9.
MPSS massively parallel signature sequencing.
mRNA messenger RNA.
NCoR nuclear receptor co-repressor 1.
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NF–kB nuclear factor kappa-light-chain-enhancer of
activated B cells.
NGS next–generation sequencing.
Nr1h3 nuclear receptor subfamily 1, group H, mem-
ber 3.
NRF nuclear factor (erythroid–derived 2)–like.
OCT octamer transcription factor.
Pam3 Pam3CSK4 - a synthetic triacylated lipopep-
tide.
PAX paired box protein.
Pol II RNA polymerase II.
Poly I:C polyinosinic–polycytidylic acid.
PPARγ peroxisome proliferator-activated receptor
gamma.
PRRX2 paired mesoderm homeobox protein 2.
qPCR quantitative polymerase chain reaction.
RNA ribonucleic acid.
RNA–seq RNA sequencing.
RNase H ribonuclease H.
rRNA ribosomal RNA.
SAGE serial analysis of gene expression.
Sall spalt like transcription factor.
SAM sympathetic neuron-associated macrophage.
SCC squamous cell carcinoma.
SDTF signal–dependent transcription factor.
SE super enhancer.
Slc6a2 solute carrier family 6 member 2.
SMAD mothers against decapentaplegic homolog.
SNP single–nucleotide polymorphism.
Sono–seq sonication of cross–linked chromatin sequenc-
ing.
SOX sex determining region Y–box.
SREBP1 sterol regulatory element–binding protein 1.
STAT signal transducer and activator of transcrip-
tion.
TAC transitamplifying cell.
TAD topologically associating domain.
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TF transcription factor.
TGEM thioglycollate–elicited peritoneal macrophage.
TGFβ transforming growth factor beta.
Timd4 T–cell immunoglobulin and mucin domain
containing 4.
TLR toll–like receptor.
TNF tumor necrosis factor.
TT—seq transient transcriptome sequencing.
VCM variable chromatin module.
